[
{"Name" : "ORZID2 GMENU ABSCESSES", "Term1" : "Abscess, skin and soft tissue", "DisplayText" : "Abscesses:  Cutaneous abscess, Furuncle, Carbuncle, Pyomyositis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU CUTANEOUS ABSCESS", "DisplayText" : "Cutaneous abscess", "Text" : "Cutaneous abscess", "Mnemonic" : "4"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX PERIANAL/ANORECTAL ABSCESS", "DisplayText" : "Perianal/Anorectal Abscess", "Text" : "Perianal/Anorectal Abscess", "Mnemonic" : "6"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU FURUNCLES AND CARBUNCLES", "DisplayText" : "Furuncles and carbuncles", "Text" : "Furuncles and carbuncles", "Mnemonic" : "8"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU PYOMYOSITIS", "DisplayText" : "Pyomyositis", "Text" : "Pyomyositis", "Mnemonic" : "10"},
{"Row" : 3, "Column" : 1, "Text" : "ABSCESSES: CUTANEOUS ABSCESS, FURUNCLE, CARBUNCLE, AND PYOMYOSITIS"}, 
{"Row" : 5, "Column" : 1, "Text" : "This section describes management of skin and soft tissue infections.  For"}, 
{"Row" : 6, "Column" : 1, "Text" : "information on abscesses in other areas, please return to the main CDSS menu and"}, 
{"Row" : 7, "Column" : 1, "Text" : "choose the appropriate organ system."}, 
{"Row" : 18, "Column" : 1, "Text" : "References:"}, 
{"Row" : 19, "Column" : 1, "Text" : "Sanford keyword:  Skin infections"}
]},
{"Name" : "ORZID2 GMENU ABX 2014-2015 FLU RECOMENDATIONS", "DisplayText" : "Influenza Vaccine Recommendations ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 8, "Column" : 1, "Text" : "Influenza TRIVALENT Vaccination Recommendations:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Routine influenza vaccination is recommended for all persons aged 6 months"}, 
{"Row" : 10, "Column" : 1, "Text" : "and older. It prevents against novel H1N1, H3N2, and influenza B."}, 
{"Row" : 12, "Column" : 1, "Text" : "Standard Dose Influenza Vaccine", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Item" : "PSJZID 2014-2015 STANDARD INFLUENZA VACCINE", "DisplayText" : "Influenza Vaccine", "Mnemonic" : "10"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Disease", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU ABX 2014-2015 INFLUENZA", "DisplayText" : "INFLUENZA 2014-2015 SEASON  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "08"},
{"Row" : 8, "Column" : 1, "Text" : "SEASONAL INFLUENZA 2014-2015"}, 
{"Row" : 5, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "06"},
{"Row" : 10, "Column" : 1, "Text" : "Information contained on these pages will be updated regularly as"}, 
{"Row" : 11, "Column" : 1, "Text" : "new information becomes available during the influenza season."}, 
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX 2014-2015 FLU RECOMENDATIONS", "DisplayText" : "Influenza Vaccine Recommendations", "Mnemonic" : "10"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX 2014-2015 TREATMENT", "DisplayText" : "Early treatment as alternative to chemoprophylaxis", "Text" : "Early treatment OR Chemoprophylaxis Recommendations", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Item" : "ZZORZID2 GMENU ABX 2014-2015 ANTIVIRAL TX", "DisplayText" : "Antiviral Treatment Recommendations", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Text" : "SECTION LAST REVIEWED Sept 2014", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX 2014-2015 TREATMENT", "DisplayText" : "Early treatment as alternative to chemoprophylaxis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 8, "Column" : 1, "Text" : "Early treatment as alternative to chemoprophylaxis:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "In most cases, if a person is suspected of having been exposed to"}, 
{"Row" : 10, "Column" : 1, "Text" : "influenza, early treatment should signs or symptoms develop is preferred"}, 
{"Row" : 11, "Column" : 1, "Text" : "rather than chemoprophylaxis."}, 
{"Row" : 13, "Column" : 1, "Text" : "The provider should explain the early signs and symptoms of influenza"}, 
{"Row" : 14, "Column" : 1, "Text" : "to the patient and advise the patient to immediately contact a health"}, 
{"Row" : 15, "Column" : 1, "Text" : "care provider for evaluation and possible early treatment if these"}, 
{"Row" : 16, "Column" : 1, "Text" : "symptoms or signs develop. Influenza-like symptoms or signs include"}, 
{"Row" : 17, "Column" : 1, "Text" : "fever, cough, sore throat, runny or stuffy nose, body aches, headache,"}, 
{"Row" : 18, "Column" : 1, "Text" : "chills, fatigue, vomiting, and diarrhea. Influenza can present without"}, 
{"Row" : 19, "Column" : 1, "Text" : "fever."}, 
{"Row" : 21, "Column" : 1, "Text" : "Health care providers should use clinical judgement regarding situations"}, 
{"Row" : 22, "Column" : 1, "Text" : "where early recognition of illness and treatment might be an appropriate"}, 
{"Row" : 23, "Column" : 1, "Text" : "alternative to chemoprophylaxis."}, 
{"Row" : 25, "Column" : 1, "Text" : "Early treatment alternative or chemoprophylaxis may be considered for:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "*Persons who are part of a high-risk group and are household or close"}, 
{"Row" : 27, "Column" : 1, "Text" : "contacts of someone with influenza-like illness"}, 
{"Row" : 28, "Column" : 1, "Text" : "*Health care personnel who have occupational exposures"}, 
{"Row" : 30, "Column" : 1, "Text" : "Chemoprophylaxis can be considered for:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "*Resident of a long term care facility that had close contact with"}, 
{"Row" : 32, "Column" : 1, "Text" : "another resident or staff with influenza-like illness."}, 
{"Row" : 33, "Column" : 1, "Text" : "*Atypical situations (such as case clusters). Contact Minnesota"}, 
{"Row" : 34, "Column" : 1, "Text" : "Department of Health for consultation. Telephone number:"}, 
{"Row" : 35, "Column" : 1, "Text" : "651-201-5414 or 1-877-676-5414."}, 
{"Row" : 37, "Column" : 1, "Text" : "Antiviral Chemoprophylaxis Dosing:", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Duration of antiviral treatment is 10 days. Among long-term care"}, 
{"Row" : 39, "Column" : 1, "Text" : "residents, the antiviral use should be re-evaluated after 10 days."}, 
{"Row" : 40, "Column" : 1, "Text" : "If no further exposures have occurred, antivirals should be discontinued."}, 
{"Row" : 43, "Column" : 1, "Text" : "Recommended:", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "References:", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Centers for Disease Control (CDC)"}, 
{"Row" : 48, "Column" : 1, "Text" : "(http://www.cdc.gov/flu/about/season/index.htm)"}, 
{"Row" : 44, "Column" : 1, "Item" : "ZZPSJZID OSELTAMIVIR 75 MG PO Q24H", "DisplayText" : "Oseltamivir 75 mg po q24h", "Text" : "Oseltamivir 75 mg po q daily for 10 days ($7/day) [R]", "Mnemonic" : "12"},
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H] hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Disease", "Mnemonic" : "08"},
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]=minimal risk)"}
]},
{"Name" : "ORZID2 GMENU ABX 72HRS RE-EVALUATE N. PNEUMO", "DisplayText" : "Re-evaluate Nosocomial pneumonia at 72 hours  ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, drug properties, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "4"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "6"},
{"Row" : 64, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "8"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "RE-EVALUATE NOSOCOMIAL PNEUMONIA AT 72 HOURS"}, 
{"Row" : 9, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Step 1. Evaluate the patient", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Assess for favorable clinical response indicated by improvement in one or more"}, 
{"Row" : 14, "Column" : 1, "Text" : "of the following: fever, mental status, appetite, ability to eat, oxygenation"}, 
{"Row" : 15, "Column" : 1, "Text" : "blood pressure, pulse, leukopenia. If the patient has improved, continue to"}, 
{"Row" : 16, "Column" : 1, "Text" : "step 2."}, 
{"Row" : 18, "Column" : 1, "Text" : "If the patient has not improved, consider the following"}, 
{"Row" : 19, "Column" : 1, "Text" : "1. The patient has pneumonia with a pathogen resistant to empirical"}, 
{"Row" : 20, "Column" : 1, "Text" : "antimicrobials (e.g., resistant bacteria, fungi, mycobacteria)"}, 
{"Row" : 21, "Column" : 1, "Text" : "2. The patient does not have bacterial pneumonia. Consider alternative"}, 
{"Row" : 22, "Column" : 1, "Text" : "diagnoses including pulmonary edema, atelectasis, pulmonary embolus, ARDS,"}, 
{"Row" : 23, "Column" : 1, "Text" : "pulmonary hemorrhage, underlying disease, and neoplasm."}, 
{"Row" : 24, "Column" : 1, "Text" : "3. The patient has infectious disease outside the lungs."}, 
{"Row" : 25, "Column" : 1, "Text" : "4. The patient has one or more complications of pneumonia (e.g., empyema, lung"}, 
{"Row" : 26, "Column" : 1, "Text" : "abscess, mediastinitis, or pericarditis)"}, 
{"Row" : 27, "Column" : 1, "Text" : "5. The patient has an adverse drug event"}, 
{"Row" : 29, "Column" : 1, "Text" : "Infectious Disease or Pulmonary consult is strongly encouraged for patients w"}, 
{"Row" : 30, "Column" : 1, "Text" : "do not respond to initial therapy. If bacterial pneumonia is still considered"}, 
{"Row" : 31, "Column" : 1, "Text" : "likely, continue to step 2."}, 
{"Row" : 32, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Step 2. Evaluate microbiology results", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "____________________________________________________", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Decide whether a likely pathogen has been identified from respiratory secretions"}, 
{"Row" : 37, "Column" : 1, "Text" : "or blood. The clinician must decide whether any organisms identified on smear"}, 
{"Row" : 38, "Column" : 1, "Text" : "or culture of respiratory tract secretions reflect disease, colonization, or"}, 
{"Row" : 39, "Column" : 1, "Text" : "contamination based on clinical and microbiological information."}, 
{"Row" : 41, "Column" : 1, "Text" : "The quality of a respiratory secretion sample must be evaluated. Sputum sample"}, 
{"Row" : 42, "Column" : 1, "Text" : "with fewer than 25 polymorphonuclear leukocytes per high power field (hpf) are"}, 
{"Row" : 43, "Column" : 1, "Text" : "unlikely to be from a site of bacterial infection unless the patient is"}, 
{"Row" : 44, "Column" : 1, "Text" : "profoundly neutropenic. Sputum samples with more than 10 epithelial cells/hp"}, 
{"Row" : 45, "Column" : 1, "Text" : "are likely to be contaminated with upper respiratory tract secretions."}, 
{"Row" : 47, "Column" : 1, "Text" : "In cases of bacterial pneumonia, a gram stain of a high quality respiratory"}, 
{"Row" : 48, "Column" : 1, "Text" : "tract secretion usually contains 3| or 4| of bacteria with morphology and"}, 
{"Row" : 49, "Column" : 1, "Text" : "staining characteristics consistent with the pathogen. Culture of the"}, 
{"Row" : 50, "Column" : 1, "Text" : "respiratory tract secretion indicates the species and susceptibilities of the"}, 
{"Row" : 51, "Column" : 1, "Text" : "bacteria seen on gram stain."}, 
{"Row" : 52, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "Step 3. Adjust or discontinue antimicrobial therapy", "Header" : 1}, 
{"Row" : 54, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "Decide whether to continue, modify, or discontinue antimicrobials. If an"}, 
{"Row" : 57, "Column" : 1, "Text" : "organism likely to be a respiratory pathogen is isolated from a patient thought"}, 
{"Row" : 58, "Column" : 1, "Text" : "to have bacterial pneumonia, adjust therapy if necessary to treat this pathogen"}, 
{"Row" : 59, "Column" : 1, "Text" : "If the patient does not have convincing evidence for bacterial pneumonia and/"}, 
{"Row" : 60, "Column" : 1, "Text" : "a likely pathogen has not been isolated from respiratory secretions then stop"}, 
{"Row" : 61, "Column" : 1, "Text" : "antimicrobials for pneumonia."}, 
{"Row" : 66, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 67, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 68, "Column" : 1, "Text" : "Kalil AC et al. Clin Infect Dis 2016. 63:1"}, 
{"Row" : 69, "Column" : 1, "Text" : "Luna CM Crit Care Med 2003, 31: 676"}, 
{"Row" : 70, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 71, "Column" : 1, "Text" : "Up-to-date website"}
]},
{"Name" : "ORZID2 GMENU ABX ABOUT THE CDSS", "DisplayText" : "About the CDSS  ", "Version" : "StCloud", "Contents" : [
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX ABX RESTRICTION POLICY", "DisplayText" : "Antimicrobial restriction policy", "Text" : "More information on antimicrobial restriction policy", "Mnemonic" : "2"},
{"Row" : 49, "Column" : 1, "Item" : "ORZID2 GMENU ABX HOW TO USE CDSS", "DisplayText" : "How to use the CDSS", "Text" : "How to use the CDSS", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "ABOUT THE ANTIMICROBIAL COMPUTERIZED DECISION SUPPORT SYSTEM (CDSS)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "The Antimicrobial CDSS is a tool within the Computerized Patient Record System"}, 
{"Row" : 6, "Column" : 1, "Text" : "that offers antimicrobial prescribing advice to clinicians at the point of order"}, 
{"Row" : 7, "Column" : 1, "Text" : "entry. The system is structured as an order menu decision tree that contains"}, 
{"Row" : 8, "Column" : 1, "Text" : "quick orders pre-programmed with appropriate antimicrobial regimens for specific"}, 
{"Row" : 9, "Column" : 1, "Text" : "infectious diseases."}, 
{"Row" : 11, "Column" : 1, "Text" : "Goals", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Improve patient outcomes, reduce rates of microbial resistance, prevent adverse"}, 
{"Row" : 13, "Column" : 1, "Text" : "patient outcomes, optimize costs and improve providers' lives. In addition to"}, 
{"Row" : 14, "Column" : 1, "Text" : "these goals, the program fulfills antimicrobial stewardship quality standards"}, 
{"Row" : 15, "Column" : 1, "Text" : "implemented by the Joint Commission."}, 
{"Row" : 17, "Column" : 1, "Text" : "Rationale", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "*Improved patient outcomes"}, 
{"Row" : 19, "Column" : 1, "Text" : "In a 2013 study, Minneapolis Veterans Affairs Medical Center (MVAMC)"}, 
{"Row" : 20, "Column" : 1, "Text" : "antimicrobial courses ordered through the Antimicrobial CDSS were significantly"}, 
{"Row" : 21, "Column" : 1, "Text" : "more likely to be appropriate from start to completion, (44%) compared to non-"}, 
{"Row" : 22, "Column" : 1, "Text" : "CDSS courses (33%, P = 0.013). This is consistent with other studies that have"}, 
{"Row" : 23, "Column" : 1, "Text" : "shown significant improvement in appropriate use of antimicrobials when CDSS"}, 
{"Row" : 24, "Column" : 1, "Text" : "programs are utilized."}, 
{"Row" : 26, "Column" : 1, "Text" : "*Restricted formulary"}, 
{"Row" : 27, "Column" : 1, "Text" : "The Minneapolis VAHCS has a restricted antimicrobial formulary. A restricted"}, 
{"Row" : 28, "Column" : 1, "Text" : "formulary reduces cost of health care and is an integral part of antimicrobial"}, 
{"Row" : 29, "Column" : 1, "Text" : "stewardship. The Antimicrobial CDSS provides a method of formulary restriction"}, 
{"Row" : 30, "Column" : 1, "Text" : "that doesn't require a call back from pharmacy or a prior authorization for the"}, 
{"Row" : 31, "Column" : 1, "Text" : "antimicrobial to be approved."}, 
{"Row" : 34, "Column" : 1, "Text" : "*Increased efficiency"}, 
{"Row" : 35, "Column" : 1, "Text" : "Along with being able to order restricted antimicrobials without a prior"}, 
{"Row" : 36, "Column" : 1, "Text" : "authorization or call back from pharmacy, the Antimicrobial CDSS provides quick"}, 
{"Row" : 37, "Column" : 1, "Text" : "orders pre-programmed with appropriate antimicrobial regimens for specific"}, 
{"Row" : 38, "Column" : 1, "Text" : "infectious diseases. Using the system saves time and increases the efficiency of"}, 
{"Row" : 39, "Column" : 1, "Text" : "the ordering provider."}, 
{"Row" : 41, "Column" : 1, "Text" : "Features", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "The CDSS has been developed locally with input from a broad, representative"}, 
{"Row" : 43, "Column" : 1, "Text" : "group of clinicians. Recommendations have been based on local susceptibility"}, 
{"Row" : 44, "Column" : 1, "Text" : "patterns, clinical evidence, local preferences, and national guidelines. The"}, 
{"Row" : 45, "Column" : 1, "Text" : "CDSS provides a way for clinicians to select alternative drugs when the"}, 
{"Row" : 46, "Column" : 1, "Text" : "recommended drugs are contraindicated."}, 
{"Row" : 48, "Column" : 1, "Text" : "Detailed instructions can be found in the link below."}, 
{"Row" : 52, "Column" : 1, "Text" : "References"}, 
{"Row" : 54, "Column" : 1, "Text" : "Dellit et al. Clinical Infectious Diseases 2007, 44:159-7"}, 
{"Row" : 55, "Column" : 1, "Text" : "Filice et al. Infection Control and Hospital Epidemiology. 2013, 34.6"}, 
{"Row" : 56, "Column" : 1, "Text" : "Rawson et al. Clinical Microbiology and Infection. 2017, 1e9"}
]},
{"Name" : "ORZID2 GMENU ABX ABX RESTRICTION POLICY", "Term1" : "Restrictions on antimicrobials", "DisplayText" : "Antimicrobial restriction policy  ", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "ANTIMICROBIAL RESTRICTION POLICY"}, 
{"Row" : 5, "Column" : 1, "Text" : "Medication orders placed using the CDSS system will NOT require Infectious"}, 
{"Row" : 6, "Column" : 1, "Text" : "Disease approval.  Because prescribing advice within the system has been"}, 
{"Row" : 7, "Column" : 1, "Text" : "developed with input from a broad, representative group of clinicians and the"}, 
{"Row" : 8, "Column" : 1, "Text" : "recommendations that have emerged are  based on site-specific susceptibility"}, 
{"Row" : 9, "Column" : 1, "Text" : "patterns, clinical evidence, local preferences, and national guidelines,"}, 
{"Row" : 10, "Column" : 1, "Text" : "INFECTIOUS DISEASE APPROVAL FOR RESTRICTED ANTIMICROBIALS WILL NOT BE NEEDED at"}, 
{"Row" : 11, "Column" : 1, "Text" : "participating VA sites.  Clinicians are still encouraged to seek advice from"}, 
{"Row" : 12, "Column" : 1, "Text" : "Infectious Diseases whenever it would be helpful."}, 
{"Row" : 14, "Column" : 1, "Text" : "Restricted antimicrobials ordered outside the CDSS system will continue to need"}, 
{"Row" : 15, "Column" : 1, "Text" : "ID approval."}
]},
{"Name" : "ORZID2 GMENU ABX ACKNOWLEDGEMENTS", "DisplayText" : "Acknowledgements", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "ACKNOWLEDGEMENT", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "This project was funded as a VISN 23 Strategic Planning Project for FY2005-2007."}, 
{"Row" : 6, "Column" : 1, "Text" : "It addresses the VISN's efforts to build a culture of continuous quality"}, 
{"Row" : 7, "Column" : 1, "Text" : "improvement, evidence-based practice and optimal resource utilization."}, 
{"Row" : 9, "Column" : 1, "Text" : "This project has been guided by our project collaborators as well as the efforts"}, 
{"Row" : 10, "Column" : 1, "Text" : "of the guideline review committee members. We would like to thank these"}, 
{"Row" : 11, "Column" : 1, "Text" : "individuals for their time and thoughtful input."}
]},
{"Name" : "ORZID2 GMENU ABX ACUTE BACT PROSTATITIS", "Term1" : "Prostatitis, acute", "DisplayText" : "Acute Bacterial Prostatitis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 24, "Column" : 1, "Item" : "ORZ ADD MENU LABS (LAB COLLECT)", "DisplayText" : "1-H LABS", "Text" : "Lab menu", "Mnemonic" : "4"},
{"Row" : 39, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 500MG IM ONCE DOXY 100MG PO Q12H", "DisplayText" : "Ceftriaxone 500mg IM Once ($) [M] <AND> Doxycycline 100mg PO ($) [DI]", "Text" : "Ceftriaxone 500 mg IM once ($) [M] <AND> doxycycline 100 mg PO q12h ($) [DI] for", "Mnemonic" : "6"},
{"Row" : 43, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 1GM IM ONCE DOXY PO 100MG Q12H", "DisplayText" : "Ceftriaxone 1gm IM Once < AND > Doxycycline 100 mg po q12h", "Text" : "Ceftriaxone 1 gm IM once ($) [M] <AND> doxycycline 100 mg PO q12h ($) [DI] for", "Mnemonic" : "8"},
{"Row" : 48, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750 mg PO q24h ($0.30/day) [R,DI]", "Text" : "Levofloxacin 750 mg PO q24h ($) [R, DI] for 14 days", "Mnemonic" : "10"},
{"Row" : 50, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 750MG IV Q24H", "DisplayText" : "Levofloxacin 750 mg IV q24h ($5/day) [R,DI]", "Text" : "Levofloxacin 750 mg IV q24h ($) for 14 days", "Mnemonic" : "12"},
{"Row" : 53, "Column" : 1, "Item" : "PSJZID TRIMETH/SULFA 1 DS TAB BID", "DisplayText" : "Trimethoprim-sulfamethoxazole 1 DS PO BID (Cost $)for 10 days [R,DI]", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet q12h ($) [R,DI] for 14 days", "Mnemonic" : "14"},
{"Row" : 3, "Column" : 1, "Text" : "ACUTE BACTERIAL PROSTATITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Acute bacterial prostatitis typically presents with fever, dysuria, chills,"}, 
{"Row" : 6, "Column" : 1, "Text" : "malaise, myalgia, pelvic or perianal pain. On exam, the prostate gland is tense,"}, 
{"Row" : 7, "Column" : 1, "Text" : "boggy, and extremely tender. The urinalysis reveals pyuria, and the urine"}, 
{"Row" : 8, "Column" : 1, "Text" : "culture is positive. Men with dysuria and fever but without pyuria and/or"}, 
{"Row" : 9, "Column" : 1, "Text" : "bacteriuria should be seen by a urologist. If there is any suspicion of abscess,"}, 
{"Row" : 10, "Column" : 1, "Text" : "especially in men older than 40 years, the patient should be seen by a urologist"}, 
{"Row" : 11, "Column" : 1, "Text" : "and transurethral prostate resection for drainage should be considered."}, 
{"Row" : 13, "Column" : 1, "Text" : "Most cases in men aged 35 and older, those with recent urinary tract"}, 
{"Row" : 14, "Column" : 1, "Text" : "instrumentation or surgery (e.g., prostate biopsy, vasectomy) are associated"}, 
{"Row" : 15, "Column" : 1, "Text" : "with enteric Gram-negative rods. Most cases in men under age 35 and those who"}, 
{"Row" : 16, "Column" : 1, "Text" : "are at high risk of sexually transmitted infections are associated with N."}, 
{"Row" : 17, "Column" : 1, "Text" : "gonorrhoeae and C. trachomatis. Resistant organisms are more likely if the"}, 
{"Row" : 18, "Column" : 1, "Text" : "patient has been in the hospital for more than 48 hours or received a course of"}, 
{"Row" : 19, "Column" : 1, "Text" : "antibiotics. There is increasing resistance in urinary pathogens to"}, 
{"Row" : 20, "Column" : 1, "Text" : "ciprofloxacin."}, 
{"Row" : 22, "Column" : 1, "Text" : "A urine Gram stain and culture should be performed in all patients to guide"}, 
{"Row" : 23, "Column" : 1, "Text" : "antimicrobial therapy:"}, 
{"Row" : 26, "Column" : 1, "Text" : "Duration", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "There is limited data on duration of antimicrobial treatment for prostatitis. 14"}, 
{"Row" : 28, "Column" : 1, "Text" : "days minimum is required. 4 to 6 weeks may be necessary to completely eradicate"}, 
{"Row" : 29, "Column" : 1, "Text" : "bacteria in the prostate to ensure patient does not progress to chronic"}, 
{"Row" : 30, "Column" : 1, "Text" : "bacterial prostatitis."}, 
{"Row" : 31, "Column" : 1, "Text" : "_____________________________________________________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Empirical treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Hydration, bed rest and analgesics are recommended along with antimicrobials"}, 
{"Row" : 35, "Column" : 1, "Text" : "treatment."}, 
{"Row" : 37, "Column" : 1, "Text" : "Age < 35 years and those at high risk of sexually transmitted infections", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Patient weighing less than 300 lbs:"}, 
{"Row" : 40, "Column" : 1, "Text" : "14 days"}, 
{"Row" : 42, "Column" : 1, "Text" : "Patients weighing 300 lbs or greater:"}, 
{"Row" : 44, "Column" : 1, "Text" : "14 days"}, 
{"Row" : 46, "Column" : 1, "Text" : "Age >/= 35 years", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 49, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 52, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 54, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "References:"}, 
{"Row" : 58, "Column" : 1, "Text" : "Lipsky et al., Clinical Infectious Diseases, 2010, 50(12)1641-1652"}, 
{"Row" : 59, "Column" : 1, "Text" : "Mandell chapter: Prostatitis, Epididymitis and Orchitis"}, 
{"Row" : 60, "Column" : 1, "Text" : "Sanford keyword: Prostatitis"}, 
{"Row" : 61, "Column" : 1, "Text" : "Up-To-Date article: Acute Bacterial Prostatitis"}
]},
{"Name" : "ORZID2 GMENU ABX ADDITIONAL ASSISTANCE", "DisplayText" : "Additional assistance... ", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "WHOM TO CONTACT FOR ADDITIONAL ASSISTANCE"}, 
{"Row" : 5, "Column" : 1, "Text" : "The CDSS staff welcomes questions, suggestions, comments, and concerns.  We can"}, 
{"Row" : 7, "Column" : 1, "Text" : "individually, or anonymously (available through the website only)."}, 
{"Row" : 10, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "CDSS Project", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "CDSS project phone", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "612-467-1781"}, 
{"Row" : 10, "Column" : 2, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 11, "Column" : 2, "Text" : "Infection Control", "Header" : 1}, 
{"Row" : 12, "Column" : 2, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 2, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 2, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 17, "Column" : 2, "Text" : "Pharmacy", "Header" : 1}, 
{"Row" : 22, "Column" : 2, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 2, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 2, "Text" : "Others", "Header" : 1}, 
{"Row" : 26, "Column" : 2, "Text" : "For hospital computer problems:"}, 
{"Row" : 27, "Column" : 2, "Text" : "VISN 23 Help Desk", "Header" : 1}, 
{"Row" : 30, "Column" : 2, "Text" : "For microbiology issues:"}, 
{"Row" : 31, "Column" : 2, "Text" : "Microbiology Laboratory", "Header" : 1}, 
{"Row" : 32, "Column" : 2, "Text" : "x6392"}, 
{"Row" : 17, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "CDSS Project Staff", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Pharmacist", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Bobbie Masoud, PharmD"}, 
{"Row" : 23, "Column" : 1, "Text" : "(612) 467-3612"}, 
{"Row" : 24, "Column" : 1, "Text" : "Bobbie.Masoud@va.gov"}, 
{"Row" : 20, "Column" : 2, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "08"},
{"Row" : 28, "Column" : 2, "Text" : "Ext 4357 (HELP)"}, 
{"Row" : 6, "Column" : 1, "Text" : "be reached at via our group e-mail (VISN23AntimicrobialCDSS@va.gov),"}, 
{"Row" : 14, "Column" : 2, "Text" : "Denise A. Tracy", "Header" : 1}, 
{"Row" : 15, "Column" : 2, "Text" : "Ext 6294, Pager 409"}, 
{"Row" : 26, "Column" : 1, "Text" : "Erik Stensgard, PharmD"}, 
{"Row" : 27, "Column" : 1, "Text" : "(612) 271-4121"}, 
{"Row" : 28, "Column" : 1, "Text" : "Erik.Stensgard@va.gov"}
]},
{"Name" : "ORZID2 GMENU ABX ADJ EXIST ABX THERAPY", "DisplayText" : "Adjust existing antimicrobial therapy", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "ADJUSTING EXISTING ANTIMICROBIAL THERAPY", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "To change the DOSE of a CURRENTLY ACTIVE antimicrobial", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Right click on the active order and change the dose as needed."}, 
{"Row" : 8, "Column" : 1, "Text" : "To change from the CURRENT ANTIMICROBIAL MEDICATION", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "We encourage clinicians to consult the CDSS when considering alternative"}, 
{"Row" : 10, "Column" : 1, "Text" : "antimicrobial therapy due to an adverse drug reaction, a culture result, or a"}, 
{"Row" : 11, "Column" : 1, "Text" : "need to switch from intravenous to oral therapy. Many of the CDSS advice menus"}, 
{"Row" : 12, "Column" : 1, "Text" : "contain more than one antimicrobial recommendation. If a suitable alternative"}, 
{"Row" : 13, "Column" : 1, "Text" : "is not listed on the advice menu, clinicians have the additional resource of an"}, 
{"Row" : 14, "Column" : 1, "Text" : "expanded menu of alternative medications that can be accessed by selecting the"}, 
{"Row" : 15, "Column" : 1, "Text" : "Need an alternative antimicrobial? link at the top of each advice menu. To"}, 
{"Row" : 16, "Column" : 1, "Text" : "order an alternative medication using this link prescribers will need to"}, 
{"Row" : 17, "Column" : 1, "Text" : "indicate the rationale behind the choice."}, 
{"Row" : 19, "Column" : 1, "Text" : "Note: Restricted antimicrobials ordered outside of the CDSS system will still"}, 
{"Row" : 20, "Column" : 1, "Text" : "require Infectious Diseases approval."}
]},
{"Name" : "ORZID2 GMENU ABX AEROMONAS", "Term1" : "Aeromonas diarrhea/gastroenteritis", "DisplayText" : "Diarrhea with Aeromonas  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 9, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 750MG PO Q24H", "DisplayText" : "Ciprofloxacin 750 mg PO q24h ($) [R,DI]", "Text" : "Ciprofloxacin 750 mg PO q24h for 3 days ($) [R,DI]", "Mnemonic" : "4"},
{"Row" : 12, "Column" : 1, "Item" : "PSJZID TMP/SMX DS PO Q12H", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 DS tablet q12h", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet q12h for 3 days($) [R,DI]", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "DIARRHEA WITH AEROMONAS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Primary treatment", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 8, "Column" : 1, "Text" : "Antimicrobial treatment", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 15, "Column" : 1, "Text" : "References:"}, 
{"Row" : 17, "Column" : 1, "Text" : "Medical Letter Choice of Antimicrobials 2010, 8(94)"}, 
{"Row" : 18, "Column" : 1, "Text" : "Sanford keyword: Aeromonas sp."}, 
{"Row" : 19, "Column" : 1, "Text" : "Up-to-Date article: Aeromonas infections"}
]},
{"Name" : "ORZID2 GMENU ABX ANTIMICROBIAL SHORTAGES", "Term1" : "Antimicrobial shortages updates ", "Term2" : "Shortages of antimicrobials updates ", "Term3" : "Updates on antimicrobial shortages", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "Select individual antimicrobial listed below for current status on shortages.", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Currently NO antimicrobial shortages.", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX ANTIVIRAL TREATMENT INFLUENZA", "DisplayText" : "ANTIVIRAL TREATMENT", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 46, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 75 MG PO BID 5DAYS TREAT", "DisplayText" : "Oseltamivir 75mg PO q12h ($) [R] for 5 days", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "Antiviral Therapy Recommendations:", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Who to Treat:", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "The decision to treat should be based on clinical symptoms and/or presence of"}, 
{"Row" : 7, "Column" : 1, "Text" : "a high risk condition, and should NOT be delayed until laboratory test"}, 
{"Row" : 8, "Column" : 1, "Text" : "results are available."}, 
{"Row" : 10, "Column" : 1, "Text" : "It is important to use antiviral drugs early to treat influenza in people who"}, 
{"Row" : 11, "Column" : 1, "Text" : "are very sick with influenza (for example hospitalized people) and people who"}, 
{"Row" : 12, "Column" : 1, "Text" : "are sick with influenza and have a greater chance of getting severe"}, 
{"Row" : 13, "Column" : 1, "Text" : "complications. If a patient is not in a high-risk group or is not hospitalized,"}, 
{"Row" : 14, "Column" : 1, "Text" : "healthcare providers should use clinical judgment to guide treatment decisions."}, 
{"Row" : 16, "Column" : 1, "Text" : "People who have a greater chance of serious influenza complications include:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "*Persons who have chronic pulmonary (including asthma) or cardiovascular"}, 
{"Row" : 19, "Column" : 1, "Text" : "(except isolated hypertension), renal, hepatic, hematologic, metabolic"}, 
{"Row" : 22, "Column" : 1, "Text" : "*Persons who are immunocompromised due to any cause (including immunosuppresion"}, 
{"Row" : 23, "Column" : 1, "Text" : "caused by medications or by HIV infection)"}, 
{"Row" : 25, "Column" : 1, "Text" : "*Persons younger than 19 years of age who are receiving long-term aspirin-"}, 
{"Row" : 26, "Column" : 1, "Text" : "or salicylate-containing medications and who might be at risk for experiencing"}, 
{"Row" : 27, "Column" : 1, "Text" : "Reye syndrome after influenza virus infection"}, 
{"Row" : 28, "Column" : 1, "Text" : "*Residents of nursing homes and other long-term care facilities"}, 
{"Row" : 31, "Column" : 1, "Text" : "*Persons who are extremely obese (BMI greater than or equal to 40)"}, 
{"Row" : 33, "Column" : 1, "Text" : "Antiviral Treatment:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "If indicated, antivirals should be started as soon as possible.  Maximal"}, 
{"Row" : 35, "Column" : 1, "Text" : "benefit occurs when started within 48 hours of symptom onset.  However,"}, 
{"Row" : 36, "Column" : 1, "Text" : "antivirals should not be withheld if symptoms began more than 48 hours prior"}, 
{"Row" : 37, "Column" : 1, "Text" : "and the patient meets criteria for treatment and remains severely ill."}, 
{"Row" : 52, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "*Adults age 65 years or older"}, 
{"Row" : 20, "Column" : 1, "Text" : "disorders (including diabetes mellitus), neurologic and"}, 
{"Row" : 21, "Column" : 1, "Text" : "neuro-developmental disorders"}, 
{"Row" : 40, "Column" : 1, "Text" : "Extending the duration of treatment for oseltamivir may be needed"}, 
{"Row" : 41, "Column" : 1, "Text" : "for those patients with prolonged illness or who are immunosuppressed."}, 
{"Row" : 24, "Column" : 1, "Text" : "*Pregnant women and women up to 2 weeks after the end of pregnancy"}, 
{"Row" : 53, "Column" : 1, "Text" : "Centers for Disease Control (CDC) (Accessed 9/8/23)"}, 
{"Row" : 54, "Column" : 1, "Text" : "https://www.cdc.gov/flu/professionals/antivirals/summary-clinician"}, 
{"Row" : 55, "Column" : 1, "Text" : "UpToDate Seasonal influenza in adults: Treatment"}, 
{"Row" : 29, "Column" : 1, "Text" : "*Non-Hispanic Black persons, Hispanic or Latino persons, and American Indian"}, 
{"Row" : 30, "Column" : 1, "Text" : "or Alaska Native persons"}, 
{"Row" : 39, "Column" : 1, "Text" : "Duration:", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Dosing of oseltamivir based on renal function:", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Creatinine Clearance >60ml/min:", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Creatinine Clearance >30-60ml/min:", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "Creatinine Clearance >10-30ml/min:", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 30MG PO BID TREATMENT", "DisplayText" : "Oseltamivir 30mg PO q12h ($) [R] for 5 days", "Mnemonic" : "6"},
{"Row" : 50, "Column" : 1, "Item" : "PSJZID OSELTAMIVIR 30MG PO QDAY TREAT", "DisplayText" : "Oseltamivir 30mg PO qday ($) [R] for 5 days", "Mnemonic" : "8"}
]},
{"Name" : "ORZID2 GMENU ABX APPRO TO BACTEREMIA", "DisplayText" : "Approach to bacteremia", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU SEPSIS AND SHOCK", "DisplayText" : "Sepsis, severe sepsis, and septic shock", "Text" : "Sepsis, severe sepsis, and septic shock", "Mnemonic" : "4"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX SUSP BACT, BLD CX NOT YET POS", "DisplayText" : "Suspected bacteremia, blood cultures not yet positive", "Text" : "Suspected bacteremia, blood cultures not yet positive", "Mnemonic" : "6"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPC IN PAIRS", "DisplayText" : "Interim report of Gram-positive cocci in pairs", "Text" : "Interim report of Gram-positive cocci in pairs", "Mnemonic" : "8"},
{"Row" : 44, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPC PAIRS/CLUSTERS", "DisplayText" : "Interim report of Gram-positive cocci in pairs and clusters", "Text" : "Interim report of Gram-positive cocci in pairs and clusters", "Mnemonic" : "10"},
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPC PRS/CHAINS", "DisplayText" : "Interim report of Gram-positive cocci in pairs and chains", "Text" : "Interim report of Gram-positive cocci in pairs and chains", "Mnemonic" : "12"},
{"Row" : 46, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GNB", "DisplayText" : "Interim report of Gram-negative bacilli", "Text" : "Interim report of Gram-negative bacilli", "Mnemonic" : "14"},
{"Row" : 47, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GNC", "DisplayText" : "Interim report of Gram-negative cocci", "Text" : "Interim report of Gram-negative cocci", "Mnemonic" : "16"},
{"Row" : 48, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPR", "DisplayText" : "Interim report of Gram-positive rods", "Text" : "Interim report of Gram-positive bacilli", "Mnemonic" : "18"},
{"Row" : 49, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT YEAST", "DisplayText" : "Interim report of yeast", "Text" : "Interim report of yeast", "Mnemonic" : "20"},
{"Row" : 3, "Column" : 1, "Text" : "APPROACH TO BACTEREMIA", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Bacteremia usually results from a focal infection somewhere in the body. If a"}, 
{"Row" : 6, "Column" : 1, "Text" : "focal infection is not obvious, a careful search should be made beginning with a"}, 
{"Row" : 7, "Column" : 1, "Text" : "detailed history and physical examination."}, 
{"Row" : 9, "Column" : 1, "Text" : "If a focal infection seems to be the source of the bacteremia, select"}, 
{"Row" : 10, "Column" : 1, "Text" : "antimicrobials active against pathogens likely to be present in the focal"}, 
{"Row" : 11, "Column" : 1, "Text" : "infection. Return to the main menu and select the relevant diagnosis or"}, 
{"Row" : 12, "Column" : 1, "Text" : "syndrome."}, 
{"Row" : 14, "Column" : 1, "Text" : "For infections with signs and/or symptoms of severe sepsis, like hypotension or", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "end organ dysfunction", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Sequence of evaluation", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Obtain blood cultures before starting antibiotics when signs or symptoms suggest"}, 
{"Row" : 20, "Column" : 1, "Text" : "bacteremia. Obtain 2 or 3 blood culture sets from different venipuncture sites"}, 
{"Row" : 21, "Column" : 1, "Text" : "within a 24 hour period. When suspicion is strong and the patient's signs and"}, 
{"Row" : 22, "Column" : 1, "Text" : "symptoms have not responded, obtain 2 blood culture sets the next day. For more"}, 
{"Row" : 23, "Column" : 1, "Text" : "information about blood cultures, see recommendations on the Q-drive"}, 
{"Row" : 24, "Column" : 1, "Text" : "Q:\\MICROBIOL INFO FOR CLINICIANS\\BLOOD CULTURE Recommendations.doc"}, 
{"Row" : 26, "Column" : 1, "Text" : "Empirical treatment of suspected bacteremia if local infection is not apparent", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "and blood cultures are not yet positive", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Cultures usually become positive after 1 or more days. Usually interim results"}, 
{"Row" : 31, "Column" : 1, "Text" : "are reported first, followed by final identification and sensitivities after"}, 
{"Row" : 32, "Column" : 1, "Text" : "another day or two. Adjust antimicrobials as appropriate as this sequence"}, 
{"Row" : 33, "Column" : 1, "Text" : "unfolds."}, 
{"Row" : 35, "Column" : 1, "Text" : "Preliminary results of a positive culture are available", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "When a focal infection is not apparent, the type of bacteria growing in blood"}, 
{"Row" : 37, "Column" : 1, "Text" : "culture might suggest a focal infection and direct the search for a diagnosis."}, 
{"Row" : 38, "Column" : 1, "Text" : "When a focal infection is apparent, it may suggest the identity of the bacteria"}, 
{"Row" : 39, "Column" : 1, "Text" : "growing in blood cultures before the laboratory completes its identification."}, 
{"Row" : 40, "Column" : 1, "Text" : "Preliminary positive results should lead to changes in antimicrobial therapy to"}, 
{"Row" : 41, "Column" : 1, "Text" : "target suspected pathogens, narrow the spectrum, reduce toxicity, and reduce"}, 
{"Row" : 42, "Column" : 1, "Text" : "costs."}, 
{"Row" : 52, "Column" : 1, "Text" : "References"}, 
{"Row" : 54, "Column" : 1, "Text" : "Mandell Chapter Sepsis, Severe Sepsis and Septic Shock"}
]},
{"Name" : "ORZID2 GMENU ABX APPRO TO ENDOCARDITIS", "Term1" : "Endocarditis, approach to", "DisplayText" : "Approach to Endocarditis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX DUKE CRITERIA", "DisplayText" : "Modified Duke Diagnostic Criteria", "Text" : "Diagnosis with Duke Criteria", "Mnemonic" : "4"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX PENICILLIN DESENS PROTOCOL", "DisplayText" : "Penicillin Desensitization Protocol", "Text" : "Penicillin Desensitization protocol", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "APPROACH TO ENDOCARDITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Infectious Diseases and Cardiology consults are essential for proved cases and"}, 
{"Row" : 6, "Column" : 1, "Text" : "encouraged for suspected cases. See diagnosis page for more information."}, 
{"Row" : 10, "Column" : 1, "Text" : "Attempt to identify the pathogen before starting antimicrobials. At least three"}, 
{"Row" : 11, "Column" : 1, "Text" : "sets of blood cultures should be obtained from different venipuncture sites."}, 
{"Row" : 12, "Column" : 1, "Text" : "These cultures should be drawn at different times with the first and last"}, 
{"Row" : 13, "Column" : 1, "Text" : "culture separated by at least one hour."}, 
{"Row" : 15, "Column" : 1, "Text" : "For a patient who is not clinically stable, or if the progression of the illness"}, 
{"Row" : 16, "Column" : 1, "Text" : "is rapid, draw 3 sets of blood cultures and then initiate empirical"}, 
{"Row" : 17, "Column" : 1, "Text" : "antimicrobial therapy and/or surgical intervention."}, 
{"Row" : 19, "Column" : 1, "Text" : "Ascertain whether any antimicrobials were taken during the previous 2 weeks to"}, 
{"Row" : 20, "Column" : 1, "Text" : "help interpret culture results."}, 
{"Row" : 22, "Column" : 1, "Text" : "Penicillin susceptibility data are used to determine appropriate antimicrobial"}, 
{"Row" : 23, "Column" : 1, "Text" : "therapy for streptococcal endocarditis. Because bacteria in cardiac vegetations"}, 
{"Row" : 24, "Column" : 1, "Text" : "are not actively dividing, and are protected from host defense mechanisms,"}, 
{"Row" : 25, "Column" : 1, "Text" : "bactericidal antimicrobial regimens are necessary to treat bacterial"}, 
{"Row" : 26, "Column" : 1, "Text" : "endocarditis. The minimum inhibitory concentration (MIC) cut-off levels used to"}, 
{"Row" : 27, "Column" : 1, "Text" : "select therapy for endocarditis differ from those used to select therapy for"}, 
{"Row" : 28, "Column" : 1, "Text" : "other infectious diseases (see below)."}, 
{"Row" : 30, "Column" : 1, "Text" : "Penicillin allergy", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Beta-lactam antibiotics are more effective than vancomycin for treating"}, 
{"Row" : 32, "Column" : 1, "Text" : "susceptible gram-positive pathogens. For patients with penicillin allergy that"}, 
{"Row" : 33, "Column" : 1, "Text" : "is known or suspected to be class I (anaphylaxis, angioedema, or hives),"}, 
{"Row" : 34, "Column" : 1, "Text" : "penicillin desensitization or therapy with a cephalosporin is usually the best"}, 
{"Row" : 35, "Column" : 1, "Text" : "approach."}, 
{"Row" : 39, "Column" : 1, "Text" : "When gentamicin is used for synergy against gram positive bacteria, serum"}, 
{"Row" : 40, "Column" : 1, "Text" : "concentrations should be 3-4 mcg/ml peak and < 1 mcg/ml trough. Once daily"}, 
{"Row" : 41, "Column" : 1, "Text" : "gentamicin dosing can be used for streptococcal cases but not for staphylococcal"}, 
{"Row" : 42, "Column" : 1, "Text" : "or enterococcal cases."}, 
{"Row" : 44, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "References:"}, 
{"Row" : 47, "Column" : 1, "Text" : "Baddour et al., Circulation 2015, 132:1-52"}, 
{"Row" : 48, "Column" : 1, "Text" : "Mandell chapter: Endocarditis and intravascular infections"}, 
{"Row" : 49, "Column" : 1, "Text" : "Sanford keyword: Endocarditis"}, 
{"Row" : 50, "Column" : 1, "Text" : "Up-To-Date article: Overview of management of infective endocarditis in adults"}, 
{"Row" : 51, "Column" : 1, "Text" : "Wang et al., JAMA 2018, 320.1:72-83"}
]},
{"Name" : "ORZID2 GMENU ABX APPROACH TO ACUTE MENINGITIS", "DisplayText" : "Approach to Acute Meningitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 62, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING W/O GRM STAIN RES", "DisplayText" : "Bacterial meningitis without Gram stain results", "Text" : "Community acquired meningitis", "Mnemonic" : "4"},
{"Row" : 63, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING ASSOC TRAUMA", "DisplayText" : "Bacterial meningitis associated with trauma or nosocomial infection", "Text" : "Meningitis associated with trauma or nosocomial infection", "Mnemonic" : "6"},
{"Row" : 67, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING GRM POS DIPLO S. PNEUMO", "DisplayText" : "Bacterial meningitis with Gram positive diplococci suggesting S. pneumonia", "Text" : "Gram-positive diplococci suggesting Streptococcus pneumoniae", "Mnemonic" : "8"},
{"Row" : 68, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING GRM NEG DIPL N. MENING", "DisplayText" : "Bacterial meningitidis with Gram negative diplococci suggesting N. meningitis", "Text" : "Gram-negative diplococci suggesting Neisseria meningitidis", "Mnemonic" : "10"},
{"Row" : 69, "Column" : 1, "Item" : "ORZID2 GMENU BAC MENING GRM POS BACILLI L. MONOCYTO", "DisplayText" : "Bacterial meningitis with Gram pos bacilli suggesting L. monocytogenes", "Text" : "Gram-positive bacilli/coccobacilli suggesting Listeria monocytogenes", "Mnemonic" : "12"},
{"Row" : 70, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING GNB", "DisplayText" : "Bacterial meningitis with Gram negative bacilli", "Text" : "Gram negative bacilli", "Mnemonic" : "14"},
{"Row" : 74, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING S. PNEUMONIAE", "DisplayText" : "Bacterial meningitis with S. pneumoniae", "Text" : "S. pneumoniae", "Mnemonic" : "16"},
{"Row" : 75, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING N. MENINGITIDIS", "DisplayText" : "Bacterial meningitis with N. meningitidis", "Text" : "N. meningitidis", "Mnemonic" : "18"},
{"Row" : 76, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING L. MONOCYTOGENES", "DisplayText" : "Bacterial meningitis with L. monocytogenes", "Text" : "L. monocytogenes", "Mnemonic" : "20"},
{"Row" : 77, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING E.COLI, PSEUDOMONAS", "DisplayText" : "Bacterial meningitis with E. Coli, Pseudomonas, or other organism", "Text" : "E. Coli, Pseudomonas, or another organism", "Mnemonic" : "22"},
{"Row" : 3, "Column" : 1, "Text" : "APPROACH TO ACUTE MENINGITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Meningitis is an inflammation of the meninges and tissues surrounding the brain"}, 
{"Row" : 6, "Column" : 1, "Text" : "and spinal cord. It is characterized by an abnormal amount of white blood cells"}, 
{"Row" : 7, "Column" : 1, "Text" : "in the cerebrospinal fluid (CSF) and symptoms include headache, fever, mental"}, 
{"Row" : 8, "Column" : 1, "Text" : "status changes, nuchal rigidity, and nausea."}, 
{"Row" : 10, "Column" : 1, "Text" : "Acute Meningitis", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "The sudden onset of meningeal symptoms within hours to days caused by several"}, 
{"Row" : 12, "Column" : 1, "Text" : "infectious etiologies, including bacterial, viral, fungal and protozoa, as well"}, 
{"Row" : 13, "Column" : 1, "Text" : "as non-infectious etiologies. Bacterial meningitis is the most common type of"}, 
{"Row" : 14, "Column" : 1, "Text" : "meningitis, accounting for up to 90% of cases where a CSF culture was obtained"}, 
{"Row" : 15, "Column" : 1, "Text" : "prior to starting antimicrobials. Non-bacterial meningitis is commonly referred"}, 
{"Row" : 16, "Column" : 1, "Text" : "to as aseptic meningitis (refer to \"Negative CSF culture\" below for"}, 
{"Row" : 17, "Column" : 1, "Text" : "recommendations)."}, 
{"Row" : 19, "Column" : 1, "Text" : "Patients with acute bacterial meningitis often have severe symptoms and present"}, 
{"Row" : 20, "Column" : 1, "Text" : "soon after onset of infection. The relationship between predisposing factors and"}, 
{"Row" : 21, "Column" : 1, "Text" : "common bacterial pathogen are listed below."}, 
{"Row" : 23, "Column" : 1, "Text" : "Predisposing Factors and Common Bacterial Pathogens", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "*Age 2-50 years - S. pneumoniae, N. meningitidis"}, 
{"Row" : 25, "Column" : 1, "Text" : "*Age > 50 years - S. pneumoniae, N. meningitidis, L. monocytogenes, aerobic"}, 
{"Row" : 26, "Column" : 1, "Text" : "gram-negative bacilli"}, 
{"Row" : 27, "Column" : 1, "Text" : "*Immunocompromised state - S. pneumoniae, N. meningitidis, L. monocytogenes,"}, 
{"Row" : 28, "Column" : 1, "Text" : "aerobic gram-negative bacilli (including Pseudomonas aeruginosa)"}, 
{"Row" : 29, "Column" : 1, "Text" : "*Basilar skull fracture - S. pneumoniae: H. influenzae, group A and"}, 
{"Row" : 30, "Column" : 1, "Text" : "beta-hemolytic streptococci"}, 
{"Row" : 31, "Column" : 1, "Text" : "*Head trauma: after neurosurgery - Staphylococcus aureus, coagulase-negative"}, 
{"Row" : 32, "Column" : 1, "Text" : "staphylococci (especially Staphylococcus epidermidis), aerobic gram-negative"}, 
{"Row" : 33, "Column" : 1, "Text" : "bacilli (including P. aeruginosa)"}, 
{"Row" : 35, "Column" : 1, "Text" : "Initial Management of Suspected Acute Bacterial Meningitis", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Once a diagnosis of acute bacterial meningitis is considered likely,"}, 
{"Row" : 37, "Column" : 1, "Text" : "antimicrobials should be initiated as soon as possible after obtaining blood"}, 
{"Row" : 38, "Column" : 1, "Text" : "cultures and performing a lumbar puncture (LP) to obtain CSF. Two blood cultures"}, 
{"Row" : 39, "Column" : 1, "Text" : "should be drawn based on predisposing factors above. LP should be performed in"}, 
{"Row" : 40, "Column" : 1, "Text" : "nearly all patients to obtain CSF for establishing diagnosis and determining"}, 
{"Row" : 41, "Column" : 1, "Text" : "infectious organism/susceptibility. Computed tomography (CT) should be performed"}, 
{"Row" : 42, "Column" : 1, "Text" : "prior to LP in some patients (see list below). If CT must be obtained prior to"}, 
{"Row" : 43, "Column" : 1, "Text" : "LP or there is another delay in performing LP, empiric antimicrobials should not"}, 
{"Row" : 44, "Column" : 1, "Text" : "be delayed and initiated immediately after obtaining blood cultures only."}, 
{"Row" : 46, "Column" : 1, "Text" : "Relative LP contraindications (no absolute contraindications exist):"}, 
{"Row" : 47, "Column" : 1, "Text" : "Anticoagulation therapy or bleeding disorder, spinal epidural abscess, raised"}, 
{"Row" : 48, "Column" : 1, "Text" : "intracranial pressure."}, 
{"Row" : 50, "Column" : 1, "Text" : "Computed tomography scan should be performed prior to lumbar puncture in cases"}, 
{"Row" : 51, "Column" : 1, "Text" : "with the following: Immunocompromise, history of CNS disease, new onset seizure,"}, 
{"Row" : 52, "Column" : 1, "Text" : "papilledema, abnormal level of consciousness, focal neurologic deficit."}, 
{"Row" : 54, "Column" : 1, "Text" : "LP and CSF Analysis", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "LP opening pressure is often elevated in bacterial meningitis. CSF findings"}, 
{"Row" : 56, "Column" : 1, "Text" : "characteristic of bacterial meningitis include CSF glucose <40mg/dL, CSF to"}, 
{"Row" : 57, "Column" : 1, "Text" : "serum glucose ratio </=0.4, CSF protein concentration >/=200 mg/dL and CSF WBC"}, 
{"Row" : 58, "Column" : 1, "Text" : ">100 microL."}, 
{"Row" : 60, "Column" : 1, "Text" : "Empiric Treatment After Blood Cultures are Drawn, and CSF is Obtained, or if LP", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "Must be Delayed", "Header" : 1}, 
{"Row" : 65, "Column" : 1, "Text" : "Empiric Treatment Based on CSF Gram-Stain Results", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Text" : "When gram stain results are available, adjust antimicrobials to optimize therapy"}, 
{"Row" : 72, "Column" : 1, "Text" : "Treatment Based on CSF Isolated Organism", "Header" : 1}, 
{"Row" : 73, "Column" : 1, "Text" : "When infectious organism is identified, adjust antimicrobials to optimize therap"}, 
{"Row" : 79, "Column" : 1, "Text" : "Negative CSF Culture", "Header" : 1}, 
{"Row" : 80, "Column" : 1, "Text" : "Patients who have a negative CSF culture, but have symptoms and CSF findings"}, 
{"Row" : 81, "Column" : 1, "Text" : "consistent with bacterial meningitis should be treated based on likely pathogen."}, 
{"Row" : 82, "Column" : 1, "Text" : "Patients with negative CSF culture, symptoms of acute meningitis but have labs"}, 
{"Row" : 83, "Column" : 1, "Text" : "inconsistent with bacterial meningitis should be considered to have aseptic"}, 
{"Row" : 84, "Column" : 1, "Text" : "meningitis. Aseptic meningitis is caused by a variety of non-bacterial"}, 
{"Row" : 85, "Column" : 1, "Text" : "infectious etiologies and non-infectious etiologies. Consult Infectious Disease"}, 
{"Row" : 86, "Column" : 1, "Text" : "for more information."}, 
{"Row" : 87, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 90, "Column" : 1, "Text" : "References:"}, 
{"Row" : 91, "Column" : 1, "Text" : "Mandell chapter: Acute meningitis"}, 
{"Row" : 92, "Column" : 1, "Text" : "Sanford keyword: Meningitis, bacterial, positive gram stain"}, 
{"Row" : 93, "Column" : 1, "Text" : "Tunkel et al., Clin Infect Dis, 2004, 39.1267-84"}, 
{"Row" : 94, "Column" : 1, "Text" : "Up-to-Date Article: Clinical features and diagnosis of acute bacterial"}, 
{"Row" : 95, "Column" : 1, "Text" : "meningitis in adults"}, 
{"Row" : 96, "Column" : 1, "Text" : "Up-to-Date Article: Treatment of bacterial meningitis caused by specific"}, 
{"Row" : 97, "Column" : 1, "Text" : "pathogens in adults"}, 
{"Row" : 98, "Column" : 1, "Text" : "Van de Beek et al., Clin Microbiol Infect, 2016, 22.S37-S62"}
]},
{"Name" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX ASYMP BACTERIURIA", "DisplayText" : "Asymptomatic Bacteriuria", "Text" : "Asymptomatic bacteriuria", "Mnemonic" : "4"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Sexually Transmitted Infections and HIV Exposure", "Mnemonic" : "6"},
{"Row" : 42, "Column" : 1, "Item" : "ORZID2 GMENU ABX CANDIDA UTI", "DisplayText" : "Candida urinary tract infection", "Text" : "Candida urinary tract infections", "Mnemonic" : "8"},
{"Row" : 57, "Column" : 1, "Item" : "ORZID2 GMENU ABX UNCOMP CYSTITIS", "DisplayText" : "Uncomplicated Cystitis", "Text" : "Uncomplicated cystitis", "Mnemonic" : "10"},
{"Row" : 58, "Column" : 1, "Item" : "ORZID2 GMENU ABX COMP CYSTITIS", "DisplayText" : "Complicated Cystitis", "Text" : "Complicated cystitis", "Mnemonic" : "12"},
{"Row" : 59, "Column" : 1, "Item" : "ORZID2 GMENU ABX PYELONEPHRITIS", "DisplayText" : "Pyelonephritis", "Text" : "Pyelonephritis", "Mnemonic" : "14"},
{"Row" : 60, "Column" : 1, "Item" : "ORZID2 GMENU UROSEPSIS", "DisplayText" : "Urosepsis", "Text" : "Bacteremia or sepsis with urinary tract source (aka urosepsis)", "Mnemonic" : "16"},
{"Row" : 3, "Column" : 1, "Text" : "APPROACH TO URINARY TRACT INFECTION (UTI)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Urinary tract infections (UTI) occur in patients with symptoms of infection in"}, 
{"Row" : 6, "Column" : 1, "Text" : "the lower urinary tract (cystitis) and/or the upper urinary tract"}, 
{"Row" : 7, "Column" : 1, "Text" : "(pyelonephritis). Cystitis refers to infection of the urinary bladder, but"}, 
{"Row" : 8, "Column" : 1, "Text" : "inflammation often extends into the urethra. Typical signs and symptoms include"}, 
{"Row" : 9, "Column" : 1, "Text" : "dysuria, increased urinary frequency, urgency, and/or suprapubic tenderness."}, 
{"Row" : 11, "Column" : 1, "Text" : "Uncomplicated cystitis occurs in people with structurally and neurogenically"}, 
{"Row" : 12, "Column" : 1, "Text" : "normal urinary tract. Most cases of uncomplicated cystitis occur in"}, 
{"Row" : 13, "Column" : 1, "Text" : "pre-menopausal, non-pregnant, sexually active young women and is associated with"}, 
{"Row" : 14, "Column" : 1, "Text" : "Enterobacteriaceae (e.g. E. coli and Klebsiella sp.) and occasionally S."}, 
{"Row" : 15, "Column" : 1, "Text" : "saprophyticus. Complicated cystitis occurs in the conditions listed below and is"}, 
{"Row" : 16, "Column" : 1, "Text" : "associated with Enterobacteriaceae, but more resistant pathogens occur,"}, 
{"Row" : 17, "Column" : 1, "Text" : "including the Gram-positive pathogens staphylococci and enterococci. Features of"}, 
{"Row" : 18, "Column" : 1, "Text" : "pyelonephritis include fever/other signs of systemic infection, flank pain,"}, 
{"Row" : 19, "Column" : 1, "Text" : "costovertebral tenderness, and pelvic or perianal pain in men. In rare and"}, 
{"Row" : 20, "Column" : 1, "Text" : "severe cases, urinary tract infections can also present with bacteremia, sepsis,"}, 
{"Row" : 21, "Column" : 1, "Text" : "multiple organ system dysfunction, shock and/or acute renal failure."}, 
{"Row" : 23, "Column" : 1, "Text" : "When a patient presents with symptoms of cystitis, like dysuria, increased"}, 
{"Row" : 24, "Column" : 1, "Text" : "frequency, and suprapubic pain, perform a urine culture. Antimicrobial therapy"}, 
{"Row" : 25, "Column" : 1, "Text" : "is not indicated for pyuria in the absence of symptoms. Patients with signs and"}, 
{"Row" : 26, "Column" : 1, "Text" : "symptoms of pyelonephritis should have a urinary culture and susceptibility"}, 
{"Row" : 27, "Column" : 1, "Text" : "obtained and a urine Gram-stain performed prior to starting empirical"}, 
{"Row" : 28, "Column" : 1, "Text" : "antimicrobials to guide therapy. Patients presenting with bacteremia, sepsis,"}, 
{"Row" : 29, "Column" : 1, "Text" : "multiorgan dysfunction, shock and/or acute renal failure should be treated"}, 
{"Row" : 30, "Column" : 1, "Text" : "accordingly with urinary tract as the foci of infection."}, 
{"Row" : 32, "Column" : 1, "Text" : "Asymptomatic bacteriuria occurs in patients who have bacteria in the urine but"}, 
{"Row" : 33, "Column" : 1, "Text" : "do not have symptoms of a urinary tract infection. Asymptomatic bacteriuria is"}, 
{"Row" : 34, "Column" : 1, "Text" : "further discussed elsewhere:"}, 
{"Row" : 37, "Column" : 1, "Text" : "Patients at risk of sexually transmitted infections should be assessed for"}, 
{"Row" : 38, "Column" : 1, "Text" : "treatment:"}, 
{"Row" : 41, "Column" : 1, "Text" : "Candida urinary tract infections are discussed elsewhere:"}, 
{"Row" : 44, "Column" : 1, "Text" : "Complicating conditions", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Cystitis is considered complicated when one or more of the following is present:"}, 
{"Row" : 46, "Column" : 1, "Text" : "o Pregnant women"}, 
{"Row" : 47, "Column" : 1, "Text" : "o Structural or neurogenic abnormalities (e.g. presence of obstruction, catheter"}, 
{"Row" : 48, "Column" : 1, "Text" : "or nephrostomy tubes, neurogenic bladder, renal failure or transplantation)"}, 
{"Row" : 49, "Column" : 1, "Text" : "o Immunocompromise"}, 
{"Row" : 50, "Column" : 1, "Text" : "o Persistent infection, relapse, recurrence, or treatment failure"}, 
{"Row" : 51, "Column" : 1, "Text" : "o In some cases, men and patients admitted to health care settings may be"}, 
{"Row" : 52, "Column" : 1, "Text" : "considered complicated"}, 
{"Row" : 54, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 64, "Column" : 1, "Text" : "References:"}, 
{"Row" : 65, "Column" : 1, "Text" : "Gupta et al., Clinical Infectious Diseases, 2011, 52(5)e103-20"}, 
{"Row" : 66, "Column" : 1, "Text" : "Mandell chapter: Urinary Tract Infection"}
]},
{"Name" : "ORZID2 GMENU ABX ASPIRATION PNEUMONIA", "Term1" : "Aspiration pneumonia ", "Term2" : "Pneumonia, aspiration", "DisplayText" : "Aspiration pneumonia  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX COM-ACQ PNEUMONIA", "DisplayText" : "Community-acquired pneumonia (CAP)", "Text" : "Community acquired pneumonia (CAP)  < OR >", "Mnemonic" : "4"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX NOSO PNEUMONIA NEW", "DisplayText" : "Nosocomial pneumonia (including HAP, VAP, and HCAP)", "Text" : "Nosocomial pneumonia", "Mnemonic" : "6"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX LUNG ABSCESS", "DisplayText" : "Lung abscess", "Text" : "Lung abscess", "Mnemonic" : "8"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "10"},
{"Row" : 2, "Column" : 1, "Text" : "ASPIRATION PNEUMONIA"}, 
{"Row" : 4, "Column" : 1, "Text" : "Aspiration of oropharyngeal or gastric contents induces inflammation and is"}, 
{"Row" : 5, "Column" : 1, "Text" : "often accompanied by fever and/or an infiltrate.  Bacterial pneumonia occurs in"}, 
{"Row" : 6, "Column" : 1, "Text" : "a minority of patients who aspirate, typically about 3 days later.  The patient"}, 
{"Row" : 7, "Column" : 1, "Text" : "usually improves for the first 2 days and then worsens as bacterial pneumonia"}, 
{"Row" : 8, "Column" : 1, "Text" : "develops with increased fever, new or progressive infiltrates, leukocytosis, and"}, 
{"Row" : 9, "Column" : 1, "Text" : "newly purulent sputum."}, 
{"Row" : 11, "Column" : 1, "Text" : "Antimicrobials have no role for treatment of aspiration and their use entails"}, 
{"Row" : 12, "Column" : 1, "Text" : "risk of side effects and selection of resistant organisms."}, 
{"Row" : 14, "Column" : 1, "Text" : "Antimicrobials used for community-acquired pneumonia are appropriate for cases"}, 
{"Row" : 15, "Column" : 1, "Text" : "that develop after an episode of aspiration.  For more information, consult"}, 
{"Row" : 16, "Column" : 1, "Text" : "Pulmonary or Infectious Diseases."}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment for patients with pneumonitis but without lung abscess or putrid", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "sputum", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Therapy directed towards anaerobic pathogens is usually unnecessary.  If"}, 
{"Row" : 21, "Column" : 1, "Text" : "pneumonia is confirmed, treat as"}, 
{"Row" : 26, "Column" : 1, "Text" : "Treament for patients with LUNG ABSCESS", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 33, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 34, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 35, "Column" : 1, "Text" : "Mandell chapter: Lung Abscess"}, 
{"Row" : 36, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2003,37:1405"}, 
{"Row" : 37, "Column" : 1, "Text" : "Roig J  J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 38, "Column" : 1, "Text" : "Kalil AC et al. Clin Infect Dis 2016. 63:1"}
]},
{"Name" : "ORZID2 GMENU ABX ASSOC COLITIS", "Term1" : "Clostridium difficile, mild to moderate disease", "DisplayText" : "Antibiotic Associated Colitis (C. Difficile Colitis)", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX INI EPI ABX ASSOC COLITIS", "DisplayText" : "Initial Episode of Antibiotic Associated Colitis...", "Text" : "Initial Episode", "Mnemonic" : "4"},
{"Row" : 42, "Column" : 1, "Item" : "ORZID2 GMENU ABX FIRST RECURRENCE ABX ASSOC", "DisplayText" : "", "Text" : "First Recurrence", "Mnemonic" : "6"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX SECOND RECUR ABX ASSOC COLITIS", "DisplayText" : "ORZID2 GMENU SECOND RECURRENCE ABX ASSOC COLITIS", "Text" : "Second Recurrence", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "CLOSTRIDIUM DIFFICILE INFECTION [CDI]", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "CDI: Patient with clinical symptom onset (e.g., 3 or more unformed stools in"}, 
{"Row" : 6, "Column" : 1, "Text" : "24 hours after discontinuation of laxatives) and laboratory confirmation of CDI."}, 
{"Row" : 8, "Column" : 1, "Text" : "CDI Recurrence: Typically defined as a repeated symptomatic, laboratory"}, 
{"Row" : 9, "Column" : 1, "Text" : "case of CDI within 12 weeks after a prior episode."}, 
{"Row" : 11, "Column" : 1, "Text" : "Discontinue implicated antibiotic and avoid high risk antibiotic if antibiotic"}, 
{"Row" : 12, "Column" : 1, "Text" : "therapy is still needed. Discontinue laxatives. Reassess need for tube feeds. C."}, 
{"Row" : 13, "Column" : 1, "Text" : "difficile PCR testing should be completed to confirm diagnosis of C. difficile"}, 
{"Row" : 14, "Column" : 1, "Text" : "infection."}, 
{"Row" : 16, "Column" : 1, "Text" : "Antibiotic risk (rank order):", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "High: clindamycin, fluoroquinolones, 2nd/3rd/4th generation cephalosporins,"}, 
{"Row" : 18, "Column" : 1, "Text" : "Medium: carbapenems, penicillins, 1st generation cephalosporins, macrolides,"}, 
{"Row" : 19, "Column" : 1, "Text" : "vancomycin, metronidazole"}, 
{"Row" : 20, "Column" : 1, "Text" : "Low: tetracyclines, aminoglycosides, trimethoprim/sulfamethoxazole, rifampin"}, 
{"Row" : 21, "Column" : 1, "Text" : "Very low: sulfonamides, nitrofurantoin, fosfomycin, methenamine"}, 
{"Row" : 23, "Column" : 1, "Text" : "Avoid antiperistaltic agents (narcotics, loperamide, etc.). Increasing evidence"}, 
{"Row" : 24, "Column" : 1, "Text" : "suggests that antacid therapy, especially with PPIs and H2 blockers, increases"}, 
{"Row" : 25, "Column" : 1, "Text" : "the risk for C. difficile disease and recurrences. Avoid antacid therapy"}, 
{"Row" : 26, "Column" : 1, "Text" : "without clear indication, especially in patients at risk for primary recurrent C"}, 
{"Row" : 27, "Column" : 1, "Text" : "difficile disease."}, 
{"Row" : 29, "Column" : 1, "Text" : "The preferred route of antimicrobial therapy for C. difficile infection is by"}, 
{"Row" : 30, "Column" : 1, "Text" : "mouth. Intravenous metronidazole should be used only when oral therapy cannot"}, 
{"Row" : 31, "Column" : 1, "Text" : "be used to deliver drug to the colon. Intravenous vancomycin does not get into"}, 
{"Row" : 32, "Column" : 1, "Text" : "colonic contents and is not effective."}, 
{"Row" : 34, "Column" : 1, "Text" : "C. difficile infection usually responds to antimicrobial therapy, especially if"}, 
{"Row" : 35, "Column" : 1, "Text" : "other antimicrobial therapy has been stopped. Relapse is usually due to failure"}, 
{"Row" : 36, "Column" : 1, "Text" : "of normal colonic flora to re-establish itself, rather than antimicrobial"}, 
{"Row" : 37, "Column" : 1, "Text" : "treatment failure. If symptoms do not respond to appropriate antimicrobial"}, 
{"Row" : 38, "Column" : 1, "Text" : "therapy, re-consider the diagnosis. Relapse occurs in 6% to 25% of people after"}, 
{"Row" : 39, "Column" : 1, "Text" : "their first episode of C. difficile infection."}, 
{"Row" : 44, "Column" : 1, "Text" : "Third Recurrence: Consult Gastroenterology and/or Infectious Disease", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "References:"}, 
{"Row" : 49, "Column" : 1, "Text" : "Johnson et al, Clin Inf Dis, 2021, 73(5): e1029-e1044"}, 
{"Row" : 50, "Column" : 1, "Text" : "Criteria for Use: Fidaxomicin VA-PBM (11/21)"}, 
{"Row" : 51, "Column" : 1, "Text" : "Mandell chapter: Clostridium difficile infection"}, 
{"Row" : 52, "Column" : 1, "Text" : "Sanford keyword: Clostridium difficile"}, 
{"Row" : 53, "Column" : 1, "Text" : "Up-to-Date article: Clostridium difficile infection in adults: Clinical"}, 
{"Row" : 54, "Column" : 1, "Text" : "manifestations and diagnosis"}
]},
{"Name" : "ORZID2 GMENU ABX ASYMP BACTERIURIA", "DisplayText" : "Asymptomatic Bacteriuria ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID NITROFURANTOIN SA 100 MG PO BID", "DisplayText" : "Nitrofurantoin SA 100 mg PO q12h ($) [R,O]", "Text" : "Nitrofurantoin SA 100 mg PO q12h ($) [R,O], CrCl >30 mL/min, for 5 days", "Mnemonic" : "4"},
{"Row" : 34, "Column" : 1, "Item" : "PSJZID AMOX/CLAV 875-125MG PO Q12H", "DisplayText" : "Amoxicillin/clavulanate 875-125 mg po q12h", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h ($) [R] for 5 days", "Mnemonic" : "6"}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJZID CEFADROXIL 1000MG PO Q12H", "DisplayText" : "Cefadroxil 1000 mg PO q12h ($) [R]", "Text" : "Cefadroxil 1000 mg q12h ($) [R] for 5 days", "Mnemonic" : "8"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU SURG UROLOGICAL PROCED", "DisplayText" : "Urological procedures", "Text" : "Antimicrobial prophylaxis for urological procedures", "Mnemonic" : "10"},
{"Row" : 3, "Column" : 1, "Text" : "ASYMPTOMATIC BACTERIURIA", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Asymptomatic bacteriuria is common in women and elderly people, especially in"}, 
{"Row" : 6, "Column" : 1, "Text" : "those with chronic medical problems (e.g., diabetes, spinal cord injury,"}, 
{"Row" : 7, "Column" : 1, "Text" : "institutionalized patients, catheterized patients). Most patients have no"}, 
{"Row" : 8, "Column" : 1, "Text" : "adverse outcomes and receive no benefit from treatment of asymptomatic"}, 
{"Row" : 9, "Column" : 1, "Text" : "bacteriuria."}, 
{"Row" : 11, "Column" : 1, "Text" : "Patients who have no symptoms of cystitis (i.e., no dysuria, pain, urgency)"}, 
{"Row" : 12, "Column" : 1, "Text" : "should not be treated. The presence of pyuria (>7 wbc/hpf) or positive leukocyte"}, 
{"Row" : 13, "Column" : 1, "Text" : "esterase, urine nitrate, or urine bacteria is not a sufficient indication for"}, 
{"Row" : 14, "Column" : 1, "Text" : "antibiotic treatment. Screening and treatment of asymptomatic bacteriuria is"}, 
{"Row" : 15, "Column" : 1, "Text" : "indicated for pregnant women and patients who will have urological procedures"}, 
{"Row" : 16, "Column" : 1, "Text" : "and may be indicated in patients < 1-month post-renal transplant. If an"}, 
{"Row" : 17, "Column" : 1, "Text" : "indwelling catheter is in place and can be removed safely, it should be done as"}, 
{"Row" : 18, "Column" : 1, "Text" : "the bacteriuria may clear."}, 
{"Row" : 20, "Column" : 1, "Text" : "Bacteriuria in pregnant women is associated with pyelonephritis, premature"}, 
{"Row" : 21, "Column" : 1, "Text" : "delivery, and lower birth weight. Screening for bacteriuria is recommended at"}, 
{"Row" : 22, "Column" : 1, "Text" : "least once early in pregnancy. If bacteriuria is not found upon initial testing,"}, 
{"Row" : 23, "Column" : 1, "Text" : "further screening cultures are not needed. If bacteriuria (>10,000 CFU/mL) is"}, 
{"Row" : 24, "Column" : 1, "Text" : "present, the patient should be treated. Testing should be repeated throughout"}, 
{"Row" : 25, "Column" : 1, "Text" : "the pregnancy to detect recurrences."}, 
{"Row" : 26, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnant women, empirical treatment", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 31, "Column" : 1, "Text" : "*Avoid nitrofurantoin in the third trimester"}, 
{"Row" : 33, "Column" : 1, "Text" : "Alternatives:"}, 
{"Row" : 35, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 37, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Patients having urological procedures", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Renal transplant recipients < 1 month after transplant", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "Screening and treatment of asymptomatic bacteriuria may be indicated. Consult"}, 
{"Row" : 45, "Column" : 1, "Text" : "nephrology for recommendations."}, 
{"Row" : 46, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "References:"}, 
{"Row" : 50, "Column" : 1, "Text" : "Mandell chapter: Urinary Tract Infections"}, 
{"Row" : 51, "Column" : 1, "Text" : "Nicolle et al., Clinical Infectious Diseases, 2019, 2.68(10)e83-e110"}, 
{"Row" : 52, "Column" : 1, "Text" : "Sanford keyword: Bacteriuria, Asymptomatic"}, 
{"Row" : 53, "Column" : 1, "Text" : "Up-To-Date article: Urinary tract infections and asymptomatic bacteriuria in"}, 
{"Row" : 54, "Column" : 1, "Text" : "pregnancy"}, 
{"Row" : 55, "Column" : 1, "Text" : "Up-To-Date article: Approach to the adult with asymptomatic bacteriuria"}, 
{"Row" : 56, "Column" : 1, "Text" : "Up-To-Date article: Kidney transplantation in adults: Urinary tract infection in"}, 
{"Row" : 57, "Column" : 1, "Text" : "kidney transplant recipients"}, 
{"Row" : 58, "Column" : 1, "Text" : "US Preventive Services Task Force, JAMA, 2019, 322(12)1188-1194"}
]},
{"Name" : "ORZID2 GMENU ABX BACTEREMIA", "Term1" : "Bacteremia", "DisplayText" : "Bacteremia", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPRO TO BACTEREMIA", "DisplayText" : "Approach to bacteremia", "Text" : "Approach to bacteremia...", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 GMENU ABX SUSP BACT, BLD CX NOT YET POS", "DisplayText" : "Suspected bacteremia, blood cultures not yet positive", "Text" : "Suspected bacteremia, blood cultures not yet positive...", "Mnemonic" : "6"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GNC", "DisplayText" : "Interim report of Gram-negative cocci", "Text" : "Interim report:  Gram negative cocci", "Mnemonic" : "8"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GNB", "DisplayText" : "Interim report of Gram-negative bacilli", "Text" : "Interim report:  Gram negative bacilli", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPC IN PAIRS", "DisplayText" : "Interim report of Gram-positive cocci in pairs", "Text" : "Interim report:  Gram positive cocci in pairs", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPC PRS/CHAINS", "DisplayText" : "Interim report of Gram-positive cocci in pairs and chains", "Text" : "Interim report:  Gram positive cocci in pairs and chains", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPC PAIRS/CLUSTERS", "DisplayText" : "Interim report of Gram-positive cocci in pairs and clusters", "Text" : "Interim report:  Gram positve cocci in pair and clusters", "Mnemonic" : "16"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT GPR", "DisplayText" : "Interim report of Gram-positive rods", "Text" : "Interim report:  Gram positive bacilli", "Mnemonic" : "18"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU INT RPT YEAST", "DisplayText" : "Interim report of yeast", "Text" : "Interim report:  Yeast", "Mnemonic" : "20"},
{"Row" : 3, "Column" : 1, "Text" : "Bacteremia", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Bacteremia, PRELIMINARY results", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Last reviewed July 2017", "Header" : 1}, 
{"Row" : 11, "Column" : 2, "Item" : "ORZID2 GMENU BACTEREMIA S. AUREUS", "DisplayText" : "Bacteremia associated with Staphylococcus aureus", "Text" : "with Staphylococcus aureus", "Mnemonic" : "22"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID2 GMENU BACTEREMIA COAG NEG STAPH", "DisplayText" : "Bacteremia associated with Coagulase-negative Staphylococci (CNS)", "Text" : "with Coagulase-negative Staphylococci (CNS)", "Mnemonic" : "24"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU BACTEREMIA CANDIDA SPP.", "DisplayText" : "Bacteremia associated with Candida spp.", "Text" : "with Candida spp.", "Mnemonic" : "26"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU BACTEREMIA LISTERIA", "DisplayText" : "Bacteremia associated with Listeria monocytogenes", "Text" : "with Listeria monocytogenes", "Mnemonic" : "28"},
{"Row" : 7, "Column" : 2, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 2, "Text" : "Bacteremia, FINAL results (specific pathogens)", "Header" : 1}, 
{"Row" : 9, "Column" : 2, "Text" : "_____________________________________", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX BALANITIS", "DisplayText" : "Balanitis and Balanoposthitis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Sexually Transmitted Infections and HIV Exposure", "Mnemonic" : "4"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID CLOTRIMAZOLE 1% CREAM TOPICAL BID", "DisplayText" : "Clotrimazole 1% cream topical bid", "Text" : "Clotrimazole 1% cream topically q12h ($) [M] for 7 days", "Mnemonic" : "6"},
{"Row" : 27, "Column" : 1, "Item" : "PSJZID NYSTATIN CREAM BID", "DisplayText" : "Nystatin Cream to affected area BID ($) [M]", "Text" : "Nystatin cream 100,000 units/g cream topically q12h ($) [M] for 7 days", "Mnemonic" : "8"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 150MG PO ONCE", "DisplayText" : "Fluconazole 150MG PO once", "Text" : "Fluconazole 150 mg PO once ($) [R,DI]", "Mnemonic" : "10"},
{"Row" : 35, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 0.75% CREAM TOPICALLY Q12H", "DisplayText" : "Metronidazole 0.75% cream topically q12h ($)[DI]", "Text" : "Metronidazole 0.75% cream topically q12h ($)[DI] for 7 days", "Mnemonic" : "12"},
{"Row" : 38, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 500MG PO Q12H", "DisplayText" : "Metronidazole 500MG PO q12h", "Text" : "Metronidazole 500 mg PO q12h ($) [DI] for 7 days", "Mnemonic" : "14"},
{"Row" : 3, "Column" : 1, "Text" : "BALANITIS AND BALANOPOSTHITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Balanitis is inflammation of the glans penis and is often associated with"}, 
{"Row" : 6, "Column" : 1, "Text" : "erythema and pruritis. When the foreskin is also involved, the condition is"}, 
{"Row" : 7, "Column" : 1, "Text" : "known as balanoposthitis (also referred to as balanitis in this discussion)."}, 
{"Row" : 8, "Column" : 1, "Text" : "There are a variety of causes of balanitis, but most are due to poor hygiene of"}, 
{"Row" : 9, "Column" : 1, "Text" : "the foreskin in uncircumcised men resulting in candida infection. Other, less"}, 
{"Row" : 10, "Column" : 1, "Text" : "common causes, include bacterial infection (typically sexually transmitted or"}, 
{"Row" : 11, "Column" : 1, "Text" : "anaerobic bacteria), dermatologic conditions, malignancy as well as others. Men"}, 
{"Row" : 12, "Column" : 1, "Text" : "with Candidal balanitis often have a white curd-like exudate compared to a thick"}, 
{"Row" : 13, "Column" : 1, "Text" : "foul-smelling purulent exudate in menu with anaerobic bacterial balanitis."}, 
{"Row" : 15, "Column" : 1, "Text" : "Patients at risk of sexually transmitted infections should be assessed for"}, 
{"Row" : 16, "Column" : 1, "Text" : "treatment:"}, 
{"Row" : 18, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Candidal balanitis empirical treatment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Mild to moderate cases", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 26, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 29, "Column" : 1, "Text" : "Severe cases", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Bacterial balanitis empirical treatment", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Mild cases"}, 
{"Row" : 37, "Column" : 1, "Text" : "Moderate to severe cases"}, 
{"Row" : 39, "Column" : 1, "Text" : "___________________________________________________________________________", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "References:"}, 
{"Row" : 43, "Column" : 1, "Text" : "Edwards et al., International Journal of STD & AIDS, 2014, 25(9)615-526"}, 
{"Row" : 44, "Column" : 1, "Text" : "Sanford keyword: Balanitis"}, 
{"Row" : 45, "Column" : 1, "Text" : "Up-to-Date article: Balanitis in Adults"}, 
{"Row" : 46, "Column" : 1, "Text" : "Workowski et al., MMWR Recomm Rep, 2021, 70(4)1-187"}
]},
{"Name" : "ORZID2 GMENU ABX BELL'S PALSY", "Term1" : "Bell's palsy", "DisplayText" : "Bell's Palsy ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX LYME DISEASE", "DisplayText" : "Lyme disease", "Text" : "Lyme Disease", "Mnemonic" : "4"},
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX PREDNISONE 60MG Q24H 7D VALACYCLOVIR 1000MG PO Q8H", "DisplayText" : "PREDNISONE 60MG Q24H 7D VALACYCLOVIR 1000MG PO Q8H", "Text" : "Prednisone 60 mg q24h PO for 7 days <AND> valacyclovir 1000 mg PO q8h ($) [R]", "Mnemonic" : "6"},
{"Row" : 22, "Column" : 1, "Item" : "ORZ SET ABX PREDNISONE 60MG Q24H 7D ACYCLOVIR 400MG PO Q6H", "DisplayText" : "PREDNISONE 60MG Q24H 7D ACYCLOVIR 400MG PO Q6H", "Text" : "Prednisone 60 mg q24h PO for 7 days <AND> acyclovir 400 mg PO q6h ($) [R] for 10", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "BELL'S PALSY", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Herpes simplex and varicella-zoster are possible causes of Bell's palsy. Others"}, 
{"Row" : 6, "Column" : 1, "Text" : "include Borrelia burgdorferi trauma. Some cases are idiopathic. Risk factors for"}, 
{"Row" : 7, "Column" : 1, "Text" : "Bell's Palsy include pregnancy, diabetes, obesity, hypertension, and upper"}, 
{"Row" : 8, "Column" : 1, "Text" : "respiratory infections. Neurology consult is encouraged."}, 
{"Row" : 10, "Column" : 1, "Text" : "If Lyme disease is suspected, refer to the Lyme disease treatment page:"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment with prednisone and an antiviral within 72 hours of symptoms onset"}, 
{"Row" : 14, "Column" : 1, "Text" : "improves the chances of a complete recovery."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 19, "Column" : 1, "Text" : "for 7 days"}, 
{"Row" : 21, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 23, "Column" : 1, "Text" : "days"}, 
{"Row" : 24, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "References:"}, 
{"Row" : 28, "Column" : 1, "Text" : "Baugh et al., Otolaryngology-Head and Neck Surgery, 2013, 149(3S)S1-S27"}, 
{"Row" : 29, "Column" : 1, "Text" : "Eviston et al., J Neurol Neurosurg Psychiatry, 2015, 56.1356-1361"}, 
{"Row" : 30, "Column" : 1, "Text" : "Jalali et al., Laryngoscope, 2021, 131.1615-1625"}, 
{"Row" : 31, "Column" : 1, "Text" : "Mandell chapter: Antivirals against Herpes Viruses"}, 
{"Row" : 32, "Column" : 1, "Text" : "Sanford keyword: Herpes Simplex, Bell's Palsy"}, 
{"Row" : 33, "Column" : 1, "Text" : "Schwartz et al., Otolaryngology-Head and Neck Surgery, 2014, 150(5)709-711"}, 
{"Row" : 34, "Column" : 1, "Text" : "Up-To-Date article: Bell's palsy: Treatment and prognosis in adults"}
]},
{"Name" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment ", "Version" : "StCloud", "Contents" : [
{"Row" : 5, "Column" : 1, "Item" : "ORZ GTX ABX BETA-LACTAM ALLERGIES PDF", "DisplayText" : "Beta-lactam Allergies PDF", "Text" : "Assessment of Beta-lactam Reaction [CLICK HERE]", "Mnemonic" : "2"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX IMPORTANT BETA-LACTAM ALLERGY FACTS", "DisplayText" : "Important Beta-lactam Allergy Facts and Reaction History", "Text" : "Important Beta-Lactam Allergy Facts and Obtaining a Detailed Reaction History", "Mnemonic" : "4"},
{"Row" : 2, "Column" : 1, "Text" : "ASSESSMENT OF BETA-LACTAM REACTION AND ALTERNATIVE TREATMENT", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "Streamlined Version (PDF form)", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "This guide is intended to aid clinicians in assessment of beta-lactam"}, 
{"Row" : 8, "Column" : 1, "Text" : "reactions and selection of appropriate alternative therapy. It is not a"}, 
{"Row" : 9, "Column" : 1, "Text" : "substitute for clinical judgment and should not be used as a sole resource when"}, 
{"Row" : 10, "Column" : 1, "Text" : "selecting antimicrobial therapy."}, 
{"Row" : 13, "Column" : 1, "Text" : "Reaction Assessment and Selection of an Alternative Beta-lactam", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "- If the same or a different beta-lactam was subsequently tolerated without"}, 
{"Row" : 15, "Column" : 1, "Text" : "reaction, that beta-lactam may be used."}, 
{"Row" : 16, "Column" : 1, "Text" : "- If reaction was intolerance (e.g. headache, GI symptoms), family history of"}, 
{"Row" : 17, "Column" : 1, "Text" : "reaction, or if the patient denies allergy, any beta-lactam may be used."}, 
{"Row" : 18, "Column" : 1, "Text" : "- See below for treatment based on type of reaction (severe vs non-severe)."}, 
{"Row" : 19, "Column" : 1, "Text" : "- If reaction is unknown and patient denies any severe reactions (see below for"}, 
{"Row" : 20, "Column" : 1, "Text" : "list of severe reactions), reaction is considered non-severe."}, 
{"Row" : 21, "Column" : 1, "Text" : "- If patient is in a suitable care setting, observation during the first 15"}, 
{"Row" : 22, "Column" : 1, "Text" : "minutes to 1 hour after first dose of therapy may be performed to monitor for"}, 
{"Row" : 23, "Column" : 1, "Text" : "signs/symptoms of an allergic reaction."}, 
{"Row" : 24, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "SEVERE REACTION TO BETA-LACTAM:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "If the patient experienced a known severe reaction (use link below for severe"}, 
{"Row" : 30, "Column" : 1, "Text" : "reaction list), AVOID ALL Beta-Lactam Antibiotics. If beta-lactam therapy is"}, 
{"Row" : 31, "Column" : 1, "Text" : "ideal, contact Infectious Diseases for desensitization or alternative."}, 
{"Row" : 32, "Column" : 1, "Text" : "Severe Reaction Examples:"}, 
{"Row" : 33, "Column" : 1, "Text" : "- Anaphylaxis"}, 
{"Row" : 34, "Column" : 1, "Text" : "- Reaction needed medical intervention"}, 
{"Row" : 35, "Column" : 1, "Text" : "- Mucosal, cardiovascular or respiratory system involvement"}, 
{"Row" : 36, "Column" : 1, "Text" : "- Hemolytic anemia"}, 
{"Row" : 37, "Column" : 1, "Text" : "- Immune hepatitis"}, 
{"Row" : 38, "Column" : 1, "Text" : "- Interstitial nephritis"}, 
{"Row" : 39, "Column" : 1, "Text" : "- Acute interstitial nephritis (AIN)"}, 
{"Row" : 40, "Column" : 1, "Text" : "- Skin desquamation"}, 
{"Row" : 41, "Column" : 1, "Text" : "- Drug reaction with eosinophilia and systemic symptoms (DRESS)"}, 
{"Row" : 42, "Column" : 1, "Text" : "- Stevens-Johnson syndrome (SJS)"}, 
{"Row" : 43, "Column" : 1, "Text" : "- Generalized exanthematous pustulosis"}, 
{"Row" : 44, "Column" : 1, "Text" : "- Toxic epidermal necrolysis (TEN)"}, 
{"Row" : 45, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "NON-SEVERE REACTION TO BETA-LACTAM:", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Text" : "Select an alternative non-cross-reactive beta-lactam for therapy based on"}, 
{"Row" : 51, "Column" : 1, "Text" : "beta-lactam class patient had a reaction to. Refer to PDF document above for"}, 
{"Row" : 52, "Column" : 1, "Text" : "detailed cross-reactivity chart."}, 
{"Row" : 54, "Column" : 1, "Text" : "PENICILLIN CLASS REACTION", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "(e.g. Amoxicillin, ampicillin, cloxacillin, dicloxacillin, nafcillin, oxacillin,"}, 
{"Row" : 56, "Column" : 1, "Text" : "penicillin, piperacillin, ticarcillin)"}, 
{"Row" : 57, "Column" : 1, "Text" : "Use: Cefazolin, cefdinir, cefuroxime, ceftazidime, ceftriaxone, cefepime,", "Header" : 1}, 
{"Row" : 58, "Column" : 1, "Text" : "ertapenem, imipenem, or meropenem", "Header" : 1}, 
{"Row" : 60, "Column" : 1, "Text" : "1ST GENERATION CEPHALOSPORIN CLASS REACTION", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "(e.g. Cefadroxil, cefatrizine, cefazolin, ceftezole, cephalexin, cephalothin,"}, 
{"Row" : 62, "Column" : 1, "Text" : "cephapirin)"}, 
{"Row" : 63, "Column" : 1, "Text" : "Use: Dicloxacillin, nafcillin, cefazolin (unless reaction was to cefazolin)", "Header" : 1}, 
{"Row" : 64, "Column" : 1, "Text" : "cefdinir, ceftazidime, ceftriaxone, cefuroxime, cefepime, ertapenem, imipenem,", "Header" : 1}, 
{"Row" : 65, "Column" : 1, "Text" : "or meropenem", "Header" : 1}, 
{"Row" : 67, "Column" : 1, "Text" : "2ND GENERATION CEPHALOSPORIN CLASS REACTION", "Header" : 1}, 
{"Row" : 68, "Column" : 1, "Text" : "(e.g. Cefaclor, cefamandole, cefonicid, cefotetan, cefoxitin, cefprozil,"}, 
{"Row" : 69, "Column" : 1, "Text" : "cefuroxime)"}, 
{"Row" : 70, "Column" : 1, "Text" : "Use: Amoxicillin, ampicillin, dicloxacillin, nafcillin, piperacillin,", "Header" : 1}, 
{"Row" : 71, "Column" : 1, "Text" : "cefadroxil cefazolin, cefdinir, ceftazidime, ceftriaxone, cephalexin, cefepime,", "Header" : 1}, 
{"Row" : 72, "Column" : 1, "Text" : "ertapenem imipenem, or meropenem", "Header" : 1}, 
{"Row" : 74, "Column" : 1, "Text" : "3RD-5TH GENERATION CEPHALOSPORIN CLASS REACTION", "Header" : 1}, 
{"Row" : 75, "Column" : 1, "Text" : "(e.g. Cefdinir, cefditoren, cefepime, cefiderocol,cefixime, cefpirome,"}, 
{"Row" : 76, "Column" : 1, "Text" : "cefoperazone, cefotaxime, cefpodoxime, ceftaroline, ceftazidime, ceftibuten,"}, 
{"Row" : 77, "Column" : 1, "Text" : "ceftizoxime, ceftolozane, ceftriaxone)"}, 
{"Row" : 78, "Column" : 1, "Text" : "Use: Amoxicillin, ampicillin, dicloxacillin, nafcillin, penicillin,", "Header" : 1}, 
{"Row" : 79, "Column" : 1, "Text" : "piperacillin, cefadroxil, cefazolin, cephalexin, ertapenem, imipenem, or", "Header" : 1}, 
{"Row" : 80, "Column" : 1, "Text" : "meropenem", "Header" : 1}, 
{"Row" : 82, "Column" : 1, "Text" : "CARBAPENEM CLASS REACTION", "Header" : 1}, 
{"Row" : 83, "Column" : 1, "Text" : "(e.g. Ertapenem, imipenem and meropenem)"}, 
{"Row" : 84, "Column" : 1, "Text" : "Use: Amoxicillin, ampicillin, dicloxacillin, nafcillin, penicillin,", "Header" : 1}, 
{"Row" : 85, "Column" : 1, "Text" : "piperacillin, cefadroxil, cefazolin, cephalexin, cefdinir, ceftazidime,", "Header" : 1}, 
{"Row" : 86, "Column" : 1, "Text" : "ceftriaxone, or cefepime", "Header" : 1}, 
{"Row" : 87, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 89, "Column" : 1, "Text" : "References", "Header" : 1}, 
{"Row" : 90, "Column" : 1, "Text" : "Blumenthal et. al., Addressing Inpatient Beta-Lactam Allergies: A Multihospital"}, 
{"Row" : 91, "Column" : 1, "Text" : "Implementation. J Allergy Clin Immunol Pract. 2017, 5(3)616-625"}, 
{"Row" : 92, "Column" : 1, "Text" : "Is it Really a Penicillin Allergy? Centers for Disease Control and Prevention,"}, 
{"Row" : 93, "Column" : 1, "Text" : "2017"}, 
{"Row" : 94, "Column" : 1, "Text" : "Chaudhry et al., Cephalosporins: A Focus on Side Chains and Beta-Lactam Cross-"}, 
{"Row" : 95, "Column" : 1, "Text" : "Reactivity. Pharmacy, 2019, 7(3)103"}, 
{"Row" : 96, "Column" : 1, "Text" : "Collins, et al. Impact of an Antibiotic Side-Chain-Based Cross-reactivity Chart"}, 
{"Row" : 97, "Column" : 1, "Text" : "Combined With Enhanced Allergy Assessment Processes for Surgical Prophylaxis"}, 
{"Row" : 98, "Column" : 1, "Text" : "Antimicrobials in Patients With Beta-Lactam Allergies. Clinical Infectious"}, 
{"Row" : 99, "Column" : 1, "Text" : "Diseases, 2020"}, 
{"Row" : 100, "Column" : 1, "Text" : "Patrick et al., Beta-lactam allergy Benefits of de-labeling can be achieved"}, 
{"Row" : 101, "Column" : 1, "Text" : "safely. BC Medical Journal, 2019, 61(9)350"}, 
{"Row" : 102, "Column" : 1, "Text" : "Sakoulas et al., Is a Reported Penicillin Allergy Sufficient Grounds to Forgo"}, 
{"Row" : 103, "Column" : 1, "Text" : "the Multidimensional Antimicrobial Benefits of Beta-Lactam Antibiotics?"}, 
{"Row" : 104, "Column" : 1, "Text" : "Clinical Infectious Diseases, 2019, 68(1)157"}, 
{"Row" : 105, "Column" : 1, "Text" : "Shenoy et al., Evaluation and Management of Penicillin Allergy. JAMA. 2019,"}, 
{"Row" : 106, "Column" : 1, "Text" : "321(2)188"}, 
{"Row" : 107, "Column" : 1, "Text" : "Solensky et al., Drug Allergy: An Updated Practice Parameter. Ann Allergy Asthma"}, 
{"Row" : 108, "Column" : 1, "Text" : "Immunol. 2010, 105(4)259"}, 
{"Row" : 109, "Column" : 1, "Text" : "Sanford keyword: Drug Allergy, Beta-lactams"}, 
{"Row" : 110, "Column" : 1, "Text" : "Tribiano et al. The Three C's of Antibiotic Allergy - Classification, Cross-"}, 
{"Row" : 111, "Column" : 1, "Text" : "Reactivity and Collaboration. J Allergy Clin Immunol Pract, 2017, 5(6)1532-"}, 
{"Row" : 112, "Column" : 1, "Text" : "1542"}, 
{"Row" : 113, "Column" : 1, "Text" : "Up-to-Date article: Cephalosporin-allergic patients: Subsequent use of"}, 
{"Row" : 114, "Column" : 1, "Text" : "cephalosporins and related antibiotics"}, 
{"Row" : 115, "Column" : 1, "Text" : "Up-to-Date article: Drug allergy: Classification and clinical features"}, 
{"Row" : 116, "Column" : 1, "Text" : "Zagursky et al., Cross-reactivity in b-Lactam Allergy. J Allergy Clin Immunol"}, 
{"Row" : 117, "Column" : 1, "Text" : "Pract. 2018, 6(1)72"}
]},
{"Name" : "ORZID2 GMENU ABX BRONCHITIS", "Term1" : "Bronchitis ", "Term2" : "COPD exacerbation ", "Term3" : "Exacerbation of COPD", "DisplayText" : "Bronchitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU ABX PERTUSSIS", "DisplayText" : "Pertussis", "Text" : "Pertussis", "Mnemonic" : "4"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX BRONCHITIS NOT BENEFIT", "DisplayText" : "Bronchitis not benefited", "Text" : "Bronchitis-antibiotics not a benefit in otherwise healthy patient", "Mnemonic" : "6"},
{"Row" : 33, "Column" : 1, "Item" : "PSJZID DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO BID ($) [DI] < OR >", "Mnemonic" : "8"},
{"Row" : 34, "Column" : 1, "Item" : "PSJZID TMP/SMX DS PO Q12H", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 DS tablet q12h", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet q12h ($) [R,DI]", "Mnemonic" : "10"},
{"Row" : 37, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H 4DAYS", "DisplayText" : "AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H FOR 4 DAYS", "Text" : "Azithromycin 500mg PO once on day one then 250mg PO qday for 4 days ($) [M]", "Mnemonic" : "12"},
{"Row" : 38, "Column" : 1, "Item" : "PSJZID AMOX/CLAV 875-125MG PO Q12H", "DisplayText" : "Amoxicillin/clavulanate 875-125 mg po q12h", "Text" : "Amoxicillin-clavulanate 875-125 mg PO q12h ($) [R] < OR >", "Mnemonic" : "14"},
{"Row" : 40, "Column" : 1, "Item" : "PSJIZID AZITHROMYC 500MG IV X1 THEN 250MG IV X4DAYS", "DisplayText" : "AZITHROMYCIN 500MG IV THEN 250MG IV Q24H 4DAYS", "Text" : "Azithromycin 500 mg IV once on day 1, then 250 mg IV q24 for 4 days ($) [M< OR >", "Mnemonic" : "16"},
{"Row" : 41, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin-sulbactam 3 gm IV q6h", "Text" : "Ampicillin-sulbactam 3 gm IV q6h ($) [R]", "Mnemonic" : "18"},
{"Row" : 45, "Column" : 1, "Item" : "ORZ GTX ABX IDP FLUOROQUINOLONES FDA WARNINGS", "DisplayText" : "[Link] Fluoroquinolones FDA Serious Adverse Reactions", "Text" : "Fluoroquinolones FDA Serious Adverse Reactions", "Mnemonic" : "20"},
{"Row" : 2, "Column" : 1, "Text" : "BRONCHITIS"}, 
{"Row" : 4, "Column" : 1, "Text" : "Acute bronchitis should not be treated with antimicrobials except in specific"}, 
{"Row" : 5, "Column" : 1, "Text" : "circumstances. If pneumonia is suspected, order a chest x-ray.  If an"}, 
{"Row" : 6, "Column" : 1, "Text" : "infiltrate is not present, the patient does not have bacterial pneumonia and"}, 
{"Row" : 7, "Column" : 1, "Text" : "need not be treated for it."}, 
{"Row" : 9, "Column" : 1, "Text" : "Acute bronchitis in an otherwise HEALTHY PATIENT", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Antimicrobials provide no benefit.  If bronchitis persists beyond 2 weeks,"}, 
{"Row" : 11, "Column" : 1, "Text" : "additional diagnostic workup is needed to find a cause.  If a patient has"}, 
{"Row" : 12, "Column" : 1, "Text" : "persistent cough with inspiratory whoop, consider a diagnosis of pertussis."}, 
{"Row" : 17, "Column" : 1, "Text" : "Acute bronchitis in patients with COPD", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Symptoms of COPD exacerbation include dyspnea with increased sputum purulence"}, 
{"Row" : 19, "Column" : 1, "Text" : "and volume, together with increased cough and wheeze. Co-morbidities are"}, 
{"Row" : 20, "Column" : 1, "Text" : "common in COPD patients, thus exacerbations must be differentiated clinically"}, 
{"Row" : 21, "Column" : 1, "Text" : "from other events such as acute coronary syndrome, worsening heart failure,"}, 
{"Row" : 22, "Column" : 1, "Text" : "pulmonary embolism and pneumonia."}, 
{"Row" : 24, "Column" : 1, "Text" : "Cornerstones of therapy include oxygen, bronchodilators, and in some cases"}, 
{"Row" : 25, "Column" : 1, "Text" : "corticosteroids. Recommend antibiotics for moderately or severely ill patients"}, 
{"Row" : 26, "Column" : 1, "Text" : "with COPD exacerbation who have increased sputum purulence and volume."}, 
{"Row" : 28, "Column" : 1, "Text" : "Treatment for MILD DISEASE:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "No antibiotics recommended"}, 
{"Row" : 31, "Column" : 1, "Text" : "Treatment for MODERATE DISEASE", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Treat for 5 to 7 days."}, 
{"Row" : 36, "Column" : 1, "Text" : "Treatment for SEVERE DISEASE", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "NOTE: Fluoroquinolones are not listed as a choice because the risk of serious", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "side effects outweigh the benefits.", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "References:"}, 
{"Row" : 48, "Column" : 1, "Text" : "Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017."}, 
{"Row" : 49, "Column" : 1, "Text" : "Access: http://www.goldcopd.org"}, 
{"Row" : 50, "Column" : 1, "Text" : "Wenzel WP et al NEJM 2006, 355: 2125"}, 
{"Row" : 51, "Column" : 1, "Text" : "Mandell chapter: Bronchitis"}, 
{"Row" : 52, "Column" : 1, "Text" : "Sanford keyword: Bronchitis"}, 
{"Row" : 53, "Column" : 1, "Text" : "Murphy TF Chest 2000, 118: 204"}, 
{"Row" : 54, "Column" : 1, "Text" : "Masterton RG Int J Antimicrob Agents 2001, 18: 503"}
]},
{"Name" : "ORZID2 GMENU ABX BRONCHITIS NOT BENEFIT", "Term1" : "Bronchitis in otherwise healthy patient", "DisplayText" : "Bronchitis not benefited ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 2, "Column" : 1, "Text" : "BRONCHITIS", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "Acute bronchitis is a clinical syndrome with a brief, self-limited"}, 
{"Row" : 5, "Column" : 1, "Text" : "pneumonia on chest radiograph. It is accompanied by dry or productive cough"}, 
{"Row" : 6, "Column" : 1, "Text" : "lasting up to 3 weeks, is most prevalent in winter, and is primarily caused"}, 
{"Row" : 7, "Column" : 1, "Text" : "by viruses.More than 1 in 20 people have acute bronchitis per year, with"}, 
{"Row" : 8, "Column" : 1, "Text" : "highest rates during the winter months.  This discussion does not pertain to"}, 
{"Row" : 9, "Column" : 1, "Text" : "acute exacerbations of chronic bronchitis, a clinical syndrome also"}, 
{"Row" : 10, "Column" : 1, "Text" : "frequently associated with viral infection, but in which bacteria play a more"}, 
{"Row" : 11, "Column" : 1, "Text" : "important role."}, 
{"Row" : 13, "Column" : 1, "Text" : "Narcotic cough suppressants, expectorants, antihistamines,"}, 
{"Row" : 14, "Column" : 1, "Text" : "decongestants, and beta 2-agonists have been used to treat patients with"}, 
{"Row" : 15, "Column" : 1, "Text" : "acute bronchitis, but controlled trials have not clearly concluded that they"}, 
{"Row" : 16, "Column" : 1, "Text" : "are beneficial."}, 
{"Row" : 18, "Column" : 1, "Text" : "Empirical antibacterial therapy has repeatedly been shown to provide no"}, 
{"Row" : 19, "Column" : 1, "Text" : "benefit for most patients.  Acute bronchitis remains one of the five most"}, 
{"Row" : 20, "Column" : 1, "Text" : "frequently cited rationales for excessive antibiotic use in outpatients."}, 
{"Row" : 21, "Column" : 1, "Text" : "Acute bronchitis and other acute respiratory syndromes (otitis media,"}, 
{"Row" : 22, "Column" : 1, "Text" : "sinusitis, pharyngitis, upper respiratory infections) account for"}, 
{"Row" : 23, "Column" : 1, "Text" : "approximately 75% of ambulatory prescriptions in the United States.  Current"}, 
{"Row" : 24, "Column" : 1, "Text" : "guidelines, endorsed by a number of national societies, including the"}, 
{"Row" : 25, "Column" : 1, "Text" : "Infectious Diseases Society of America, do not recommend the routine use of"}, 
{"Row" : 26, "Column" : 1, "Text" : "antibiotics for uncomplicated acute bronchitis in otherwise normal persons."}, 
{"Row" : 28, "Column" : 1, "Text" : "If pertussis is suspected, early therapy with macrolides or"}, 
{"Row" : 29, "Column" : 1, "Text" : "tetracyclines is indicated to prevent transmission, although the clinical"}, 
{"Row" : 30, "Column" : 1, "Text" : "findings early in pertussis infection are indistinguishable from viral causes"}, 
{"Row" : 31, "Column" : 1, "Text" : "of bronchitis, and the incidence of disease is very low.  Treat for pertussis"}, 
{"Row" : 32, "Column" : 1, "Text" : "only when a patient has likely been exposed to other cases."}, 
{"Row" : 34, "Column" : 1, "Text" : "Asthma attacks often have symptoms resembling bronchitis.  Asthma"}, 
{"Row" : 35, "Column" : 1, "Text" : "attacks do not benefit from antimicrobial therapy."}
]},
{"Name" : "ORZID2 GMENU ABX C.DIFF 1ST RECURRENCE", "Term" : "050712 njt CDSS update", "DisplayText" : "First Recurrence of Antibiotic Associated Colitis...", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ EGD OUTPT", "DisplayText" : "EGD Consult", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 10, "Column" : 1, "Text" : "FIRST RECURRENCE OF ANTIBIOTIC ASSOCIATED COLITIS (CLOSTRIDIUM DIFFICILE", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "COLITIS) WITHOUT ILEUS OR TOXIC MEGACOLON", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "First Recurrence: Same as initial episode", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Discontinue implicated antibiotic and avoid high risk antibiotic if"}, 
{"Row" : 14, "Column" : 1, "Text" : "antibiotic still needed. Discontinue any antacid therapy if possible."}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred Treatment:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJZID VANCOMYCIN 125MG PO Q6H", "DisplayText" : "Vancomycin 125mg po q6h", "Text" : "Vancomycin 125 mg po q6h for 10 days ($15.00/day) [R]", "Mnemonic" : "12"},
{"Row" : 21, "Column" : 1, "Text" : "If patient cannot tolerate vancomycin:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJZID METRON 500MG PO Q8H", "DisplayText" : "Metronidazole 500mg po q8h", "Text" : "Metronidazole 500 mg PO q8h for 10 days ($0.48/day) [DI]", "Mnemonic" : "14"},
{"Row" : 24, "Column" : 1, "Text" : "Complicated:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX TOXI MEGACOLON", "DisplayText" : "Severe disease - Ileus/Toxic megacolon", "Text" : "Select for complicated cases: shock, ileus, megacolon", "Mnemonic" : "16"},
{"Row" : 25, "Column" : 1, "Text" : "Gastroenterology and/or Infectious Diseases consults are essential."}, 
{"Row" : 30, "Column" : 1, "Text" : "Johnson S et al Clinical Infectious Diseases 2014 59(3) 345-54"}, 
{"Row" : 31, "Column" : 1, "Text" : "Cohen SH et al Infect Control Hosp Epidemiol 2010 Vol. 31. 431-55"}
]},
{"Name" : "ORZID2 GMENU ABX C.DIFF 2ND RECURRENCE", "Term" : "050712 njt CDSS update", "DisplayText" : "Second Recurrence of Antibiotic Associated Colitis...  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ EGD OUTPT", "DisplayText" : "EGD Consult", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Text" : "Second Recurrence:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "SECOND RECURRENCE OF ANTIBIOTIC ASSOCIATED COLITIS", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "(CLOSTRIDIUM DIFFICILE COLITIS) WITHOUT ILEUS OR TOXIC MEGACOLON", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Cases with more than one recurrence are complex and difficult. One commonly"}, 
{"Row" : 13, "Column" : 1, "Text" : "used approach to therapy is given below, but there are several others."}, 
{"Row" : 14, "Column" : 1, "Text" : "Infectious disease or gastroenterology consultation is recommended."}, 
{"Row" : 16, "Column" : 1, "Text" : "Discontinue any antibiotics if possible and avoid high risk antibiotics if"}, 
{"Row" : 17, "Column" : 1, "Text" : "antibiotic still needed. Discontinue any antacid therapy if possible."}, 
{"Row" : 22, "Column" : 1, "Text" : "then \"taper and pulse\" with"}, 
{"Row" : 23, "Column" : 1, "Text" : "Vancomycin 125 mg po q12h for 7 days ($7.40/day) [R]"}, 
{"Row" : 24, "Column" : 1, "Text" : "then"}, 
{"Row" : 27, "Column" : 1, "Text" : "Vancomycin 125 mg every other day for 6 weeks. ($3.70/day) [R]"}, 
{"Row" : 29, "Column" : 1, "Text" : "Third or more recurrence: Consult Gastroenterology or Infectious Disease", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Item" : "PSJZID VANCOMYCIN TAPER AND PULSE DOSING", "DisplayText" : "Vancomycin Taper and Pulse Dosing", "Text" : "Vancomycin 125 mg PO q6h for 10 days ($15.00/day) [R]", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Text" : "Vancomycin 125 mg PO daily for 7 days ($3.70/day) [R]"}, 
{"Row" : 26, "Column" : 1, "Text" : "then"}, 
{"Row" : 32, "Column" : 1, "Text" : "Cohen SH et al Infect Control Hosp Epidemiol 2010 Vol. 31. 431-55"}
]},
{"Name" : "ORZID2 GMENU ABX C.DIFF INITIAL", "Term" : "050712 njt CDSS update", "DisplayText" : "Initial Antibiotic Associated Colitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ EGD OUTPT", "DisplayText" : "EGD Consult", "Text" : "Gastroenterology consult", "Mnemonic" : "08"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 9, "Column" : 1, "Text" : "INITIAL EPISODE OF ANTIBIOTIC ASSOCIATED COLITIS (CLOSTRIDIUM DIFFICILE", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "COLITIS) WITHOUT ILEUS OR TOXIC MEGACOLON", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Discontinue implicated antibiotic and avoid high risk antibiotic if"}, 
{"Row" : 14, "Column" : 1, "Text" : "antibiotic still needed. Discontinue any antacid therapy if possible."}, 
{"Row" : 16, "Column" : 1, "Text" : "Initial Episode", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Item" : "PSJZID VANCOMYCIN 125MG PO Q6H", "DisplayText" : "Vancomycin 125mg po q6h", "Text" : "Vancomycin 125mg po q6h for 10 days ($15.00/day) [R]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Text" : "Complicated:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Preferred Treatment:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "If patient cannot tolerate vancomycin:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Item" : "PSJZID METRON 500MG PO Q8H", "DisplayText" : "Metronidazole 500mg po q8h", "Text" : "Metronidazole 500 mg PO q8h for 10 days ($0.48/day) [DI]", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Text" : "Gastroenterology and/or Infectious Diseases consults are essential."}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX TOXI MEGACOLON", "DisplayText" : "Severe disease - Ileus/Toxic megacolon", "Text" : "Select for complicated cases: shock, ileus, megacolon", "Mnemonic" : "16"},
{"Row" : 30, "Column" : 1, "Text" : "Johnson S et al Clinical Infectious Diseases 2014 59(3) 345-54"}, 
{"Row" : 31, "Column" : 1, "Text" : "Cohen SH et al Infect Control Hosp Epidemiol 2010 Vol. 31. 431-55"}
]},
{"Name" : "ORZID2 GMENU ABX CAMPYLOBACTER", "Term1" : "Campylobacter diarrhea/gastroenteritis", "DisplayText" : "Diarrhea with Campylobacter ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 12, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1GM PO once", "Text" : "Azithromycin 1000 mg PO one-time dose ($) [M]", "Mnemonic" : "4"},
{"Row" : 14, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO Q24H", "DisplayText" : "Azithromycin 500 mg PO q24h", "Text" : "Azithromycin 500 mg PO q24h for 3 days ($) [M]", "Mnemonic" : "6"},
{"Row" : 17, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h for 5 days ($)[R,DI]", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "DIARRHEA WITH CAMPYLOBACTER", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Fluoroquinolone resistance is increasing worldwide. Macrolide resistance is"}, 
{"Row" : 6, "Column" : 1, "Text" : "rare."}, 
{"Row" : 8, "Column" : 1, "Text" : "Primary treatment", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 11, "Column" : 1, "Text" : "Antimicrobial treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 16, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 20, "Column" : 1, "Text" : "References:"}, 
{"Row" : 22, "Column" : 1, "Text" : "Sanford keyword: Campylobacter"}, 
{"Row" : 23, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 24, "Column" : 1, "Text" : "Up-to-Date article: Clinical manifestations, diagnosis, and treatment of"}, 
{"Row" : 25, "Column" : 1, "Text" : "Campylobacter infection"}
]},
{"Name" : "ORZID2 GMENU ABX CANDIDA UTI", "Term1" : "Candida urinary tract infection ", "Term2" : "Urinary tract infection (UTI), candida", "DisplayText" : "Candida urinary tract infection", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU BACTEREMIA CANDIDA SPP.", "DisplayText" : "Bacteremia associated with Candida spp.", "Text" : "Fungemia Associated with Candida spp.", "Mnemonic" : "4"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 400 mg (6 mg/kg) PO q24h ($) [R,DI] for 3 days before and 3 days", "Mnemonic" : "6"},
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID FLUCONAZOLE 400MG IV Q24H", "DisplayText" : "Fluconazole 400mg iv q24h", "Text" : "Fluconazole 400 mg (6 mg/kg) IV q24h ($) [R,DI] for 3 days before and 3 days", "Mnemonic" : "8"},
{"Row" : 29, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 200MG PO Q24H", "DisplayText" : "Fluconazole 200 mg po q24h ($0.20) [R", "Text" : "Fluconazole 200 mg (3 mg/kg) PO q24h ($) [R,DI] for 14 days", "Mnemonic" : "10"},
{"Row" : 31, "Column" : 1, "Item" : "PSJIZID FLUCONAZOLE 200-400MG IV Q24H", "DisplayText" : "Fluconazole 200-400 mg IV q24h ($13/day) [R", "Text" : "Fluconazole 200 mg (3 mg/kg) IV q24h ($) [R,DI] for 14 days", "Mnemonic" : "12"}, 
{"Row" : 34, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 400MG PO Q24H", "DisplayText" : "Fluconazole 400mg po q24h", "Text" : "Fluconazole 400 mg (6 mg/kg) PO q24h ($) [R,DI] for 14 days", "Mnemonic" : "14"},
{"Row" : 36, "Column" : 1, "Item" : "PSJIZID FLUCONAZOLE 400MG IV Q24H", "DisplayText" : "Fluconazole 400mg iv q24h", "Text" : "Fluconazole 400 mg (6 mg/kg) IV q24h ($) [R,DI] for 14 days", "Mnemonic" : "16"},
{"Row" : 3, "Column" : 1, "Text" : "CANDIDA URINARY TRACT INFECTIONS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "A positive urine culture for candida usually reflects colonization. Treat"}, 
{"Row" : 6, "Column" : 1, "Text" : "cystitis only if the patient has symptoms of urinary tract infection (e.g."}, 
{"Row" : 7, "Column" : 1, "Text" : "dysuria, frequency, urgency, and/or suprapubic tenderness) or if the patient"}, 
{"Row" : 8, "Column" : 1, "Text" : "will undergo invasive urological manipulation"}, 
{"Row" : 10, "Column" : 1, "Text" : "Asymptomatic candiduria in a patient with a urinary catheter should not be"}, 
{"Row" : 11, "Column" : 1, "Text" : "treated without an additional indication. Removal of catheter is strongly"}, 
{"Row" : 12, "Column" : 1, "Text" : "recommended. Contact Infectious Diseases for more information."}, 
{"Row" : 14, "Column" : 1, "Text" : "Neutropenic patients with asymptomatic candiduria should be assessed for"}, 
{"Row" : 15, "Column" : 1, "Text" : "candidemia because they are at risk of dissemination. Obtain blood cultures and"}, 
{"Row" : 16, "Column" : 1, "Text" : "assess potential sources of candidemia such as central venous catheters. Refer"}, 
{"Row" : 17, "Column" : 1, "Text" : "to fungemia page for treatment recommendations."}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Patient undergoing invasive urological manipulation:"}, 
{"Row" : 23, "Column" : 1, "Text" : "after procedure"}, 
{"Row" : 24, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 26, "Column" : 1, "Text" : "after procedure"}, 
{"Row" : 28, "Column" : 1, "Text" : "Symptomatic candida cystitis:"}, 
{"Row" : 30, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 33, "Column" : 1, "Text" : "Pyelonephritis:"}, 
{"Row" : 35, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 38, "Column" : 1, "Text" : "Resistant candida:"}, 
{"Row" : 40, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "References:"}, 
{"Row" : 44, "Column" : 1, "Text" : "Pappas et al., Clinical Infectious Diseases, 2016, 62(4)e1-e50"}, 
{"Row" : 45, "Column" : 1, "Text" : "Mandell chapter: Urinary Tract Infections"}, 
{"Row" : 46, "Column" : 1, "Text" : "Up-To-Date article: Candida Infections of the Bladder and Kidneys"}, 
{"Row" : 47, "Column" : 1, "Text" : "Up-To Date article: Candidemia in adults: Epidemiology, microbiology, and"}, 
{"Row" : 48, "Column" : 1, "Text" : "pathogenesis"}, 
{"Row" : 49, "Column" : 1, "Text" : "Sanford keyword: Candidiasis, Urinary Tract Infections"}, 
{"Row" : 39, "Column" : 1, "Text" : "Consult Infectious Diseases for treatment recommendations"}
]},
{"Name" : "ORZID2 GMENU ABX CANDIDA VULVO-VAGINITIS", "Term1" : "Candida vulvo-vaginitis ", "Term2" : "Vaginitis, Candida ", "Term3" : "Vulvo-vaginitis, candida", "DisplayText" : "Candida Vulvo-Vaginitis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 150MG PO ONCE", "DisplayText" : "Fluconazole 150MG PO once", "Text" : "Fluconazole 150 mg PO once ($) [R,DI]", "Mnemonic" : "4"},
{"Row" : 26, "Column" : 1, "Item" : "PSJZID CLOTRIMAZOLE VAGINAL CRM 1% 1 APPLFUL QHS", "DisplayText" : "Clotrimazole vaginal cream 1% 1 applicatorful qhs", "Text" : "Clotrimazole vaginal 1% cream 1 applicator full qhs ($) [M] for 7 to 14 days", "Mnemonic" : "6"},
{"Row" : 28, "Column" : 1, "Item" : "PSJZID TERCONAZOLE 0.4% CRM VAG QHS", "DisplayText" : "Terconazole 0.4% cream vaginal QHS", "Text" : "Terconazole 0.4% vaginal cream 1 applicator full qhs ($) [M] for 7 days", "Mnemonic" : "8"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 150MG PO Q72H", "DisplayText" : "Fluconazole 150 mg PO q72h for 7 days (3 doses) ($) [R,DI]", "Text" : "Fluconazole 150 mg PO q72h for 7 days (3 doses) ($) [R,DI]", "Mnemonic" : "10"},
{"Row" : 34, "Column" : 1, "Item" : "PSJZID CLOTRIMAZOLE VAGINAL CRM 1% 1 APPLFUL QHS", "DisplayText" : "Clotrimazole vaginal cream 1% 1 applicatorful qhs", "Text" : "Clotrimazole vaginal 1% cream 1 applicator full qhs ($) [M] for 10-14 days", "Mnemonic" : "12"},
{"Row" : 36, "Column" : 1, "Item" : "PSJZID TERCONAZOLE 0.4% CRM VAG QHS", "DisplayText" : "Terconazole 0.4% cream vaginal QHS", "Text" : "Terconazole 0.4% vaginal cream 1 applicator full qhs ($) [M] for 10-14 days", "Mnemonic" : "14"},
{"Row" : 40, "Column" : 1, "Item" : "PSJZID FLUCONAZOLE 150MG PO QWEEK", "DisplayText" : "Fluconazole 150 mg PO q week", "Text" : "Fluconazole 150 mg PO every 7 days ($) [R,DI] for 6 months", "Mnemonic" : "16"},
{"Row" : 3, "Column" : 1, "Text" : "CANDIDA VULVOVAGINITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Candida vulvovaginitis typically presents with valvular irritation, burning or"}, 
{"Row" : 6, "Column" : 1, "Text" : "pruritus. Vaginal pH should be measured, and the specimen should be examined"}, 
{"Row" : 7, "Column" : 1, "Text" : "under the microscope for clue cells (epithelial cell coated with bacteria) to"}, 
{"Row" : 8, "Column" : 1, "Text" : "exclude bacterial vaginosis. In candida vulvovaginitis, the vaginal pH is"}, 
{"Row" : 9, "Column" : 1, "Text" : "typically normal (4-4.5) and vaginal discharge is typically thick and curdy with"}, 
{"Row" : 10, "Column" : 1, "Text" : "white plaques on vaginal mucosa. Diagnosis is confirmed by identifying fungus or"}, 
{"Row" : 11, "Column" : 1, "Text" : "yeast with KOH prep."}, 
{"Row" : 13, "Column" : 1, "Text" : "Most non-C. albicans species respond to fluconazole treatment except C. krusei"}, 
{"Row" : 14, "Column" : 1, "Text" : "and C. glabrata. C. krusei can be treated with topical agents as for complicated"}, 
{"Row" : 15, "Column" : 1, "Text" : "candida vulvovaginitis below. C. glabrata treatment is complicated and azole"}, 
{"Row" : 16, "Column" : 1, "Text" : "therapy is frequently unsuccessful. Consult Infectious Diseases in patients with"}, 
{"Row" : 17, "Column" : 1, "Text" : "C. glabrata vulvovaginitis."}, 
{"Row" : 19, "Column" : 1, "Text" : "Recurrent candida vulvovaginitis is treated as complicated candida"}, 
{"Row" : 20, "Column" : 1, "Text" : "vulvovaginitis for induction treatment, followed by maintenance regimen for 6"}, 
{"Row" : 21, "Column" : 1, "Text" : "months."}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment of uncomplicated candida vulvovaginitis", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 27, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 30, "Column" : 1, "Text" : "Treatment of complicated candida vulvovaginitis (e.g. immunocompromised, severe", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "disease, pregnancy) or recurrent infection induction treatment", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 35, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 38, "Column" : 1, "Text" : "Recurrent candida vulvovaginitis maintenance regimen following induction", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "treatment above", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Treatment of C. glabrate vulvovaginitis", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Failure of azole therapy is common, alternative topical treatments below require"}, 
{"Row" : 44, "Column" : 1, "Text" : "compounding by a pharmacist. Please call pharmacy to order."}, 
{"Row" : 45, "Column" : 1, "Text" : "Topical flucytosine cream (17%) qhs for 14 days"}, 
{"Row" : 46, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 47, "Column" : 1, "Text" : "Topical boric acid capsule 600 mg intravaginal qhs for 14 days"}, 
{"Row" : 48, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "References:"}, 
{"Row" : 52, "Column" : 1, "Text" : "Mandell chapter: Vulvovaginitis and cervicitis"}, 
{"Row" : 53, "Column" : 1, "Text" : "IDSA Guidelines: Pappas et al, Clin Infect Dis (2016) 62.409"}, 
{"Row" : 54, "Column" : 1, "Text" : "Sanford keyword: Candidiasis, Vulvovaginitis"}, 
{"Row" : 55, "Column" : 1, "Text" : "Up-to-Date article: Candida vulvovaginitis: Treatment"}, 
{"Row" : 56, "Column" : 1, "Text" : "Up-to-Date article: Candida vulvovaginitis: Clinical manifestations and"}, 
{"Row" : 57, "Column" : 1, "Text" : "diagnosis"}, 
{"Row" : 58, "Column" : 1, "Text" : "Workowski et al., MMWR Recomm Rep, 2021, 70(4)1-187"}
]},
{"Name" : "ORZID2 GMENU ABX CAP ANAEROBES", "DisplayText" : "CAP with Anaerobes ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Mnemonic" : "12"},
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600 mg IV q8h ($) [H,O]  < OR >", "Mnemonic" : "14"},
{"Row" : 26, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($) [H,O]", "Mnemonic" : "16"},
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID AMPICILLIN-SULBACTAM 3GM IV Q6H", "DisplayText" : "Ampicillin-sulbactam 3 gm IV q6h", "Text" : "Ampicillin-sulbactam 3 gm IV q6h ($$) [R]  < OR >", "Mnemonic" : "18"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID AMOXICILLIN-CLAVULANATE 875-125 MG PO Q12H", "DisplayText" : "Amoxicillin-Clavulanate 875-125 MG PO Q12H", "Text" : "Amoxicillin-Clavulanate 875-125 MG PO q12h ($) [R]", "Mnemonic" : "20"},
{"Row" : 33, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "22"},
{"Row" : 34, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "24"}, 
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 11, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH ANAEROBIC BACTERIA"}, 
{"Row" : 13, "Column" : 1, "Text" : "Recent trials have not demonstrated a need to treat anaerobic bacteria with"}, 
{"Row" : 14, "Column" : 1, "Text" : "drugs traditionally used to treat anaerobic infections in the majority of CAP"}, 
{"Row" : 15, "Column" : 1, "Text" : "cases."}, 
{"Row" : 17, "Column" : 1, "Text" : "Anaerobic coverage is clearly indicated only in the classic aspiration"}, 
{"Row" : 18, "Column" : 1, "Text" : "pleuropulmonary syndrome in patients with a history of loss of consciousness has"}, 
{"Row" : 19, "Column" : 1, "Text" : "concomitant gingival disease or esophageal motility disorders."}, 
{"Row" : 21, "Column" : 1, "Text" : "Preferred treatment for classic aspiration pleuropulmonary syndrome", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treat for 7-10 days."}, 
{"Row" : 28, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "Bartlett JG Anaerobe 2011, 18:235"}, 
{"Row" : 39, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2007, 44: S27"}, 
{"Row" : 40, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 41, "Column" : 1, "Text" : "Roig J  J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 42, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 43, "Column" : 1, "Text" : "Up-to-date website"}
]},
{"Name" : "ORZID2 GMENU ABX CAP CHLAMYDOPHILA PNEUMONIAE", "DisplayText" : "CAP with Chlamydophila (Chlamydia) pneumoniae ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO Q24H", "DisplayText" : "Azithromycin 500 mg PO q24h", "Text" : "Azithromycin 500 mg PO q24h for 10 days ($) [M]", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID2 DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO q12h for 10 to 14 days ($) [DI]", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "18"},
{"Row" : 23, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "20"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 11, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH CHLAMYDOPHILA PNEUMONIAE"}, 
{"Row" : 13, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Alternative treatment:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Kohlhof SA Expert Opin Pharmacother 2015, 16:205"}, 
{"Row" : 27, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2007,44:S27-72"}, 
{"Row" : 29, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU ABX CAP LEGIONELLA PNEUMO", "DisplayText" : "CAP with Legionella pneumophila", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID AZITH 500MG IV Q24H", "DisplayText" : "Azithromycin 500MG IV Q24H", "Text" : "Azithromycin 500 mg IV q24h for 7 to 10 days ($) [M]  OR >", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 750MG IV Q24H", "DisplayText" : "Levofloxacin 750 mg IV q24h ($5/day) [R,DI]", "Text" : "Levofloxacin 750 mg IV q24h for 7 to 10 days ($) [R,DI]", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO Q24H", "DisplayText" : "Azithromycin 500 mg PO q24h", "Text" : "Azithromycin 500 mg PO q24h for 7 to 10 days ($) [M]  < OR >", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750 mg PO q24h ($0.30/day) [R,DI]", "Text" : "Levofloxacin 750 mg PO q24h for 7 to 10 days ($) [R,DI]", "Mnemonic" : "20"},
{"Row" : 28, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "22"},
{"Row" : 29, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "24"}, 
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "26"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH LEGIONELLA PNEUMOPHILA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Recommend parenteral treatment initially for all patients until signs"}, 
{"Row" : 14, "Column" : 1, "Text" : "and symptoms improve."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treat for 7 to 10 days. Consider longer courses of therapy in"}, 
{"Row" : 17, "Column" : 1, "Text" : "immunocompromised patients with severe illness."}, 
{"Row" : 19, "Column" : 1, "Text" : "Recommended to start with parenteral:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Switch to oral to complete therapy:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2007, 44: S27"}, 
{"Row" : 33, "Column" : 1, "Text" : "Phin N Lancet Infectious Diseases 2014, 14:1011"}, 
{"Row" : 34, "Column" : 1, "Text" : "Sanford: Pneumonia Legionella"}, 
{"Row" : 36, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU ABX CAP MYCOPLASMA PNEUMONIAE", "DisplayText" : "CAP with Mycoplasma pneumoniae ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Mnemonic" : "12"},
{"Row" : 16, "Column" : 1, "Item" : "PSJZID2 DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO q12h ($) [DI] < OR >", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H 4DAYS", "DisplayText" : "AZITHROMYCIN 500MG PO ONCE THEN 250MG PO Q24H FOR 4 DAYS", "Text" : "Azithromycin 500 mg PO x 1 on day 1, then 250 mg PO Q24H", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "18"},
{"Row" : 23, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "20"}, 
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "22"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH MYCOPLASMA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Treat for 7 to 10 days."}, 
{"Row" : 19, "Column" : 1, "Text" : "for 4 days ($) [M]"}, 
{"Row" : 21, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2007,44:S27-72"}, 
{"Row" : 27, "Column" : 1, "Text" : "Sanford: Pneumonia Mycoplasma"}, 
{"Row" : 29, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU ABX CAP P. AERUGINOSA", "DisplayText" : "CAP with Pseudomonas aeruginosa", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CEFTAZIDIME 2GM IV Q8H", "DisplayText" : "Ceftazidime 2 gm IV q8h", "Text" : "Ceftazidime 2 gm IV q8h ($$) [R]  < OR >", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID PIPERACILLIN/TAZOBACTAM 4.5GM IV Q6H", "DisplayText" : "Piperacillin/Tazobactam 4.5 gm IV q6h", "Text" : "Piperacillin-tazobactam 4.5 gm IV q6h ($$) [R] < OR >", "Mnemonic" : "16"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CIPROFLOX 400MG IV Q8H", "DisplayText" : "Ciprofloxacin 400 mg IV q8h", "Text" : "Ciprofloxacin 400 mg IV q8h ($) [R,DI]", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Item" : "ORZ SET ABX CEFTAZIDIME 2GM IV Q8H GENT 5MG IV QD", "DisplayText" : "CEFTAZIDIME 2GM IV Q8H GENT 5MG IV QD", "Text" : "Ceftazidime 2 gm IV q8h ($$) [R] <AND> gentamicin 5mg/kg IV q24h", "Mnemonic" : "20"},
{"Row" : 28, "Column" : 1, "Item" : "ORZ SET ABX CIP 400MG IV Q8H GENT 5MG IV QD", "DisplayText" : "CIPROFL 400MG IV Q8H GENT 5MG IV QD", "Text" : "Ciprofloxacin 400 mg IV q8h ($) [R,DI] <AND> gentamicin 5mg/kg IV q24h", "Mnemonic" : "22"},
{"Row" : 31, "Column" : 1, "Item" : "ORZ SET ABX PIP/TAZO 4.5 GM IV Q6H GENT 5MG IV QD", "DisplayText" : "PIP/TAZO 4.5GM IV Q6H GENT 5MG IV QD", "Text" : "Piperacillin-tazobactam 4.5 gm IV q6h ($$) [R] < AND > gentamicin 5", "Mnemonic" : "24"},
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX CIP 400MG IV Q8H CEFTAZIDIME 2GM IV Q8H", "DisplayText" : "CIPROFL 400MG IV Q8H CEFTAZIDIME 2GM IV Q8H", "Text" : "Ciprofloxacin 400 mg IV q8h ($/day) [R,DI] <AND> ceftazidime 2 gm IV q8h", "Mnemonic" : "26"},
{"Row" : 39, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($) [R,DI]", "Mnemonic" : "28"},
{"Row" : 42, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "30"},
{"Row" : 43, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "32"}, 
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "34"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 10, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH PSEUDOMONAS AERUGINOSA"}, 
{"Row" : 12, "Column" : 1, "Text" : "Single drug therapy is as effective as combination therapy in mild to moderate"}, 
{"Row" : 13, "Column" : 1, "Text" : "cases."}, 
{"Row" : 15, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE DISEASE", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 14 days."}, 
{"Row" : 20, "Column" : 1, "Text" : "If isolate is known susceptible:"}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment for SEVERE DISEASE", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treat for 14 to 21 days."}, 
{"Row" : 26, "Column" : 1, "Text" : "($) [R,O]  < OR >"}, 
{"Row" : 29, "Column" : 1, "Text" : "($) [R,O] < OR >"}, 
{"Row" : 32, "Column" : 1, "Text" : "mg/kg IV q24h ($) [R,O] < OR >"}, 
{"Row" : 35, "Column" : 1, "Text" : "($$) [R]"}, 
{"Row" : 37, "Column" : 1, "Text" : "Oral therapy if isolate is susceptible (usually given after several days", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "of intravenous therapy)", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 47, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 48, "Column" : 1, "Text" : "Kalil AC et al. Clin Infect Dis 2016. 63:1"}, 
{"Row" : 49, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 50, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2007, 44: S27"}, 
{"Row" : 51, "Column" : 1, "Text" : "Roig J  J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 53, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 54, "Column" : 1, "Text" : "Up-to-date website"}
]},
{"Name" : "ORZID2 GMENU ABX CAP S. PNEUMONIAE", "DisplayText" : "CAP with Streptococcus pneumoniae ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Mnemonic" : "12"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID PENICILLIN G 4 MILLION UNITS IV Q4H", "DisplayText" : "PENICILLIN G 4 MILLION UNITS IV Q4H", "Text" : "Penicillin G 4 million units IV q4h ($) [R] < OR >", "Mnemonic" : "14"},
{"Row" : 19, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IV Q24H", "DisplayText" : "Ceftriaxone 1GM IV Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($) [M]  < OR >", "Mnemonic" : "16"},
{"Row" : 20, "Column" : 1, "Item" : "PSJZID AMOXICILLIN 1000MG PO Q8H", "DisplayText" : "Amoxicillin 1000 mg PO q8h", "Text" : "Amoxicillin 1000 mg PO q8h ($) [R]", "Mnemonic" : "18"},
{"Row" : 23, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750 mg PO q24h ($0.30/day) [R,DI]", "Text" : "Levofloxacin 750 mg PO q24h ($) [R,DI]", "Mnemonic" : "20"},
{"Row" : 27, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 1GM IV QD AND AZITHROMYCIN 500MG PO", "DisplayText" : "Ceftriaxone 1 gm IV q24h <AND> azithromycin 500 mg PO", "Text" : "Ceftriaxone 1 gm IV q24h ($) [M] <AND> azithromycin 500 mg PO x 1", "Mnemonic" : "22"},
{"Row" : 30, "Column" : 1, "Item" : "ORZ SET ABX CEF 1GM IV AND AZITHROMYCIN 500MG IV", "DisplayText" : "CEFTRIAXONE 1GM IV AND AZITHROMYCIN 500MG IV", "Text" : "Ceftriaxone 1 gm IV q24h($) [M] <AND> azithromycin 500 mg IV once", "Mnemonic" : "24"},
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX LEVOFLOX 750 IV AZTREON 2G IV Q8H", "DisplayText" : "LEVO AZTREO", "Text" : "Levofloxacin 750 mg IV q24h ($) [R,DI] <AND> Aztreonam 2 gm IV q8h ($$$$)[R]", "Mnemonic" : "26"},
{"Row" : 37, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "28"},
{"Row" : 38, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "30"}, 
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "32"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 11, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA WITH STREPTOCOCCUS PNEUMONIAE"}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat until the patient is afebrile for 72 hours.  For severe pneumococcal"}, 
{"Row" : 14, "Column" : 1, "Text" : "pneumonia with bacteremia, combination treatment with a cephalosporin and a"}, 
{"Row" : 15, "Column" : 1, "Text" : "macrolide may be superior to monotherapy."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment for MILD TO MODERATE DISEASE", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Treatment for SEVERE DISEASE", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "on day 1, then 250 mg PO Q24H ($) [M] < OR >"}, 
{"Row" : 31, "Column" : 1, "Text" : "on day 1, then 250 mg IV Q24H ($) [M]"}, 
{"Row" : 33, "Column" : 1, "Text" : "Alternative:", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Chastre J JAMA 2003, 290: 2588"}, 
{"Row" : 42, "Column" : 1, "Text" : "Dennesen PJ Am J Respir Crit Care Med 2001, 163: 1371"}, 
{"Row" : 43, "Column" : 1, "Text" : "Kalil AC et al. Clin Infect Dis 2016. 63:1"}, 
{"Row" : 44, "Column" : 1, "Text" : "Luna CM  Crit Care Med 2003, 31: 676"}, 
{"Row" : 45, "Column" : 1, "Text" : "Mandell LA Clin Infect Dis 2007,44: S27"}, 
{"Row" : 46, "Column" : 1, "Text" : "Roig J J Antimicrob Chemother 2003, 51: 1119"}, 
{"Row" : 48, "Column" : 1, "Text" : "Singh N Am J Resp Crit Care Med 2000, 162: 505"}, 
{"Row" : 49, "Column" : 1, "Text" : "Up-to-date"}
]},
{"Name" : "ORZID2 GMENU ABX CAP STAPHYLOCOCCUS PNEUMONIA", "DisplayText" : "CAP with Staphylococcus aureus ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Disease", "Mnemonic" : "10"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Mnemonic" : "12"},
{"Row" : 20, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IV Q8H", "DisplayText" : "Cefazolin 2 gm IV q8h", "Text" : "Cefazolin 2 gm IV q8h ($/day) [R] < OR >", "Mnemonic" : "14"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID NAFCILLIN 2GM IV Q4H", "DisplayText" : "Nafcillin 2GM IV Q4H", "Text" : "Nafcilin 2 gm IV q4h ($$) [DI]", "Mnemonic" : "16"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "20"}, 
{"Row" : 30, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 500MG PO Q6H", "DisplayText" : "Cephalexin 500MG PO q6h", "Text" : "Cephalexin 500 mg PO q6h ($) [R] < OR >", "Mnemonic" : "22"},
{"Row" : 31, "Column" : 1, "Item" : "PSJZID MINOCYCLINE 100MG PO Q12H", "DisplayText" : "Minocycline 100 mg PO q12h", "Text" : "Minocycline 100 mg PO q12h ($) [DI] <OR>", "Mnemonic" : "24"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID DICLOXACILLIN 500MG PO Q6H", "DisplayText" : "Dicloxacillin 500MG PO q6h", "Text" : "Dicloxacillin 500 mg PO q6h ($) [R]", "Mnemonic" : "26"},
{"Row" : 48, "Column" : 1, "Item" : "PSJIZID VANCO 15MG/KG IV Q12H", "DisplayText" : "Vancomycin 15mg/kg iv q12h", "Text" : "Vancomycin 15 mg/kg IV q12h ($) [R] < OR >", "Mnemonic" : "28"},
{"Row" : 49, "Column" : 1, "Item" : "PSJIZID LINEZOLID 600MG IV Q12H", "DisplayText" : "Linezolid 600 mg IV Q12h", "Text" : "Linezolid 600 mg IV q12h ($$$$) [DI,O]", "Mnemonic" : "30"},
{"Row" : 52, "Column" : 1, "Item" : "PSJZID PREDNISONE 40MG PO QDAY X5DAYS", "DisplayText" : "Prednisone 40 mg PO q day for 5 days ($) [O]<OR>", "Text" : "Prednisone 40 mg PO q day for 5 days ($) [O]", "Mnemonic" : "32"},
{"Row" : 53, "Column" : 1, "Item" : "PSJZID METHYLPREDNISOLONE 40MG IV DAILY FOR 5 DAYS", "DisplayText" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Text" : "Methylprednisolone 40 mg IV qday for 5 days ($) [O]", "Mnemonic" : "34"}, 
{"Row" : 59, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($) [H,O] < OR >", "Mnemonic" : "36"},
{"Row" : 60, "Column" : 1, "Item" : "PSJZID MINOCYCLINE 100MG PO Q12H", "DisplayText" : "Minocycline 100 mg PO q12h", "Text" : "Minocycline 100 mg PO q12h ($) [DI] < OR >", "Mnemonic" : "38"},
{"Row" : 61, "Column" : 1, "Item" : "PSJZID TMP/SMX DS PO Q12H", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 DS tablet q12h", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO bid ($) [R,DI] < OR >", "Mnemonic" : "40"},
{"Row" : 62, "Column" : 1, "Item" : "PSJZID LINEZOLID 600MG PO Q12H", "DisplayText" : "Linezolid 600 mg PO Q12h", "Text" : "Linezolid 600 mg PO q12h ($) [DI,O]", "Mnemonic" : "42"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 10, "Column" : 1, "Text" : "STAPHYLOCOCCUS AUREUS CAP PNEUMONIA", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "For hospitalized patients with severe community acquired pneumonia defined by"}, 
{"Row" : 13, "Column" : 1, "Text" : "any one of the following: (1) a requirement for intensive care unit (ICU)"}, 
{"Row" : 14, "Column" : 1, "Text" : "admission, (2) necrotizing or cavitary infiltrates, or (3) empyema, empirical"}, 
{"Row" : 15, "Column" : 1, "Text" : "therapy for MRSA is recommended pending sputum and/or blood culture results."}, 
{"Row" : 17, "Column" : 1, "Text" : "Known Methicillin-SUSCEPTIBLE Staphylococcus aureus pneumonia", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Duration of therapy 7-14 days."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Oral therapy (usually given after several days of intravenous therapy):", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "A patient who is substantially improved, without fever for at least 2 days"}, 
{"Row" : 29, "Column" : 1, "Text" : "can be treated with an oral agent to which the isolate is susceptible."}, 
{"Row" : 33, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Methicillin-RESISTANT or Suceptibilities Unknown Staphlococcus aureus", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "In patients with MRSA pneumonia complicated by empyema, antimicrobial therapy"}, 
{"Row" : 37, "Column" : 1, "Text" : "should be used in conjunction with drainage procedures."}, 
{"Row" : 39, "Column" : 1, "Text" : "NOTE: A prospective trial comparing Linezolid to Vancomycin for MRSA"}, 
{"Row" : 40, "Column" : 1, "Text" : "pneumonia, including ventilator-associated pneumonia, showed higher clinical"}, 
{"Row" : 41, "Column" : 1, "Text" : "cure rate (p=0.042) for linezolid (95/165, 57.6%) than for vancomycin"}, 
{"Row" : 42, "Column" : 1, "Text" : "(81/174, 46.6%) but no difference in mortality (15.7% for linezolid vs. 17%"}, 
{"Row" : 43, "Column" : 1, "Text" : "for vancomycin).  Other factors to consider are the drug-drug interactions"}, 
{"Row" : 44, "Column" : 1, "Text" : "associated with linezolid and cost."}, 
{"Row" : 46, "Column" : 1, "Text" : "Antimicrobial therapy:", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Duration of therapy 7-14 days"}, 
{"Row" : 51, "Column" : 1, "Text" : "Adjunctive corticosteroid:", "Header" : 1}, 
{"Row" : 55, "Column" : 1, "Text" : "Oral therapy (usually given after several days of intravenous therapy:", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "In cases when a patient has substantially improved and has not had a fever"}, 
{"Row" : 57, "Column" : 1, "Text" : "for at least 2 days, it may be appropriate to treat with an oral agent to"}, 
{"Row" : 58, "Column" : 1, "Text" : "which the isolate is susceptible."}, 
{"Row" : 64, "Column" : 1, "Text" : "References:", "Header" : 1}, 
{"Row" : 65, "Column" : 1, "Text" : "Liu C, Clin Infect Dis. 2011:52:285"}, 
{"Row" : 66, "Column" : 1, "Text" : "Rybak MJ, Clin Infect 2009: Dis 49:325"}, 
{"Row" : 67, "Column" : 1, "Text" : "Sanford Keyword:Staphlococcus aureus pneumonia"}, 
{"Row" : 69, "Column" : 1, "Text" : "Wunderink RG, Clin Infect Dis. 2012: 54:621"}
]},
{"Name" : "ORZID2 GMENU ABX CARDIOVASCULAR", "Term1" : "Cardiovascular Section", "DisplayText" : "Cardiovascular  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPRO TO ENDOCARDITIS", "DisplayText" : "Approach to Endocarditis", "Text" : "Approach to Endocarditis", "Mnemonic" : "4"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ABX DIAGNOSIS OF ENDOCARDITIS", "DisplayText" : "Diagnosis of Endocarditis", "Text" : "Diagnosis of Endocarditis", "Mnemonic" : "6"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU EC NV EMP THERA", "DisplayText" : "Native Valve Endocarditis - Empirical Therapy", "Text" : "Empirical Therapy", "Mnemonic" : "8"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU EC NV SEL PATH", "DisplayText" : "Native Valve Endocarditis--Selected Pathogens", "Text" : "Selected Pathogens", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU EC PV EMP THERAPY", "DisplayText" : "Prosthetic Valve Endocarditis--Empicaral Therapy", "Text" : "Empirical Therapy", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU EC PV SEL PATH", "DisplayText" : "Prosthetic Valve Endocarditis--Selected Pathogens", "Text" : "Selected Pathogens", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU LYME CARDIAC DISEASE", "DisplayText" : "Cardiac disease associated with Lyme disease", "Text" : "Cardiac Lyme Disease", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX INFECT INVOLVES CARD DEVICES", "DisplayText" : "Infections involves cardiovascular devices (excluding valves)", "Text" : "Cardiovascular Device Infections (Excluding Valves)", "Mnemonic" : "18"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU INTRAVASC CATH-ASSOC INFECT", "DisplayText" : "Intravascular catheter-associated infection", "Text" : "Catheter-Related Bloodstream Infections", "Mnemonic" : "20"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX MYOCARDITIS", "DisplayText" : "Myocarditis", "Text" : "Myocarditis", "Mnemonic" : "22"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX PERICARDITIS", "DisplayText" : "Pericarditis", "Text" : "Pericarditis", "Mnemonic" : "24"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX SUPPURATIVE THROMBO EMP THERAPY", "DisplayText" : "Suppurative Thrombophlebitis--Empirical Therapy", "Text" : "Suppurative Thrombophlebitis", "Mnemonic" : "26"},
{"Row" : 3, "Column" : 1, "Text" : "++  CARDIOVASCULAR  ++", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Endocarditis", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Native Valve Endocarditis"}, 
{"Row" : 13, "Column" : 1, "Text" : "Prosthetic Valve Endocarditis"}, 
{"Row" : 17, "Column" : 1, "Text" : "Other", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Section last reviewed  9/2020", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX CDSS VERSION", "DisplayText" : "CDSS VERSION ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "VERSION 1.0"}, 
{"Row" : 2, "Column" : 1, "Text" : "3-5-2020"}
]},
{"Name" : "ORZID2 GMENU ABX CELLULITIS", "Term1" : "Cellulitis", "DisplayText" : "Cellulitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU MORE ABOUT CELLULITIS", "DisplayText" : "The approach to cellulitis", "Text" : "More about cellulitis...", "Mnemonic" : "4"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID DICLOXACILLIN 500MG PO Q6H", "DisplayText" : "Dicloxacillin 500MG PO q6h", "Text" : "Dicloxacillin 500 mg PO q6h ($) [DI]", "Mnemonic" : "6"},
{"Row" : 26, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 500MG PO Q6H", "DisplayText" : "Cephalexin 500MG PO q6h", "Text" : "Cephalexin 500 mg PO q6h ($) [R]", "Mnemonic" : "8"},
{"Row" : 31, "Column" : 1, "Item" : "PSJZID TMP/SMX DS PO Q12H", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 DS tablet q12h", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h ($) [R,DI]", "Mnemonic" : "10"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO q12h ($) [DI]", "Mnemonic" : "12"},
{"Row" : 33, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($) [H,O]", "Mnemonic" : "14"},
{"Row" : 37, "Column" : 1, "Item" : "PSJIZID NAFCILLIN 2GM IV Q4H", "DisplayText" : "Nafcillin 2GM IV Q4H", "Text" : "Nafcillin 2 gm IV q4h ($$) [DI]", "Mnemonic" : "16"},
{"Row" : 38, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IV Q8H", "DisplayText" : "Cefazolin 2 gm IV q8h", "Text" : "Cefazolin 2 gm IV q8h ($) [R]", "Mnemonic" : "18"},
{"Row" : 41, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600 mg IV q8h ($$) [H,O]", "Mnemonic" : "20"},
{"Row" : 42, "Column" : 1, "Item" : "PSJIZID VANCO 15MG/KG IV Q12H", "DisplayText" : "Vancomycin 15mg/kg iv q12h", "Text" : "Vancomycin 15 mg/kg IV q12h ($) [R]", "Mnemonic" : "22"},
{"Row" : 51, "Column" : 1, "Item" : "ORZ SET ABX PIP/TAZO 3.375GM IV Q6H VANCO 15MG/KG IV Q12H", "DisplayText" : "Piperacillin-tazobactam 3.375 gm IV q6h ($$) [R] <AND> vancomycin 15 mg/kg", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($$) [R] <AND> vancomycin 15mg/kg IV", "Mnemonic" : "24"},
{"Row" : 55, "Column" : 1, "Item" : "ORZ SET ABX VANCO 15MG/KG CIPRO 400MG METRO 500MG IV Q8H", "DisplayText" : "Vancomycin 15mg/kg iv q12h Cipro 400mg iv q8h Metro 500 mg iv q12h", "Text" : "Ciprofloxacin 400 mg IV q12h ($) [R,DI] <AND> Vancomycin 15 mg/kg IV", "Mnemonic" : "26"},
{"Row" : 58, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "28"},
{"Row" : 2, "Column" : 1, "Text" : "BACTERIAL CELLULITIS"}, 
{"Row" : 4, "Column" : 1, "Text" : "Cellulitis refers to inflammation of the skin and subcutaneous tissue and is"}, 
{"Row" : 5, "Column" : 1, "Text" : "often associated with bacterial pathogens.  The most common pathogens are group"}, 
{"Row" : 6, "Column" : 1, "Text" : "A streptococci and Staphylococcus aureus.  Group B streptococci are associated"}, 
{"Row" : 7, "Column" : 1, "Text" : "with cellulitis in elderly people, in those with diabetes mellitus, and on feet"}, 
{"Row" : 8, "Column" : 1, "Text" : "and legs of patients with athlete's foot (tinea pedis)."}, 
{"Row" : 10, "Column" : 1, "Text" : "Mild cases can be treated with oral antimicrobials.  Moderate to severe cases"}, 
{"Row" : 11, "Column" : 1, "Text" : "should be treated initially with intravenous antimicrobials.  Switch to oral"}, 
{"Row" : 12, "Column" : 1, "Text" : "drugs after clinical improvement."}, 
{"Row" : 14, "Column" : 1, "Text" : "Consider MRSA coverage for cellulitis associated with penetrating trauma, a"}, 
{"Row" : 15, "Column" : 1, "Text" : "history of MRSA infection, injection drug use, or infections not responding"}, 
{"Row" : 16, "Column" : 1, "Text" : "to first line beta-lactams."}, 
{"Row" : 20, "Column" : 1, "Text" : "Duration: Treat for 5 days. Re-evaluate the patient and extend/modify treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "if not improved in this time.", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Mild: Cellulitis without systemic signs of infection", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Empirical treatment for MILD cellulitis", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Alternative for Penicillin Allergy or MRSA suspected", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "MRSA Suspected Mild Cellulitis", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Moderate: Cellulitis with systemic signs of infection", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Empirical treatment for MODERATE cellulitis", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Alternative for penicillin allergy or MRSA suspected", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "Severe: Cellulitis in patients with signs of deeper infections", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "(e.g. bullae, skin sloughing, hypotension, or evidence of organ dysfunction)."}, 
{"Row" : 46, "Column" : 1, "Text" : "Patients may also qualify as severe if they are neutropenic, have a"}, 
{"Row" : 47, "Column" : 1, "Text" : "hematologic malignancy or congenital immunodeficiency, or are receiving"}, 
{"Row" : 48, "Column" : 1, "Text" : "immunosuppressant therapy.  Consider whether surgical drainage is necessary."}, 
{"Row" : 50, "Column" : 1, "Text" : "Empirical treatment for SEVERE infection", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Text" : "q12h ($) [R]"}, 
{"Row" : 54, "Column" : 1, "Text" : "Alternative for penicillin allergy or MRSA suspected:", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "q12h ($) [R] <AND> Metronidazole 500 mg IV q8h ($) [DI,H]"}, 
{"Row" : 59, "Column" : 1, "Text" : "Stevens DL Clin Infect Dis 2014, 59: 147"}, 
{"Row" : 60, "Column" : 1, "Text" : "Mandell chapter: Cellulitis and subcutaneous tissue infections"}
]},
{"Name" : "ORZID2 GMENU ABX CHLAMYDIA URETHRITIS", "DisplayText" : "Chlamydia Urethritis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "PSJZID DOXYCYCLINE 100MG PO Q12H", "DisplayText" : "Doxycycline 100MG PO Q12H", "Text" : "Doxycycline 100 mg PO BID for 7 days ($) [DI]", "Mnemonic" : "4"},
{"Row" : 8, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1GM PO once", "Text" : "Azithromycin 1 gm PO ONCE ($) [M]", "Mnemonic" : "6"},
{"Row" : 11, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1GM PO once", "Text" : "Azithromycin 1 gm PO ONCE ($) [M]", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "CHLAMYDIAL OR NON-GONOCOCCAL URETHRITIS OR CERVICITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Treatment for chlamydial or non-gonococcal urethritis or cervicitis", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment for chlamydial or non-gonococcal cervicitis in pregnant women", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "References:"}, 
{"Row" : 15, "Column" : 1, "Text" : "CDC STD Treatment Guidelines: MMWR (2015) 64.3"}, 
{"Row" : 16, "Column" : 1, "Text" : "Mandell chapter: Urethritis"}, 
{"Row" : 17, "Column" : 1, "Text" : "Mandell chapter: Vulvovaginitis and Cervicitis"}, 
{"Row" : 18, "Column" : 1, "Text" : "Sanford keyword: Urethritis, cervicitis: chlamydial"}, 
{"Row" : 19, "Column" : 1, "Text" : "Up-To-Date article: Acute cervicitis"}, 
{"Row" : 20, "Column" : 1, "Text" : "Up-To-Date article: Urethritis in men"}
]},
{"Name" : "ORZID2 GMENU ABX CHOLANGITIS", "Term1" : "Cholangitis", "DisplayText" : "Cholangitis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 12, "Column" : 1, "Item" : "PSJIZID PIP/TAZO 3.375 GM IV Q6H", "DisplayText" : "Piperacillin/tazobactam 3.375 GM IV Q6H", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h for 7 to 10 days ($$) [R]", "Mnemonic" : "4"},
{"Row" : 15, "Column" : 1, "Item" : "PSJIZID MOXIFLOXACIN 400MG IV Q24H", "DisplayText" : "Moxifloxacin 400mg iv q24h", "Text" : "Moxifloxacin 400 mg IV q24h for 7 to 10 days [R,DI]", "Mnemonic" : "6"},
{"Row" : 17, "Column" : 1, "Item" : "ORZ SET ABX LEVOFLOXACIN 750MG IV AND METRO 500MG IV", "DisplayText" : "Levofloxacin 750 mg IV q24h ($) [R,DI] <AND> metronidazole 500 mg IV q8h", "Text" : "Levofloxacin 750 mg IV q24h ($) [R,DI] <AND> metronidazole 500 mg IV q8h ($)", "Mnemonic" : "8"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM IV Q8H", "DisplayText" : "Meropenem 1 gm IV q8h ($$) [R,O]", "Text" : "Meropenem 1 gm IV q8h ($$) [R,O]", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX AZTREO 2GM METRONI 500MG VANCO 15MG/KG", "DisplayText" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Text" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Mnemonic" : "12"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID AMOXICILLIN-CLAVULANATE 875-125 MG PO Q12H", "DisplayText" : "Amoxicillin-Clavulanate 875-125 MG PO Q12H", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h ($) [R]", "Mnemonic" : "14"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID MOXIFLOXACIN 400 MG PO Q24H", "DisplayText" : "Moxifloxacin 400 mg PO q24h ($) [R,DI]", "Text" : "Moxifloxacin 400 mg PO q24h ($) [R,DI]", "Mnemonic" : "16"},
{"Row" : 34, "Column" : 1, "Item" : "ORZ SET ABX LEVOFL 500MG PO Q24H METRO 1 GM PO Q12H", "DisplayText" : "Levofloxacin 500 mg PO q24h ($) [R,DI] <AND> metronidazole 1000 mg PO q12h ($)", "Text" : "Levofloxacin 500 mg PO q24h ($) [R,DI] <AND> metronidazole 1000 mg PO q12h", "Mnemonic" : "18"},
{"Row" : 3, "Column" : 1, "Text" : "CHOLANGITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Most cases are due to common bile duct obstruction. Obstruction (if present)"}, 
{"Row" : 6, "Column" : 1, "Text" : "must be relieved with an endoscopical, transcutaneous, or surgical procedure."}, 
{"Row" : 7, "Column" : 1, "Text" : "The most common pathogens isolated are E. coli, Klebsiela, Enterococcus and"}, 
{"Row" : 8, "Column" : 1, "Text" : "Enterobacter. Anaerobes such as Bacteriodes and Clostridia can be present as"}, 
{"Row" : 9, "Column" : 1, "Text" : "part of a mixed infection."}, 
{"Row" : 11, "Column" : 1, "Text" : "Treatment of mild to moderate disease", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 16, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 18, "Column" : 1, "Text" : "[DI] for 7 to 10 days"}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment of severe disease", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 25, "Column" : 1, "Text" : "<AND> vancomycin 15 mg/kg IV q12h ($) [R]"}, 
{"Row" : 27, "Column" : 1, "Text" : "Step down treatment for completion of antimicrobial course after initial", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "intravenous treatment in patients who can tolerate oral therapy. Base selection", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "on culture results.", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 33, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 35, "Column" : 1, "Text" : "($) [DI]"}, 
{"Row" : 38, "Column" : 1, "Text" : "References:"}, 
{"Row" : 40, "Column" : 1, "Text" : "Mandell chapter: Infections of the Liver and Biliary System (Liver Abscess,"}, 
{"Row" : 41, "Column" : 1, "Text" : "Cholangitis, Cholecystitis)"}, 
{"Row" : 42, "Column" : 1, "Text" : "Sanford keyword: Gallbladder Infections"}, 
{"Row" : 43, "Column" : 1, "Text" : "Solomkin et al, Clin Infect Dis, 2010, 50:133-64"}, 
{"Row" : 44, "Column" : 1, "Text" : "Up-to-Date article: Acute cholangitis"}
]},
{"Name" : "ORZID2 GMENU ABX CHOLECYSTITIS", "Term1" : "Cholecystitis", "DisplayText" : "Cholecystitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IV Q24H", "DisplayText" : "Ceftriaxone 1GM IV Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($) [M]", "Mnemonic" : "4"},
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 750MG IV Q24H", "DisplayText" : "Levofloxacin 750 mg IV q24h ($5/day) [R,DI]", "Text" : "Levofloxacin 750 mg IV q24h ($) [R,DI]", "Mnemonic" : "6"},
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID PIP/TAZO 3.375 GM IV Q6H", "DisplayText" : "Piperacillin/tazobactam 3.375 GM IV Q6H", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($$) [R]", "Mnemonic" : "8"},
{"Row" : 33, "Column" : 1, "Item" : "PSJIZID MOXIFLOXACIN 400MG IV Q24H", "DisplayText" : "Moxifloxacin 400mg iv q24h", "Text" : "Moxifloxacin 400 mg IV q24h ($$) [R,DI]", "Mnemonic" : "10"},
{"Row" : 35, "Column" : 1, "Item" : "ORZ SET ABX LEVOFLOXACIN 750MG IV AND METRO 500MG IV", "DisplayText" : "Levofloxacin 750 mg IV q24h ($) [R,DI] <AND> metronidazole 500 mg IV q8h", "Text" : "Levofloxacin 750 mg IV q24h ($) [R,DI] <AND> metronidazole 500 mg IV q8h", "Mnemonic" : "12"},
{"Row" : 39, "Column" : 1, "Item" : "PSJIZID PIP/TAZO 3.375 GM IV Q6H", "DisplayText" : "Piperacillin/tazobactam 3.375 GM IV Q6H", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($$) [R]", "Mnemonic" : "14"},
{"Row" : 41, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM IV Q8H", "DisplayText" : "Meropenem 1 gm IV q8h ($$) [R,O]", "Text" : "Meropenem 1 gm IV q8h ($$) [R,O]", "Mnemonic" : "16"},
{"Row" : 44, "Column" : 1, "Item" : "ORZ SET ABX AZTREO 2GM METRONI 500MG VANCO 15MG/KG", "DisplayText" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Text" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Mnemonic" : "18"},
{"Row" : 48, "Column" : 1, "Item" : "ORZ SET ABX PIP/TAZO 3.375GM IV Q6H VANCO 15MG/KG IV Q12H", "DisplayText" : "Piperacillin-tazobactam 3.375 gm IV q6h ($$) [R] <AND> vancomycin 15 mg/kg", "Text" : "Piperacillin-tazobactam 3.375 gm IV q6h ($$) [R] <AND> vancomycin 15 mg/kg", "Mnemonic" : "20"},
{"Row" : 51, "Column" : 1, "Item" : "ORZ SET ABX MEROPENEM 1GM IV Q8H VANCO 15MG/KG IV Q12H", "DisplayText" : "Meropenem 1 gm IV q8h ($$) [R] <AND> vancomycin 15 mg/kg IV q12h ($) [R]", "Text" : "Meropenem 1 gm IV q8h ($$) [R] <AND> vancomycin 15 mg/kg IV q12h ($) [R]", "Mnemonic" : "22"},
{"Row" : 54, "Column" : 1, "Item" : "ORZ SET ABX AZTREO 2GM METRONI 500MG VANCO 15MG/KG", "DisplayText" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Text" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Mnemonic" : "24"},
{"Row" : 61, "Column" : 1, "Item" : "PSJZID AMOXICILLIN-CLAVULANATE 875-125 MG PO Q12H", "DisplayText" : "Amoxicillin-Clavulanate 875-125 MG PO Q12H", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h ($) [R]", "Mnemonic" : "26"},
{"Row" : 63, "Column" : 1, "Item" : "PSJZID MOXIFLOXACIN 400 MG PO Q24H", "DisplayText" : "Moxifloxacin 400 mg PO q24h ($) [R,DI]", "Text" : "Moxifloxacin 400 mg PO q24h ($) [R,DI]", "Mnemonic" : "28"},
{"Row" : 65, "Column" : 1, "Item" : "ORZ SET ABX LEVOFL 500MG PO Q24H METRO 1 GM PO Q12H", "DisplayText" : "Levofloxacin 500 mg PO q24h ($) [R,DI] <AND> metronidazole 1000 mg PO q12h ($)", "Text" : "Levofloxacin 500 mg PO q24h ($) [R,DI] <AND> metronidazole 1000 mg PO q12h", "Mnemonic" : "30"},
{"Row" : 3, "Column" : 1, "Text" : "CHOLECYSTITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Adequate biliary drainage is the definitive treatment. Antimicrobials should be"}, 
{"Row" : 6, "Column" : 1, "Text" : "prescribed only if signs of infection like leukocytosis or fever are present or"}, 
{"Row" : 7, "Column" : 1, "Text" : "if the patient is elderly. Surgery and Gastroenterology involvement are"}, 
{"Row" : 8, "Column" : 1, "Text" : "essential."}, 
{"Row" : 10, "Column" : 1, "Text" : "Most cases are associated with E. coli, Enterococcus, Klebsiella, and"}, 
{"Row" : 11, "Column" : 1, "Text" : "Enterobacter. Anaerobic coverage is not indicated unless a biliary-enteric"}, 
{"Row" : 12, "Column" : 1, "Text" : "anastomosis is present. For community-acquired acute cholecystitis, enterococcal"}, 
{"Row" : 13, "Column" : 1, "Text" : "coverage is not required because Enterococcus has not been shown to be"}, 
{"Row" : 14, "Column" : 1, "Text" : "pathogenic in these patients."}, 
{"Row" : 16, "Column" : 1, "Text" : "Duration of antimicrobial therapy", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "If needed, antimicrobial therapy should be continued only until adequate"}, 
{"Row" : 18, "Column" : 1, "Text" : "drainage is established, then stopped."}, 
{"Row" : 19, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Community-acquired acute cholecystitis", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment of mild to moderate infection without biliary-enteric anastomosis", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 29, "Column" : 1, "Text" : "Treatment of mild to moderate infection and biliary-enteric anastomosis present", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 34, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 36, "Column" : 1, "Text" : "($) [DI]"}, 
{"Row" : 38, "Column" : 1, "Text" : "Treatment of severe infection, advanced age or immunocompromised patient", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 43, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 45, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Health care-associated infection", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "IV q12h ($) [R]"}, 
{"Row" : 50, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 53, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 55, "Column" : 1, "Text" : "<AND> vancomycin 15 mg/kg IV q12h ($) [R]"}, 
{"Row" : 56, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 58, "Column" : 1, "Text" : "Step down treatment for completion of antimicrobial course after initial", "Header" : 1}, 
{"Row" : 59, "Column" : 1, "Text" : "intravenous treatment in patients who can tolerate oral therapy. Base selection", "Header" : 1}, 
{"Row" : 60, "Column" : 1, "Text" : "on culture results.", "Header" : 1}, 
{"Row" : 62, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 64, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 66, "Column" : 1, "Text" : "($) [DI]"}, 
{"Row" : 69, "Column" : 1, "Text" : "References:"}, 
{"Row" : 71, "Column" : 1, "Text" : "Mandell chapter: Infections of the Liver and Biliary System (Liver Abscess,"}, 
{"Row" : 72, "Column" : 1, "Text" : "Cholangitis, Cholecystitis)"}, 
{"Row" : 73, "Column" : 1, "Text" : "Sanford keyword: Gallbladder Infections, Acute Cholecystitis"}, 
{"Row" : 74, "Column" : 1, "Text" : "Solomkin et al, Clin Infect Dis, 2010, 50:133-64"}, 
{"Row" : 75, "Column" : 1, "Text" : "Up-to-Date article: Treatment of acute calculous cholecystitis"}
]},
{"Name" : "ORZID2 GMENU ABX CHOLERA", "Term1" : "Vibrio cholerae diarrhea/gastroenteritis", "DisplayText" : "Diarrhea with Cholera (Vibrio cholera)  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 9, "Column" : 1, "Item" : "PSJZID DOXYCYCLINE 300MG PO ONCE", "DisplayText" : "Doxycycline 300mg po once", "Text" : "Doxycycline 300 mg PO one-time dose ($) [DI]", "Mnemonic" : "4"},
{"Row" : 12, "Column" : 1, "Item" : "PSJZID CIPROFLOX 1000MG PO ONCE", "DisplayText" : "Ciprofloxacin 1000 mg PO one-time dose ($) [R,DI]", "Text" : "Ciprofloxacin 1000 mg PO one-time dose ($) [R,DI]", "Mnemonic" : "6"},
{"Row" : 14, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Azithromycin 1GM PO once", "Text" : "Azithromycin 1000 mg PO one-time dose ($) [M]", "Mnemonic" : "8"},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IV Q24H", "DisplayText" : "Ceftriaxone 1GM IV Q24H", "Text" : "Ceftriaxone 1 gm IV q24h for 3 days ($) [M]", "Mnemonic" : "10"},
{"Row" : 3, "Column" : 1, "Text" : "DIARRHEA WITH CHOLERA (VIBRIO CHOLERAE)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Primary Treatment", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Aggressive hydration and electrolyte replacement are essential"}, 
{"Row" : 8, "Column" : 1, "Text" : "Antimicrobial treatment", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Tetracycline intolerant patient"}, 
{"Row" : 13, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 16, "Column" : 1, "Text" : "For patients who are hospitalized or unable to take oral medications"}, 
{"Row" : 20, "Column" : 1, "Text" : "References:"}, 
{"Row" : 22, "Column" : 1, "Text" : "Sanford keyword: Gastroenteritis, Vibrio cholerae"}, 
{"Row" : 23, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 24, "Column" : 1, "Text" : "Up-to-Date article: Cholera: Clinical features, diagnosis, treatment, and"}, 
{"Row" : 25, "Column" : 1, "Text" : "prevention"}
]},
{"Name" : "ORZID2 GMENU ABX CHRON PROS/PELVIC PAIN SYN", "Term1" : "Pelvic pain syndrome/prostatitis, chronic ", "Term2" : "Prostatitis/pelvic pain syndrome, chronic", "DisplayText" : "Chronic protatitis/Chronic pelvic pain syndrome  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 12, "Column" : 1, "Item" : "PSJZID IBUPROFEN 600MG PO Q8H", "DisplayText" : "Ibuprofen 600 mg PO Q8h", "Text" : "Ibuprofen 400 mg PO q8h for 2 to 3 weeks", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "CHRONIC PROSTATITIS / CHRONIC PELVIC PAIN SYNDROME", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "This syndrome presents with intermittent perineal and/or low back pain,"}, 
{"Row" : 6, "Column" : 1, "Text" : "obstructive voiding symptoms, relatively normal examination, and negative urine"}, 
{"Row" : 7, "Column" : 1, "Text" : "cultures. Antimicrobial therapy is not indicated."}, 
{"Row" : 8, "Column" : 1, "Text" : "Consult urology for non-antimicrobial therapy recommendations (e.g."}, 
{"Row" : 9, "Column" : 1, "Text" : "alpha-adrenergic antagonists, anti-inflammatory medications) to reduce symptoms."}, 
{"Row" : 11, "Column" : 1, "Text" : "Anti-inflammatory treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "References:"}, 
{"Row" : 17, "Column" : 1, "Text" : "Mandell chapter: Prostatitis, Epididymitis and Orchitis"}, 
{"Row" : 18, "Column" : 1, "Text" : "Up-To-Date article: Chronic prostatitis/chronic pelvic pain syndrome"}
]},
{"Name" : "ORZID2 GMENU ABX CHRONIC BACT PROSTATITIS", "Term1" : "Prostatitis, chronic", "DisplayText" : "Chronic bacterial prostatitis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 16, "Column" : 1, "Item" : "ORZ ADD MENU LABS (LAB COLLECT)", "DisplayText" : "1-H LABS", "Text" : "Lab menu", "Mnemonic" : "4"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX CHRON PROS/PELVIC PAIN SYN", "DisplayText" : "Chronic protatitis/Chronic pelvic pain syndrome", "Text" : "Chronic prostate pain syndrome", "Mnemonic" : "6"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750 mg PO q24h ($0.30/day) [R,DI]", "Text" : "Levofloxacin 750 mg PO q24h ($) [R,DI] for 4 weeks", "Mnemonic" : "8"},
{"Row" : 32, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 750MG IV Q24H", "DisplayText" : "Levofloxacin 750 mg IV q24h ($5/day) [R,DI]", "Text" : "Levofloxacin 750 mg IV q24h ($) [R,DI] for 4 weeks", "Mnemonic" : "10"},
{"Row" : 35, "Column" : 1, "Item" : "PSJZID TRIMETH/SULFA 1 DS TAB BID", "DisplayText" : "Trimethoprim-sulfamethoxazole 1 DS PO BID (Cost $)for 10 days [R,DI]", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO q12h ($) [R,DI] for 4 weeks", "Mnemonic" : "12"},
{"Row" : 3, "Column" : 1, "Text" : "CHRONIC BACTERIAL PROSTATITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Chronic bacterial prostatitis usually presents as recurrent urinary tract"}, 
{"Row" : 6, "Column" : 1, "Text" : "infections with the same bacterial etiology. Pain, tenderness, and fever may"}, 
{"Row" : 7, "Column" : 1, "Text" : "accompany intermittent episodes of cystitis, but men are usually asymptomatic"}, 
{"Row" : 8, "Column" : 1, "Text" : "between episodes and the prostate examination may be normal. Non-steroidal anti-"}, 
{"Row" : 9, "Column" : 1, "Text" : "inflammatory drugs (NSAIDs) often relieve pain. If the diagnosis is uncertain or"}, 
{"Row" : 10, "Column" : 1, "Text" : "if the patient's symptoms do not respond to therapy, consult urology. The"}, 
{"Row" : 11, "Column" : 1, "Text" : "presence of hematuria may be a sign of carcinoma, especially in older men, and a"}, 
{"Row" : 12, "Column" : 1, "Text" : "urology consult should be requested."}, 
{"Row" : 14, "Column" : 1, "Text" : "A urine culture should be performed in all patients to guide antimicrobial"}, 
{"Row" : 15, "Column" : 1, "Text" : "therapy:"}, 
{"Row" : 18, "Column" : 1, "Text" : "Chronic prostate pain syndrome should be considered in patients who have"}, 
{"Row" : 19, "Column" : 1, "Text" : "symptoms of prostatitis but have negative urine cultures. Chronic prostate pain"}, 
{"Row" : 20, "Column" : 1, "Text" : "syndrome is discussed elsewhere:"}, 
{"Row" : 23, "Column" : 1, "Text" : "Duration", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "4 weeks minimum and up to 6 weeks of treatment is required. Durations longer"}, 
{"Row" : 25, "Column" : 1, "Text" : "than 6 weeks may be needed in treatment of resistant organisms. Treatment with"}, 
{"Row" : 26, "Column" : 1, "Text" : "trimethoprim/sulfamethoxazole requires a treatment duration of 1 to 3 months."}, 
{"Row" : 28, "Column" : 1, "Text" : "Empirical treatment", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 31, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 34, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 36, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "References:"}, 
{"Row" : 40, "Column" : 1, "Text" : "Rees et al., BJU Int, 2015,116.509-525"}, 
{"Row" : 41, "Column" : 1, "Text" : "Lipsky et al., Clinical Infectious Diseases, 2010, 50(12)1641-1652"}, 
{"Row" : 42, "Column" : 1, "Text" : "Mandell chapter: Prostatitis, Epididymitis and Orchitis"}, 
{"Row" : 43, "Column" : 1, "Text" : "Sanford keyword: Prostatitis"}, 
{"Row" : 44, "Column" : 1, "Text" : "Up-To-Date article: Chronic bacterial prostatitis"}
]},
{"Name" : "ORZID2 GMENU ABX CHRONIC MENINGITIS", "DisplayText" : "Chronic Meningitis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "CHRONIC MENINGITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Subacute meningeal symptoms, including headache, fever, and nausea for 4 weeks"}, 
{"Row" : 6, "Column" : 1, "Text" : "or more. Chronic meningitis is caused by a long list of infectious and"}, 
{"Row" : 7, "Column" : 1, "Text" : "non-infectious etiologies. Treatment is based on etiology and empirical"}, 
{"Row" : 8, "Column" : 1, "Text" : "treatment is not urgent unless tuberculosis is suspected. Consult Infectious"}, 
{"Row" : 9, "Column" : 1, "Text" : "Diseases for more information."}, 
{"Row" : 10, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "References:"}, 
{"Row" : 14, "Column" : 1, "Text" : "Mandell chapter: Chronic meningitis"}, 
{"Row" : 15, "Column" : 1, "Text" : "Sanford keyword: Chronic meningitis"}, 
{"Row" : 16, "Column" : 1, "Text" : "Tunkel et al., Clin Infect Dis, 2004, 39.1267-84"}, 
{"Row" : 17, "Column" : 1, "Text" : "Up-to-Date Article: Approach to the patient with chronic meningitis"}, 
{"Row" : 18, "Column" : 1, "Text" : "Van de Beek et al., Clin Microbiol Infect, 2016, 22.S37-S62"}
]},
{"Name" : "ORZID2 GMENU ABX CHRONIC PNEUMONIA", "Term1" : "Pneumonia, chronic", "DisplayText" : "Chronic pneumonia  ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases (inpatient)", "Mnemonic" : "4"},
{"Row" : 4, "Column" : 1, "Item" : "zzGMRCTZ MPLS PULMONARY CONSULT", "DisplayText" : "Mpls Pulmonary Consult", "Text" : "Consult Pulmonary (inpatient)", "Mnemonic" : "6"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Chronic pneumonia", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Chronic pneumonia syndrome is a pulmonary parenchymal process that can"}, 
{"Row" : 10, "Column" : 1, "Text" : "be infectious or noninfectious, has been present for weeks to months"}, 
{"Row" : 11, "Column" : 1, "Text" : "rather than for days, and is manifested by abnormal chest radiographic"}, 
{"Row" : 12, "Column" : 1, "Text" : "findings and by chronic or progressive pulmonary symptoms. Diagnosis is"}, 
{"Row" : 13, "Column" : 1, "Text" : "essential and empirical therapy is not indicated. Consult Infectious"}, 
{"Row" : 14, "Column" : 1, "Text" : "Diseases and/or Pulmonary."}, 
{"Row" : 17, "Column" : 1, "Text" : "References"}, 
{"Row" : 19, "Column" : 1, "Text" : "Mandell Chapter: Principles and Practice of Infectious Diseases"}
]},
{"Name" : "ORZID2 GMENU ABX CHRONIC SUP OTITIS MEDIA", "DisplayText" : "Chronic Suppurative Otitis Media With Perforation", "Version" : "StCloud", "Contents" : [
{"Row" : 5, "Column" : 1, "Text" : "* *  THIS PAGE UNDER CONSTRUCTION  * *"}
]},
{"Name" : "ORZID2 GMENU ABX CMV COLITIS OR ESOPHAGISTIS", "DisplayText" : "CMV Colitis or Esophagistis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Diseases", "Mnemonic" : "10"},
{"Row" : 23, "Column" : 1, "Text" : "CMV COLITIS OR ESOPHAGITIS"}, 
{"Row" : 26, "Column" : 1, "Text" : "initial treatment regimens are equivalent.  The major toxicities of both"}, 
{"Row" : 27, "Column" : 1, "Text" : "ganciclovir and valganciclovir are neutropenia.  The major toxicities of both"}, 
{"Row" : 28, "Column" : 1, "Text" : "cidofovir and foscarnet are nephrotoxicity.  Intravenous therapy is used for"}, 
{"Row" : 29, "Column" : 1, "Text" : "severe disease.  Valganciclovir given by mouth is effective for mild or moderate"}, 
{"Row" : 30, "Column" : 1, "Text" : "disease, or after severe disease has improved."}, 
{"Row" : 34, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Treat for 3 to 6 weeks."}, 
{"Row" : 36, "Column" : 1, "Item" : "PSJZID VALGANCICLOVIR 900MG PO Q12H", "DisplayText" : "Valgancicilovir 900MG PO q12h", "Text" : "Valganciclovir 900 mg PO q12h ($68/day) [R,O]", "Mnemonic" : "12"},
{"Row" : 38, "Column" : 1, "Text" : "Alternative", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Treat for 3 to 6 weeks."}, 
{"Row" : 40, "Column" : 1, "Item" : "PSJIZID GANCICLOVIR 5 MG/KG IV Q12H", "DisplayText" : "Ganciclovir 5 mg/kg IV Q12H", "Text" : "Ganciclovir 5 mg/kg IV q12h ($36/day) [R,O]  < OR >", "Mnemonic" : "14"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 25, "Column" : 1, "Text" : "Treatment is complex and requires Infectious Diseases consultation.  Several"}, 
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ EGD OUTPT", "DisplayText" : "EGD Consult", "Text" : "Consult Gastroenterology", "Mnemonic" : "08"},
{"Row" : 45, "Column" : 1, "Text" : "\"Sanford\" keyword: Cytomegalovirus"}, 
{"Row" : 46, "Column" : 1, "Text" : "\"Mandell\" chapter: Cytomegalovirus"}, 
{"Row" : 32, "Column" : 1, "Text" : "Consider transfer to a higher level of care."}, 
{"Row" : 12, "Column" : 1, "Text" : "Immunocompetent patient", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Infection is usually asymptomatic. Mononucleosis can be associated with CMV,"}, 
{"Row" : 14, "Column" : 1, "Text" : "but is more commonly associated with Epstein Barr virus. Antiviral treatment is"}, 
{"Row" : 15, "Column" : 1, "Text" : "rarely necessary."}, 
{"Row" : 17, "Column" : 1, "Text" : "Immunocompromised patient", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Patients in whom the risk for CMV disease is increased include solid organ and"}, 
{"Row" : 19, "Column" : 1, "Text" : "bone marrow transplant recipients, persons receiving prolonged immunosuppressive"}, 
{"Row" : 20, "Column" : 1, "Text" : "chemotherapy, and persons with advanced HIV disease indicated by a CD4 count"}, 
{"Row" : 21, "Column" : 1, "Text" : "of less than 50 cells/microliter."}, 
{"Row" : 10, "Column" : 1, "Text" : "CMV DISEASE IN GENERAL"}
]},
{"Name" : "ORZID2 GMENU ABX CMV COLITIS OR ESOPHAGITIS", "Term1" : "Colitis, cytomegalovirus (CMV)", "DisplayText" : "CMV Colitis or Esophagistis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID VALGANCICLOVIR 900MG PO Q12H", "DisplayText" : "Valgancicilovir 900MG PO q12h", "Text" : "Valganciclovir 900 mg PO q12h ($$$) [R,O]", "Mnemonic" : "4"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID GANCICLOVIR 5 MG/KG IV Q12H", "DisplayText" : "Ganciclovir 5 mg/kg IV Q12H", "Text" : "Ganciclovir 5 mg/kg IV q12h ($$$$) [R,O]", "Mnemonic" : "6"},
{"Row" : 23, "Column" : 1, "Item" : "PSJIZID FOSCARNET 90 MG/KG IV Q12H", "DisplayText" : "Foscarnet 90 mg/kg IV Q12H", "Text" : "Foscarnet 90 mg/kg IV q12h ($$$$) [R,O]", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "CMV COLITIS OR ESOPHAGITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Infection in immunocompetent patients is rare and usually associated with"}, 
{"Row" : 6, "Column" : 1, "Text" : "minimal or no symptoms. Patients in whom the risk for CMV disease is increased"}, 
{"Row" : 7, "Column" : 1, "Text" : "include solid organ and bone marrow transplant recipients, persons receiving"}, 
{"Row" : 8, "Column" : 1, "Text" : "prolonged immunosuppressive chemotherapy, and persons with advanced HIV disease"}, 
{"Row" : 9, "Column" : 1, "Text" : "indicated by a CD4 count of less than 50 cells/microliter. Treatment is complex"}, 
{"Row" : 10, "Column" : 1, "Text" : "and requires Infectious Diseases consultation."}, 
{"Row" : 12, "Column" : 1, "Text" : "Duration of antimicrobial therapy", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Treat for 3-6 weeks. Patients may be converted to oral therapy after initial"}, 
{"Row" : 14, "Column" : 1, "Text" : "intravenous therapy and after clinical improvement of severe disease."}, 
{"Row" : 16, "Column" : 1, "Text" : "Treatment of mild to moderate disease or following clinical improvement of", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "severe disease", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment of severe disease", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 26, "Column" : 1, "Text" : "References:"}, 
{"Row" : 28, "Column" : 1, "Text" : "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV"}, 
{"Row" : 29, "Column" : 1, "Text" : "Infected Adults and Adolescents. AIDSinfo (2015) 1-282"}, 
{"Row" : 30, "Column" : 1, "Text" : "Mandell chapter: Cytomegalovirus"}, 
{"Row" : 31, "Column" : 1, "Text" : "Sanford keyword: Cytomegalovirus"}, 
{"Row" : 32, "Column" : 1, "Text" : "Up-to-Date article: Epidemiology, clinical manifestations, and treatment of"}, 
{"Row" : 33, "Column" : 1, "Text" : "cytomegalovirus infection in immunocompetent adults"}
]},
{"Name" : "ORZID2 GMENU ABX CMV ENCEPHALITIS", "Term1" : "Encephalitis, Cytomegalovirus (CMV)", "DisplayText" : "CMV Encephalitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 18, "Column" : 1, "Item" : "ORZ SET ABX GANCICLOVIR 5MG/KG IV Q12H FOSCAR 90MG/KG IV Q12H", "DisplayText" : "Ganciclovir 5 mg/kg IV Q12H Foscarnet 90 mg/kg IV Q12H", "Text" : "Ganciclovir 5 mg/kg IV q12h ($$$$) [R,O] <AND> foscarnet 90 mg/kg IV q12h", "Mnemonic" : "4"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID VALGANCICLOVIR 900MG PO Q12H", "DisplayText" : "Valgancicilovir 900MG PO q12h", "Text" : "Valganciclovir 900 mg PO q12h ($$$) [R,O]", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "CMV ENCEPHALITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Infection in immunocompetent patients is rare and usually associated with"}, 
{"Row" : 6, "Column" : 1, "Text" : "minimal or no symptoms. Patients in whom the risk for CMV disease is increased"}, 
{"Row" : 7, "Column" : 1, "Text" : "include solid organ and bone marrow transplant recipients, persons receiving"}, 
{"Row" : 8, "Column" : 1, "Text" : "prolonged immunosuppressive chemotherapy, and persons with advanced HIV disease"}, 
{"Row" : 9, "Column" : 1, "Text" : "indicated by a CD4 count of less than 50 cells/microliter. Treatment is complex"}, 
{"Row" : 10, "Column" : 1, "Text" : "and requires Infectious Diseases consultation."}, 
{"Row" : 12, "Column" : 1, "Text" : "Duration of antimicrobial therapy", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Duration is likely to be prolonged and is individualized based on response."}, 
{"Row" : 14, "Column" : 1, "Text" : "Patients may be converted to oral therapy after initial intravenous therapy and"}, 
{"Row" : 15, "Column" : 1, "Text" : "after clinical improvement of severe disease."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "($$$$) [R,O]"}, 
{"Row" : 21, "Column" : 1, "Text" : "Oral treatment following clinical improvement", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "References:"}, 
{"Row" : 28, "Column" : 1, "Text" : "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV"}, 
{"Row" : 29, "Column" : 1, "Text" : "Infected Adults and Adolescents. AIDSinfo (2015) 1-282"}, 
{"Row" : 30, "Column" : 1, "Text" : "Mandell chapter: Cytomegalovirus"}, 
{"Row" : 31, "Column" : 1, "Text" : "Sanford keyword: Cytomegalovirus"}, 
{"Row" : 32, "Column" : 1, "Text" : "Up-to-Date article: Epidemiology, clinical manifestations, and treatment of"}, 
{"Row" : 33, "Column" : 1, "Text" : "cytomegalovirus infection in immunocompetent adults"}
]},
{"Name" : "ORZID2 GMENU ABX CMV MAIN PAGE", "Term1" : "Cytomegalovirus (CMV)", "DisplayText" : "Cytomegalovirus (CMV) Main Page", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX CMV COLITIS OR ESOPHAGITIS", "DisplayText" : "CMV Colitis or Esophagistis", "Text" : "Colitis or esophagitis", "Mnemonic" : "4"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX CMV ENCEPHALITIS", "DisplayText" : "CMV Encephalitis", "Text" : "Encephalitis", "Mnemonic" : "6"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX CMV POLYRADICULOPATHY", "DisplayText" : "CMV Polyradiculopathy", "Text" : "Polyradiculopathy", "Mnemonic" : "8"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX CMV RETINITIS", "DisplayText" : "CMV Retinitis", "Text" : "Retinitis", "Mnemonic" : "10"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX CMV PNEUMONIA", "DisplayText" : "CMV Pneumonia", "Text" : "Pneumonia", "Mnemonic" : "12"},
{"Row" : 3, "Column" : 1, "Text" : "CYTOMEGALOVIRUS (CMV)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Antiviral toxicity information", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "The major toxicities of both ganciclovir and valganciclovir are neutropenia."}, 
{"Row" : 7, "Column" : 1, "Text" : "Nephrotoxicity is the major toxicity associated with foscarnet, which may be"}, 
{"Row" : 8, "Column" : 1, "Text" : "reduced by concomitant saline administration (generally 0.5-1L)."}, 
{"Row" : 9, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Immunocompetent patient", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Infection is rare and usually associated with minimal or no symptoms."}, 
{"Row" : 13, "Column" : 1, "Text" : "Mononucleosis can be associated with CMV, but is more commonly associated with"}, 
{"Row" : 14, "Column" : 1, "Text" : "Epstein Barr virus. Antiviral treatment is not usually necessary as most"}, 
{"Row" : 15, "Column" : 1, "Text" : "patients recover without intervention."}, 
{"Row" : 16, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Immunocompromised patient", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Patients in whom the risk for CMV disease is increased include solid organ and"}, 
{"Row" : 20, "Column" : 1, "Text" : "bone marrow transplant recipients, persons receiving prolonged immunosuppressive"}, 
{"Row" : 21, "Column" : 1, "Text" : "chemotherapy, and persons with advanced HIV disease indicated by a CD4 count of"}, 
{"Row" : 22, "Column" : 1, "Text" : "less than 50 cells/microliter."}, 
{"Row" : 24, "Column" : 1, "Text" : "CMV treatment recommendations", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "References:"}, 
{"Row" : 34, "Column" : 1, "Text" : "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV"}, 
{"Row" : 35, "Column" : 1, "Text" : "Infected Adults and Adolescents. AIDSinfo (2015) 1-282"}, 
{"Row" : 36, "Column" : 1, "Text" : "Mandell chapter: Cytomegalovirus"}, 
{"Row" : 37, "Column" : 1, "Text" : "Sanford keyword: Cytomegalovirus"}, 
{"Row" : 38, "Column" : 1, "Text" : "Up-to-Date article: Epidemiology, clinical manifestations, and treatment of"}, 
{"Row" : 39, "Column" : 1, "Text" : "cytomegalovirus infection in immunocompetent adults"}
]},
{"Name" : "ORZID2 GMENU ABX CMV PNEUMONIA", "Term1" : "Pneumonia, Cytomegalovirus (CMV)", "DisplayText" : "CMV Pneumonia", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 15, "Column" : 1, "Item" : "ORZ SET ABX GANCICLOVIR 5 MG/KG IV Q12H IMMUNE IG 0.5 GM/KG", "DisplayText" : "Ganciclovir 5 mg/kg and IV IG 0.5 gm/kg IV qother day", "Text" : "Ganciclovir 5 mg/kg IV q12h ($$$$) [R,O] <AND> intravenous immune globulin", "Mnemonic" : "4"},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID VALGANCICLOVIR 900 MG PO Q24H", "DisplayText" : "Valganciclovir 900 mg po q24h", "Text" : "Valganciclovir 900 mg PO Q24h ($$$) [R,O]", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "CMV PNEUMONIA", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "CMV pneumonia occurs almost exclusively in bone marrow transplant recipients,"}, 
{"Row" : 6, "Column" : 1, "Text" : "usually within the first 120 days after transplantation. In these patients, CMV"}, 
{"Row" : 7, "Column" : 1, "Text" : "pneumonia is severe and requires aggressive treatment. Treatment is complex and"}, 
{"Row" : 8, "Column" : 1, "Text" : "requires Infectious Diseases consultation."}, 
{"Row" : 10, "Column" : 1, "Text" : "Duration of antimicrobial therapy", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Induction therapy is indicated for 3 to 6 weeks, followed by maintenance"}, 
{"Row" : 12, "Column" : 1, "Text" : "therapy. Duration of maintenance therapy is not well established."}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "0.5 grams/kg IV every other day"}, 
{"Row" : 18, "Column" : 1, "Text" : "Maintenance therapy", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "References:"}, 
{"Row" : 24, "Column" : 1, "Text" : "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV"}, 
{"Row" : 25, "Column" : 1, "Text" : "Infected Adults and Adolescents. AIDSinfo (2015) 1-282"}, 
{"Row" : 26, "Column" : 1, "Text" : "Mandell chapter: Cytomegalovirus"}, 
{"Row" : 27, "Column" : 1, "Text" : "Sanford keyword: Cytomegalovirus"}, 
{"Row" : 28, "Column" : 1, "Text" : "Up-to-Date article: Epidemiology, clinical manifestations, and treatment of"}, 
{"Row" : 29, "Column" : 1, "Text" : "cytomegalovirus infection in immunocompetent adults"}
]},
{"Name" : "ORZID2 GMENU ABX CMV POLYRADICULOPATHY", "Term1" : "Polyradiculopathy, Cytomegalovirus (CMV)", "DisplayText" : "CMV Polyradiculopathy ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID VALGANCICLOVIR 900MG PO Q12H", "DisplayText" : "Valgancicilovir 900MG PO q12h", "Text" : "Valganciclovir 900 mg PO q12h ($$$) [R,O]", "Mnemonic" : "4"},
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID GANCICLOVIR 5 MG/KG IV Q12H", "DisplayText" : "Ganciclovir 5 mg/kg IV Q12H", "Text" : "Ganciclovir 5 mg/kg IV q12h ($$$$) [R,O]", "Mnemonic" : "6"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID FOSCARNET 90 MG/KG IV Q12H", "DisplayText" : "Foscarnet 90 mg/kg IV Q12H", "Text" : "Foscarnet 90 mg/kg IV q12h ($$$$) [R,O]", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "CMV POLYRADICULOPATHY", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Infection in immunocompetent patients is rare and usually associated with"}, 
{"Row" : 6, "Column" : 1, "Text" : "minimal or no symptoms. Patients in whom the risk for CMV disease is increased"}, 
{"Row" : 7, "Column" : 1, "Text" : "include solid organ and bone marrow transplant recipients, persons receiving"}, 
{"Row" : 8, "Column" : 1, "Text" : "prolonged immunosuppressive chemotherapy, and persons with advanced HIV disease"}, 
{"Row" : 9, "Column" : 1, "Text" : "indicated by a CD4 count of less than 50 cells/microliter. Treatment is complex"}, 
{"Row" : 10, "Column" : 1, "Text" : "and requires Infectious Diseases consultation."}, 
{"Row" : 12, "Column" : 1, "Text" : "Duration of antimicrobial therapy", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Duration is likely to be prolonged and is individualized based on response."}, 
{"Row" : 14, "Column" : 1, "Text" : "Patients may be converted to oral therapy after initial intravenous therapy and"}, 
{"Row" : 15, "Column" : 1, "Text" : "after clinical improvement of severe disease."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment of mild to moderate disease or following clinical improvement of", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "severe disease", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Treatment of severe disease", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 27, "Column" : 1, "Text" : "References:"}, 
{"Row" : 29, "Column" : 1, "Text" : "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV"}, 
{"Row" : 30, "Column" : 1, "Text" : "Infected Adults and Adolescents. AIDSinfo (2015) 1-282"}, 
{"Row" : 31, "Column" : 1, "Text" : "Mandell chapter: Cytomegalovirus"}, 
{"Row" : 32, "Column" : 1, "Text" : "Sanford keyword: Cytomegalovirus"}, 
{"Row" : 33, "Column" : 1, "Text" : "Up-to-Date article: Epidemiology, clinical manifestations, and treatment of"}, 
{"Row" : 34, "Column" : 1, "Text" : "cytomegalovirus infection in immunocompetent adults"}
]},
{"Name" : "ORZID2 GMENU ABX CMV RETINITIS", "DisplayText" : "CMV Retinitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID VALGANCICLOVIR 900MG PO Q12H", "DisplayText" : "Valgancicilovir 900MG PO q12h", "Text" : "Valganciclovir 900 mg PO q12h($$$) [R,O]", "Mnemonic" : "4"},
{"Row" : 27, "Column" : 1, "Item" : "PSJIZID GANCICLOVIR 5 MG/KG IV Q12H", "DisplayText" : "Ganciclovir 5 mg/kg IV Q12H", "Text" : "Ganciclovir 5 mg/kg IV q12h ($$$$) [R,O]", "Mnemonic" : "6"},
{"Row" : 29, "Column" : 1, "Item" : "PSJIZID FOSCARNET 90 MG/KG IV Q12H", "DisplayText" : "Foscarnet 90 mg/kg IV Q12H", "Text" : "Foscarnet 90 mg/kg IV q12h ($$$$) [R,O]", "Mnemonic" : "8"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID VALGANCICLOVIR 900 MG PO Q24H", "DisplayText" : "Valganciclovir 900 mg po q24h", "Text" : "Valganciclovir 900 mg PO q24h ($$$) [R,O]", "Mnemonic" : "10"},
{"Row" : 35, "Column" : 1, "Item" : "ORZ SET ABX GANCICLOVIR 5MG/KG IV Q12H FOSCAR 90MG/KG IV Q12H", "DisplayText" : "Ganciclovir 5 mg/kg IV Q12H Foscarnet 90 mg/kg IV Q12H", "Text" : "Ganciclovir 5 mg/kg IV q12h ($$$$) [R,O] <AND> foscarnet 90 mg/kg IV q12h", "Mnemonic" : "12"},
{"Row" : 3, "Column" : 1, "Text" : "CMV RETINITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Infection in immunocompetent patients is rare and usually associated with"}, 
{"Row" : 6, "Column" : 1, "Text" : "minimal or no symptoms. Patients in whom the risk for CMV disease is increased"}, 
{"Row" : 7, "Column" : 1, "Text" : "include solid organ and bone marrow transplant recipients, persons receiving"}, 
{"Row" : 8, "Column" : 1, "Text" : "prolonged immunosuppressive chemotherapy, and persons with advanced HIV disease"}, 
{"Row" : 9, "Column" : 1, "Text" : "indicated by a CD4 count of less than 50 cells/microliter. Treatment is complex"}, 
{"Row" : 10, "Column" : 1, "Text" : "and requires Infectious Diseases consultation."}, 
{"Row" : 12, "Column" : 1, "Text" : "For sight threatening lesions (lesions within 1500 microns of the fovea)"}, 
{"Row" : 13, "Column" : 1, "Text" : "intravitreal infections of ganciclovir or foscarnet are recommended in addition"}, 
{"Row" : 14, "Column" : 1, "Text" : "to systemic treatment. Contact Infectious Diseases for more information."}, 
{"Row" : 16, "Column" : 1, "Text" : "Duration of antimicrobial therapy", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Treat for 14 to 21 days. Patients may be converted to oral therapy after initial"}, 
{"Row" : 18, "Column" : 1, "Text" : "intravenous therapy and after clinical improvement of severe disease."}, 
{"Row" : 19, "Column" : 1, "Text" : "Maintenance therapy after completion of treatment is indicated when CD4 count"}, 
{"Row" : 20, "Column" : 1, "Text" : "<100. Discontinue maintenance therapy when CD4 count is >100 for 6 months."}, 
{"Row" : 22, "Column" : 1, "Text" : "Treatment of mild to moderate disease or after clinical improvement of severe", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "disease", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Treatment of severe disease", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 31, "Column" : 1, "Text" : "Maintenance therapy", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "For cases not responsive to therapy with foscarnet and ganciclovir used alone", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "($$$$) [R,O]"}, 
{"Row" : 38, "Column" : 1, "Text" : "In cases not responsive to first-line therapy, second-line therapies may be"}, 
{"Row" : 39, "Column" : 1, "Text" : "effective. Their use is highly specialized and must be done by someone"}, 
{"Row" : 40, "Column" : 1, "Text" : "experienced with HIV/AIDS medicine."}, 
{"Row" : 43, "Column" : 1, "Text" : "References:"}, 
{"Row" : 45, "Column" : 1, "Text" : "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV"}, 
{"Row" : 46, "Column" : 1, "Text" : "Infected Adults and Adolescents. AIDSinfo (2015) 1-282"}, 
{"Row" : 47, "Column" : 1, "Text" : "Mandell chapter: Cytomegalovirus"}, 
{"Row" : 48, "Column" : 1, "Text" : "Sanford keyword: Cytomegalovirus"}, 
{"Row" : 49, "Column" : 1, "Text" : "Up-to-Date article: Epidemiology, clinical manifestations, and treatment of"}, 
{"Row" : 50, "Column" : 1, "Text" : "cytomegalovirus infection in immunocompetent adults"}
]},
{"Name" : "ORZID2 GMENU ABX CNS", "Term1" : "Abscess, brain ", "Term2" : "Central Nervous System section", "DisplayText" : "Central Nervous System", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO ACUTE MENINGITIS", "DisplayText" : "Approach to Acute Meningitis", "Text" : "Approach to acute meningitis", "Mnemonic" : "4"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING W/O GRM STAIN RES", "DisplayText" : "Bacterial meningitis without Gram stain results", "Text" : "Community acquired", "Mnemonic" : "6"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING ASSOC TRAUMA", "DisplayText" : "Bacterial meningitis associated with trauma or nosocomial infection", "Text" : "Associated with trauma or nosocomial infection", "Mnemonic" : "8"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING GRM POS DIPLO S. PNEUMO", "DisplayText" : "Bacterial meningitis with Gram positive diplococci suggesting S. pneumonia", "Text" : "Gram-positive diplococci suggesting Streptococcus pneumoniae", "Mnemonic" : "10"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING GRM NEG DIPL N. MENING", "DisplayText" : "Bacterial meningitidis with Gram negative diplococci suggesting N. meningitis", "Text" : "Gram-negative diplococci suggesting Neisseria meningitidis", "Mnemonic" : "12"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU BAC MENING GRM POS BACILLI L. MONOCYTO", "DisplayText" : "Bacterial meningitis with Gram pos bacilli suggesting L. monocytogenes", "Text" : "Gram-positive bacilli/coccobacilli suggesting Listeria monocytogenes", "Mnemonic" : "14"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING GNB", "DisplayText" : "Bacterial meningitis with Gram negative bacilli", "Text" : "Gram negative bacilli", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING S. PNEUMONIAE", "DisplayText" : "Bacterial meningitis with S. pneumoniae", "Text" : "S. pneumoniae", "Mnemonic" : "18"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING N. MENINGITIDIS", "DisplayText" : "Bacterial meningitis with N. meningitidis", "Text" : "N. meningitidis", "Mnemonic" : "20"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING L. MONOCYTOGENES", "DisplayText" : "Bacterial meningitis with L. monocytogenes", "Text" : "L. monocytogenes", "Mnemonic" : "22"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU BACT MENING E.COLI, PSEUDOMONAS", "DisplayText" : "Bacterial meningitis with E. Coli, Pseudomonas, or other organism", "Text" : "E. Coli, Pseudomonas, or another organism", "Mnemonic" : "24"},
{"Row" : 3, "Column" : 1, "Text" : "++ CENTRAL NERVOUS SYSTEM ++", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Acute Meningitis", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Empiric Treatment Prior to Gram Stain Results"}, 
{"Row" : 12, "Column" : 1, "Text" : "Empiric Treatment Based on Gram Stain Results"}, 
{"Row" : 18, "Column" : 1, "Text" : "Treatment Based on Isolated Pathogen"}, 
{"Row" : 28, "Column" : 1, "Text" : "Last reviewed 11/2021", "Header" : 1}, 
{"Row" : 6, "Column" : 2, "Item" : "ORZID2 GMENU APPROACH TO BRAIN ABSCESS", "DisplayText" : "Approach to Brain Abscess", "Text" : "Approach to brain abscess", "Mnemonic" : "26"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 GMENU BRN ABSC CONT HEMATO SPRD INFECT", "DisplayText" : "Brain abscess resulting from contiguous or hematogenous spread of infection", "Text" : "Contiguous or hematogenous spread of infection", "Mnemonic" : "28"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID2 GMENU BRN ABSC POST SURG POST TRAUMATIC", "DisplayText" : "Post-surgical or post-traumatic brain abscess", "Text" : "Post-surgical or post-traumatic", "Mnemonic" : "30"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU BRN ABSC NOCARDIA SPP", "DisplayText" : "Brain Abscess with Nocardia spp.", "Text" : "Nocardia spp.", "Mnemonic" : "32"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU BRN ABSC PSEUDOMONAS SPP.", "DisplayText" : "Brain Abscess with Pseudomonas spp.", "Text" : "Pseudomonas spp.", "Mnemonic" : "34"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID2 GMENU BRN ABSC TOXOPLASMA GONDII", "DisplayText" : "Brain Abscess with Toxoplasma gondii", "Text" : "Toxoplasma gondii", "Mnemonic" : "36"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU ABX BELL'S PALSY", "DisplayText" : "Bell's Palsy", "Text" : "Bell's Palsy", "Mnemonic" : "38"},
{"Row" : 19, "Column" : 2, "Item" : "ORZID2 GMENU ABX CHRONIC MENINGITIS", "DisplayText" : "Chronic Meningitis", "Text" : "Chronic Meningitis", "Mnemonic" : "40"},
{"Row" : 20, "Column" : 2, "Item" : "ORZID2 GMENU CRANIAL EPIDURAL ABSCESS", "DisplayText" : "Cranial epidural abscess", "Text" : "Cranial epidural abscess", "Mnemonic" : "42"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU SURG NEUROSURGERY", "DisplayText" : "Neurosurgery", "Text" : "Neurosurgery prophylaxis", "Mnemonic" : "44"},
{"Row" : 22, "Column" : 2, "Item" : "ORZID2 GMENU ABX HSV ENCEPHALITIS", "DisplayText" : "HSV Encephalitis", "Text" : "Herpes simplex encephalitis", "Mnemonic" : "46"},
{"Row" : 23, "Column" : 2, "Item" : "ORZID2 GMENU ABX LYME DISEASE", "DisplayText" : "Lyme disease", "Text" : "Lyme disease", "Mnemonic" : "48"},
{"Row" : 24, "Column" : 2, "Item" : "ORZID2 GMENU SPINAL EPIDURAL ABSCESS", "DisplayText" : "Spinal epidural abscess", "Text" : "Spinal epidural abscess", "Mnemonic" : "50"},
{"Row" : 25, "Column" : 2, "Item" : "ORZID2 GMENU SUBDURAL EMPYEMA", "DisplayText" : "Subdural Empyema", "Text" : "Subdural empyema", "Mnemonic" : "52"},
{"Row" : 26, "Column" : 2, "Item" : "ORZID2 GMENU SUPP INTRACRANIAL THROMBOPH", "DisplayText" : "Suppurative intracranial thrombophlebitis", "Text" : "Suppurative intracranial thrombophilia", "Mnemonic" : "54"},
{"Row" : 5, "Column" : 2, "Text" : "Brain abscess", "Header" : 1}, 
{"Row" : 8, "Column" : 2, "Text" : "Empiric Treatment"}, 
{"Row" : 12, "Column" : 2, "Text" : "Treatment based on Isolated Pathogen"}, 
{"Row" : 17, "Column" : 2, "Text" : "Other", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX COLONIZED RESPIRATORY TRACT VENTILATOR", "Term1" : "Colonized respiratory tract patient on a ventilator", "DisplayText" : "Colonized respiratory tract in patient with a ventilator  ", "Version" : "StCloud", "Contents" : [
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX NOSO PNEUMONIA NEW", "DisplayText" : "Nosocomial pneumonia (including HAP, VAP, and HCAP)", "Text" : "Nosocomial Pneumonia", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "COLONIZED RESPIRATORY TRACT IN A PATIENT ON A VENTILATOR", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "The respiratory tracts of persons who are intubated, have a"}, 
{"Row" : 6, "Column" : 1, "Text" : "tracheostomy, or have other abnormalities of the larynx or trachea are"}, 
{"Row" : 7, "Column" : 1, "Text" : "usually colonized with bacteria and often fungi. The bacteria can be of"}, 
{"Row" : 8, "Column" : 1, "Text" : "relatively low virulence (e.g. coagulase negative staphylococci, streptococci,"}, 
{"Row" : 9, "Column" : 1, "Text" : "candida) or of potentially greater virulence (Staphylococcus aureus,"}, 
{"Row" : 10, "Column" : 1, "Text" : "enterobacteriaceae, pseudomonas). Candida and enterococci are common"}, 
{"Row" : 11, "Column" : 1, "Text" : "respiratory tract colonizers and they almost never cause pneumonia. There is"}, 
{"Row" : 12, "Column" : 1, "Text" : "no benefit from treatment of patients with systemic antimicrobials simply"}, 
{"Row" : 13, "Column" : 1, "Text" : "because the respiratory tract is colonized with a potential pathogen and there"}, 
{"Row" : 14, "Column" : 1, "Text" : "is no evidence of an infiltrate. Systemic antimicrobial therapy will select for"}, 
{"Row" : 15, "Column" : 1, "Text" : "resistant organisms and may lead to other adverse effects."}, 
{"Row" : 17, "Column" : 1, "Text" : "See below for ventilator-associated pneumonia treatment recommendations in"}, 
{"Row" : 18, "Column" : 1, "Text" : "patients with a new or progressive infiltrate and at least one of the following:"}, 
{"Row" : 19, "Column" : 1, "Text" : "fever greater than 100.4F, leukocytosis, leukopenia or purulent bronchial"}, 
{"Row" : 20, "Column" : 1, "Text" : "secretions."}, 
{"Row" : 24, "Column" : 1, "Text" : "References"}, 
{"Row" : 26, "Column" : 1, "Text" : "Kalil et al. Clin Infect Dis, 2016, 63(5): e61-e111."}
]},
{"Name" : "ORZID2 GMENU ABX COLONIZED WOUNDS", "Term1" : "Colonized wound ", "Term2" : "Wound, colonized", "DisplayText" : "Colonized wounds", "Version" : "StCloud", "Contents" : [
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU DECUBITUS ULCERS", "DisplayText" : "Decubitus ulcers", "Text" : "Decubitus ulcers", "Mnemonic" : "2"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU FOOT ULCER WITH DM", "DisplayText" : "Foot ulcer in patient with diabetes mellitus", "Text" : "Diabetic foot ulcers", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "COLONIZED WOUNDS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Open wounds are usually colonized with bacteria and often fungi. This is true of"}, 
{"Row" : 6, "Column" : 1, "Text" : "ulcers (see below), post-operative wounds, traumatic wounds, and others. Then"}, 
{"Row" : 7, "Column" : 1, "Text" : "bacteria can be of relatively low virulence (eg, coagulase negative"}, 
{"Row" : 8, "Column" : 1, "Text" : "staphylococci, diphtheroids) or of potentially greater virulence (Staphylococcus"}, 
{"Row" : 9, "Column" : 1, "Text" : "aureus, enterobacteriaceae, pseudomonas). Candida is commonly present on wounds"}, 
{"Row" : 10, "Column" : 1, "Text" : "that are moist or covered. There is no need to treat patients with systemic"}, 
{"Row" : 11, "Column" : 1, "Text" : "antimicrobials simply because a wound culture is positive for a potential"}, 
{"Row" : 12, "Column" : 1, "Text" : "pathogen. Topical antimicrobials are not effective in nearly all circumstances"}, 
{"Row" : 13, "Column" : 1, "Text" : "and can select for resistant organisms or lead to other adverse effects."}, 
{"Row" : 14, "Column" : 1, "Text" : "Systemic antimicrobial therapy may be indicated if there are signs of infection."}, 
{"Row" : 20, "Column" : 1, "Text" : "References"}, 
{"Row" : 22, "Column" : 1, "Text" : "Lipsky et al, Clin Infect Dis, 2012, 54(12): e132-e173"}, 
{"Row" : 23, "Column" : 1, "Text" : "Up-to-Date article: Clinical assessment of chronic wounds"}
]},
{"Name" : "ORZID2 GMENU ABX COM-ACQ PNEUMONIA", "Term1" : "Community-acquired pneumonia (CAP) ", "Term2" : "Pneumonia, community-acquired (CAP)", "DisplayText" : "Community-acquired pneumonia (CAP)", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 21, "Column" : 1, "Item" : "ORZ GTX ABX CAP PSI", "DisplayText" : "CAP Pneumonia Severity Index (PSI) Calculator", "Text" : "CAP Pneumonia Severity Index (PSI) Calculator", "Mnemonic" : "4"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU CAP INPATIENT TREATED SETTING NON-SEVERE CAP", "DisplayText" : "CAP NON-SEVERE treated in an Inpatient Ward setting", "Text" : "CAP NON-SEVERE treated in an Inpatient Ward setting", "Mnemonic" : "6"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU CAP INPATIENT TREATED SETTING SEVERE CAP", "DisplayText" : "CAP SEVERE treated in an ICU setting", "Text" : "CAP SEVERE treated in an ICU setting", "Mnemonic" : "8"},
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU CAP OUTPATIENT TREATED SETTING", "DisplayText" : "CAP treated in an OUTPATIENT setting", "Text" : "Stepdown empiric treatment for CAP with oral antibiotics", "Mnemonic" : "10"},
{"Row" : 3, "Column" : 1, "Text" : "COMMUNITY-ACQUIRED PNEUMONIA (CAP)"}, 
{"Row" : 5, "Column" : 1, "Text" : "Empirical regimens listed here cover the usual pathogens associated with CAP,"}, 
{"Row" : 6, "Column" : 1, "Text" : "including atypical pathogens.  Specific therapy should be guided by culture"}, 
{"Row" : 7, "Column" : 1, "Text" : "results."}, 
{"Row" : 8, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Diagnosis", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "CAP Pneumonia Severity Index (PSI) or PORT Score", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "The CAP pneumonia severity index is useful for estimation of mortality risk for"}, 
{"Row" : 13, "Column" : 1, "Text" : "a patient with pneumonia.  Pre-estimated risk can then be used to determine how"}, 
{"Row" : 14, "Column" : 1, "Text" : "aggressively to treat the patient's pneumonia and whether the patient can be"}, 
{"Row" : 15, "Column" : 1, "Text" : "treated safely outside of the hospital."}, 
{"Row" : 16, "Column" : 1, "Text" : "The Community-Acquired Pneumonia Severity Index (PSI) is a guide and"}, 
{"Row" : 17, "Column" : 1, "Text" : "should be used to augment clinical judgment. If social circumstances"}, 
{"Row" : 18, "Column" : 1, "Text" : "or cognitive dysfunction would interfere with success of outpatient"}, 
{"Row" : 19, "Column" : 1, "Text" : "treatment, the patient should be hospitalized."}, 
{"Row" : 22, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Empirical treatment", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "_________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "If a patient has taken an antimicrobial in the previous 3 months, it is prudent"}, 
{"Row" : 26, "Column" : 1, "Text" : "to avoid giving the same or a similar drug for the current episode of pneumonia."}, 
{"Row" : 28, "Column" : 1, "Text" : "Empiric treatment for CAP treated in an Inpatient setting:", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Stepdown empiric treatment for CAP (Intravenous to Oral conversion)", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Note: These regimens may also be used to convert patients to oral medications"}, 
{"Row" : 35, "Column" : 1, "Text" : "prior to discharge."}, 
{"Row" : 37, "Column" : 1, "Text" : "References:"}, 
{"Row" : 38, "Column" : 1, "Text" : "Fine MJ, et al. N Engl J Med (1997) 336:243-250"}
]},
{"Name" : "ORZID2 GMENU ABX COMMON INFECT UTI", "DisplayText" : "Urinary tract infection  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "618061", "DisplayText" : "", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "04"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ABX ASYMP BACTERIURIA", "DisplayText" : "Asymptomatic Bacteriuria", "Text" : "Asymptomatic bacteriuria", "Mnemonic" : "06"},
{"Row" : 5, "Column" : 1, "Text" : "Urinary tract infections", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX COMP CYSTITIS", "DisplayText" : "Complicated Cystitis", "Text" : "Complicated cystitis", "Mnemonic" : "08"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX UNCOMP CYSTITIS", "DisplayText" : "Uncomplicated Cystitis", "Text" : "Uncomplicated cystitis", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU ABX PYELONEPHRITIS", "DisplayText" : "Pyelonephritis", "Text" : "Pyelonephritis", "Mnemonic" : "12"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX EPIDIDYMITIS", "DisplayText" : "Epididymitis", "Text" : "Epididymitis", "Mnemonic" : "14"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU ABX PID", "DisplayText" : "Pelvic Inflammatory Disease", "Text" : "Pelvic inflammatory disorder (PID)", "Mnemonic" : "16"},
{"Row" : 17, "Column" : 1, "Text" : "SECTION LAST REVIEWED NOVEMBER 2012", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX COMP CYSTITIS", "Term1" : "Complicated cystitis ", "Term2" : "Cystitis, complicated", "DisplayText" : "Complicated Cystitis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX PYELONEPHRITIS", "DisplayText" : "Pyelonephritis", "Text" : "Pyelonephritis", "Mnemonic" : "4"},
{"Row" : 20, "Column" : 1, "Item" : "ORZ ADD MENU LABS (LAB COLLECT)", "DisplayText" : "1-H LABS", "Text" : "Lab menu", "Mnemonic" : "6"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX ACUTE BACT PROSTATITIS", "DisplayText" : "Acute Bacterial Prostatitis", "Text" : "Acute prostatitis", "Mnemonic" : "8"},
{"Row" : 48, "Column" : 1, "Item" : "PSJZID TRIMETH/SULFA 1 DS TAB BID", "DisplayText" : "Trimethoprim-sulfamethoxazole 1 DS PO BID (Cost $)for 10 days [R,DI]", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO q12h ($) [R,DI] for 7 days", "Mnemonic" : "10"},
{"Row" : 51, "Column" : 1, "Item" : "PSJZID NITROFURANTOIN SA 100 MG PO BID", "DisplayText" : "Nitrofurantoin SA 100 mg PO q12h ($) [R,O]", "Text" : "Nitrofurantoin SA 100 mg PO q12h ($) [R,O], CrCl =/>30mL/min, for 7 days", "Mnemonic" : "12"},
{"Row" : 55, "Column" : 1, "Item" : "PSJZID AMOXICILLIN-CLAVULANATE 875-125 MG PO Q12H", "DisplayText" : "Amoxicillin-Clavulanate 875-125 MG PO Q12H", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h ($) [R] for 7 days", "Mnemonic" : "14"},
{"Row" : 57, "Column" : 1, "Item" : "PSJZID FOSFOMYCIN 3GM PO QOD 3 DOSES", "DisplayText" : "Fosfomycin 3 gm sachet PO every other day ($$) [M] x 3 doses", "Text" : "Fosfomycin 3 gm sachet PO every other day ($$) [M] x 3 doses", "Mnemonic" : "16"},
{"Row" : 59, "Column" : 1, "Item" : "PSJZID CEFDINIR 300MG PO Q12H", "DisplayText" : "Cefdinir 300 mg PO q12h ($) [R]", "Text" : "Cefdinir 300 mg PO q12h ($) [R] for 7 days", "Mnemonic" : "18"},
{"Row" : 62, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Assessment of Beta-lactam Reaction", "Mnemonic" : "20"},
{"Row" : 63, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($) [R,DI] for 7 days", "Mnemonic" : "22"},
{"Row" : 67, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IV Q24H", "DisplayText" : "Ceftriaxone 2 gm IV Q24h", "Text" : "Ceftriaxone 2 gm IV q24h ($) [M] for 7 days", "Mnemonic" : "24"},
{"Row" : 70, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Assessment of Beta-lactam Reaction", "Mnemonic" : "26"},
{"Row" : 71, "Column" : 1, "Item" : "PSJIZID ERTAPENEM 1GM IV Q24H", "DisplayText" : "ERTAPENEM 1GM IV Q24H", "Text" : "Ertapenem 1 gm IV q24h ($$) [R,O]", "Mnemonic" : "28"},
{"Row" : 74, "Column" : 1, "Item" : "PSJIZID PIP/TAZ 4.5GM IV Q6H(NE-EXTINF,CI-CEFEP/METRO)", "DisplayText" : "Piperacillin-tazobactam 4.5 gm IV q6h ($$) [R]", "Mnemonic" : "30"},
{"Row" : 76, "Column" : 1, "Item" : "PSJIZID CEFEPIME 2 GM IV Q12H", "DisplayText" : "Cefepime 2g IV q12h ($$) [R]", "Text" : "Cefepime 2 gm IV q12h ($$) [R] for 7 days", "Mnemonic" : "32"},
{"Row" : 83, "Column" : 1, "Item" : "PSJZID CEFADROXIL 1000MG PO Q12H", "DisplayText" : "Cefadroxil 1000 mg PO q12h ($) [R]", "Text" : "Cefadroxil 1000 mg PO q12h ($) [R] for 7 days", "Mnemonic" : "34"},
{"Row" : 85, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IV Q24H", "DisplayText" : "Ceftriaxone 2 gm IV Q24h", "Text" : "Ceftriaxone 2 gm IV q24h ($) [M] for 7 days", "Mnemonic" : "36"},
{"Row" : 88, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Assessment of Beta-lactam Reaction", "Mnemonic" : "38"},
{"Row" : 89, "Column" : 1, "Item" : "PSJZID TRIMETH/SULFA 1 DS TAB BID", "DisplayText" : "Trimethoprim-sulfamethoxazole 1 DS PO BID (Cost $)for 10 days [R,DI]", "Text" : "Trimethoprim/sulfamethoxazole 1 DS tablet PO q12h ($) [R,DI] for 7 days", "Mnemonic" : "40"},
{"Row" : 99, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 750MG PO Q12H", "DisplayText" : "Ciprofloxacin 750MG PO Q12h", "Text" : "Ciprofloxacin 750 mg PO q12h ($) [R,DI] for 7 days", "Mnemonic" : "42"},
{"Row" : 101, "Column" : 1, "Item" : "PSJIZID PIP/TAZ 4.5GM IV Q6H(NE-EXTINF,CI-CEFEP/METRO)", "DisplayText" : "Piperacillin-tazobactam 4.5 gm IV q6h ($$) [R]", "Mnemonic" : "44"},
{"Row" : 103, "Column" : 1, "Item" : "PSJIZID CEFEPIME 2 GM IV Q12H", "DisplayText" : "Cefepime 2g IV q12h ($$) [R]", "Text" : "Cefepime 2 gm IV q12h ($$) [R] for 7 days", "Mnemonic" : "46"},
{"Row" : 107, "Column" : 1, "Item" : "PSJZID AMOXICILLIN 500MG PO Q8H", "DisplayText" : "Amoxicillin 500 mg PO q8h ($) [R]", "Text" : "Amoxicillin 500 mg PO q8h ($) [R] for 7 days", "Mnemonic" : "48"},
{"Row" : 109, "Column" : 1, "Item" : "PSJIZID AMPICILLIN 1GM IV Q6H", "DisplayText" : "Ampicillin 1GM IV Q6H", "Text" : "Ampicillin 1 gm IV q6h ($$) [R] for 7 days", "Mnemonic" : "50"},
{"Row" : 112, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Assessment of Beta-lactam Reaction", "Mnemonic" : "52"},
{"Row" : 113, "Column" : 1, "Item" : "PSJZID FOSFOMYCIN 3GM PO QOD 3 DOSES", "DisplayText" : "Fosfomycin 3 gm sachet PO every other day ($$) [M] x 3 doses", "Text" : "Fosfomycin 3 gm sachet PO every other day ($$) [M] x 3 doses", "Mnemonic" : "54"},
{"Row" : 115, "Column" : 1, "Item" : "PSJZID NITROFURANTOIN SA 100 MG PO BID", "DisplayText" : "Nitrofurantoin SA 100 mg PO q12h ($) [R,O]", "Text" : "Nitrofurantoin SA 100 mg PO q12h ($) [R,O], CrCl =/>30 mL/min, for 7 days", "Mnemonic" : "56"},
{"Row" : 118, "Column" : 1, "Item" : "ORZ SET ABX VANCO NEW START 15MG/KG Q12H + MRSA NARES SCREENING", "DisplayText" : "Vancomycin 15mg/kg IV q12h ($) [R]", "Text" : "Vancomycin 15 mg/kg IV q12h ($) [R] for 7 days", "Mnemonic" : "58"},
{"Row" : 3, "Column" : 1, "Text" : "COMPLICATED CYSTITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Complicated cystitis is defined as symptomatic bladder inflammation and symptoms"}, 
{"Row" : 6, "Column" : 1, "Text" : "due to a bacterial infection in people with certain conditions (see below)."}, 
{"Row" : 7, "Column" : 1, "Text" : "Symptoms usually include dysuria, lower abdominal pain, and urgency. Complicated"}, 
{"Row" : 8, "Column" : 1, "Text" : "cystitis is commonly associated with Enterobacteriaceae, but more resistant"}, 
{"Row" : 9, "Column" : 1, "Text" : "pathogens occur, including the Gram-positive pathogens staphylococci and"}, 
{"Row" : 10, "Column" : 1, "Text" : "enterococci."}, 
{"Row" : 12, "Column" : 1, "Text" : "Signs and symptoms that may indicate infection has extended beyond the bladder"}, 
{"Row" : 13, "Column" : 1, "Text" : "include fever/other signs of systemic infection, flank pain, costovertebral"}, 
{"Row" : 14, "Column" : 1, "Text" : "tenderness, and pelvic or perianal pain in men. Pyelonephritis should be"}, 
{"Row" : 15, "Column" : 1, "Text" : "considered in these patients:"}, 
{"Row" : 18, "Column" : 1, "Text" : "Urine culture should be obtained before antimicrobials are given to guide"}, 
{"Row" : 19, "Column" : 1, "Text" : "treatment of complicated cystitis:"}, 
{"Row" : 22, "Column" : 1, "Text" : "Prostatitis should be considered in men with recurrence of urinary tract"}, 
{"Row" : 23, "Column" : 1, "Text" : "infection:"}, 
{"Row" : 26, "Column" : 1, "Text" : "When patients who require paraenteral therapy are afebrile, clinically stable,"}, 
{"Row" : 27, "Column" : 1, "Text" : "and can take oral medication, convert to oral therapy based on the"}, 
{"Row" : 28, "Column" : 1, "Text" : "identification and susceptibility of the isolate."}, 
{"Row" : 30, "Column" : 1, "Text" : "Complicating conditions", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Cystitis is considered complicated when one or more of the following is present:"}, 
{"Row" : 32, "Column" : 1, "Text" : "o Pregnant women"}, 
{"Row" : 33, "Column" : 1, "Text" : "o Structural or neurogenic abnormalities (e.g. presence of obstruction, catheter"}, 
{"Row" : 34, "Column" : 1, "Text" : "or nephrostomy tubes, neurogenic bladder, renal failure or transplantation)"}, 
{"Row" : 35, "Column" : 1, "Text" : "o Immunocompromise"}, 
{"Row" : 36, "Column" : 1, "Text" : "o Persistent infection, relapse, recurrence, or treatment failure"}, 
{"Row" : 37, "Column" : 1, "Text" : "o In some cases, men and patients admitted to health care settings may be"}, 
{"Row" : 38, "Column" : 1, "Text" : "considered complicated"}, 
{"Row" : 40, "Column" : 1, "Text" : "Duration", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Treat for 7 days. If patient is febrile, may extend duration up to 14 days total"}, 
{"Row" : 42, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "Empirical treatment", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Mild to moderate disease", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 49, "Column" : 1, "Text" : "*Avoid trimethoprim/sulfamethoxazole in the first and third trimesters"}, 
{"Row" : 50, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 52, "Column" : 1, "Text" : "*Avoid nitrofurantoin in the third trimester"}, 
{"Row" : 54, "Column" : 1, "Text" : "Primary alternatives:"}, 
{"Row" : 56, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 58, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 61, "Column" : 1, "Text" : "Secondary alternative:"}, 
{"Row" : 65, "Column" : 1, "Text" : "Severe disease or if patient cannot take oral therapy", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 69, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 73, "Column" : 1, "Text" : "High risk of Pseudomonas or Gram-negative MDR bacteria:"}, 
{"Row" : 75, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 77, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 79, "Column" : 1, "Text" : "Treatment for specific pathogens", "Header" : 1}, 
{"Row" : 81, "Column" : 1, "Text" : "Enterobacteria including E. coli, klebsiella, and proteus", "Header" : 1}, 
{"Row" : 82, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 84, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 87, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 90, "Column" : 1, "Text" : "*Avoid trimethoprim/sulfamethoxazole in the first and third trimesters"}, 
{"Row" : 92, "Column" : 1, "Text" : "Staphylococcus aureus", "Header" : 1}, 
{"Row" : 93, "Column" : 1, "Text" : "S. aureus is an uncommon urinary tract pathogen and presence in the urine may be"}, 
{"Row" : 94, "Column" : 1, "Text" : "due to hematogenous seeding from another site. Blood cultures are indicated to"}, 
{"Row" : 95, "Column" : 1, "Text" : "rule out bacteremia in patients who have S. aureus isolated from the urine."}, 
{"Row" : 96, "Column" : 1, "Text" : "Consult Infectious Diseases for more information."}, 
{"Row" : 98, "Column" : 1, "Text" : "Pseudomonas", "Header" : 1}, 
{"Row" : 100, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 102, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 105, "Column" : 1, "Text" : "Enterococcus", "Header" : 1}, 
{"Row" : 106, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 108, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 111, "Column" : 1, "Text" : "Alternatives:"}, 
{"Row" : 114, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 116, "Column" : 1, "Text" : "*Avoid nitrofurantoin in the third trimester"}, 
{"Row" : 117, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 119, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 122, "Column" : 1, "Text" : "References:"}, 
{"Row" : 123, "Column" : 1, "Text" : "Drekonja et al., JAMA, 2021, 326(4)324-331"}, 
{"Row" : 124, "Column" : 1, "Text" : "Gupta et al., Clinical Infectious Diseases, 2011, 52(5)e103-20"}, 
{"Row" : 125, "Column" : 1, "Text" : "Mandell chapter: Urinary tract infections"}, 
{"Row" : 126, "Column" : 1, "Text" : "Sanford keyword: Cystitis"}, 
{"Row" : 127, "Column" : 1, "Text" : "Sanford keyword: Enterococcus faecium"}, 
{"Row" : 128, "Column" : 1, "Text" : "Sanford keyword: Pseudomonas aeruginosa"}, 
{"Row" : 129, "Column" : 1, "Text" : "Tamma et al., Clinical Infectious Diseases, 2021, 72(7)1109-16"}, 
{"Row" : 130, "Column" : 1, "Text" : "Up-To-Date article: Acute complicated urinary tract infection (including"}, 
{"Row" : 131, "Column" : 1, "Text" : "pyelonephritis) in adults"}, 
{"Row" : 132, "Column" : 1, "Text" : "Up-To-Date article: Pseudomonas aeruginosa infections of the eye, ear, urinary"}, 
{"Row" : 133, "Column" : 1, "Text" : "tract, gastrointestinal tract, and central nervous system"}, 
{"Row" : 134, "Column" : 1, "Text" : "Up-To-Date article: Treatment of enterococcal infections"}, 
{"Row" : 135, "Column" : 1, "Text" : "Walker et al., Clinical Infectious Diseases, 2016, 63(7)960-5"}
]},
{"Name" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "ANTIMICROBIAL COST INFORMATION", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Cost is represented as dollar ($) signs in parenthesis following the antibiotic."}, 
{"Row" : 6, "Column" : 1, "Text" : "The number of $ signs represent the cost ranges below:"}, 
{"Row" : 8, "Column" : 1, "Text" : "$ = Less than 10 dollars per day"}, 
{"Row" : 9, "Column" : 1, "Text" : "$$ = 10-50 dollars per day"}, 
{"Row" : 10, "Column" : 1, "Text" : "$$$ = 51-100 dollars per day"}, 
{"Row" : 11, "Column" : 1, "Text" : "$$$$ = 101-400 dollars per day"}, 
{"Row" : 12, "Column" : 1, "Text" : "$$$$ = Greater than 400 dollars per day"}, 
{"Row" : 14, "Column" : 1, "Text" : "The displayed cost of an antibiotic is an estimate based on usual daily doses"}, 
{"Row" : 15, "Column" : 1, "Text" : "for an 80kg patient. Costs may change frequently due to VA contract negotiations"}, 
{"Row" : 16, "Column" : 1, "Text" : "as well as supply and demand effects. Antibiotic cost and formulary are reviewed"}, 
{"Row" : 17, "Column" : 1, "Text" : "by members of the Antimicrobial Subcommittee annually."}
]},
{"Name" : "ORZID2 GMENU ABX COVID-19 MPLS PHARMACOLOGIC GUIDELINE", "DisplayText" : "COVID-19 PHARMACOLOGIC GUIDELINE  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "ORZ GTX ABX URL MINNEAPOLIS COVID SHAREPOINT SITE", "DisplayText" : "Minneapolis COVID-19 SharePoint Site", "Text" : "Minneapolis VAHCS COVID-19 SharePoint Site", "Mnemonic" : "6"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX NIRMATRELVIR RITONAVIR (PAXLOVID) EUA", "DisplayText" : "Nirmatrelvir-ritonavir (Paxlovid) for Treatment of COVID-19", "Text" : "Paxlovid PO (EUA)", "Mnemonic" : "18"},
{"Row" : 3, "Column" : 1, "Text" : "CLC COVID-19 PHARMACOLOGIC TREATMENT GUIDELINES", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Refer to the Minneapolis VAHCS COVID-19 SharePoint site for additional info."}, 
{"Row" : 8, "Column" : 1, "Text" : "***COVID-19 therapy is a rapidly evolving field, including the widespread", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "dissemination of therapies with little or no evidence for benefit. Therapies an", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "dosages not specifically listed here or on the NIH clinical guidelines should b", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "discussed with the infectious diseases service. ***", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Treatment is recommended for patients with confirmed mild to moderate COVID-19"}, 
{"Row" : 15, "Column" : 1, "Text" : "and are at high risk of progressing to severe COVID-19."}, 
{"Row" : 17, "Column" : 1, "Text" : "Preferred for patients within 5 days of symptom onset", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX MOLNUPIRAVIR EUA", "DisplayText" : "Molnupiravir for treatment of COVID-19", "Text" : "Molnupiravir PO (EUA)", "Mnemonic" : "19"},
{"Row" : 19, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 22, "Column" : 1, "Text" : "Alternative for patients within 7 days of symptom onset", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Monitor labs with Remdesivir therapy: CMP, CBC with Diff, INR"}, 
{"Row" : 24, "Column" : 1, "Item" : "ORZ SET ABX REMDESIVIR 200MG LOAD THEN 100MG Q24H 2DAYS", "DisplayText" : "Remdesivir 200mg IV once on day 1, then 100mg IV daily for 2 additional days", "Mnemonic" : "22"}
]},
{"Name" : "ORZID2 GMENU ABX CRYPTOSPORIDIA", "Term1" : "Cryptosporidium parvum diarrhea/gastroenteritis", "DisplayText" : "Diarrhea with Cryptosporidium parvum ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 12, "Column" : 1, "Item" : "PSJZID NITAZOXANIDE 500MG PO Q12H", "DisplayText" : "Nitazoxanide 500mg po q12h", "Text" : "Nitazoxanide 500 mg PO q12h for 3 days ($$$) [M]", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "DIARRHEA WITH CRYPTOSPORIDIUM PARVUM", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Antibiotic therapy is usually used only for persons with severe disease or"}, 
{"Row" : 6, "Column" : 1, "Text" : "immunocompromised persons."}, 
{"Row" : 8, "Column" : 1, "Text" : "Primary treatment", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 11, "Column" : 1, "Text" : "Antimicrobial treatment for patients without HIV/AIDS", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Antimicrobial treatment for patients with HIV/AIDS", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Consult Infectious Diseases for patients with HIV/AIDS."}, 
{"Row" : 18, "Column" : 1, "Text" : "References:"}, 
{"Row" : 20, "Column" : 1, "Text" : "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV"}, 
{"Row" : 21, "Column" : 1, "Text" : "Infected Adults and Adolescents. AIDSinfo (2015) 1-282"}, 
{"Row" : 22, "Column" : 1, "Text" : "Sanford keyword: Cryptosporidiosis"}, 
{"Row" : 23, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 24, "Column" : 1, "Text" : "Up-to-Date article: Treatment and prevention of cryptosporidiosis"}
]},
{"Name" : "ORZID2 GMENU ABX CYCLOSPORA", "Term1" : "Cyclospora cayetanensis diarrhea/gastroenteritis", "DisplayText" : "Cyclospora cayetanensis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 11, "Column" : 1, "Item" : "PSJZID TMP/SMX DS PO Q12H", "DisplayText" : "Trimethoprim/sulfamethoxazole 1 DS tablet q12h", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet q12h for 7 to 10 days ($) [R,DI]", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "DIARRHEA WITH CYCLOSPORA CAYETANENSIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Consult Infectious Diseases for patients with allergy to sulfonamides."}, 
{"Row" : 7, "Column" : 1, "Text" : "Primary treatment", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 10, "Column" : 1, "Text" : "Antimicrobial treatment for patients without HIV/AIDS", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Antimicrobial treatment for patients with HIV/AIDS", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Consult Infectious Diseases for patients with HIV/AIDS."}, 
{"Row" : 17, "Column" : 1, "Text" : "References:"}, 
{"Row" : 19, "Column" : 1, "Text" : "Sanford keyword: Cyclosporiasis"}, 
{"Row" : 20, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 21, "Column" : 1, "Text" : "Up-to-Date article: Cyclospora infection"}
]},
{"Name" : "ORZID2 GMENU ABX DELAYED STANDARD ABX CV SURG", "DisplayText" : "Standard (Non PCN allergic) ", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Item" : "ORZ SET ABX VANCOMYCIN 1500MG PREOP AND 1000MG INTRAOPERATIVE", "DisplayText" : "VANCOMYCIN 1500MG PREOP AND 1000MG INTRAOPERATIVE OPEN HEART", "Text" : "Vancomycin 1500mg PRE-OPERATIVE dose **AND** 1000mg INTRAOPERATIVE dose", "Mnemonic" : "2"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ SET ABX CEFUROXIME 1500MG PRE-OP & INTRA-OP DOSES", "DisplayText" : "CEFUROXIME 1500MG PRE-OPERATIVE & INTRA-OPERATIVE OPEN HEART", "Text" : "Cefuroxime 1.5gm PRE-OPERATIVE dose **AND** 1.5gm INTRAOPERATIVE dose", "Mnemonic" : "4"}
]},
{"Name" : "ORZID2 GMENU ABX DERMATOLOGIC SURGERY GUIDELINES", "DisplayText" : "Dermatologic Surgery Guidelines", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Text" : "Consult Infectious Diseases"}, 
{"Row" : 7, "Column" : 1, "Text" : "Consult Dermatology"}, 
{"Row" : 9, "Column" : 1, "Text" : "GUIDELINES FOR PREVENTION OF POST-OPERATIVE SKIN INFECTIONS", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "AND ENDOCARDITIS PROPHYLAXIS", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Most dermatologic surgeries involve \"clean\" sites that are unlikely to develop"}, 
{"Row" : 13, "Column" : 1, "Text" : "post-operative infections. Antibiotics are not recommended in these cases"}, 
{"Row" : 14, "Column" : 1, "Text" : "because the risks of antibiotic adverse events outweigh potential benefits. In"}, 
{"Row" : 15, "Column" : 1, "Text" : "general, antibiotics are used to prevent post-operative wound infection"}, 
{"Row" : 16, "Column" : 1, "Text" : "only in clean-contaminated surgery."}, 
{"Row" : 18, "Column" : 1, "Text" : "For background information on surgical prophylaxis in dermatological surgery:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "For specific recommendations on surgical prophylaxis in dermatological surgery:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Antibiotics are used to prevent endocarditis that might result from a surgical"}, 
{"Row" : 25, "Column" : 1, "Text" : "procedure, but the benefits are theoretical, not evidence-based, and there is"}, 
{"Row" : 26, "Column" : 1, "Text" : "general agreement that benefits outweigh antibiotic risks only when the risk of"}, 
{"Row" : 27, "Column" : 1, "Text" : "endocarditis is high and the surgical procedure is likely to result in"}, 
{"Row" : 28, "Column" : 1, "Text" : "bacteremia. For dermatological surgery, antibiotics to prevent endocarditis"}, 
{"Row" : 29, "Column" : 1, "Text" : "should be considered for surgery on mucosal sites, groin sites, or an inflamed"}, 
{"Row" : 30, "Column" : 1, "Text" : "or infected site. For more on prevention of endocarditis and drug"}, 
{"Row" : 31, "Column" : 1, "Text" : "recommendations:"}, 
{"Row" : 35, "Column" : 1, "Text" : "For information and drug recommendations on management of cases of infection", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "after skin surgery:", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "\"Stanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 43, "Column" : 1, "Text" : "Wilson et al. Prevention of Infective Endocarditis: Circulation 2007"}, 
{"Row" : 44, "Column" : 1, "Text" : "Wright et al. Antibiotic Prophylaxis in dermatologic Surgery: Advisory statement"}, 
{"Row" : 45, "Column" : 1, "Text" : "2008. J Am Acd Dermatol 2008"}, 
{"Row" : 46, "Column" : 1, "Text" : "Nishimura et al. Acc/Aha 2008 Guidelines Update on Valvular Heart Disease:"}, 
{"Row" : 47, "Column" : 1, "Text" : "Circulation 2008."}, 
{"Row" : 48, "Column" : 1, "Text" : "Hirschmann JV. When Antibiotics are Unnecessary. Dermatol Clin 2009."}, 
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX PROPHYLAXIS AND DERMATOLOGIC SURGERY", "DisplayText" : "Prophylaxis and dermatologic surgery", "Text" : "Antimicrobial Prophylaxis and Dermatologic Surgery", "Mnemonic" : "12"},
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ENDOCARDITIS PREVENTION POST-OP DERM", "DisplayText" : "Guidelines for endocarditis prophylaxis and prevention for post-op derm", "Text" : "Prevention of Endocarditis in patients with high risk cardiac lesions", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU SURG PROPHYL GENRL INFO", "DisplayText" : "Surgical prophylaxis general information", "Text" : "Prevention of Surgical Site Infections", "Mnemonic" : "14"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU SURG POST-OP WND INFECT", "DisplayText" : "Post-operative wound infection", "Text" : "Management of Post-Operative infections", "Mnemonic" : "18"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "20"},
{"Row" : 51, "Column" : 1, "Text" : "SECTION LAST REVIEWED JANUARY 2013", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX DERMATOLOGY MAIN", "Term1" : "Dermatological Infections section ", "Term2" : "Skin Infections section", "DisplayText" : "Skin Infections ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 GMENU ABX IMPETIGO", "DisplayText" : "Impetigo", "Text" : "Impetigo", "Mnemonic" : "4"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU FOLLICULITIS", "DisplayText" : "Folliculitis", "Text" : "Folliculitis", "Mnemonic" : "6"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ERYSIPELAS", "DisplayText" : "Erysipelas", "Text" : "Erysipelas", "Mnemonic" : "8"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU FURUNCLES AND CARBUNCLES", "DisplayText" : "Furuncles and carbuncles", "Text" : "Furuncles and carbuncles", "Mnemonic" : "10"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX CELLULITIS", "DisplayText" : "Cellulitis", "Text" : "Cellulitis", "Mnemonic" : "12"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU NECROTIZING INFECTIONS", "DisplayText" : "Necrotizing infections", "Text" : "Necrotizing infections", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ECTHYMA GANGRENOSUM", "DisplayText" : "Ecthyma Gangrenosum", "Text" : "Ecthyma gangrenosum", "Mnemonic" : "16"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU STAPH SCALDED SYNDROME", "DisplayText" : "Staphylococcal Scalded Skin Syndrom (Ritter's Disease)", "Text" : "Scalded Skin Syndrome", "Mnemonic" : "18"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU HIDRADENITIS SUPPURATIVA", "DisplayText" : "Hidradenitis Suppurativa", "Text" : "Hidradenitis Suppurativa", "Mnemonic" : "20"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU TOXIC SHOCK SYNDROME", "DisplayText" : "Toxic Shock Syndrome", "Text" : "Toxic Shock Syndrome", "Mnemonic" : "22"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ERYTHRASMA", "DisplayText" : "Erythrasma", "Text" : "Erythrasma", "Mnemonic" : "24"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ERYSIPELOID", "DisplayText" : "Erysipeloid", "Text" : "Erysipeloid", "Mnemonic" : "26"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU CAT-SCATCH DISEASE", "DisplayText" : "Cat-Scratch Disease", "Text" : "Cat-scratch disease", "Mnemonic" : "28"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU LEISHMANIASIS", "DisplayText" : "Leishmaniasis", "Text" : "Leishmaniasis", "Mnemonic" : "30"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ROCKY MTN SPOT FEVER", "DisplayText" : "Rocky Mountain Spotted Fever", "Text" : "Rocky Mountain Spotted Fever", "Mnemonic" : "32"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID3 GMENU ABX DERM POST-OP INFECTIONS", "DisplayText" : "", "Text" : "Dermatology Post-Op Infection", "Mnemonic" : "34"},
{"Row" : 3, "Column" : 1, "Text" : "++  DERMATOLOGICAL INFECTIONS ++", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Section reviewed January 2018", "Header" : 1}, 
{"Row" : 5, "Column" : 2, "Item" : "ORZID2 GMENU CUTANEOUS CANDIDIASIS", "DisplayText" : "Cutaneous Candidiasis", "Text" : "Candidiasis", "Mnemonic" : "36"},
{"Row" : 6, "Column" : 2, "Item" : "ORZID2 GMENU PARONYCHIA", "DisplayText" : "Paronychia", "Text" : "Paronychia", "Mnemonic" : "38"},
{"Row" : 7, "Column" : 2, "Item" : "ORZID2 GMENU BED BUGS (HEMIPTERA)", "DisplayText" : "Bed Bugs (Hemiptera)", "Text" : "Bed bugs (hemiptera)", "Mnemonic" : "40"},
{"Row" : 8, "Column" : 2, "Item" : "ORZID2 GMENU HEAD LICE (PEDICULOSIS CAPITIS)", "DisplayText" : "Head Lice (Pediculosis Capitis)", "Text" : "Head lice (Pediculosis Capitis)", "Mnemonic" : "42"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 GMENU BODY LICE (PEDICULOSIS CORPORIS)", "DisplayText" : "Body Lice (Pediculosis Corporis)", "Text" : "Body lice (Pediculosis corporis)", "Mnemonic" : "44"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID2 GMENU PUBIC LICE (PEDICULOSIS PUBIS)", "DisplayText" : "Pubic Lice (Pediculosis Pubis)", "Text" : "Pubic lice (Pediculosis pubis)", "Mnemonic" : "46"},
{"Row" : 11, "Column" : 2, "Item" : "ORZID2 GMENU SCABIES", "DisplayText" : "Scabies", "Text" : "Scabies", "Mnemonic" : "48"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU ABX LYME DISEASE", "DisplayText" : "Lyme disease", "Text" : "Lyme disease", "Mnemonic" : "50"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU FUNGI BLASTOMYCES DERMATIDIS", "DisplayText" : "Blastomyces dermatidis", "Text" : "Blastomycosis", "Mnemonic" : "52"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID2 GMENU SPOROTRICHOSIS", "DisplayText" : "Sporotrichosis", "Text" : "Sporotrichosis", "Mnemonic" : "54"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Sexually Transmitted Infections", "Mnemonic" : "56"},
{"Row" : 19, "Column" : 2, "Item" : "ORZID2 GMENU ABX HERPES WHITLOW", "DisplayText" : "Herpes Whitlow", "Text" : "Herpes Whitlow (digit/hand cellulitis)", "Mnemonic" : "58"},
{"Row" : 20, "Column" : 2, "Item" : "ORZID2 GMENU ABX OROLABIAL HERPES", "DisplayText" : "Orolabial Herpes", "Text" : "Oral lesions: Mouth, Lips (Cold sores)", "Mnemonic" : "60"},
{"Row" : 23, "Column" : 2, "Item" : "ORZID2 GMENU TINEA CAPITIS (RINGWORM)", "DisplayText" : "Tinea Capitis (Ringworm)", "Text" : "Tinea capitis (ringworm)", "Mnemonic" : "62"},
{"Row" : 24, "Column" : 2, "Item" : "ORZID2 GMENU TINEA UNGUIUM (ONYCHOMYCOSIS)", "DisplayText" : "Tinea Unguium (Onychomycosis)", "Text" : "Tinea unguium (onychomycosis)", "Mnemonic" : "64"},
{"Row" : 25, "Column" : 2, "Item" : "ORZID2 GMENU TINEA PEDIS (ATHLETE'S FOOT)", "DisplayText" : "Tinea Pedis (Athlete's Foot), Tinea Coporis, or Tinea Cruris", "Text" : "Tinea pedis, Tinea corporis, Tinea cruris", "Mnemonic" : "66"},
{"Row" : 26, "Column" : 2, "Item" : "ORZID2 GMENU TINEA VERSICOLOR", "DisplayText" : "Tinea Versicolor", "Text" : "Tinea versicolor", "Mnemonic" : "68"},
{"Row" : 29, "Column" : 2, "Item" : "ORZID2 GMENU ABX PRIM INFECT CHICKENPOX", "DisplayText" : "Primary infection (Chickenpox)", "Text" : "Varicella/Chickenpox (primary infection)", "Mnemonic" : "70"},
{"Row" : 30, "Column" : 2, "Item" : "ORZID2 GMENU ABX REACT PRIM INFECT ZOSTER", "DisplayText" : "Reactivation of primary infection (Zoster or \"Shingles\")", "Text" : "Zoster/Shingles (reactivation)", "Mnemonic" : "72"},
{"Row" : 17, "Column" : 2, "Text" : "Herpes simplex virus infections", "Header" : 1}, 
{"Row" : 22, "Column" : 2, "Text" : "Tinea fungal infections", "Header" : 1}, 
{"Row" : 28, "Column" : 2, "Text" : "Varicella-Zoster virus infections", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX DEVICE-RELATED INFECTIONS", "Term1" : "Device-related infections", "DisplayText" : "Device-related infections", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU INTRAVASC CATH-ASSOC INFECT", "DisplayText" : "Intravascular catheter-associated infection", "Text" : "Intravascular catheter-related infection", "Mnemonic" : "4"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU EC PV EMP THERAPY", "DisplayText" : "Prosthetic Valve Endocarditis--Empicaral Therapy", "Text" : "Prosthetic-valve endocarditis - Empirical therapy", "Mnemonic" : "6"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU EC PV SEL PATH", "DisplayText" : "Prosthetic Valve Endocarditis--Selected Pathogens", "Text" : "Prosthetic-valve endocarditis - Selected pathogens", "Mnemonic" : "8"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX INFECT INVOLVES CARD DEVICES", "DisplayText" : "Infections involves cardiovascular devices (excluding valves)", "Text" : "Infections involving cardiovascular devices (except valves)", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU PROS JOINT BONE INFECT", "DisplayText" : "Infections in bone or joint prostheses", "Text" : "Infections in bone or joint prostheses", "Mnemonic" : "12"},
{"Row" : 3, "Column" : 1, "Text" : "++  DEVICE-RELATED INFECTIONS  ++", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "If the desired syndrome is not listed below, return to the main menu and refer"}, 
{"Row" : 6, "Column" : 1, "Text" : "to the pertinent organ-system."}, 
{"Row" : 14, "Column" : 1, "Text" : "Last reviewed 11/17", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX DEXAMETHASONE FOR COVID", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID DEXAMETHASONE 6MG PO QDAY FOR 10DAYS COVID", "DisplayText" : "Dexamethasone 6 MG PO q24h for up to 10 days", "Text" : "Dexamethasone 6 MG PO q24h for up to 10 days", "Mnemonic" : "4"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID DEXAMETHASONE 6MG IV QDAY FOR 10 DAYS COVID", "DisplayText" : "Dexamethasone 6 MG IV q24h for up to 10 days", "Text" : "Dexamethasone 6 MG IV q24h for up to 10 days", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "DEXAMETHASONE (RECOVERY trial) for COVID-19", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "-Dexamethasone (for up to 10 days) decreases mortality in patients with severe"}, 
{"Row" : 5, "Column" : 1, "Text" : "or critical COVID-19 (RECOVERY trial)."}, 
{"Row" : 6, "Column" : 1, "Text" : "-Dexamethasone may increase mortality in patients with mild/moderate COVID."}, 
{"Row" : 7, "Column" : 1, "Text" : "-Dexamethasone is the preferred steroid, but a meta-analysis supports the use of"}, 
{"Row" : 8, "Column" : 1, "Text" : "other steroids (hydrocortisone, methylprednisolone, or hydrocortisone) if"}, 
{"Row" : 9, "Column" : 1, "Text" : "dexamethasone is not available."}, 
{"Row" : 11, "Column" : 1, "Text" : "Indications:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "COVID with hypoxia (<89% O2 at rest for more than an hour, not just a transient"}, 
{"Row" : 13, "Column" : 1, "Text" : "episode or nocturnal hypoxia due to sleep apnea). May be discontinued early"}, 
{"Row" : 14, "Column" : 1, "Text" : "if patient is no longer hypoxic."}, 
{"Row" : 16, "Column" : 1, "Text" : "Contraindications: Lack of hypoxia", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Dexamethasone (PO/IV):", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 23, "Column" : 1, "Text" : "References:"}, 
{"Row" : 24, "Column" : 1, "Text" : "RECOVERY Collaborative Group, N Engl J Med. (2021) 384(8):693-704."}
]},
{"Name" : "ORZID2 GMENU ABX DIAGNOSIS OF ENDOCARDITIS", "Term1" : "Endocarditis, diagnosis of", "DisplayText" : "Diagnosis of Endocarditis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX DUKE CRITERIA", "DisplayText" : "Modified Duke Diagnostic Criteria", "Text" : "Modified Duke Diagnostic Criteria", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "DIAGNOSIS OF ENDOCARDITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Diagnosis and management are complex. Cardiology, Infectious Disease, and"}, 
{"Row" : 6, "Column" : 1, "Text" : "Surgery services should all be involved in diagnosis and management of infective"}, 
{"Row" : 7, "Column" : 1, "Text" : "endocarditis."}, 
{"Row" : 9, "Column" : 1, "Text" : "Endocarditis is the result of growth of microorganisms on endothelium of the"}, 
{"Row" : 10, "Column" : 1, "Text" : "heart. The integrity of the endothelial surface must be compromised in order to"}, 
{"Row" : 11, "Column" : 1, "Text" : "allow microorganisms to attach and proliferate. Often such lesions are caused by"}, 
{"Row" : 12, "Column" : 1, "Text" : "abnormal blood flow or thrombi resulting from heart valvular disease, prosthetic"}, 
{"Row" : 13, "Column" : 1, "Text" : "heart valves, or from foreign material or microorganisms introduced to the"}, 
{"Row" : 14, "Column" : 1, "Text" : "bloodstream as byproducts of illicit intravenous drug use."}, 
{"Row" : 16, "Column" : 1, "Text" : "Endocarditis should be considered a possible diagnosis in a patient with"}, 
{"Row" : 17, "Column" : 1, "Text" : "persistent bacteremia without an identifiable focal infection, especially when"}, 
{"Row" : 18, "Column" : 1, "Text" : "the patient has a structural heart abnormality, prosthesis, or has a recent"}, 
{"Row" : 19, "Column" : 1, "Text" : "history of intravenous illicit drug use."}, 
{"Row" : 21, "Column" : 1, "Text" : "Diagnosis of endocarditis can be based on several combinations of signs and"}, 
{"Row" : 22, "Column" : 1, "Text" : "symptoms. The Duke criteria help categorize cases as definite or possible"}, 
{"Row" : 23, "Column" : 1, "Text" : "endocarditis based on major and minor criteria. The Duke criteria also indicate"}, 
{"Row" : 24, "Column" : 1, "Text" : "when a diagnosis of endocarditis can be excluded."}, 
{"Row" : 28, "Column" : 1, "Text" : "Severity of Disease", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Endocarditis is categorized by time course and severity of symptoms of illness"}, 
{"Row" : 30, "Column" : 1, "Text" : "into acute and subacute. These classifications help suggest which pathogens may"}, 
{"Row" : 31, "Column" : 1, "Text" : "be more likely associated with symptoms."}, 
{"Row" : 33, "Column" : 1, "Text" : "Acute", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Acute endocarditis is a rapidly progressing illness that often causes fever. It"}, 
{"Row" : 35, "Column" : 1, "Text" : "can be associated with spread of infection to other parts of the body and can"}, 
{"Row" : 36, "Column" : 1, "Text" : "cause death within a matter of weeks. In patient with suspected acute"}, 
{"Row" : 37, "Column" : 1, "Text" : "endocarditis, three sets of blood cultures should be obtained with the first and"}, 
{"Row" : 38, "Column" : 1, "Text" : "last cultures separated by at least one hour. Empiric antimicrobial therapy"}, 
{"Row" : 39, "Column" : 1, "Text" : "should then be initiated as soon as possible."}, 
{"Row" : 41, "Column" : 1, "Text" : "Subacute", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Subacute endocarditis follows an indolent course. Generally, patients have had"}, 
{"Row" : 43, "Column" : 1, "Text" : "some symptoms for at least 2 weeks. Symptoms are more subtle and spread of"}, 
{"Row" : 44, "Column" : 1, "Text" : "infection to other systems is uncommon. In patients with suspected subacute"}, 
{"Row" : 45, "Column" : 1, "Text" : "endocarditis, every attempt should be made to identify a pathogen prior to"}, 
{"Row" : 46, "Column" : 1, "Text" : "initiating antimicrobial therapy. These patients should be observed carefully"}, 
{"Row" : 47, "Column" : 1, "Text" : "for signs of heart failure or embolic complications, and if signs are noted,"}, 
{"Row" : 48, "Column" : 1, "Text" : "surgery should be consulted immediately."}, 
{"Row" : 50, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Text" : "References:"}, 
{"Row" : 53, "Column" : 1, "Text" : "Baddour et al., Circulation 2015, 132:1-52"}, 
{"Row" : 54, "Column" : 1, "Text" : "Mandell chapter: Endocarditis and intravascular infections"}, 
{"Row" : 55, "Column" : 1, "Text" : "Sanford keyword: Endocarditis"}, 
{"Row" : 56, "Column" : 1, "Text" : "Up-To-Date article: Overview of management of infective endocarditis in adults"}, 
{"Row" : 57, "Column" : 1, "Text" : "Wang et al., JAMA 2018, 320.1:72-83"}
]},
{"Name" : "ORZID2 GMENU ABX DIVERTICULITIS", "Term1" : "Diverticulitis", "DisplayText" : "Diverticulitis  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 11, "Column" : 1, "Item" : "PSJZID AMOXICILLIN-CLAVULANATE 875-125 MG PO Q12H", "DisplayText" : "Amoxicillin-Clavulanate 875-125 MG PO Q12H", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h for 7 to 10 days ($) [R] < OR >", "Mnemonic" : "4"},
{"Row" : 14, "Column" : 1, "Item" : "ORZ SET ABX TRIMETH/SULFA DS Q12H METRO 1 GM PO Q12H", "DisplayText" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h ($) [R,DI] <AND>", "Text" : "Trimethoprim-sulfamethoxazole 1 DS tablet PO q12h ($) [R,DI] <AND>", "Mnemonic" : "6"},
{"Row" : 17, "Column" : 1, "Item" : "PSJZID MOXIFLOXACIN 400MG PO Q24H", "DisplayText" : "Moxifloxacin 400mg po q24h", "Text" : "Moxifloxacin 400 mg PO q24h for 7 to 10 days ($) [R,DI]", "Mnemonic" : "8"},
{"Row" : 19, "Column" : 1, "Item" : "ORZ SET ABX CIPROF 500MG PO Q12H METRO 1G PO Q12H", "DisplayText" : "Ciprofloxacin 500 mg PO q12h ($) [R,DI] <AND> metronidazole 1000 mg PO q12h", "Text" : "Ciprofloxacin 500 mg PO q12h ($) [R,DI] <AND> metronidazole 1000 mg PO", "Mnemonic" : "10"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID PIP/TAZO 3.375 GM IV Q6H", "DisplayText" : "Piperacillin/tazobactam 3.375 GM IV Q6H", "Text" : "Piperacillin-Tazobactam 3.375g IV q6h for 7 to 10 days ($$) [R]", "Mnemonic" : "12"}, 
{"Row" : 26, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAX 1 GM IV QD METRONIDAZOLE 500 MG IV Q8H", "DisplayText" : "CEFTRIAX 1 GM IV QD METRONIDAZOLE 500MG IV Q8H", "Text" : "Ceftriaxone 1 gm IV q24h ($) [M] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Mnemonic" : "14"},
{"Row" : 30, "Column" : 1, "Item" : "PSJIZID MOXIFLOXACIN 400MG IV Q24H", "DisplayText" : "Moxifloxacin 400mg iv q24h", "Text" : "Moxifloxacin 400 mg IV q24h for 7 to 10 days ($$) [R,DI]", "Mnemonic" : "16"},
{"Row" : 32, "Column" : 1, "Item" : "ORZ SET ABX CIPROF 400MG IV Q12 METRON 500MG IV Q8H", "DisplayText" : "Ciprofloxacin 400 mg IV q12h ($) [R,DI] <AND> metronidazole 500 mg IV q8h", "Text" : "Ciprofloxacin 400 mg IV q12h ($) [R,DI] <AND> metronidazole 500 mg IV q8h", "Mnemonic" : "18"},
{"Row" : 37, "Column" : 1, "Item" : "PSJIZID PIPERACILLIN/TAZOBACTAM 4.5GM IV Q6H", "DisplayText" : "Piperacillin/Tazobactam 4.5 gm IV q6h", "Text" : "Piperacillin-tazobactam 4.5 gm IV q6h for 10-14 days ($$) [R]", "Mnemonic" : "20"},
{"Row" : 39, "Column" : 1, "Item" : "PSJIZID MEROPENEM 1GM IV Q8H", "DisplayText" : "Meropenem 1 gm IV q8h ($$) [R,O]", "Text" : "Meropenem 1 gm IV q8h ($$) [R,O]", "Mnemonic" : "22"},
{"Row" : 42, "Column" : 1, "Item" : "ORZ SET ABX AZTREO 2GM METRONI 500MG VANCO 15MG/KG", "DisplayText" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Text" : "Aztreonam 2 gm IV q8h ($$$$) [R] <AND> metronidazole 500 mg IV q8h ($) [DI]", "Mnemonic" : "24"},
{"Row" : 3, "Column" : 1, "Text" : "DIVERTICULITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Diverticulitis involves inflammation of an intestinal diverticulum, usually in"}, 
{"Row" : 6, "Column" : 1, "Text" : "the colon, causing pain and disturbed bowel function."}, 
{"Row" : 8, "Column" : 1, "Text" : "Mild disease or Step-down treatment for completion of antimicrobial course", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "after initial intravenous treatment in patients who can tolerate oral therapy.", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Base selection on culture results.", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 15, "Column" : 1, "Text" : "metronidazole 1000 mg PO q12h ($) [DI] for 7 to 10 days"}, 
{"Row" : 16, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 18, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 20, "Column" : 1, "Text" : "q12h ($) [DI] for 7 to 10 days"}, 
{"Row" : 22, "Column" : 1, "Text" : "Moderate disease", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "If symptoms fail to respond within 48 to 72 hours, consult General Surgery."}, 
{"Row" : 25, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 27, "Column" : 1, "Text" : "for 7 to 10 days"}, 
{"Row" : 29, "Column" : 1, "Text" : "Alternative for beta lactam allergy"}, 
{"Row" : 31, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 33, "Column" : 1, "Text" : "($) [DI] for 7 to 10 days"}, 
{"Row" : 35, "Column" : 1, "Text" : "Severe, life-threatening disease", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Consult General Surgery."}, 
{"Row" : 38, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 41, "Column" : 1, "Text" : "Alternative for beta-lactam allergy"}, 
{"Row" : 43, "Column" : 1, "Text" : "<AND> vancomycin 15 mg/kg IV q12h ($) [R]"}, 
{"Row" : 46, "Column" : 1, "Text" : "References:"}, 
{"Row" : 48, "Column" : 1, "Text" : "Mandell chapter: Diverticulitis and Typhlitis"}, 
{"Row" : 49, "Column" : 1, "Text" : "Sanford keyword: Diverticulitis"}, 
{"Row" : 50, "Column" : 1, "Text" : "Solomkin et al, Clin Infect Dis, 2010, 50:133-64"}, 
{"Row" : 51, "Column" : 1, "Text" : "Up-to-Date article: Acute colonic diverticulitis: Medical management"}
]},
{"Name" : "ORZID2 GMENU ABX DRUG ALLERGIES", "Term1" : "Allergy information ", "Term2" : "Drug allergy information", "DisplayText" : "Drug allergies  ", "Version" : "StCloud", "Contents" : [
{"Row" : 53, "Column" : 1, "Item" : "ORZID2 GMENU ABX PENICILLIN DESENS PROTOCOL", "DisplayText" : "Penicillin Desensitization Protocol", "Text" : "Link to penicillin desensitization protocol", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "DRUG ALLERGIES", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Importance of history", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "The nature and circumstances of a possible previous reaction including the"}, 
{"Row" : 7, "Column" : 1, "Text" : "timing should be considered. In many cases, previous reactions are clearly"}, 
{"Row" : 8, "Column" : 1, "Text" : "not due to drug allergy."}, 
{"Row" : 10, "Column" : 1, "Text" : "Types of reactions", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "*Immediate - within one hour of starting drug administration."}, 
{"Row" : 12, "Column" : 1, "Text" : "Type I reactions present with urticaria, hypotension, angioedema, bronchospasm,"}, 
{"Row" : 13, "Column" : 1, "Text" : "or anaphylaxis and occur within an hour of exposure. These reactions are"}, 
{"Row" : 14, "Column" : 1, "Text" : "immunoglobulin E (IgE) and mast cell and/or basophil mediated."}, 
{"Row" : 16, "Column" : 1, "Text" : "*Delayed - After one hour of starting administration (usually after 6 days)"}, 
{"Row" : 17, "Column" : 1, "Text" : "1) Type II reactions manifest as hemolytic anemia, thrombocytopenia and"}, 
{"Row" : 18, "Column" : 1, "Text" : "neutropenia. They are caused by antibody (usually IgG)- mediated cell"}, 
{"Row" : 19, "Column" : 1, "Text" : "destruction."}, 
{"Row" : 20, "Column" : 1, "Text" : "2) Type III reactions can manifest as serum sickness, vasculitis or Arthus"}, 
{"Row" : 21, "Column" : 1, "Text" : "reaction, and are caused by IgG:drug immune complex deposition and complement"}, 
{"Row" : 22, "Column" : 1, "Text" : "activation."}, 
{"Row" : 23, "Column" : 1, "Text" : "3) Type IV reactions typically manifest as contact dermatitis, morbilliform"}, 
{"Row" : 24, "Column" : 1, "Text" : "reactions, severe exfoliative dermatoses (Stevens-Johnson syndrome/toxic"}, 
{"Row" : 25, "Column" : 1, "Text" : "epidermal necrolysis) and other presentations. They are T-cell mediated."}, 
{"Row" : 27, "Column" : 1, "Text" : "Repeated exposures lead to reactions that are of the same type."}, 
{"Row" : 29, "Column" : 1, "Text" : "Beta-lactam allergies", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Approximately 10% of patients report a beta-lactam allergy. Up to 90% of these"}, 
{"Row" : 31, "Column" : 1, "Text" : "patients can tolerate penicillin and have been designated penicillin allergic"}, 
{"Row" : 32, "Column" : 1, "Text" : "unnecessarily. Patients allergic to cephalosporins will have a cross-reaction to"}, 
{"Row" : 33, "Column" : 1, "Text" : "penicillins 3% to 5% of the time. Overall, patients with a history of penicillin"}, 
{"Row" : 34, "Column" : 1, "Text" : "allergy can tolerate cephalosporins although there are rare reports to severe,"}, 
{"Row" : 35, "Column" : 1, "Text" : "sometimes fatal anaphylactic reactions. Neither penicillin- or cephalosporin-"}, 
{"Row" : 36, "Column" : 1, "Text" : "allergic patients will react to aztreonam. The degree of cross-reactivity of"}, 
{"Row" : 37, "Column" : 1, "Text" : "penicillins and cephalosporins with carbapenems appears to be low."}, 
{"Row" : 39, "Column" : 1, "Text" : "Therapeutic implications", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "If a patient has had an immediate reaction to a drug in the past, an allergy"}, 
{"Row" : 41, "Column" : 1, "Text" : "specialist should evaluate the patient before a drug of the same class is"}, 
{"Row" : 42, "Column" : 1, "Text" : "administered to the patient. Patients with delayed onset reactions causing"}, 
{"Row" : 43, "Column" : 1, "Text" : "fever, systemic symptoms or mucosal involvement should also be evaluated by an"}, 
{"Row" : 44, "Column" : 1, "Text" : "allergy specialist before a drug of the same class is administered."}, 
{"Row" : 46, "Column" : 1, "Text" : "Desensitization", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "A patient with previous Type I reaction to a beta-lactam can be desensitized and"}, 
{"Row" : 48, "Column" : 1, "Text" : "then receive therapeutic doses of the same class within a day. Severe"}, 
{"Row" : 49, "Column" : 1, "Text" : "reactions during desensitization are uncommon. Pharmacy service must be"}, 
{"Row" : 50, "Column" : 1, "Text" : "contacted for assistance and drug preparation. Infectious Disease consultation"}, 
{"Row" : 51, "Column" : 1, "Text" : "strongly recommended."}, 
{"Row" : 56, "Column" : 1, "Text" : "References"}, 
{"Row" : 58, "Column" : 1, "Text" : "JAMA 2001, 285: 249"}, 
{"Row" : 59, "Column" : 1, "Text" : "Joint Task Force on Practice Parameters: Drug Allergy - An Updated Practice"}, 
{"Row" : 60, "Column" : 1, "Text" : "Parameter (2010)"}, 
{"Row" : 61, "Column" : 1, "Text" : "Kelkar PS NEJM 2001, 345: 804"}, 
{"Row" : 62, "Column" : 1, "Text" : "Mayo Clinic Proc 1999, 74: 290"}, 
{"Row" : 63, "Column" : 1, "Text" : "Up-to-Date article: Cephalosporin-allergic patients: Subsequent use of"}, 
{"Row" : 64, "Column" : 1, "Text" : "cephalosporins and related antibiotics"}, 
{"Row" : 65, "Column" : 1, "Text" : "Up-to-Date article: Drug allergy: Classification and clinical features"}, 
{"Row" : 66, "Column" : 1, "Text" : "Weiss ME, Adkinson NF. Immediate hypersensitivity reactions to penicillin and"}, 
{"Row" : 67, "Column" : 1, "Text" : "related antibiotics. Clin Allergy 1988, 18:515"}
]},
{"Name" : "ORZID2 GMENU ABX DRUG INFO PAGE", "Term1" : "Drug Information", "DisplayText" : "Important Drug Properties Page ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "++ IMPORTANT DRUG PROPERTIES PAGE ++", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ACYCLOVIR PO", "DisplayText" : "Acyclovir PO", "Text" : "Acyclovir PO", "Mnemonic" : "08"},
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ACYCL IV", "DisplayText" : "Acyclovir IV", "Text" : "Acyclovir IV", "Mnemonic" : "10"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMANTADINE PO", "DisplayText" : "Amantadine PO", "Text" : "Amantadine PO", "Mnemonic" : "12"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMBISOME IV", "DisplayText" : "Ambisome IV", "Text" : "Ambisome IV", "Mnemonic" : "14"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMIKACIN IV", "DisplayText" : "Amikacin IV", "Text" : "Amikacin IV", "Mnemonic" : "16"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMOXICILLIN PO", "DisplayText" : "Amoxicillin PO", "Text" : "Amoxicillin PO", "Mnemonic" : "18"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMOX/CLAV PO", "DisplayText" : "Amoxicillin-clavulanate PO", "Text" : "Amoxicillin-clavulanate PO", "Mnemonic" : "20"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMPHOTERICIN B IV", "DisplayText" : "Amphotericin B IV", "Text" : "Amphotericin B IV", "Mnemonic" : "22"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMPICILLIN IV", "DisplayText" : "Ampicillin IV", "Text" : "Ampicillin IV", "Mnemonic" : "24"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMPIC/SULBACT IV", "DisplayText" : "Ampicillin-sulbactam IV", "Text" : "Ampicillin-sulbactam IV", "Mnemonic" : "26"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ATOVAQUONE PO", "DisplayText" : "Atovaquone PO", "Text" : "Atovaquone PO", "Mnemonic" : "28"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AZITHROMYCIN PO", "DisplayText" : "Azithromycin PO", "Text" : "Azithromycin PO", "Mnemonic" : "30"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AZITH IV", "DisplayText" : "Azithromycin IV", "Text" : "Azithromycin IV", "Mnemonic" : "32"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AZTREONAM IV", "DisplayText" : "", "Text" : "Aztreonam IV", "Mnemonic" : "34"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP BENZATHINE PENICILLIN IM", "DisplayText" : "Benzathine Penicillin IM", "Text" : "Benzathine penicillin IM", "Mnemonic" : "36"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CASPOFUNGIN IV", "DisplayText" : "Caspofungin IV", "Text" : "Caspofungin IV", "Mnemonic" : "38"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFAZOLIN IV", "DisplayText" : "Cefazolin IV", "Text" : "Cefazolin IV", "Mnemonic" : "40"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFEPIME IV", "DisplayText" : "Cefepime IV", "Text" : "Cefepime IV", "Mnemonic" : "42"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFOTETAN IV", "DisplayText" : "Cefotetan IV", "Text" : "Cefotetan IV", "Mnemonic" : "44"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFOXITIN IV", "DisplayText" : "Cefoxitin IV", "Text" : "Cefoxitin IV", "Mnemonic" : "46"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTAZIDIME IV", "DisplayText" : "Ceftazidime IV", "Text" : "Ceftazidime IV", "Mnemonic" : "48"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTIZOXIME IV", "DisplayText" : "Ceftizoxime IV", "Text" : "Ceftizoxime IV", "Mnemonic" : "50"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTRIAXONE IM", "DisplayText" : "Ceftriaxone IM", "Text" : "Ceftriaxone IM", "Mnemonic" : "52"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFTRIAX INTRAVENOUS", "DisplayText" : "Ceftriaxone IV", "Text" : "Ceftriaxone IV", "Mnemonic" : "54"},
{"Row" : 29, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEFUROXIME PO", "DisplayText" : "Cefuroxime PO", "Text" : "Cefuroxime PO", "Mnemonic" : "56"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CEPHALEXIN PO", "DisplayText" : "Cephalexin PO", "Text" : "Cephalexin PO", "Mnemonic" : "58"},
{"Row" : 31, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CHLORAMPHENICOL IV", "DisplayText" : "Chloramphenicol IV", "Text" : "Chloramphenicol IV", "Mnemonic" : "60"},
{"Row" : 32, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CIPROFLOXACIN PO", "DisplayText" : "Ciprofloxacin PO", "Text" : "Ciprofloxacin PO", "Mnemonic" : "62"},
{"Row" : 33, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV CIPROFLOXACIN", "DisplayText" : "Ciprofloxacin IV", "Text" : "Ciprofloxacin IV", "Mnemonic" : "64"},
{"Row" : 34, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CLARITHROMYCIN PO", "DisplayText" : "Clarithromycin PO", "Text" : "Clarithromycin PO", "Mnemonic" : "66"},
{"Row" : 35, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CLINDAMYCIN PO", "DisplayText" : "Clindamycin PO", "Text" : "Clindamycin PO", "Mnemonic" : "68"},
{"Row" : 36, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV CLINDAMYCIN", "DisplayText" : "Clindamycin IV", "Text" : "Clindamycin IV", "Mnemonic" : "70"},
{"Row" : 37, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP VAGINAL CLINDAMYCIN", "DisplayText" : "Clindamycin Vaginal", "Text" : "Clindamycin Vaginal", "Mnemonic" : "72"},
{"Row" : 38, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP CLOTRIMAZOLE TOPICAL", "DisplayText" : "Clotrimazole Topical", "Text" : "Clotrimazole Topical", "Mnemonic" : "74"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP VAG CLOTRIMAZOLE", "DisplayText" : "Clotrimazole vaginal", "Text" : "Clotrimazole Vaginal", "Mnemonic" : "76"},
{"Row" : 40, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DAPTOMYCIN IV", "DisplayText" : "Daptomycin IV", "Text" : "Daptomycin IV", "Mnemonic" : "78"},
{"Row" : 41, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DICLOXACILLIN PO", "DisplayText" : "Dicloxacillin PO", "Text" : "Dicloxacillin PO", "Mnemonic" : "80"},
{"Row" : 42, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DOXYCYCLINE PO", "DisplayText" : "Doxycycline PO", "Text" : "Doxycycline PO", "Mnemonic" : "82"},
{"Row" : 43, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV DOXYCYCLINE", "DisplayText" : "Doxycycline IV", "Text" : "Doxycycline IV", "Mnemonic" : "84"},
{"Row" : 44, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ERTAPENEM IV", "DisplayText" : "Ertapenem IV", "Text" : "Ertapenem IV", "Mnemonic" : "86"},
{"Row" : 45, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP OPHTHALMIC ERYTHROMYCIN", "DisplayText" : "Erythromycin Ophthalmic", "Text" : "Erythromycin Ophthalmic", "Mnemonic" : "88"},
{"Row" : 46, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ERYTHROMYCIN PO", "DisplayText" : "Erythromycin PO", "Text" : "Erythromycin PO", "Mnemonic" : "90"},
{"Row" : 47, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP IV ERYTHROMYCIN", "DisplayText" : "Erythromycin IV", "Text" : "Erythromycin IV", "Mnemonic" : "92"},
{"Row" : 6, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP FLUCONAZOLE PO", "DisplayText" : "Fluconazole PO", "Text" : "Fluconazole PO", "Mnemonic" : "94"},
{"Row" : 7, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV FLUCONAZOLE", "DisplayText" : "Fluconazole IV", "Text" : "Fluconazole IV", "Mnemonic" : "96"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP FOSCARNET IV", "DisplayText" : "Foscarnet IV", "Text" : "Foscarnet IV", "Mnemonic" : "98"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP GANCICLOVIR IV", "DisplayText" : "Ganciclovir IV", "Text" : "Ganciclovir IV", "Mnemonic" : "100"},
{"Row" : 11, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP GATIFLOXACIN PO", "DisplayText" : "Gatifloxacin PO", "Text" : "Gatifloxacin PO", "Mnemonic" : "102"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV GATIFLOXACIN", "DisplayText" : "Gatifloxacin IV", "Text" : "Gatifloxacin IV", "Mnemonic" : "104"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP GENTAMICIN IV", "DisplayText" : "", "Text" : "Gentamicin IV", "Mnemonic" : "106"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP ITRACONAZOLE IV", "DisplayText" : "Itraconazole IV", "Text" : "Itraconazole IV", "Mnemonic" : "108"},
{"Row" : 16, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP LINEZOLID PO", "DisplayText" : "Linezolid PO", "Text" : "Linezolid PO", "Mnemonic" : "110"},
{"Row" : 17, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV LINEZOLID", "DisplayText" : "Linezolid IV", "Text" : "Linezolid IV", "Mnemonic" : "112"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP METRONIDAZOLE PO", "DisplayText" : "Metronidazole PO", "Text" : "Metronidazole PO", "Mnemonic" : "114"},
{"Row" : 19, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV METRONIDAZOLE", "DisplayText" : "Metronidazole IV", "Text" : "Metronidazole IV", "Mnemonic" : "116"},
{"Row" : 20, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VAGINAL METRONIDAZOLE", "DisplayText" : "Metronidazole Vaginal", "Text" : "Metronidazole Vaginal", "Mnemonic" : "118"},
{"Row" : 22, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MINOCYCLINE PO", "DisplayText" : "Minocycline PO", "Text" : "Minocycline PO", "Mnemonic" : "120"},
{"Row" : 23, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MOXIFLOXACIN OPHTHALMIC", "DisplayText" : "Moxifloxacin Ophthalmic", "Text" : "Moxifloxacin Ophthalmic", "Mnemonic" : "121"},
{"Row" : 26, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NAFCILLIN IV", "DisplayText" : "Nafcillin IV", "Text" : "Nafcillin IV", "Mnemonic" : "124"},
{"Row" : 27, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NEOMYCIN PO", "DisplayText" : "Neomycin PO", "Text" : "Neomycin PO", "Mnemonic" : "126"},
{"Row" : 29, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NITROFURANTOIN PO", "DisplayText" : "Nitrofurantoin PO", "Text" : "Nitrofurantoin PO", "Mnemonic" : "128"},
{"Row" : 30, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP OSELTAMIVIR PO", "DisplayText" : "Oseltamivir PO", "Text" : "Oseltamivir PO", "Mnemonic" : "130"},
{"Row" : 32, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PENICILLIN PO", "DisplayText" : "Penicillin PO", "Text" : "Penicillin PO", "Mnemonic" : "132"},
{"Row" : 33, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV PENICILLIN", "DisplayText" : "Penicillin IV", "Text" : "Penicillin IV", "Mnemonic" : "134"},
{"Row" : 34, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PIPERACILLIN-TAZOBACTAM IV", "DisplayText" : "Piperacillin-tazobactam IV", "Text" : "Piperacillin-tazobactam IV", "Mnemonic" : "136"},
{"Row" : 35, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PYRIMETHAMINE", "DisplayText" : "Pyrimethamine PO", "Text" : "Pyrimethamine PO", "Mnemonic" : "138"},
{"Row" : 36, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP QUINUPRISTIN-DALFOPRISIN", "DisplayText" : "Quinupristin-dalfoprisin", "Text" : "Quinupristin-dalfoprisin IV", "Mnemonic" : "140"},
{"Row" : 39, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIFAXIMIN PO", "DisplayText" : "Rifaximin PO", "Text" : "Rifaximin PO", "Mnemonic" : "144"},
{"Row" : 38, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIFAMPIN IV", "DisplayText" : "Rifampin IV", "Text" : "Rifampin IV", "Mnemonic" : "142"},
{"Row" : 40, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIMANTADINE PO", "DisplayText" : "Rimantadine PO", "Text" : "Rimantadine PO", "Mnemonic" : "146"},
{"Row" : 41, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP STREPTOMYCIN IV", "DisplayText" : "Streptomycin IV", "Text" : "Streptomycin IV", "Mnemonic" : "148"},
{"Row" : 42, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP SULFACETAMIDE OPHTHALMIC", "DisplayText" : "Sulfacetamide Ophthalmic", "Text" : "Sulfacetamide Ophthalmic", "Mnemonic" : "150"},
{"Row" : 43, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP SULFADIAZINE PO", "DisplayText" : "Sulfadiazine PO", "Text" : "Sulfadiazine PO", "Mnemonic" : "152"},
{"Row" : 44, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TERCONAZOLE 0.4% VAGINAL", "DisplayText" : "Terconazole 0.4% Vaginal", "Text" : "Terconazole 0.4% Vaginal", "Mnemonic" : "154"},
{"Row" : 45, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TETRACYCLINE PO", "DisplayText" : "Tetracycline PO", "Text" : "Tetracycline PO", "Mnemonic" : "156"},
{"Row" : 46, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TICARCILLIN-CLAVULANATE IV", "DisplayText" : "Ticarcillin-clavulanate IV", "Text" : "Ticarcillin-clavulanate IV", "Mnemonic" : "158"},
{"Row" : 47, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TOBRAMYCIN IV", "DisplayText" : "Tobramycin IV", "Text" : "Tobramycin IV", "Mnemonic" : "160"},
{"Row" : 48, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP TRIMETHOPRIM-SULFAMETHOXAZOLE PO", "DisplayText" : "", "Text" : "Trimethoprim-sulfamethoxazole PO", "Mnemonic" : "162"},
{"Row" : 49, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IV TRIMETHOPRIM-SULFA", "DisplayText" : "", "Text" : "Trimethoprim-sulfamethoxazole IV", "Mnemonic" : "164"},
{"Row" : 50, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VALACYCLOVIR PO", "DisplayText" : "", "Text" : "Valacyclovir PO", "Mnemonic" : "166"},
{"Row" : 51, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VALGANCICLOVIR PO", "DisplayText" : "", "Text" : "Valganciclovir PO", "Mnemonic" : "168"},
{"Row" : 52, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VANCOMYCIN IV", "DisplayText" : "Vancomycin IV", "Text" : "Vancomycin IV", "Mnemonic" : "170"},
{"Row" : 53, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP VORICONAZOLE PO", "DisplayText" : "Voriconazole PO", "Text" : "Voriconazole PO", "Mnemonic" : "172"},
{"Row" : 54, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP ZANAMIVIR INH", "DisplayText" : "Zanamivir INH", "Text" : "Zanamivir INH", "Mnemonic" : "174"},
{"Row" : 31, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP PAROMOMYCIN PO", "DisplayText" : "Paromomycin PO", "Text" : "Paromomycin PO", "Mnemonic" : "131"},
{"Row" : 37, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP RIFABUTIN PO", "DisplayText" : "Ribabutin PO", "Text" : "Rifabutin PO", "Mnemonic" : "141"},
{"Row" : 48, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ETHAMBUTOL PO", "DisplayText" : "Ethambutol PO", "Text" : "Ethambutol PO", "Mnemonic" : "93"},
{"Row" : 8, "Column" : 2, "Item" : "ORZID2 GMENU IDP FLUCYTOSINE PO", "DisplayText" : "Flucytosine PO", "Text" : "Flucytosine PO", "Mnemonic" : "97"},
{"Row" : 28, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP NITAZOXANIDE PO", "DisplayText" : "Nitazoxanide PO", "Text" : "Nitazoxanide PO", "Mnemonic" : "127"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP IODOQUINOL PO", "DisplayText" : "Iodoquinol PO", "Text" : "Iodoquinol PO", "Mnemonic" : "107"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP ALBENDAZOLE PO", "DisplayText" : "Albendazole PO", "Text" : "Albendazole PO", "Mnemonic" : "11"},
{"Row" : 24, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MOXIFLOX PO", "DisplayText" : "Moxifloxacin PO", "Text" : "Moxifloxacin PO", "Mnemonic" : "122"},
{"Row" : 25, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MOXIFL IV", "DisplayText" : "Moxifloxacin IV", "Text" : "Moxifloxacin IV", "Mnemonic" : "123"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU ABX IDP MICAFUNGIN IV", "DisplayText" : "Micafungin IV", "Mnemonic" : "119"}
]},
{"Name" : "ORZID2 GMENU ABX DUKE CRITERIA", "DisplayText" : "Modified Duke Diagnostic Criteria ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX DUKE LISTING", "DisplayText" : "Duke Diagnostic Criteria Listing", "Text" : "Modified Duke Criteria Diagnostic Listing", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "MODIFIED DUKE DIAGNOSTIC CRITERIA", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "The Modified Duke criteria are used to diagnose endocarditis on clinical"}, 
{"Row" : 6, "Column" : 1, "Text" : "grounds. Endocarditis may also be diagnosed by pathology results."}, 
{"Row" : 10, "Column" : 1, "Text" : "Requirements for definite diagnosis of endocarditis", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Two major criteria"}, 
{"Row" : 12, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 13, "Column" : 1, "Text" : "One major criterion and three minor criteria"}, 
{"Row" : 14, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 15, "Column" : 1, "Text" : "Five minor criteria"}, 
{"Row" : 17, "Column" : 1, "Text" : "Requirements for possible diagnosis of endocarditis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "One major criterion and one minor criterion"}, 
{"Row" : 19, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 20, "Column" : 1, "Text" : "Three minor criteria"}, 
{"Row" : 22, "Column" : 1, "Text" : "Requirements for rejection of diagnosis of endocarditis", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Firm alternative diagnosis explaining evidence of endocarditis"}, 
{"Row" : 24, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 25, "Column" : 1, "Text" : "Resolution of endocarditis syndrome with antibiotic therapy for less than 4 days"}, 
{"Row" : 26, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 27, "Column" : 1, "Text" : "No pathological evidence of endocarditis at surgery or autopsy, with antibiotic"}, 
{"Row" : 28, "Column" : 1, "Text" : "therapy for less than 4 days"}, 
{"Row" : 29, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 30, "Column" : 1, "Text" : "Does not meet criteria for possible endocarditis as above."}, 
{"Row" : 32, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "References:"}, 
{"Row" : 35, "Column" : 1, "Text" : "Baddour et al., Circulation 2015, 132:1-52"}, 
{"Row" : 36, "Column" : 1, "Text" : "Mandell chapter: Endocarditis and intravascular infections"}, 
{"Row" : 37, "Column" : 1, "Text" : "Sanford keyword: Endocarditis"}, 
{"Row" : 38, "Column" : 1, "Text" : "Up-To-Date article: Overview of management of infective endocarditis in adults"}, 
{"Row" : 39, "Column" : 1, "Text" : "Wang et al., JAMA 2018, 320.1:72-83"}
]},
{"Name" : "ORZID2 GMENU ABX DUKE LISTING", "DisplayText" : "Duke Diagnostic Criteria Listing  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "MODIFIED DUKE CRITERIA DIAGNOSTIC LISTING", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Major criteria", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Blood culture positive", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "*Typical microorganisms consistent with IE from 2 separate blood cultures:"}, 
{"Row" : 8, "Column" : 1, "Text" : "Viridans streptococci, Streptococcus bovis, HACEK group organisms (Haemophilus"}, 
{"Row" : 9, "Column" : 1, "Text" : "species, Aggregatibacter species, Cardiobacterium species, Eikenella corrodens,"}, 
{"Row" : 10, "Column" : 1, "Text" : "and Kingella species), Staphylococcus aureus, or community-acquired enterococci"}, 
{"Row" : 11, "Column" : 1, "Text" : "in the absence of a primary focus, or microorganisms consistent with IE from"}, 
{"Row" : 12, "Column" : 1, "Text" : "persistently positive blood cultures defined as follows: at least 2 positive"}, 
{"Row" : 13, "Column" : 1, "Text" : "cultures of blood samples drawn >12h apart or all 3 or a majority of 4 separate"}, 
{"Row" : 14, "Column" : 1, "Text" : "cultures of blood (with first and last sample drawn at least 1 h apart)"}, 
{"Row" : 16, "Column" : 1, "Text" : "*Single culture positive for Coxiella burnetii or anti-phase 1 IgG antibody"}, 
{"Row" : 17, "Column" : 1, "Text" : "titer greater than or equal to 1:800"}, 
{"Row" : 19, "Column" : 1, "Text" : "Echocardiogram positive for endocarditis", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "*Echocardiographic evidence for endocarditis, defined as:"}, 
{"Row" : 21, "Column" : 1, "Text" : "An echo dense, intracardiac mass attached to valve or supporting structures, in"}, 
{"Row" : 22, "Column" : 1, "Text" : "the path of regurgitant jets, or a mass present on implanted material in the"}, 
{"Row" : 23, "Column" : 1, "Text" : "absence of an alternative anatomic explanation"}, 
{"Row" : 24, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 25, "Column" : 1, "Text" : "Paravalvular abscess"}, 
{"Row" : 26, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 27, "Column" : 1, "Text" : "New partial dehiscence of prosthetic valve or new valvular regurgitation"}, 
{"Row" : 28, "Column" : 1, "Text" : "(worsening or changing or preexisting murmur is not sufficient for a major"}, 
{"Row" : 29, "Column" : 1, "Text" : "criterion)"}, 
{"Row" : 31, "Column" : 1, "Text" : "Note: Echocardiography should be performed in all patients suspected of having"}, 
{"Row" : 32, "Column" : 1, "Text" : "endocarditis. Transesophageal echocardiograph (TEE) is recommended for patients"}, 
{"Row" : 33, "Column" : 1, "Text" : "with prosthetic valves. Transthoracic echocardiograph (TTE) is often adequate"}, 
{"Row" : 34, "Column" : 1, "Text" : "for patients suspected of having native valve endocarditis, especially on the"}, 
{"Row" : 35, "Column" : 1, "Text" : "aortic valve, but TEE may be needed for these patients as well. Contact"}, 
{"Row" : 36, "Column" : 1, "Text" : "infectious diseases or cardiology for more information."}, 
{"Row" : 38, "Column" : 1, "Text" : "Minor criteria", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Predisposing heart condition or intravenous drug user", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Fever", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Temperature over 38 degrees Celsius (100.4 degrees Fahrenheit)"}, 
{"Row" : 44, "Column" : 1, "Text" : "Vascular phenomena", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Major arterial embolus, septic pulmonary infarcts, mycotic aneurysm,"}, 
{"Row" : 46, "Column" : 1, "Text" : "intracranial hemorrhage, conjunctival hemorrhages, or Janeway's lesions"}, 
{"Row" : 48, "Column" : 1, "Text" : "Immunologic phenomena", "Header" : 1}, 
{"Row" : 49, "Column" : 1, "Text" : "Glomerulonephritis, Osler's nodes, Roth's spots, or rheumatoid factor"}, 
{"Row" : 51, "Column" : 1, "Text" : "Microbiological evidence", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Text" : "A case with a positive blood culture, but with results that don't meet the blood"}, 
{"Row" : 53, "Column" : 1, "Text" : "culture criteria listed above or serological evidence of active infection with"}, 
{"Row" : 54, "Column" : 1, "Text" : "organism consistent with endocarditis. Microbiological evidence is not intended"}, 
{"Row" : 55, "Column" : 1, "Text" : "to include all positive blood cultures. For example, a single positive culture"}, 
{"Row" : 56, "Column" : 1, "Text" : "for coagulase-negative staphylococci or a culture yielding an organism that is"}, 
{"Row" : 57, "Column" : 1, "Text" : "not a cause of endocarditis would not support a diagnosis of endocarditis."}, 
{"Row" : 59, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "References:"}, 
{"Row" : 62, "Column" : 1, "Text" : "Baddour et al., Circulation 2015, 132:1-52"}, 
{"Row" : 63, "Column" : 1, "Text" : "Mandell chapter: Endocarditis and intravascular infections"}, 
{"Row" : 64, "Column" : 1, "Text" : "Sanford keyword: Endocarditis"}, 
{"Row" : 65, "Column" : 1, "Text" : "Up-To-Date article: Overview of management of infective endocarditis in adults"}, 
{"Row" : 66, "Column" : 1, "Text" : "Wang et al., JAMA 2018, 320.1:72-83"}
]},
{"Name" : "ORZID2 GMENU ABX DURATION OF ABX THERAPY", "DisplayText" : "Duration of antimicrobial therapy ", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "DURATION OF ANTIMICROBIAL THERAPY", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "In general, duration of therapy is based on multiple factors, including"}, 
{"Row" : 6, "Column" : 1, "Text" : "infection severity, rapidity of improvement, and pathogen susceptibility. For a"}, 
{"Row" : 7, "Column" : 1, "Text" : "few diseases guidelines are established based on available evidence and opinion."}, 
{"Row" : 8, "Column" : 1, "Text" : "For many more diseases, guidelines have not been established."}, 
{"Row" : 10, "Column" : 1, "Text" : "For outpatient prescriptions, when a range is recommended by CDSS, the"}, 
{"Row" : 11, "Column" : 1, "Text" : "prescription order will default to the lowest dose and day supply. For inpatient"}, 
{"Row" : 12, "Column" : 1, "Text" : "orders, durations are listed in the recommendations but are not included in the"}, 
{"Row" : 13, "Column" : 1, "Text" : "quick order. The provider must select a duration, if desired, when completing an"}, 
{"Row" : 14, "Column" : 1, "Text" : "inpatient quick order."}, 
{"Row" : 15, "Column" : 1, "Text" : "For all cases clinical judgment is important. More information is given within"}, 
{"Row" : 16, "Column" : 1, "Text" : "specific diagnoses or syndromes sections."}
]},
{"Name" : "ORZID2 GMENU ABX E COLI INFECT", "Term1" : "Escherichia coli diarrhea/gastroenteritis", "DisplayText" : "Diarrhea with Enterohemorrhagic E. coli ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 750MG PO Q24H", "DisplayText" : "Ciprofloxacin 750 mg PO q24h ($) [R,DI]", "Text" : "Ciprofloxacin 750 mg PO q24h for 3 days ($) [R,DI]", "Mnemonic" : "4"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h for 7 days ($) [R,DI]", "Mnemonic" : "6"},
{"Row" : 28, "Column" : 1, "Item" : "PSJZID RIFAXAMIN 200MG PO Q8H", "DisplayText" : "Rifaximin 200 mg q8h ($$) [M]", "Text" : "Rifaximin 200 mg q8h for 3 days ($$) [M]", "Mnemonic" : "8"},
{"Row" : 46, "Column" : 1, "Item" : "ORZID2 GMENU ABX SHIGELLA SPECIES", "DisplayText" : "Diarrhea with Shigella species (bacillary dysentery)", "Text" : "Link to Shigella/Enteroinvasive E. coli menu", "Mnemonic" : "10"},
{"Row" : 3, "Column" : 1, "Text" : "DIARRHEA WITH ESCHERICHIA COLI", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Enteroaggretive E. coli (EAEC), Enteropathogenic E. coli (EPEC), and", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Enterotoxigenic E. coli (ETEC)", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "EAEC infection can cause watery diarrhea with mucus that is occasionally bloody."}, 
{"Row" : 8, "Column" : 1, "Text" : "It is more common in patients with HIV and those who have traveled to developing"}, 
{"Row" : 9, "Column" : 1, "Text" : "regions. EPEC infection is associated with severe acute watery diarrhea that is"}, 
{"Row" : 10, "Column" : 1, "Text" : "occasionally bloody. ETEC infection causes acute watery diarrhea that is"}, 
{"Row" : 11, "Column" : 1, "Text" : "occasionally severe. It is most common in travelers to tropical regions who are"}, 
{"Row" : 12, "Column" : 1, "Text" : "exposed to contaminated food and water."}, 
{"Row" : 14, "Column" : 1, "Text" : "Antibiotic therapy is not required for mild to moderate disease caused by these"}, 
{"Row" : 15, "Column" : 1, "Text" : "organisms because diarrhea often resolves on its own. Do not use antimotility"}, 
{"Row" : 16, "Column" : 1, "Text" : "agents in patients with bloody stool."}, 
{"Row" : 18, "Column" : 1, "Text" : "Primary treatment"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 21, "Column" : 1, "Text" : "Antimicrobial treatment of severe diarrhea"}, 
{"Row" : 24, "Column" : 1, "Text" : "Antimicrobial treatment in patients with HIV"}, 
{"Row" : 27, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 30, "Column" : 1, "Text" : "Enterohemorrhagic E. coli (EHEC) and Shiga Toxin-producing E. coli (STEC)", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "EHEC and STEC disease often presents as bloody diarrhea. It is more common in"}, 
{"Row" : 32, "Column" : 1, "Text" : "people who have consumed undercooked meats or poultry, fruits or unpasteurized"}, 
{"Row" : 33, "Column" : 1, "Text" : "fruit juices, vegetables, leafy greens or seed sprouts. Exposure risks include"}, 
{"Row" : 34, "Column" : 1, "Text" : "swimming in or drinking untreated fresh water and visiting a farm, petting zoo,"}, 
{"Row" : 35, "Column" : 1, "Text" : "healthcare facility, prison or childcare facility."}, 
{"Row" : 37, "Column" : 1, "Text" : "Treatment includes supportive measures such as volume repletion and"}, 
{"Row" : 38, "Column" : 1, "Text" : "administering appropriate nutrition. Do not use antimotility or antimicrobial"}, 
{"Row" : 39, "Column" : 1, "Text" : "agents as they can increase shiga-toxin release and increase the risk of"}, 
{"Row" : 40, "Column" : 1, "Text" : "hemolytic uremia syndrome (HUS)."}, 
{"Row" : 42, "Column" : 1, "Text" : "Enteroinvasive E. coli (EIEC)", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "EIEC disease typically presents as watery diarrhea, sometimes progressing to"}, 
{"Row" : 44, "Column" : 1, "Text" : "bloody diarrhea. Refer to Shigella/Enteroinvasive E. coli menu for"}, 
{"Row" : 45, "Column" : 1, "Text" : "recommendations."}, 
{"Row" : 49, "Column" : 1, "Text" : "References:"}, 
{"Row" : 51, "Column" : 1, "Text" : "Brunette, Gary W. CDC Yellow Book 2018: Oxford University Press, 2017"}, 
{"Row" : 52, "Column" : 1, "Text" : "Sanford keyword: Enterohemorrhagic E. coli / Shiga toxin-producing E. coli"}, 
{"Row" : 53, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 54, "Column" : 1, "Text" : "Up-to-Date article: Pathogenic Escherichia coli"}
]},
{"Name" : "ORZID2 GMENU ABX ELEMENTS OF CDSS ADVICE PAGE", "DisplayText" : "Elements of a CDSS Advice Page ", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "ELEMENTS OF A CDSS ADVICE MENU", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Advice menus are comprised of the following elements:"}, 
{"Row" : 7, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "TYPICALLY present on an advice menu", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "1) Diagnosis or condition label-at the top of each advice menu."}, 
{"Row" : 15, "Column" : 1, "Text" : "2) Treatment. Empirical treatment as well as treatment for selected pathogens"}, 
{"Row" : 16, "Column" : 1, "Text" : "is presented with links to antimicrobial quick orders unless stated otherwise."}, 
{"Row" : 17, "Column" : 1, "Text" : "In addition to the drug, dose, and route, each quick order text includes the"}, 
{"Row" : 18, "Column" : 1, "Text" : "drug's approximate cost per day and coding for important drug properties of"}, 
{"Row" : 19, "Column" : 1, "Text" : "note. Drugs clustered together are considered equivalent."}, 
{"Row" : 21, "Column" : 1, "Text" : "3) Help. At the top of each advice menu. There are links to a variety of"}, 
{"Row" : 22, "Column" : 1, "Text" : "resources (susceptibilities, important drug properties, section-specific"}, 
{"Row" : 23, "Column" : 1, "Text" : "consults, etc.)."}, 
{"Row" : 25, "Column" : 1, "Text" : "4) References. At the bottom on each advice menu. These are key references for"}, 
{"Row" : 26, "Column" : 1, "Text" : "the recommendations on the menu."}, 
{"Row" : 28, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "DISCRETIONARY advice menu components", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "_____________________________________", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "1) (Treatment) Alternative. Following the (preferred) Treatment section with"}, 
{"Row" : 34, "Column" : 1, "Text" : "quick orders for common alternative antimicrobials. Antimicrobial listed under"}, 
{"Row" : 35, "Column" : 1, "Text" : "each alternative header are equivalents among those listed. A broader selection"}, 
{"Row" : 36, "Column" : 1, "Text" : "of medications can be accessed through the Need an alternative menu within the"}, 
{"Row" : 37, "Column" : 1, "Text" : "help section. For some conditions we recommend alternative antimicrobials when"}, 
{"Row" : 38, "Column" : 1, "Text" : "recommended drugs are not suitable for an individual patient. Unless otherwise"}, 
{"Row" : 39, "Column" : 1, "Text" : "stated drugs clustered together under Alternatives are considered equivalent."}, 
{"Row" : 41, "Column" : 1, "Text" : "If none of the recommended or alternative drugs is suitable you can find more"}, 
{"Row" : 42, "Column" : 1, "Text" : "drugs by clicking on the Need an alternative link at the top of the menu."}, 
{"Row" : 44, "Column" : 1, "Text" : "2) Consults. At the top of the menu, these are consultation requests pertinent"}, 
{"Row" : 45, "Column" : 1, "Text" : "to the clinical problem addressed by the menu. Links to context-specific"}, 
{"Row" : 46, "Column" : 1, "Text" : "consults can be found on advice menus, as appropriate. For example, the herpes"}, 
{"Row" : 47, "Column" : 1, "Text" : "simplex encephalitis menu contains a link to a request for neurology consult."}, 
{"Row" : 49, "Column" : 1, "Text" : "3) Resources. Pertinent to the clinical problem and addressed by the menu is"}, 
{"Row" : 50, "Column" : 1, "Text" : "provided for example. For some menus, supplemental resources have been"}, 
{"Row" : 51, "Column" : 1, "Text" : "identified (e.g., PORT score calculator for Community Acquired Pneumonia,"}, 
{"Row" : 52, "Column" : 1, "Text" : "diagnostic tools, Epidemiology, etc.) the information is included on the advice"}, 
{"Row" : 53, "Column" : 1, "Text" : "menu."}
]},
{"Name" : "ORZID2 GMENU ABX EMPYEMA", "Term1" : "Empyema", "DisplayText" : "Empyema", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 16, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IV Q24H", "DisplayText" : "Ceftriaxone 1GM IV Q24H", "Text" : "Ceftriaxone 1 gm IV q24h ($)[M]", "Mnemonic" : "4"},
{"Row" : 17, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 500MG IV Q24H", "DisplayText" : "Levofloxacin 500mg IV Q24H ($5/day)[R,DI]", "Text" : "Levofloxacin 500 mg IV Q24H ($) [R,DI]", "Mnemonic" : "6"},
{"Row" : 18, "Column" : 1, "Item" : "PSJZID LEVOFLOX 500MG PO Q24H", "DisplayText" : "Levofloxacin 500 mg PO q24h ($) [R,DI]", "Text" : "Levofloxacin 500 mg PO q24h ($) [R]", "Mnemonic" : "8"},
{"Row" : 21, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV Q8H", "DisplayText" : "Clindamycin 600MG IV Q8H", "Text" : "Clindamycin 600 mg IV q8h ($)[H,O]", "Mnemonic" : "10"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 300MG PO Q6H", "DisplayText" : "Clindamycin 300 mg PO q6h", "Text" : "Clindamycin 300 mg PO q6h ($)[H,O]", "Mnemonic" : "12"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID METRONIDAZOLE 500 MG IV Q8H", "DisplayText" : "Metronidazole 500mg IV q8h", "Text" : "Metronidazole 500 mg IV q8h ($) [DI]", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 1000MG PO Q12H", "DisplayText" : "METRONIDAZOLE 1000MG PO Q12H", "Text" : "Metronidazole 1000 mg PO q12h ($) [DI]", "Mnemonic" : "16"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "18"},
{"Row" : 2, "Column" : 1, "Text" : "EMPYEMA"}, 
{"Row" : 4, "Column" : 1, "Text" : "Empyema is usually a complication of pneumonia.  Blood cultures should be drawn"}, 
{"Row" : 5, "Column" : 1, "Text" : "and whenever possible, diagnostic thoracentesis should be performed before"}, 
{"Row" : 6, "Column" : 1, "Text" : "antimicrobials are begun to guide therapy.  Drainage is essential, and a chest"}, 
{"Row" : 7, "Column" : 1, "Text" : "tube is often required.  Pulmonary or Infectious Diseases consultation is"}, 
{"Row" : 8, "Column" : 1, "Text" : "essential."}, 
{"Row" : 9, "Column" : 1, "Text" : "The duration of antibiotic therapy for bacterial empyema is determined on"}, 
{"Row" : 10, "Column" : 1, "Text" : "a patient-by-patient basis based on clinical and radiographic improvement."}, 
{"Row" : 12, "Column" : 1, "Text" : "Preferred treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Choose two antimicrobials, one from Group A and one from Group B."}, 
{"Row" : 15, "Column" : 1, "Text" : ">>  Group A  <<", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : ">>  Group B <<", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Mandell Chapter:  Principles and Practice of Infectious Diseases"}, 
{"Row" : 31, "Column" : 1, "Text" : "Harrison's chapter: Infections due to mixed organisms"}, 
{"Row" : 32, "Column" : 1, "Text" : "Up-to-date website"}
]},
{"Name" : "ORZID2 GMENU ABX ENDOCARDITIS PROPHYL AND PREVENT DERM INFECT", "DisplayText" : "Endocarditis prophylaxis and prevent of post-op derm infections ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, microbiology, drug properties, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID3 GMENU NEED AN ALT ABX MAIN", "DisplayText" : "Alternative Drug Needed? (Outpatient)", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Text" : "Consult Infectious Diseases"}, 
{"Row" : 7, "Column" : 1, "Text" : "Consult Dermatology"}, 
{"Row" : 70, "Column" : 1, "Text" : "\"Stanford\" Table 2: Recommended antimicrobial agents"}, 
{"Row" : 71, "Column" : 1, "Text" : "Wilson et al. Prevention of Infective Endocarditis: Circulation 2007"}, 
{"Row" : 72, "Column" : 1, "Text" : "Wright et al. Antibiotic Prophylaxis in dermatologic Surgery: Advisory statement"}, 
{"Row" : 73, "Column" : 1, "Text" : "2008. J Am Acd Dermatol 2008"}, 
{"Row" : 74, "Column" : 1, "Text" : "Nishimura et al. Acc/Aha 2008 Guidelines Update on Valvular Heart Disease:"}, 
{"Row" : 75, "Column" : 1, "Text" : "Circulation 2008."}, 
{"Row" : 76, "Column" : 1, "Text" : "Hirschmann JV. When Antibiotics are Unnecessary. Dermatol Clin 2009."}, 
{"Row" : 9, "Column" : 1, "Text" : "GUIDELINES FOR ENDOCARDITIS PROPHYLAXIS AND PREVENTION OF", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Antibiotic prophylaxis in dermatologic surgery remains an area of"}, 
{"Row" : 13, "Column" : 1, "Text" : "uncertainty due to a paucity of data. Large, randomized, controlled trials"}, 
{"Row" : 14, "Column" : 1, "Text" : "delineating the risk of surgical site infection, hematogenous total joint"}, 
{"Row" : 15, "Column" : 1, "Text" : "infection, or infective endocardits following dermatologic surgery do not exist."}, 
{"Row" : 16, "Column" : 1, "Text" : "The common mechanistic pathway of both infective endocarditis and hematogenous"}, 
{"Row" : 17, "Column" : 1, "Text" : "total joint infection is bacteremia. Bacteremia can occur as bacteria gain"}, 
{"Row" : 18, "Column" : 1, "Text" : "intravascular access during a perforating dermatologic surgical procedure or may"}, 
{"Row" : 19, "Column" : 1, "Text" : "intravascular or intralymphatic space."}, 
{"Row" : 21, "Column" : 1, "Text" : "nn Pre-Op surgical site preparation", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "nn Post-Op Surgical site care instructions", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "nn Dermatology Surgery Post-Op infections", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Pre-Op Prophylaxis for Prevention of Bacteremia", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Indicated for Mucosal Sites or Surgery of an Infected Site", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Artificial heart valves"}, 
{"Row" : 28, "Column" : 1, "Text" : "History of Infective Endocarditis"}, 
{"Row" : 29, "Column" : 1, "Text" : "Congenital Heart Disease"}, 
{"Row" : 31, "Column" : 1, "Text" : "Pre-Op/Peri-Op Prophylaxis for Prevention of Infection of High Risk Site", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Wound near cartilage or bone (e.g. some nose, scalp or ear sites)"}, 
{"Row" : 33, "Column" : 1, "Text" : "Wedge resection or lip"}, 
{"Row" : 34, "Column" : 1, "Text" : "Skin flaps and grafts"}, 
{"Row" : 35, "Column" : 1, "Text" : "Groin or Lower Extremities"}, 
{"Row" : 36, "Column" : 1, "Text" : "Extensive inflammation (e.g. high tension)"}, 
{"Row" : 37, "Column" : 1, "Text" : "Large wound (>5cm)"}, 
{"Row" : 38, "Column" : 1, "Text" : "Long procedure where wound is open for a long time"}, 
{"Row" : 40, "Column" : 1, "Text" : "Antibiotic Doses for Pre-Op/Peri-Op Conditions Above", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 42, "Column" : 1, "Text" : "Give antibiotics 30-60 minutes before procedure or as soon as condition becomes"}, 
{"Row" : 43, "Column" : 1, "Text" : "apparent (for high risk sites)"}, 
{"Row" : 45, "Column" : 1, "Text" : "Pre-Op Prophylaxis", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "POST-OP DERMATOLOGY INFECTIONS", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Item" : "PSJZID CEPHALEXIN 2GM PO ONCE 'C'", "DisplayText" : "Cephalexin 2gm po once", "Text" : "Cephalexin 2 GM PO 1 hour before procedure ($0.36/day) [R]< OR >", "Mnemonic" : "12"},
{"Row" : 48, "Column" : 1, "Item" : "PSJZID DICLOXACILLIN 500MG 'C'", "DisplayText" : "Dicloxacillin 500mg before procedure", "Text" : "Dicloxacillin 2 GM PO 1 hour before procedure ($1.44/day) [DI]", "Mnemonic" : "14"},
{"Row" : 50, "Column" : 1, "Text" : "Penicillin Allergy", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 52, "Column" : 1, "Item" : "PSJZID CLINDAMYCIN 600MG PO ONCE 'C'", "DisplayText" : "Clindamycin 600mg po once", "Text" : "Clindamycin 600 mg PO ($25/day) [H,O] < OR >", "Mnemonic" : "16"},
{"Row" : 53, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 500 MG PO ONCE 'C'", "DisplayText" : "Azithromycin 500mg po once", "Text" : "Azithromycin 500 mg PO 1 hour before procedure ($1.82/day) [M]", "Mnemonic" : "18"},
{"Row" : 55, "Column" : 1, "Text" : "Unable to take PO", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 1GM IV ONCE 'C'", "DisplayText" : "Cefazolin 1gm iv once", "Text" : "Cefazolin 1 GM IV over 20 minutes, beginning 60 minutes before incision", "Mnemonic" : "20"},
{"Row" : 58, "Column" : 1, "Text" : "($1.72/day)[R]"}, 
{"Row" : 60, "Column" : 1, "Text" : "Unable to take PO with Penicillin Allergy", "Header" : 1}, 
{"Row" : 61, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}, 
{"Row" : 69, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "36"},
{"Row" : 62, "Column" : 1, "Item" : "PSJIZID CLINDAMYCIN 600MG IV ONCE 'C'", "DisplayText" : "Clindamycin 600mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes, beginning 60 minutes before incision", "Mnemonic" : "22"},
{"Row" : 63, "Column" : 1, "Text" : "($5.51/day) [H,O]"}, 
{"Row" : 65, "Column" : 1, "Text" : "Oral Surgical Site", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Text" : "________________________________________________________", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX ENTAMOEBA HISTOLYTICA", "Term1" : "Entamoeba histolytica diarrhea/gastroenteritis", "DisplayText" : "Entoemeba histolytica ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 11, "Column" : 1, "Item" : "ORZ SET ABX METRO 750MG PO Q8H PAROMOMYC 25-35MG/KG/DAY PO Q8H", "DisplayText" : "Metronidazole 750 mg PO q8h for 10 days ($) [DI] <FOLLOWED BY> paromomycin", "Text" : "Metronidazole 750 mg PO q8h for 10 days ($) [DI] <FOLLOWED BY> paromomycin", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "ENTAMOEBA HISTOLYTICA", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Primary treatment for gastroenteritis", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 8, "Column" : 1, "Text" : "Antimicrobial treatment for gastroenteritis or extraintestinal disease", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Consult Infectious Diseases in all cases. Paromomycin is nonformulary and must"}, 
{"Row" : 10, "Column" : 1, "Text" : "be ordered by Infectious Diseases."}, 
{"Row" : 12, "Column" : 1, "Text" : "25-35 mg/kg/day PO q8h for 7 days ($) [M]"}, 
{"Row" : 15, "Column" : 1, "Text" : "References:"}, 
{"Row" : 17, "Column" : 1, "Text" : "Sanford keyword: Amoebiasis, Entamoeba histolytica"}, 
{"Row" : 18, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 19, "Column" : 1, "Text" : "Up-to-Date article: Intestinal Entamoeba histolytica amoebiasis"}
]},
{"Name" : "ORZID2 GMENU ABX ENTERIC FEVER", "Term1" : "Enteric fever ", "Term2" : "Paratyphoid fever ", "Term3" : "Typhoid fever", "DisplayText" : "Enteric Fever", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 16, "Column" : 1, "Item" : "PSJZID CIPROFLOXACIN 500MG PO Q12H", "DisplayText" : "Ciprofloxacin 500mg po q12h", "Text" : "Ciprofloxacin 500 mg PO q12h for 7-10 days ($) [R,DI]", "Mnemonic" : "4"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CIPROFLOXACIN 400MG IV Q12H", "DisplayText" : "Ciprofloxacin 400MG IV Q12H", "Text" : "Ciprofloxacin 400 mg IV q12h for 7-10 days ($) [R,DI]", "Mnemonic" : "6"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID AZITHROMYCIN 1GM ONCE THEN 500MG PO Q24H 5DAYS", "DisplayText" : "Azithromycin 1 gm PO once then 500 mg PO q24h for 5 days ($) [M]", "Text" : "Azithromycin 1 gm PO once then 500 mg PO q24h for 5 to 7 days ($) [M]", "Mnemonic" : "8"},
{"Row" : 24, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1GM IV Q24H", "DisplayText" : "Ceftriaxone 1GM IV Q24H", "Text" : "Ceftriaxone 1 gm IV q24h for 7 to 14 days ($) [M]", "Mnemonic" : "10"},
{"Row" : 3, "Column" : 1, "Text" : "ENTERIC FEVER (INCLUDING TYPHOID AND PARATYPHOID FEVER)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Enteric fever is a systemic febrile illness caused by Salmonella enterica"}, 
{"Row" : 6, "Column" : 1, "Text" : "serotypes Typhi and Paratyphi A, B, or C. It is characterized by dramatic fever"}, 
{"Row" : 7, "Column" : 1, "Text" : "and abdominal pain. Enteric fever typically occurs in patients who have traveled"}, 
{"Row" : 8, "Column" : 1, "Text" : "to impoverished areas where the organisms are endemic, but can also be acquired"}, 
{"Row" : 9, "Column" : 1, "Text" : "within the United States. Treatment is based on location of acquisition due to"}, 
{"Row" : 10, "Column" : 1, "Text" : "increasing rates of fluoroquinolone resistance in Asia."}, 
{"Row" : 12, "Column" : 1, "Text" : "Primary treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 15, "Column" : 1, "Text" : "Antimicrobial treatment for infection NOT acquired in Asia", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 21, "Column" : 1, "Text" : "Antimicrobial treatment for infection acquired in Asia", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 27, "Column" : 1, "Text" : "References:"}, 
{"Row" : 29, "Column" : 1, "Text" : "Sanford keyword: Typhoid Fever, Enteric Fever"}, 
{"Row" : 30, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 31, "Column" : 1, "Text" : "Up-to-Date article: Treatment and prevention of enteric (typhoid and"}, 
{"Row" : 32, "Column" : 1, "Text" : "paratyphoid) fever"}
]},
{"Name" : "ORZID2 GMENU ABX EPIDIDYMITIS", "Term1" : "Epididymitis", "DisplayText" : "Epididymitis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 22, "Column" : 1, "Item" : "ORZ ADD MENU LABS (LAB COLLECT)", "DisplayText" : "1-H LABS", "Text" : "Lab menu", "Mnemonic" : "4"},
{"Row" : 39, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 500MG IM ONCE LEVOFLOX 500MG PO Q24H", "DisplayText" : "Ceftriaxone 500 mg IM once ($) [M] < AND > levofloxacin 500 mg PO q24h", "Text" : "Ceftriaxone 500 mg IM once ($) [M] < AND > levofloxacin 500 mg PO q24h", "Mnemonic" : "6"},
{"Row" : 49, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 750MG PO Q24H", "DisplayText" : "Levofloxacin 750 mg PO q24h ($0.30/day) [R,DI]", "Text" : "Levofloxacin 750 mg PO q24h ($) [R, DI] for 10 days", "Mnemonic" : "8"},
{"Row" : 51, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 750MG IV Q24H", "DisplayText" : "Levofloxacin 750 mg IV q24h ($5/day) [R,DI]", "Text" : "Levofloxacin 750 mg IV q24h ($) for 10 days", "Mnemonic" : "10"},
{"Row" : 54, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 2GM IV Q24H", "DisplayText" : "Ceftriaxone 2 gm IV Q24h", "Text" : "Ceftriaxone 2 gm IV q24h ($) [M] for 10 days", "Mnemonic" : "12"},
{"Row" : 56, "Column" : 1, "Item" : "PSJZID AMOXICILLIN-CLAVULANATE 875-125 MG PO Q12H", "DisplayText" : "Amoxicillin-Clavulanate 875-125 MG PO Q12H", "Text" : "Amoxicillin-clavulanate 875/125 mg PO q12h ($) [R] for 10 days", "Mnemonic" : "14"},
{"Row" : 61, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 500MG IM ONCE DOXY 100MG PO Q12H", "DisplayText" : "Ceftriaxone 500mg IM Once ($) [M] <AND> Doxycycline 100mg PO ($) [DI]", "Text" : "Ceftriaxone 500 mg IM once ($) [M] <AND> doxycycline 100 mg PO q12h ($) [DI] for", "Mnemonic" : "16"},
{"Row" : 65, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 1GM IM ONCE DOXY PO 100MG Q12H", "DisplayText" : "Ceftriaxone 1gm IM Once < AND > Doxycycline 100 mg po q12h", "Text" : "Ceftriaxone 1 gm IM once ($) [M] <AND> doxycycline 100 mg PO q12h ($) [DI] for", "Mnemonic" : "18"},
{"Row" : 69, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Assessment of Beta-lactam Reaction", "Mnemonic" : "20"},
{"Row" : 70, "Column" : 1, "Item" : "PSJZID LEVOFLOX 500MG PO Q24H", "DisplayText" : "Levofloxacin 500 mg PO q24h ($) [R,DI]", "Text" : "Levofloxacin 500 mg PO q24h ($) [R, DI] for 10 days", "Mnemonic" : "22"},
{"Row" : 72, "Column" : 1, "Item" : "PSJIZID LEVOFLOXACIN 500MG IV Q24H", "DisplayText" : "Levofloxacin 500mg IV Q24H ($5/day)[R,DI]", "Text" : "Levofloxacin 500 mg IV q24h ($) for 10 days", "Mnemonic" : "24"},
{"Row" : 3, "Column" : 1, "Text" : "EPIDIDYMITIS AND EPIDIDYMO-ORCHITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Epididymitis is inflammation of the epididymis and when testicles are involved"}, 
{"Row" : 6, "Column" : 1, "Text" : "is referred to as epididymo-orchitis. Acute epididymitis is the most common"}, 
{"Row" : 7, "Column" : 1, "Text" : "cause of scrotal pain in adults. Other features include scrotal erythema and"}, 
{"Row" : 8, "Column" : 1, "Text" : "edema, pyuria, dysuria, thickened epididymis, swollen testis, and is usually"}, 
{"Row" : 9, "Column" : 1, "Text" : "unilateral. It is primarily caused by infection but can also result from trauma"}, 
{"Row" : 10, "Column" : 1, "Text" : "and autoimmune diseases. Testicular torsion should be ruled out before"}, 
{"Row" : 11, "Column" : 1, "Text" : "treatment. Most cases in men aged 35 and older, those with recent urinary tract"}, 
{"Row" : 12, "Column" : 1, "Text" : "instrumentation or surgery (e.g., prostate biopsy, vasectomy) are associated"}, 
{"Row" : 13, "Column" : 1, "Text" : "with enteric Gram-negative rods. Most cases in men under age 35 are associated"}, 
{"Row" : 14, "Column" : 1, "Text" : "with N. gonorrhoeae and C. trachomatis. Resistant organisms are more likely if"}, 
{"Row" : 15, "Column" : 1, "Text" : "the patient has been in the hospital for more than 48 hours or received a course"}, 
{"Row" : 16, "Column" : 1, "Text" : "of antibiotics. There is increasing resistance in urinary pathogens to"}, 
{"Row" : 17, "Column" : 1, "Text" : "ciprofloxacin."}, 
{"Row" : 19, "Column" : 1, "Text" : "A urine analysis, urine culture and urine nucleic acid amplification test (NAAT)"}, 
{"Row" : 20, "Column" : 1, "Text" : "should be performed in all cases of suspected epididymitis before starting"}, 
{"Row" : 21, "Column" : 1, "Text" : "treatment to guide therapy:"}, 
{"Row" : 24, "Column" : 1, "Text" : "Patients at risk of sexually transmitted infections should be assessed for"}, 
{"Row" : 25, "Column" : 1, "Text" : "treatment. Refer to the Urogenital section of the Antimicrobial CDSS for more"}, 
{"Row" : 26, "Column" : 1, "Text" : "information."}, 
{"Row" : 28, "Column" : 1, "Text" : "Patients with bacterial epididymitis treated with antibiotics should improve"}, 
{"Row" : 29, "Column" : 1, "Text" : "within two or three days. If no improvement is noted, other causes of scrotal"}, 
{"Row" : 30, "Column" : 1, "Text" : "pain and referral to a urologist should be considered."}, 
{"Row" : 32, "Column" : 1, "Text" : "Management should include bed rest, analgesics, and scrotal elevation. Older men"}, 
{"Row" : 33, "Column" : 1, "Text" : "should have their residual urinary volume checked. If the residual volume is"}, 
{"Row" : 34, "Column" : 1, "Text" : "elevated, the patient should be seen by a urologist as epididymitis is unlikely"}, 
{"Row" : 35, "Column" : 1, "Text" : "to respond if the prostate is blocking the vas deferens."}, 
{"Row" : 36, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 38, "Column" : 1, "Text" : "Empirical treatment in men who practice insertive anal intercourse", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "for 10 days ($) [R, DI]"}, 
{"Row" : 41, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 43, "Column" : 1, "Text" : "Empirical treatment in men who do not practice insertive anal intercourse", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Age >/= 35 years or", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Recent urinary tract instrumentation or urinary tract surgery (e.g., prostate", "Header" : 1}, 
{"Row" : 47, "Column" : 1, "Text" : "biopsy, vasectomy):", "Header" : 1}, 
{"Row" : 48, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 50, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 53, "Column" : 1, "Text" : "Alternatives:"}, 
{"Row" : 55, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 58, "Column" : 1, "Text" : "Age < 35 years", "Header" : 1}, 
{"Row" : 59, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 60, "Column" : 1, "Text" : "Patient weighing less than 300 lbs"}, 
{"Row" : 62, "Column" : 1, "Text" : "10 days"}, 
{"Row" : 64, "Column" : 1, "Text" : "Patients weighing 300 lbs or greater"}, 
{"Row" : 66, "Column" : 1, "Text" : "10 days"}, 
{"Row" : 68, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 71, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 73, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 76, "Column" : 1, "Text" : "References:"}, 
{"Row" : 77, "Column" : 1, "Text" : "Mandell Chapter: Prostatitis, Epididymitis and Orchitis"}, 
{"Row" : 78, "Column" : 1, "Text" : "Sanford keyword: Epididymo-orchitis"}, 
{"Row" : 79, "Column" : 1, "Text" : "Taylor, Stephanie, Clinical Infectious Diseases, 2015, 61(S8)S770-3"}, 
{"Row" : 80, "Column" : 1, "Text" : "Up-To-Date article: Evaluation of acute scrotal pain in adults"}, 
{"Row" : 81, "Column" : 1, "Text" : "Workowski et al., MMWR Recomm Rep, 2021, 70(4)1-187"}
]},
{"Name" : "ORZID2 GMENU ABX EPIGLOTTITIS", "Term1" : "Epiglottitis", "DisplayText" : "Epiglottitis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 14, "Column" : 1, "Item" : "ORZ SET ABX CETRIAX 2G Q24H VANCO 15MG/KG Q12H", "DisplayText" : "", "Text" : "Ceftriaxone 2 gm IV q24h ($) [M] <AND> vancomycin 15 mg/kg IV q 12h ($) [R]", "Mnemonic" : "4"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Assessment of Beta-lactam Reaction", "Mnemonic" : "6"},
{"Row" : 19, "Column" : 1, "Item" : "ORZ SET ABX LEVOFLOX 500MG QD VANCO 15MG/KG Q12", "DisplayText" : "", "Text" : "Levofloxacin 500 mg IV q24h ($) [R,DI] <AND> vancomycin 15 mg/kg IV q12h ($) [R]", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "EPIGLOTTITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Maintaining the airway is the key to management. Call ENT service and ask them"}, 
{"Row" : 6, "Column" : 1, "Text" : "to see the patient immediately. Blood cultures and epiglottal cultures (in"}, 
{"Row" : 7, "Column" : 1, "Text" : "intubated patients) should be used to direct antimicrobial therapy. Empirical"}, 
{"Row" : 8, "Column" : 1, "Text" : "therapy should be initiated prior to results of cultures as infection is life"}, 
{"Row" : 9, "Column" : 1, "Text" : "threatening and cover for likely pathogens (H. influenza type b, penicillin"}, 
{"Row" : 10, "Column" : 1, "Text" : "resistant S. pneumonia, beta-hemolytic streptococci and possibly Staph. aureus)"}, 
{"Row" : 12, "Column" : 1, "Text" : "Empirical Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred:"}, 
{"Row" : 15, "Column" : 1, "Text" : "for 7 days"}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternative:"}, 
{"Row" : 20, "Column" : 1, "Text" : "for 7 days"}, 
{"Row" : 22, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "References:"}, 
{"Row" : 25, "Column" : 1, "Text" : "Mandell chapter: Epiglottitis"}, 
{"Row" : 26, "Column" : 1, "Text" : "Rafei et al., Pediatric Clinics 2006, 53.2, 215-242"}, 
{"Row" : 27, "Column" : 1, "Text" : "Sanford keyword: Epiglottitis, Supraglottis"}, 
{"Row" : 28, "Column" : 1, "Text" : "Up-to-date article: Epiglottis (supraglottis): Treatment and prevention"}
]},
{"Name" : "ORZID2 GMENU ABX ESBL", "Term" : "012913 njt CDSS update", "DisplayText" : "ESBLs, Amp-C beta-lactamases, and Carbapenemases ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Text" : "EXTENDED-SPECTRUM BETA-LACTAMASES, AMPC BETA-LACTAMASES, AND CARBAPENEMASES", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "In some Enterobacteriaceae and other Gram-negative bacilli, potent bacterial"}, 
{"Row" : 5, "Column" : 1, "Text" : "enzymes have emerged that inactive many newer broad-spectrum beta lactam drugs."}, 
{"Row" : 6, "Column" : 1, "Text" : "These include extended-spectrum beta-lactamases (ESBLs), AmpC beta-lactamases,"}, 
{"Row" : 7, "Column" : 1, "Text" : "and carbapenemases. These enzymes are most common in strains of Escherichia"}, 
{"Row" : 8, "Column" : 1, "Text" : "coli, Klebsiella, Proteus, Acinetobacter, Salmonella, and Enterobacter. The"}, 
{"Row" : 9, "Column" : 1, "Text" : "enzymes can be latent under many circumstances. However, in patients receiving"}, 
{"Row" : 10, "Column" : 1, "Text" : "beta lactam antibiotics, the enzymes can be expressed and contribute to"}, 
{"Row" : 11, "Column" : 1, "Text" : "treatment failure. Because of this, and since the enzymes continue to evolve,"}, 
{"Row" : 12, "Column" : 1, "Text" : "they are difficult to detect in clinical microbiology laboratories. Bacteria"}, 
{"Row" : 13, "Column" : 1, "Text" : "carrying these enzymes are often also resistant to many other commonly used"}, 
{"Row" : 14, "Column" : 1, "Text" : "antimicrobials, including trimethoprim-sulfamethoxazole, quinolones,"}, 
{"Row" : 15, "Column" : 1, "Text" : "aminoglycosides, and others, through different mechanisms."}, 
{"Row" : 17, "Column" : 1, "Text" : "The St Cloud VA and the Minneapolis Microbiology Laboratories screen for"}, 
{"Row" : 18, "Column" : 1, "Text" : "these enzymes, but no screening method is 100% sensitive."}, 
{"Row" : 20, "Column" : 1, "Text" : "If a patient is suspected of having a Gram-negative infection and is likely to"}, 
{"Row" : 21, "Column" : 1, "Text" : "be colonized with bacteria carrying ESBLs, AmpC beta-lactamases, or"}, 
{"Row" : 22, "Column" : 1, "Text" : "carbapenemases, empirical therapy with alternative drugs that are not"}, 
{"Row" : 23, "Column" : 1, "Text" : "inactivated by these enzymes should be considered. Typical alternatives are"}, 
{"Row" : 24, "Column" : 1, "Text" : "listed below."}, 
{"Row" : 26, "Column" : 1, "Text" : "ESBLs inactivate most cephalosporins, monobactams, and peneicillins."}, 
{"Row" : 27, "Column" : 1, "Text" : "Alternatives include carbapenems, aminoglycosides, quinolones (although co-"}, 
{"Row" : 28, "Column" : 1, "Text" : "resistence is common), cefepime, trimethoprim-sulfamethoxazole, and colistin."}, 
{"Row" : 30, "Column" : 1, "Text" : "AmpC beta-lactamases inactivate many cephalosporins, most penicillins, and beta"}, 
{"Row" : 31, "Column" : 1, "Text" : "lactam-beta lactam inhibitor combinations. Alternatives include cefepime,"}, 
{"Row" : 32, "Column" : 1, "Text" : "carbapenems, aminoglycosides, quinolones (although co-resistence is common),"}, 
{"Row" : 33, "Column" : 1, "Text" : "trimethoprim-sulfamethoxazole, and colistin."}, 
{"Row" : 35, "Column" : 1, "Text" : "Carbapenemases inactivate carbapenems. Most strains are also resistant to most"}, 
{"Row" : 36, "Column" : 1, "Text" : "other antibiotic classes. Alternatives include aminoglycosides and colistin."}, 
{"Row" : 38, "Column" : 1, "Text" : "Risk factors for colonization or infection with ESBL, Amp-C beta-lactamase or"}, 
{"Row" : 39, "Column" : 1, "Text" : "carbapenemase-producing organisms include:"}, 
{"Row" : 41, "Column" : 1, "Text" : "Travel to Asia"}, 
{"Row" : 42, "Column" : 1, "Text" : "Central venous catheters and other indwelling tubes and drains"}, 
{"Row" : 43, "Column" : 1, "Text" : "Recent surgical procedures"}, 
{"Row" : 44, "Column" : 1, "Text" : "Recent antibiotic therapy"}, 
{"Row" : 45, "Column" : 1, "Text" : "Long-term care facility residence"}, 
{"Row" : 46, "Column" : 1, "Text" : "Multiple, severe chronic illnesses"}, 
{"Row" : 47, "Column" : 1, "Text" : "Ventilator assistance"}, 
{"Row" : 48, "Column" : 1, "Text" : "Hemodialysis"}, 
{"Row" : 49, "Column" : 1, "Text" : "Long hospital or ICU stay"}, 
{"Row" : 51, "Column" : 1, "Text" : "The Microbiology Laboratory report will indicate when one of these enzymes has"}, 
{"Row" : 52, "Column" : 1, "Text" : "been detected. Clinicians must be aware that these enzymes may not be detected"}, 
{"Row" : 53, "Column" : 1, "Text" : "in all strains that carry them. If a Gram-negative infection is not responding"}, 
{"Row" : 54, "Column" : 1, "Text" : "to therapy with a beta-lactam drug, consider adding or switching to a drug that"}, 
{"Row" : 55, "Column" : 1, "Text" : "is not a beta lactam and appears active in the susceptibility report."}, 
{"Row" : 57, "Column" : 1, "Text" : "These new enzymes have made therapy of enterobacteriaceae infections"}, 
{"Row" : 58, "Column" : 1, "Text" : "more complicated and difficult. Please contact or consult the Infectious"}, 
{"Row" : 59, "Column" : 1, "Text" : "Disease service with questions or for assistance."}
]},
{"Name" : "ORZID2 GMENU ABX ESBL KPC ETC", "Term1" : "Resistant bacteria, more about", "DisplayText" : "NULL", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "Gram-Negative Bacilli Drug Resistance", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "In some Gram-negative bacilli, potent bacterial enzymes have emerged that"}, 
{"Row" : 6, "Column" : 1, "Text" : "inactive many newer broad-spectrum beta lactam drugs. These include extended-"}, 
{"Row" : 7, "Column" : 1, "Text" : "spectrum beta-lactamases (ESBLs), serine carbapenemases, metallo-beta-"}, 
{"Row" : 8, "Column" : 1, "Text" : "lactamases, AmpC beta-lactamases and oxacillinases. These enzymes are most"}, 
{"Row" : 9, "Column" : 1, "Text" : "common in strains of Acinetobacter, Citrobacter, Enterobacter, Escherichia coli,"}, 
{"Row" : 10, "Column" : 1, "Text" : "Klebsiella, Proteus, Pseudomonas aeruginosa, Salmonella, and Serratia"}, 
{"Row" : 11, "Column" : 1, "Text" : "marcescens. The enzymes can be latent under many circumstances. However, in"}, 
{"Row" : 12, "Column" : 1, "Text" : "patients receiving beta lactam antibiotics, the enzymes can be expressed and"}, 
{"Row" : 13, "Column" : 1, "Text" : "contribute to treatment failure. Because of this, and since the enzymes continue"}, 
{"Row" : 14, "Column" : 1, "Text" : "to evolve, they are difficult to detect in clinical microbiology laboratories."}, 
{"Row" : 15, "Column" : 1, "Text" : "Bacteria carrying these enzymes are often also resistant to many other commonly"}, 
{"Row" : 16, "Column" : 1, "Text" : "used antimicrobials, including trimethoprim-sulfamethoxazole, quinolones, and"}, 
{"Row" : 17, "Column" : 1, "Text" : "others, through different mechanisms. Enterobacteriaceae, Pseudomonas and"}, 
{"Row" : 18, "Column" : 1, "Text" : "Acinetobacter are increasingly resistant to all antimicrobials."}, 
{"Row" : 20, "Column" : 1, "Text" : "Clinicians must be aware that these enzymes may not be detected in all strains"}, 
{"Row" : 21, "Column" : 1, "Text" : "that carry them. If a Gram-negative infection is not responding to therapy with"}, 
{"Row" : 22, "Column" : 1, "Text" : "a beta lactam drug, consider adding or switching to a drug that is not a beta"}, 
{"Row" : 23, "Column" : 1, "Text" : "lactam and appears active in the susceptibility report."}, 
{"Row" : 25, "Column" : 1, "Text" : "If a patient is suspected of having a Gram-negative infection and is likely to"}, 
{"Row" : 26, "Column" : 1, "Text" : "be colonized with bacteria carrying these enzymes, empirical therapy with"}, 
{"Row" : 27, "Column" : 1, "Text" : "alternative drugs that are not inactivated by them should be considered."}, 
{"Row" : 29, "Column" : 1, "Text" : "Risk factors for colonization or infection with resistant gram-negative bacilli", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "1. Travel to Asia"}, 
{"Row" : 31, "Column" : 1, "Text" : "2. Central venous catheters and other indwelling tube and drains"}, 
{"Row" : 32, "Column" : 1, "Text" : "3. Recent surgical procedures"}, 
{"Row" : 33, "Column" : 1, "Text" : "4. Recent antibiotic therapy"}, 
{"Row" : 34, "Column" : 1, "Text" : "5. Long-term care facility residence"}, 
{"Row" : 35, "Column" : 1, "Text" : "6. Multiple, severe chronic illnesses"}, 
{"Row" : 36, "Column" : 1, "Text" : "7. Ventilator assistance"}, 
{"Row" : 37, "Column" : 1, "Text" : "8. Hemodialysis"}, 
{"Row" : 38, "Column" : 1, "Text" : "9. Long hospital or ICU stay."}, 
{"Row" : 40, "Column" : 1, "Text" : "AmpC beta-lactamases alternative antimicrobials", "Header" : 1}, 
{"Row" : 41, "Column" : 1, "Text" : "Inactivate many cephalosporins, most penicillins, and beta-lactam inhibitor"}, 
{"Row" : 42, "Column" : 1, "Text" : "combinations. Alternatives include aminoglycosides, carbapenems, cefepime and"}, 
{"Row" : 43, "Column" : 1, "Text" : "colistin."}, 
{"Row" : 45, "Column" : 1, "Text" : "ESBLs alternative antimicrobials", "Header" : 1}, 
{"Row" : 46, "Column" : 1, "Text" : "Inactivate most cephalosporins, monobactams, and penicillins. Alternatives"}, 
{"Row" : 47, "Column" : 1, "Text" : "include aminoglycosides, carbapenems and colistin."}, 
{"Row" : 49, "Column" : 1, "Text" : "Serine carbapenemases, metallo-beta-lactamases and oxacillinases alternative", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Text" : "antimicrobials", "Header" : 1}, 
{"Row" : 51, "Column" : 1, "Text" : "Confer resistance to all beta-lactams. Most strains are also resistant to most"}, 
{"Row" : 52, "Column" : 1, "Text" : "other antibiotic classes. Alternatives include aminoglycosides and colistin."}, 
{"Row" : 53, "Column" : 1, "Text" : "Infectious Diseases consultation is recommended."}, 
{"Row" : 55, "Column" : 1, "Text" : "Additional alternative antimicrobials", "Header" : 1}, 
{"Row" : 56, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole and quinolones are non-beta-lactam alternative"}, 
{"Row" : 57, "Column" : 1, "Text" : "antimicrobials, especially useful for IV to PO conversion. Gram negative bacilli"}, 
{"Row" : 58, "Column" : 1, "Text" : "co-resistance to these antimicrobials is common however. Tigecycline (restricted"}, 
{"Row" : 59, "Column" : 1, "Text" : "to ID) and ceftazidime-avibactam (non-formulary) are also potential options for"}, 
{"Row" : 60, "Column" : 1, "Text" : "susceptible isolates. Infectious Diseases consultation is required for their"}, 
{"Row" : 61, "Column" : 1, "Text" : "use."}, 
{"Row" : 64, "Column" : 1, "Text" : "References"}, 
{"Row" : 66, "Column" : 1, "Text" : "Mandell chapter: Molecular Mechanisms of Antibiotic Resistance in Bacteria"}, 
{"Row" : 67, "Column" : 1, "Text" : "Up-to-Date article: Extended-spectrum beta-lactamases"}, 
{"Row" : 68, "Column" : 1, "Text" : "Up-to-Date article: Overview of carbapenemase-producing gram-negative bacilli"}, 
{"Row" : 69, "Column" : 1, "Text" : "Rodríguez-Bano et al. Clinical microbiology reviews, 2018, 31(2): e00079-17"}, 
{"Row" : 70, "Column" : 1, "Text" : "Sanford guide keyword: Gram Negative Bacilli, Drug Resistance, Overview"}, 
{"Row" : 74, "Column" : 1, "Text" : "Last Reviewed 9/18", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX ESOPHAGITIS", "Term1" : "Esophagitis", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI CANDIDA ALBICANS", "DisplayText" : "Candida albicans", "Text" : "Candidiasis", "Mnemonic" : "4"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU ABX CMV COLITIS OR ESOPHAGITIS", "DisplayText" : "CMV Colitis or Esophagistis", "Text" : "CMV Esophagitis", "Mnemonic" : "6"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX HERPES SIMPLEX ESOPHAGITIS", "DisplayText" : "", "Text" : "Herpes Simplex Esophagitis", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "ESOPHAGITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Esophagitis is usually associated with non-infectious diseases like"}, 
{"Row" : 6, "Column" : 1, "Text" : "gastroesophageal reflux disease, mucositis and pill-induced esophagitis."}, 
{"Row" : 7, "Column" : 1, "Text" : "Esophageal infection occurs primarily in immunosuppressed individuals (e.g."}, 
{"Row" : 8, "Column" : 1, "Text" : "chemotherapy, transplantation, HIV) and rarely in healthy individuals. The"}, 
{"Row" : 9, "Column" : 1, "Text" : "majority of infectious esophagitis is caused by Candida albicans,"}, 
{"Row" : 10, "Column" : 1, "Text" : "cytomegalovirus (CMV) and herpes simplex virus. Aphthous ulceration of the"}, 
{"Row" : 11, "Column" : 1, "Text" : "esophagus is common in HIV infection."}, 
{"Row" : 17, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "References:"}, 
{"Row" : 20, "Column" : 1, "Text" : "Mandell chapter: Esophagitis"}, 
{"Row" : 21, "Column" : 1, "Text" : "Up-To-Date article: AIDS-related cytomegalovirus gastrointestinal disease"}, 
{"Row" : 22, "Column" : 1, "Text" : "Up-To-Date article: Clinical pathological cases in gastroenterology: Esophagus"}, 
{"Row" : 23, "Column" : 1, "Text" : "Up-To-Date article: Herpes simplex virus infection of the esophagus"}
]},
{"Name" : "ORZID2 GMENU ABX EXCLUSIONS", "Term1" : "Diseases and Syndromes not covered", "DisplayText" : "Exclusions", "Version" : "StCloud", "Contents" : [
{"Row" : 11, "Column" : 1, "Item" : "ORZ GTX ABX CDSS EMAIL", "DisplayText" : "E-mail Antimicrobial CDSS Staff", "Text" : "Email the VISN23 Antimicrobial CDSS Program Staff", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "DISEASES AND SYNDROMES NOT COVERED", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Our system provides advice for the treatment of most infectious diseases likely"}, 
{"Row" : 6, "Column" : 1, "Text" : "to be encountered in our patient population. Diseases that do not require"}, 
{"Row" : 7, "Column" : 1, "Text" : "antimicrobial therapy are not included. For more information on a syndrome not"}, 
{"Row" : 8, "Column" : 1, "Text" : "described in our system, please contact infectious diseases. If you feel that a"}, 
{"Row" : 9, "Column" : 1, "Text" : "syndrome should be included in our system please contact us."}, 
{"Row" : 12, "Column" : 1, "Text" : "Erik Stensgard, PharmD: 612-467-1781"}, 
{"Row" : 13, "Column" : 1, "Text" : "Bobbie Masoud, PharmD: 612-467-4916"}
]},
{"Name" : "ORZID2 GMENU ABX FIRST RECURRENCE ABX ASSOC", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 13, "Column" : 1, "Item" : "PSJZID FIDAXOMICIN 200MG Q12H 10D", "DisplayText" : "Fidaxomicin 200 mg po q12h for 10 days ($$) [M]", "Text" : "Fidaxomicin 200 mg po q12h for 10 days ($$) [M]", "Mnemonic" : "4"},
{"Row" : 15, "Column" : 1, "Item" : "PSJZID FIDAXAMICIN EXTENDED-PULSE REGIMEN", "DisplayText" : "Fidaxomicin Extended-Pulse Regimen ($$) [M]", "Text" : "Fidaxomicin Extended-Pulse Regimen ($$) [M]", "Mnemonic" : "6"},
{"Row" : 19, "Column" : 1, "Item" : "PSJZID VANCOMYCIN 125MG PO Q6H X10DAYS CDIFF", "DisplayText" : "Vancomycin 125mg PO q6h for 10 days for C.difficile infection. ($$) [M]", "Text" : "Vancomycin 125 mg PO q6h for 10 days ($) [M]", "Mnemonic" : "8"},
{"Row" : 21, "Column" : 1, "Item" : "PSJZID VANCOMYCIN TAPER AND PULSE DOSING", "DisplayText" : "Vancomycin Taper and Pulse Dosing", "Text" : "Vancomycin Extended-Pulse Taper Regimen ($) [M]", "Mnemonic" : "10"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID2 GMENU ABX TOXI MEGACOLON", "DisplayText" : "Severe disease - Ileus/Toxic megacolon", "Text" : "Select for Fulminant CDI", "Mnemonic" : "12"},
{"Row" : 3, "Column" : 1, "Text" : "FIRST RECCURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "CDI Recurrence: Typically defined as a repeated symptomatic, laboratory"}, 
{"Row" : 6, "Column" : 1, "Text" : "confirmed case of CDI within 12 weeks after a prior episode."}, 
{"Row" : 8, "Column" : 1, "Text" : "Discontinue implicated antibiotic and avoid high-risk antibiotic if"}, 
{"Row" : 9, "Column" : 1, "Text" : "antibiotic therapy is still needed. Discontinue antacid therapy if possible."}, 
{"Row" : 11, "Column" : 1, "Text" : "First Recurrence CDI: *The REGIMEN should be different from initial treatment.*", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 16, "Column" : 1, "Text" : "(Fidaxomicin 200mg po bid x5days,then 200mg qother day x20days)"}, 
{"Row" : 18, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 20, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 22, "Column" : 1, "Text" : "(Vancomycin 125 mg PO q6h for 10 days, then taper and pulse with"}, 
{"Row" : 23, "Column" : 1, "Text" : "125 mg po twice daily for seven days, then 125mg po qday for 7 days, then"}, 
{"Row" : 24, "Column" : 1, "Text" : "125mg every other day for 6 weeks)"}, 
{"Row" : 26, "Column" : 1, "Text" : "Fulminant CDI:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Severe/life-threatening disease (shock, ileus, megacolon)"}, 
{"Row" : 31, "Column" : 1, "Text" : "References:"}, 
{"Row" : 33, "Column" : 1, "Text" : "Johnson et al, Clin Inf Dis, 2021, 73(5): e1029-e1044"}, 
{"Row" : 34, "Column" : 1, "Text" : "Criteria for Use: Fidaxomicin VA-PBM (11/21)"}, 
{"Row" : 35, "Column" : 1, "Text" : "Mandell chapter: Clostridium difficile infection"}, 
{"Row" : 36, "Column" : 1, "Text" : "Sanford keyword: Clostridium difficile"}, 
{"Row" : 37, "Column" : 1, "Text" : "Up-to-Date article: Clostridium difficile infection in adults: Treatment and"}, 
{"Row" : 38, "Column" : 1, "Text" : "prevention"}
]},
{"Name" : "ORZID2 GMENU ABX FUNGUS", "Term1" : "Fungi section", "DisplayText" : "Fungi  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI ASPERGILLUS SPP.", "DisplayText" : "Aspergillus spp.", "Text" : "Aspergillus and other moulds", "Mnemonic" : "4"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI BLASTOMYCES DERMATIDIS", "DisplayText" : "Blastomyces dermatidis", "Text" : "Blastomyces dermatitidis", "Mnemonic" : "6"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI CANDIDA ALBICANS", "DisplayText" : "Candida albicans", "Text" : "Candida albicans", "Mnemonic" : "8"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI CANDIDA GLABRATA", "DisplayText" : "Candida glabrata", "Text" : "Candida glabrata", "Mnemonic" : "10"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI CANDIDA KRUSEI", "DisplayText" : "Candida krusei", "Text" : "Candida krusei", "Mnemonic" : "12"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI COCCIDIOIDOMYCES", "DisplayText" : "Coccidioidomyces", "Text" : "Coccidioidomyces", "Mnemonic" : "14"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI CRYPTOCOCCUS NEOFORMANS", "DisplayText" : "Cryptococcus Neoformans", "Text" : "Cryptococcus neoformans", "Mnemonic" : "16"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU FUNGI HISTOPLASMA CAPSULATUM", "DisplayText" : "Histoplasma capsulatum", "Text" : "Histoplasma capsulatum", "Mnemonic" : "18"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU PNEUMOCYSTIS JIROVECII", "DisplayText" : "Pneumocyctis Jirovecii Disease", "Text" : "Pneumocystis (considered a fungus)", "Mnemonic" : "20"},
{"Row" : 3, "Column" : 1, "Text" : "++ FUNGI ++", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Always consider disease or syndrome, site of infection, penetration of drug(s)"}, 
{"Row" : 6, "Column" : 1, "Text" : "into site, and whether organism is pathogen, colonizer, or contaminant. See"}, 
{"Row" : 7, "Column" : 1, "Text" : "disease/syndrome section for more information."}, 
{"Row" : 21, "Column" : 1, "Text" : "Last reviewed 8/18", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX GASTROINTESTINAL", "Term1" : "Gastrointestinal and Intraabdominal section", "DisplayText" : "Gastrointestinal and Intraabdominal  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX LIVER PYOGENIC ABSCESS", "DisplayText" : "", "Text" : "Hepatic abscess", "Mnemonic" : "4"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ABX SECOND PERITONITIS", "DisplayText" : "Secondary Peritonitis", "Text" : "Intraabdominal abscess", "Mnemonic" : "6"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX SECOND PERITONITIS", "DisplayText" : "Secondary Peritonitis", "Text" : "Intraperitoneal abscess", "Mnemonic" : "8"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX PERIANAL/ANORECTAL ABSCESS", "DisplayText" : "Perianal/Anorectal Abscess", "Text" : "Perirectal/Anorectal abscess", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU APPENDICITIS W/O PERFORATION", "DisplayText" : "Appendicitis without perforation", "Text" : "Appendicitis without perforation", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU APPENDICITIS WITH PERFORATION", "DisplayText" : "Appendicitis with perforation", "Text" : "Appendicitis with perforation", "Mnemonic" : "14"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX CHOLECYSTITIS", "DisplayText" : "Cholecystitis", "Text" : "[click here]", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX CHOLANGITIS", "DisplayText" : "Cholangitis", "Text" : "[click here]", "Mnemonic" : "18"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX ASSOC COLITIS", "DisplayText" : "Antibiotic Associated Colitis (C. Difficile Colitis)", "Text" : "Mild to moderate disease", "Mnemonic" : "20"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX TOXI MEGACOLON", "DisplayText" : "Severe disease - Ileus/Toxic megacolon", "Text" : "Severe/life-threatening disease", "Mnemonic" : "22"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU INFECT DIARRHEA/GASTRO", "DisplayText" : "Infectious diarrhea/Gastroenteritis", "Text" : "[click here]", "Mnemonic" : "24"},
{"Row" : 30, "Column" : 1, "Item" : "ORZID2 GMENU ABX DIVERTICULITIS", "DisplayText" : "Diverticulitis", "Text" : "[click here]", "Mnemonic" : "26"},
{"Row" : 3, "Column" : 1, "Text" : "++ GASTROINTESTINAL ++", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Abscess", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Appendicitis", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Cholecystitis", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Cholangitis", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Clostridium difficile disease", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "(shock, ileus and megacolon)"}, 
{"Row" : 26, "Column" : 1, "Text" : "Diarrhea, infectious", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Diverticulitis", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "SECTION LAST REVIEWED MAY 2018", "Header" : 1}, 
{"Row" : 6, "Column" : 2, "Item" : "ORZID2 GMENU ABX ENTERIC FEVER", "DisplayText" : "Enteric Fever", "Text" : "[click here]", "Mnemonic" : "28"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 GMENU H. PYLORI INFECT", "DisplayText" : "Helicobacter pylori infection", "Text" : "[click here]", "Mnemonic" : "30"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID2 GMENU ABX HEPATITIS A", "DisplayText" : "Hepatitis A", "Text" : "Hepatitis A", "Mnemonic" : "32"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU ABX HEPATITIS B", "DisplayText" : "Hepatitis B", "Text" : "Hepatitis B", "Mnemonic" : "34"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU ABX HEPATITIS C", "DisplayText" : "Hepatitis C", "Text" : "Hepatitis C", "Mnemonic" : "36"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU ABX TYPHLITIS", "DisplayText" : "Neutropenic Enterocolitis (Typhlitis)", "Text" : "[click here]", "Mnemonic" : "38"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU ABX PANCREATITIS", "DisplayText" : "Pancreatitis", "Text" : "[click here]", "Mnemonic" : "40"},
{"Row" : 24, "Column" : 2, "Item" : "ORZID2 GMENU ABX SPON BACT PERITONITIS", "DisplayText" : "Acute spontaneous bacterial peritonitis (SBP)", "Text" : "Acute Spontaneous Bacterial Peritonitis (SBP)", "Mnemonic" : "42"},
{"Row" : 25, "Column" : 2, "Item" : "ORZID2 GMENU ABX PERI ASSOC W PERI DIAL", "DisplayText" : "Peritonitis associated with peritoneal dialysis", "Text" : "Peritonitis associated with", "Mnemonic" : "44"},
{"Row" : 27, "Column" : 2, "Item" : "ORZID2 GMENU ABX SECOND PERITONITIS", "DisplayText" : "Secondary Peritonitis", "Text" : "Secondary peritonitis", "Mnemonic" : "46"},
{"Row" : 30, "Column" : 2, "Item" : "ORZID2 GMENU ABX THRUSH", "DisplayText" : "Thrush (Oropharyngeal and Esophageal Candidiasis)", "Text" : "[click here]", "Mnemonic" : "48"},
{"Row" : 5, "Column" : 2, "Text" : "Enteric Fever", "Header" : 1}, 
{"Row" : 8, "Column" : 2, "Text" : "Helicobacter pylori infection", "Header" : 1}, 
{"Row" : 11, "Column" : 2, "Text" : "Hepatitis", "Header" : 1}, 
{"Row" : 16, "Column" : 2, "Text" : "Neutropenic enterocolitis", "Header" : 1}, 
{"Row" : 17, "Column" : 2, "Text" : "(Typhlitis)", "Header" : 1}, 
{"Row" : 20, "Column" : 2, "Text" : "Pancreatitis", "Header" : 1}, 
{"Row" : 23, "Column" : 2, "Text" : "Peritonitis", "Header" : 1}, 
{"Row" : 26, "Column" : 2, "Text" : "peritoneal dialysis"}, 
{"Row" : 29, "Column" : 2, "Text" : "Thrush", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)  ", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help and Additional Information Menu", "Mnemonic" : "2"},
{"Row" : 4, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Infectious Diseases Consult", "Mnemonic" : "4"},
{"Row" : 5, "Column" : 1, "Item" : "ORZ ADD MENU CONSULTS-ALL UPDATED", "DisplayText" : "Consults All...", "Text" : "Consult Menu - place consults to specialty service", "Mnemonic" : "6"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX SUSCEPTIBILITIES (ANTIBIOGRAM)", "DisplayText" : "Antimicrobial Susceptibilities (Antibiogram)", "Text" : "Antibiogram", "Mnemonic" : "8"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALT AM LIST", "DisplayText" : "List of antimicrobials", "Text" : "Alternative Antimicrobials to CDSS Recommendations - select here", "Mnemonic" : "10"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX ADDITIONAL ASSISTANCE", "DisplayText" : "Additional assistance...", "Text" : "Contact Information", "Mnemonic" : "12"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Antimicrobial Information", "Mnemonic" : "14"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ABX IMPORTANT DRUG PROPERTIES", "DisplayText" : "Important drug properties", "Text" : "Important Drug Properties", "Mnemonic" : "16"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX COST INFORMATION", "DisplayText" : "Cost(dollars/day)= $(<10) $$(10-50) $$$(51-100) $$$$(101-400) $$$$$(>400)", "Text" : "Antimicrobial Cost Information", "Mnemonic" : "18"},
{"Row" : 1, "Column" : 1, "Text" : "GENERAL INFORMATION", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "LEGEND ________________________________________________________________________", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "[DI] = Important interactions between antimicrobial and other drugs"}, 
{"Row" : 15, "Column" : 1, "Text" : "[H] = Hepatic excretion of antimicrobial"}, 
{"Row" : 16, "Column" : 1, "Text" : "[M] = Minimal risk posed by antimicrobial"}, 
{"Row" : 17, "Column" : 1, "Text" : "[O] = Other important antimicrobial property"}, 
{"Row" : 18, "Column" : 1, "Text" : "[R] = Renal excretion of antimicrobial"}, 
{"Row" : 21, "Column" : 1, "Text" : "($) = <10 dollars per day"}, 
{"Row" : 22, "Column" : 1, "Text" : "($$) = 10-50 dollars per day"}, 
{"Row" : 23, "Column" : 1, "Text" : "($$$) = 51-100 dollars per day"}, 
{"Row" : 24, "Column" : 1, "Text" : "($$$$) = 101-400 dollars per day"}, 
{"Row" : 25, "Column" : 1, "Text" : "($$$$$) = >400 dollars per day"}, 
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Beta-lactam Reaction Assessment", "Mnemonic" : "11"}
]},
{"Name" : "ORZID2 GMENU ABX GENITAL HERPES", "Term1" : "Genital herpes ", "Term2" : "Herpes, genital ", "Term3" : "Sexually transmitted infection, genital warts", "DisplayText" : "Genital herpes  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 14, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h for 7-10 days ($) [R]", "Mnemonic" : "4"},
{"Row" : 17, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h for 7-10 days ($) [R]", "Mnemonic" : "6"},
{"Row" : 28, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h for 5 days ($) [R]", "Mnemonic" : "8"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 800MG PO TID", "DisplayText" : "Acyclovir 800MG PO TID", "Text" : "Acyclovir 800 mg PO q8h for 2 days ($) [R]", "Mnemonic" : "10"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 500MG PO BID", "DisplayText" : "Valacyclovir 500MG PO BID", "Text" : "Valacyclovir 500 mg PO q12h for 3 days ($) [R]", "Mnemonic" : "12"},
{"Row" : 51, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h ($) [R]", "Mnemonic" : "14"},
{"Row" : 54, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h ($) [R]", "Mnemonic" : "16"},
{"Row" : 58, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 5 MG/KG IV Q8H", "DisplayText" : "Acyclovir 5 mg/kg IV Q8H", "Text" : "Acyclovir 5 mg/kg IV q8h ($$) [R]", "Mnemonic" : "18"},
{"Row" : 70, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO BID", "DisplayText" : "Acyclovir 400MG PO BID", "Text" : "Acyclovir 400 mg PO q12h ($) [R]", "Mnemonic" : "20"},
{"Row" : 73, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 500MG PO Q24H", "DisplayText" : "Valacyclovir 500MG PO Q24H", "Text" : "Valacyclovir 500 mg PO Q24h ($) [R]", "Mnemonic" : "22"},
{"Row" : 76, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1000 MG PO Q24H", "DisplayText" : "VALACYCLOVIR 1000 MG PO Q24h", "Text" : "Valacyclovir 1000 mg PO Q24h ($) [R]", "Mnemonic" : "24"},
{"Row" : 3, "Column" : 1, "Text" : "GENITAL HERPES", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment of the initial episode decreases the duration of pain, lesions, and"}, 
{"Row" : 11, "Column" : 1, "Text" : "viral shedding by 1 to 2 days. Treatment of the initial episode does not"}, 
{"Row" : 12, "Column" : 1, "Text" : "decrease likelihood of recurrent episodes."}, 
{"Row" : 13, "Column" : 1, "Text" : "Treatment"}, 
{"Row" : 16, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 19, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Episodic therapy for relapses", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Treatment of recurrent episodes must be started within 24 hours of symptom"}, 
{"Row" : 25, "Column" : 1, "Text" : "onset. Treatment decreases the duration of pain and lesions, and viral shedding"}, 
{"Row" : 26, "Column" : 1, "Text" : "by 1 to 2 days. Consider suppressive treatment for patients with more than 6"}, 
{"Row" : 27, "Column" : 1, "Text" : "episodes per year."}, 
{"Row" : 29, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 31, "Column" : 1, "Text" : "< OR >"}, 
{"Row" : 34, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 36, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 37, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Immunocompromised patients in whom genital herpes simplex disease is often"}, 
{"Row" : 40, "Column" : 1, "Text" : "severe include: patients with HIV infection, organ transplants, malnourishment,"}, 
{"Row" : 41, "Column" : 1, "Text" : "eczema or severe burns, and in patients receiving immunosuppressive"}, 
{"Row" : 42, "Column" : 1, "Text" : "chemotherapy."}, 
{"Row" : 44, "Column" : 1, "Text" : "Duration of antimicrobial therapy", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Treat mild to moderate disease for 10 days. In severe disease, treat with"}, 
{"Row" : 46, "Column" : 1, "Text" : "intravenous acyclovir for 2 to 7 days based on clinical response, then treat"}, 
{"Row" : 47, "Column" : 1, "Text" : "with an oral antiviral for a total duration of 10 days."}, 
{"Row" : 49, "Column" : 1, "Text" : "Treatment for mild to moderate disease or after clinical improvement of severe", "Header" : 1}, 
{"Row" : 50, "Column" : 1, "Text" : "disease", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 56, "Column" : 1, "Text" : "Treatment for severe disease", "Header" : 1}, 
{"Row" : 57, "Column" : 1, "Text" : "Infectious Diseases consult encouraged."}, 
{"Row" : 60, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 62, "Column" : 1, "Text" : "Chronic suppressive therapy", "Header" : 1}, 
{"Row" : 63, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 65, "Column" : 1, "Text" : "Suppressive therapy is indicated in patients with more than 6 episodes per year."}, 
{"Row" : 66, "Column" : 1, "Text" : "Suppressive therapy is optional, and some patients may find episodic treatment"}, 
{"Row" : 67, "Column" : 1, "Text" : "more convenient. The frequency of recurrences usually decreases after 1 to 5"}, 
{"Row" : 68, "Column" : 1, "Text" : "years, and suppressive therapy should be stopped every few years to see if it is"}, 
{"Row" : 69, "Column" : 1, "Text" : "still needed."}, 
{"Row" : 72, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 75, "Column" : 1, "Text" : "For a patient with more than 9 episodes per year", "Header" : 1}, 
{"Row" : 79, "Column" : 1, "Text" : "References:"}, 
{"Row" : 81, "Column" : 1, "Text" : "Center for Disease Control. MMWR 55(RR 11) 1-94"}, 
{"Row" : 82, "Column" : 1, "Text" : "Mandell chapter: Herpes simplex virus"}, 
{"Row" : 83, "Column" : 1, "Text" : "Sanford keyword: Herpes simplex"}
]},
{"Name" : "ORZID2 GMENU ABX GENITOURINARY", "Term1" : "Genitourinary section", "DisplayText" : "Genitourinary", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX APPROACH TO UTI", "DisplayText" : "Approach to Urinary tract infection", "Text" : "Approach to Urinary Tract Infection (UTI)", "Mnemonic" : "4"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU ABX ASYMP BACTERIURIA", "DisplayText" : "Asymptomatic Bacteriuria", "Text" : "Asymptomatic bacteriuria", "Mnemonic" : "6"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU UROSEPSIS", "DisplayText" : "Urosepsis", "Text" : "Bacteremia/sepsis urinary tract source, Urosepsis", "Mnemonic" : "8"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU ABX CANDIDA UTI", "DisplayText" : "Candida urinary tract infection", "Text" : "Candida Urinary Tract Infection", "Mnemonic" : "10"},
{"Row" : 10, "Column" : 1, "Item" : "ORZID2 GMENU ABX COMP CYSTITIS", "DisplayText" : "Complicated Cystitis", "Text" : "Complicated cystitis", "Mnemonic" : "12"},
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX PYELONEPHRITIS", "DisplayText" : "Pyelonephritis", "Text" : "Pyelonephritis", "Mnemonic" : "14"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU ABX UNCOMP CYSTITIS", "DisplayText" : "Uncomplicated Cystitis", "Text" : "Uncomplicated cystitis", "Mnemonic" : "16"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX ACUTE BACT PROSTATITIS", "DisplayText" : "Acute Bacterial Prostatitis", "Text" : "Acute bacterial prostatitis", "Mnemonic" : "18"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX BALANITIS", "DisplayText" : "Balanitis and Balanoposthitis", "Text" : "Balanitis and Balanoposthitis", "Mnemonic" : "20"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX CHRONIC BACT PROSTATITIS", "DisplayText" : "Chronic bacterial prostatitis", "Text" : "Chronic bacterial prostatitis", "Mnemonic" : "22"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX CHRON PROS/PELVIC PAIN SYN", "DisplayText" : "Chronic protatitis/Chronic pelvic pain syndrome", "Text" : "Chronic prostatitis/Chronic pelvic pain syndrome", "Mnemonic" : "24"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID2 GMENU ABX EPIDIDYMITIS", "DisplayText" : "Epididymitis", "Text" : "Epididymitis and Epididymo-Orchitis", "Mnemonic" : "26"},
{"Row" : 20, "Column" : 1, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Urethritis", "Mnemonic" : "28"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU ABX VAGINITIS", "DisplayText" : "Bacterial Vaginosis", "Text" : "Bacterial vaginosis", "Mnemonic" : "30"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU ABX CANDIDA VULVO-VAGINITIS", "DisplayText" : "Candida Vulvo-Vaginitis", "Text" : "Candida vulvovaginitis", "Mnemonic" : "32"},
{"Row" : 25, "Column" : 1, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Cervicitis", "Mnemonic" : "34"},
{"Row" : 26, "Column" : 1, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Pelvic Inflammatory Disease (PID)", "Mnemonic" : "36"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Trichomonas vaginitis", "Mnemonic" : "38"},
{"Row" : 3, "Column" : 1, "Text" : "++ GENITOURINARY ++", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Urinary tract infections", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "Male specific infections", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Female specific Infections", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Last updated July 2022", "Header" : 1}, 
{"Row" : 6, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Cervicitis", "Mnemonic" : "40"},
{"Row" : 8, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Epididymitis", "Mnemonic" : "42"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Genital Herpes", "Mnemonic" : "44"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Gonorrhea infection with/without Chlamydia", "Mnemonic" : "46"},
{"Row" : 11, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Human Immunodeficiency Virus (HIV)", "Mnemonic" : "48"},
{"Row" : 12, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Pelvic Inflammatory Disease (PID)", "Mnemonic" : "50"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Syphilis", "Mnemonic" : "52"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Trichomonas Vaginitis", "Mnemonic" : "54"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID2 GMENU ABX SEXUALLY TRANSMITTED INFECTION", "DisplayText" : "Sexually Transmitted Infections", "Text" : "Urethritis", "Mnemonic" : "56"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU NECROTIZING INFECTIONS", "DisplayText" : "Necrotizing infections", "Text" : "Necrotizing infection", "Mnemonic" : "58"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU SURG SURGICAL SITE INFECT", "DisplayText" : "Surgical Site Infection", "Text" : "Surgical site infection", "Mnemonic" : "60"},
{"Row" : 5, "Column" : 2, "Text" : "Sexually Transmitted Infections (STI)", "Header" : 1}, 
{"Row" : 7, "Column" : 2, "Text" : "Chlamydia (See Cervicitis or Urethritis)"}, 
{"Row" : 17, "Column" : 2, "Text" : "Necrotizing Infection (including Fournier gangrene)", "Header" : 1}, 
{"Row" : 20, "Column" : 2, "Text" : "Surgical Site Infection", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX GI EUS-FNA ENDO PROCED", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 13, "Column" : 1, "Item" : "PSJZID LEVOFLOXACIN 500MG PO QDAY 4DAYS PROCEDURE", "DisplayText" : "Levofloxacin 500 mg po qday for 4 days starting 60min before proce", "Text" : "Levofloxacin 500 mg PO q24h for 4 days, beginning 60 minutes before", "Mnemonic" : "4"},
{"Row" : 16, "Column" : 1, "Item" : "PSOZID LEVOFLOXACIN 500MG PO ONCE THEN QDAY 3DAYS", "DisplayText" : "Levofloxacin 500 mg PO q24h for 4 days", "Text" : "Levofloxacin 500 mg PO q24h for 4 days, beginning 60 minutes before", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "Antibiotic Prophylaxis for GI Endoscopic Ultrasound FNA Procedures", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "The purpose of antibiotic prophylaxis during GI endoscopy is to reduce the"}, 
{"Row" : 6, "Column" : 1, "Text" : "risk of iatrogenic infectious complications."}, 
{"Row" : 8, "Column" : 1, "Text" : "Cystic lesions along GI tract including mediastinum:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Antibiotic prophylaxis is recommended before a FNA for cystic lesions along"}, 
{"Row" : 10, "Column" : 1, "Text" : "the GI tract to prevent cyst infection."}, 
{"Row" : 11, "Column" : 1, "Text" : "Recommendation:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "INPATIENT:", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : "endoscopic procedure ($) [R,DI]"}, 
{"Row" : 15, "Column" : 1, "Text" : "OUTPATIENT:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "endoscopic procedure ($) [R,DI]"}, 
{"Row" : 19, "Column" : 1, "Text" : "Solid Lesions along the upper or lower GI tract:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Antibiotic prophylaxis is not recommended before a diagnostic EUS or EUS-FNA"}, 
{"Row" : 21, "Column" : 1, "Text" : "of solid lesions along the upper or lower GI tract."}, 
{"Row" : 23, "Column" : 1, "Text" : "References:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Up-to-Date website"}, 
{"Row" : 25, "Column" : 1, "Text" : "Guideline: Antibiotic prophylaxis for GI endoscopy, Gastrointestinal"}, 
{"Row" : 26, "Column" : 1, "Text" : "Endoscopy 2008, 67:791-795"}
]},
{"Name" : "ORZID2 GMENU ABX GI PEG TUBE PLACEMENT", "DisplayText" : "GI PEG TUBE PLACEMENT ", "Version" : "StCloud", "Contents" : [
{"Row" : 8, "Column" : 1, "Text" : "Antibiotic Prophylaxis for Placement of Percutaneous Gastrostomy (PEG) Tube", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "Antibiotics are recommended for all patients prior to placement of PEG tube"}, 
{"Row" : 11, "Column" : 1, "Text" : "to reduce the risk of peristomal wound infection."}, 
{"Row" : 13, "Column" : 1, "Text" : "Preferred Prophylaxis:", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Item" : "PSJIZID CEFAZOLIN 2GM IV ONCE", "DisplayText" : "Cefazolin 2gm iv once", "Text" : "Cefazolin 2 gm IV over 30 minutes beginning 60 minutes before incision", "Mnemonic" : "10"},
{"Row" : 15, "Column" : 1, "Text" : "($1.72/day) [R]"}, 
{"Row" : 17, "Column" : 1, "Text" : "Alternative for patient with severe penicillin allergy:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID CLINDAMY 900MG IV ONCE '30MIN-60MIN'", "DisplayText" : "Clindamycin 900mg iv once", "Text" : "Clindamycin 600 mg IV over 30 minutes beginning 60 minutes", "Mnemonic" : "12"},
{"Row" : 19, "Column" : 1, "Text" : "before incision. ($5.51/day) [H,O]"}, 
{"Row" : 21, "Column" : 1, "Text" : "References:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Up-to-Date website"}, 
{"Row" : 23, "Column" : 1, "Text" : "Guideline: Antibiotic prophylaxis for GI endoscopy, Gastrointestinal"}, 
{"Row" : 24, "Column" : 1, "Text" : "Endoscopy 2008, 67:791-795"}, 
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZID2 GMENU ABX HELP PAGE", "DisplayText" : "Help page...", "Text" : "Help page (instructions, restrictions, microbiology, etc.)", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG INFO PAGE", "DisplayText" : "Important Drug Properties Page", "Text" : "Click for drug information. ([R]=renal excretion, [H]=hepatic excretion,", "Mnemonic" : "04"}, 
{"Row" : 4, "Column" : 1, "Text" : "[DI]=important drug interactions, [O]=other, [M]= minimal risk)"}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID GMENU ABX GENRL ALTERNATIVE DRUG", "DisplayText" : "Alternative Drug Needed?", "Text" : "Need an alternative antimicrobial?", "Mnemonic" : "06"},
{"Row" : 6, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "Consult Infectious Disease Minneapolis", "Mnemonic" : "08"}
]},
{"Name" : "ORZID2 GMENU ABX GIARDIA", "Term1" : "Giardia lamblia diarrhea", "DisplayText" : "Diarrhea with Giardia lamblia  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 21, "Column" : 1, "Item" : "PSJZID NITAZOXANIDE 500MG PO Q12H", "DisplayText" : "Nitazoxanide 500mg po q12h", "Text" : "Nitazoxanide 500 mg PO q12h for 3 days ($$$)[M]", "Mnemonic" : "4"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID METRONIDAZOLE 250 MG PO Q8H", "DisplayText" : "Metronidazole 250 mg PO q8h for 5 days($0.24/Day) [DI]", "Text" : "Metronidazole 250 mg PO q8h for 5 to 7 days ($) [DI]", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "DIARRHEA WITH GIARDIA DUODENALIS (ALSO KNOWN AS G. LAMBLIA AND G.INTESTINALIS)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Illness with Giardia is typically subacute but varies widely in its time course."}, 
{"Row" : 6, "Column" : 1, "Text" : "Treatment is necessary when the patient has symptomatic disease. Diarrhea,"}, 
{"Row" : 7, "Column" : 1, "Text" : "abdominal pain, bloating, belching, flatus, nausea, and vomiting are present"}, 
{"Row" : 8, "Column" : 1, "Text" : "acutely and after several days give way to flatus, loose stools, belching, and"}, 
{"Row" : 9, "Column" : 1, "Text" : "weight loss."}, 
{"Row" : 11, "Column" : 1, "Text" : "Asymptomatic carriage of Giardia is common in household contacts of people who"}, 
{"Row" : 12, "Column" : 1, "Text" : "are infected with Giardia. Treatment of asymptomatic patients can be considered"}, 
{"Row" : 13, "Column" : 1, "Text" : "if they have contact with immunocompromised or pregnant people or live or work"}, 
{"Row" : 14, "Column" : 1, "Text" : "in settings where there is risk of spreading infection to others (e.g., food"}, 
{"Row" : 15, "Column" : 1, "Text" : "handlers, daycare, nursing home)."}, 
{"Row" : 17, "Column" : 1, "Text" : "Primary treatment", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Hydration and electrolyte replacement"}, 
{"Row" : 20, "Column" : 1, "Text" : "Antimicrobial treatment", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 27, "Column" : 1, "Text" : "References:"}, 
{"Row" : 29, "Column" : 1, "Text" : "Minetti et al, BMJ, 2016, 355.i5369"}, 
{"Row" : 30, "Column" : 1, "Text" : "Sanford keyword: Giardia duodenalis (G. intestinalis, G. lamblia)"}, 
{"Row" : 31, "Column" : 1, "Text" : "Shane et al, Clinical Infectious Diseases 2017, 65(12):45-80"}, 
{"Row" : 32, "Column" : 1, "Text" : "Up-to-Date article: Giardiasis: Treatment and prevention"}
]},
{"Name" : "ORZID2 GMENU ABX GONOCOCCAL", "DisplayText" : "Gonococcal Urethritis ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 11, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 250MG IM ONCE AZITHROMYCIN 1GM PO ONCE", "DisplayText" : "Ceftriaxone 250 mg IM ONCE ($) [M] < AND > azithromycin 1 gm PO ONCE ($) [M]", "Text" : "Ceftriaxone 250 mg IM ONCE ($) [M] < AND > azithromycin 1 gm PO ONCE ($) [M]", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "GONOCOCCAL URETHRITIS OR CERVICITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Ceftriaxone is the drug of choice. Due to increasing fluoroquinolone"}, 
{"Row" : 6, "Column" : 1, "Text" : "resistance, fluoroquinolones are no longer recommended for the treatment of N."}, 
{"Row" : 7, "Column" : 1, "Text" : "gonorrhea. For patients who have severe allergies to cephalosporins, call"}, 
{"Row" : 8, "Column" : 1, "Text" : "Infectious Diseases."}, 
{"Row" : 10, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Alternative"}, 
{"Row" : 14, "Column" : 1, "Text" : "Consult Infectious Diseases (inpatient)"}, 
{"Row" : 17, "Column" : 1, "Text" : "References:"}, 
{"Row" : 19, "Column" : 1, "Text" : "CDC STD Treatment Guidelines: MMWR (2015) 64.3"}, 
{"Row" : 20, "Column" : 1, "Text" : "Mandell chapter: Urethritis"}, 
{"Row" : 21, "Column" : 1, "Text" : "Mandell chapter: Vulvovaginitis and Cervicitis"}, 
{"Row" : 22, "Column" : 1, "Text" : "Sanford keyword: Gonorrhea"}, 
{"Row" : 23, "Column" : 1, "Text" : "Up-To-Date article: Urethritis in men"}
]},
{"Name" : "ORZID2 GMENU ABX GONOCOCCAL NEW", "DisplayText" : "Gonococcal", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID3 GMENU ABX GENERAL INFORMATION OUTPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Opt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Op)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "Gonococcal Infections:", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "-When diagnosed with sexually transmitted disease, the patient's sexual"}, 
{"Row" : 5, "Column" : 1, "Text" : "partner(s) during the previous 60 days should be evaluated for sexually"}, 
{"Row" : 6, "Column" : 1, "Text" : "transmitted infection."}, 
{"Row" : 8, "Column" : 1, "Text" : "Uncomplicated gonococcal infections of the pharynx, cervix, urethra, or rectum:", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "-If chlamydial infection has not been excluded, recommend to treat for"}, 
{"Row" : 10, "Column" : 1, "Text" : "chlamydia."}, 
{"Row" : 11, "Column" : 1, "Text" : "-A test-of-cure is unnecessary for uncomplicated urogenital or rectal"}, 
{"Row" : 12, "Column" : 1, "Text" : "gonorrhea for patients treated with the recommended or alternative regimen"}, 
{"Row" : 13, "Column" : 1, "Text" : "-A test-of-cure is recommended for patients with pharyngeal gonorrhea."}, 
{"Row" : 14, "Column" : 1, "Text" : "Obtain nucleic acid amplification test (NAAT) 7 to 14 days after initial"}, 
{"Row" : 15, "Column" : 1, "Text" : "treatment, regardless of regimen used for pharyngeal gonorrhea."}, 
{"Row" : 17, "Column" : 1, "Text" : "Chlamydial infection and no co-infection:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Preferred treatment for patients and no chlamydial co-infection:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Patients weighing less than 300lbs:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Patients weighing 300lbs or greater:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Preferred treatment with chlamydial co-infection or chlamydial infection has", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "not been excluded:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Patients weighing less than 300lbs:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Patients weighing 300lbs or greater:", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Alternative treatment for beta-lactam allergy for cervix, urethra, or rectum:", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "For persons with a history of a beta-lactam allergy, a thorough assessment"}, 
{"Row" : 36, "Column" : 1, "Text" : "of the reaction is recommended."}, 
{"Row" : 39, "Column" : 1, "Text" : "Alternative treatment for beta-lactam allergy for pharynx:", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "No reliable alternative treatments are available for pharyngeal gonorrhea."}, 
{"Row" : 41, "Column" : 1, "Text" : "For persons with a history of a beta-lactam allergy, a thorough assessment"}, 
{"Row" : 42, "Column" : 1, "Text" : "of the reaction is recommended. For persons with an anaphylactic or other"}, 
{"Row" : 43, "Column" : 1, "Text" : "severe reaction to ceftriaxone, consult Infectious Disease for alternative"}, 
{"Row" : 44, "Column" : 1, "Text" : "treatment recommendation."}, 
{"Row" : 47, "Column" : 1, "Text" : "St. Cyr S, et al. MMWR Morb Mortal Wkly Rep 2020, 69:1911-1916."}, 
{"Row" : 46, "Column" : 1, "Text" : "References:"}, 
{"Row" : 32, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 1GM IMX1+DOXY 100MG BIDX7DAYS CHLAMY", "DisplayText" : "Ceftriaxone 1GM IM Once ($) [M] <AND> Doxycycline 100mg PO bid x7days ($)", "Mnemonic" : "14"},
{"Row" : 25, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 1 GM IM X1 GONOCOCCAL", "DisplayText" : "Ceftriaxone 1 GM IM x1 dose ($) [M]", "Text" : "Ceftriaxone 1 GM IM x1 dose ($) [M]", "Mnemonic" : "10"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU ABX CHLAMYDIA URETHRITIS", "DisplayText" : "Chlamydia Urethritis", "Text" : "[Click here] Chlamydial infection and no co-infection", "Mnemonic" : "06"},
{"Row" : 37, "Column" : 1, "Item" : "ORZ SET ABX OP GENTAMICIN 240MG IM X1 + AZITHROMYCIN 2GM PO X1", "DisplayText" : "Gentamicin 240 MG IM Once ($) [R] <AND> Azithromycin 2000 mg PO On", "Text" : "Gentamicin 240 MG IM Once ($) [R] <AND> Azithromycin 2000 mg PO Once ($) [DI]", "Mnemonic" : "16"},
{"Row" : 22, "Column" : 1, "Item" : "PSJIZID CEFTRIAXONE 500MG IM X1DOSE GONOCOCCAL", "DisplayText" : "Ceftriaxone 500 MG IM x1 dose ($) [M]", "Mnemonic" : "08"},
{"Row" : 30, "Column" : 1, "Item" : "ORZ SET ABX CEFTRIAXONE 500MG IMX1 +DOXY 100MG BIDX7D", "DisplayText" : "Ceftriaxone 500MG IM Once ($) [M] <AND> Doxycycline 100mg PO bid x7days($)", "Mnemonic" : "12"}
]},
{"Name" : "ORZID2 GMENU ABX HEAD AND NECK", "Term1" : "Ear, nose, throat (ENT)/Head and Neck section ", "Term2" : "Head and Neck/ENT section", "DisplayText" : "Head and Neck", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU MALIGNANT OTITIS EXTERNA", "DisplayText" : "Malignant Otitis Externa", "Text" : "Malignant Otitis Externa", "Mnemonic" : "4"},
{"Row" : 7, "Column" : 1, "Item" : "ORZID2 GMENU MASTOIDITIS", "DisplayText" : "Mastoiditis", "Text" : "Mastoiditis", "Mnemonic" : "6"},
{"Row" : 8, "Column" : 1, "Item" : "ORZID2 GMENU OTITIS EXTERNA", "DisplayText" : "Otitis Externa", "Text" : "Otitis Externa", "Mnemonic" : "8"},
{"Row" : 9, "Column" : 1, "Item" : "ORZID2 GMENU OTITIS MEDIA", "DisplayText" : "Otitis Media", "Text" : "Otitis Media", "Mnemonic" : "10"},
{"Row" : 12, "Column" : 1, "Item" : "ORZID2 GMENU CONJUNCTIVITIS", "DisplayText" : "Conjunctivitis", "Text" : "Conjunctivitis", "Mnemonic" : "12"},
{"Row" : 13, "Column" : 1, "Item" : "ORZID2 GMENU ENDOOPTHALMITIS", "DisplayText" : "Endophthalmitis", "Text" : "Endophthalmitis", "Mnemonic" : "14"},
{"Row" : 14, "Column" : 1, "Item" : "ORZID2 GMENU KERATITIS", "DisplayText" : "", "Text" : "Keratitis", "Mnemonic" : "16"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU PERIOCULAR INFECTIONS", "DisplayText" : "Periocular Infections", "Text" : "Periocular Infections", "Mnemonic" : "18"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU PROPHYLAXIS OPTH SURG", "DisplayText" : "Prophylaxis for ophthalmic surgery", "Text" : "Prophylaxis for Ophthalmic Surgery", "Mnemonic" : "20"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU RETINITIS", "DisplayText" : "Retinitis", "Text" : "Retinitis", "Mnemonic" : "22"},
{"Row" : 18, "Column" : 1, "Item" : "ORZID2 GMENU UVEITIS", "DisplayText" : "Uveitis", "Text" : "Uveitis", "Mnemonic" : "24"},
{"Row" : 21, "Column" : 1, "Item" : "ORZID2 GMENU ABX BELL'S PALSY", "DisplayText" : "Bell's Palsy", "Text" : "Bell's Palsy", "Mnemonic" : "26"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU PRESEPTAL CELLULITIS", "DisplayText" : "Preseptal Cellulitis", "Text" : "Pre-septal Cellulitis", "Mnemonic" : "28"},
{"Row" : 23, "Column" : 1, "Item" : "ORZID2 GMENU POSTSEPTAL CELLULITIS", "DisplayText" : "Postseptal Cellulitis", "Text" : "Post-septal Cellulitis (Orbital Cellulitis)", "Mnemonic" : "30"},
{"Row" : 3, "Column" : 1, "Text" : "++  HEAD AND NECK++", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Ear/Otologic", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Eye/Ophthalmologic", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Facial", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Section last reviewed June 2021", "Header" : 1}, 
{"Row" : 6, "Column" : 2, "Item" : "ORZID2 GMENU ACUTE SINUSITIS", "DisplayText" : "Acute Sinusitis--Mild to Moderate Disease", "Text" : "Acute Sinusitis", "Mnemonic" : "32"},
{"Row" : 7, "Column" : 2, "Item" : "ORZID2 GMENU CHRONIC SINUSITIS", "DisplayText" : "Chronic Sinusitis", "Text" : "Chronic Sinusitis", "Mnemonic" : "34"},
{"Row" : 8, "Column" : 2, "Item" : "ORZID2 GMENU FUNGAL SINUSITIS", "DisplayText" : "Fungal Sinusitis", "Text" : "Fungal Sinusitis", "Mnemonic" : "36"},
{"Row" : 9, "Column" : 2, "Item" : "ORZID2 GMENU ABX NASAL PACKING", "DisplayText" : "Nasal Packing (to prevent infection)", "Text" : "Nasal Packing (to prevent infection)", "Mnemonic" : "38"},
{"Row" : 10, "Column" : 2, "Item" : "ORZID2 GMENU NOSOCOMIAL SINUSITIS", "DisplayText" : "Nosocomial Sinusitis", "Text" : "Nosocomial Sinusitis", "Mnemonic" : "40"},
{"Row" : 13, "Column" : 2, "Item" : "ORZID2 GMENU DEEP OROPHAR INFECT", "DisplayText" : "Deep Oropharyngeal Infections", "Text" : "Deep Oropharyngeal Infections", "Mnemonic" : "42"},
{"Row" : 14, "Column" : 2, "Item" : "ORZID2 GMENU SUPP ODONTOGENIC INFECT", "DisplayText" : "Suppurative odontogenic infections", "Text" : "Dental Infections", "Mnemonic" : "44"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID2 GMENU ABX EPIGLOTTITIS", "DisplayText" : "Epiglottitis", "Text" : "Epiglottitis", "Mnemonic" : "46"},
{"Row" : 16, "Column" : 2, "Item" : "ORZID2 GMENU ABX ESOPHAGITIS", "DisplayText" : "", "Text" : "Esophagitis", "Mnemonic" : "48"},
{"Row" : 17, "Column" : 2, "Item" : "ORZID2 GMENU ABX LARYNGITIS AND CROUP", "DisplayText" : "Laryngitis and Croup", "Text" : "Laryngitis", "Mnemonic" : "50"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU ABX PAROTITIS", "DisplayText" : "Parotitis", "Text" : "Parotitis", "Mnemonic" : "52"},
{"Row" : 19, "Column" : 2, "Item" : "ORZID2 GMENU PERIODENTAL DISEASE", "DisplayText" : "Periodental disease", "Text" : "Periodontal Disease", "Mnemonic" : "54"},
{"Row" : 20, "Column" : 2, "Item" : "ORZID2 GMENU ABX PERTUSSIS", "DisplayText" : "Pertussis", "Text" : "Pertussis", "Mnemonic" : "56"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU ABX PHARYNGITIS", "DisplayText" : "Pharyngitis", "Text" : "Pharyngitis", "Mnemonic" : "58"},
{"Row" : 22, "Column" : 2, "Item" : "ORZID2 GMENU ABX THRUSH", "DisplayText" : "Thrush (Oropharyngeal and Esophageal Candidiasis)", "Text" : "Thrush", "Mnemonic" : "60"},
{"Row" : 23, "Column" : 2, "Item" : "ORZID2 GMENU ABX PHARYNGITIS", "DisplayText" : "Pharyngitis", "Text" : "Tonsillitis", "Mnemonic" : "62"},
{"Row" : 24, "Column" : 2, "Item" : "ORZID2 GMENU SUPP ODONTOGENIC INFECT", "DisplayText" : "Suppurative odontogenic infections", "Text" : "Tooth Abscess and other Suppurative Odonotogenic Infections", "Mnemonic" : "64"},
{"Row" : 5, "Column" : 2, "Text" : "Nasal/Sinus", "Header" : 1}, 
{"Row" : 12, "Column" : 2, "Text" : "Throat/Oropharyngeal", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX HELP PAGE", "Term1" : "Help", "DisplayText" : "Help page... ", "Version" : "StCloud", "Contents" : [
{"Row" : 11, "Column" : 1, "Item" : "ORZID2 GMENU ABX HOW TO FIND ALT ABX", "DisplayText" : "How to find an alternative antimicrobial", "Text" : "[Click Here]", "Mnemonic" : "6"},
{"Row" : 14, "Column" : 1, "Item" : "ORZ GTX URL ANTIMICROBIAL FORMULARY", "DisplayText" : "Antimicrobial Formulary Hyperlink", "Text" : "Formulary", "Mnemonic" : "8"},
{"Row" : 15, "Column" : 1, "Item" : "ORZID2 GMENU ABX IMPORTANT DRUG PROPERTIES", "DisplayText" : "Important drug properties", "Text" : "Important drug properties", "Mnemonic" : "10"},
{"Row" : 16, "Column" : 1, "Item" : "ORZID3 GMENU PREGNANCY RISK INFO", "DisplayText" : "List of Antimicrobials with Pregnancy Risk Category", "Text" : "Pregnancy and lactation risk", "Mnemonic" : "12"},
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX SUSCEPTIBILITIES (ANTIBIOGRAM)", "DisplayText" : "Antimicrobial Susceptibilities (Antibiogram)", "Text" : "Susceptibilities (Antibiogram)", "Mnemonic" : "14"},
{"Row" : 18, "Column" : 1, "Item" : "ORZ GTX ABX URL RESOURCE QTC", "DisplayText" : "Resource QTC Prolongation for Drugs", "Text" : "QTc prolongation drug resource", "Mnemonic" : "16"},
{"Row" : 19, "Column" : 1, "Item" : "ORZID3 GMENU WARFARIN DRUG INTERACTIONS", "DisplayText" : "Warfarin Drug Interactions", "Text" : "Warfarin interactions", "Mnemonic" : "18"},
{"Row" : 22, "Column" : 1, "Item" : "ORZID2 GMENU ABX ADDITIONAL ASSISTANCE", "DisplayText" : "Additional assistance...", "Text" : "Additional assistance", "Mnemonic" : "20"},
{"Row" : 23, "Column" : 1, "Item" : "ORZ GTX URL ON-CALL SCHEDULE", "DisplayText" : "Minneapolis Clinical On-Call Schedule", "Text" : "Clinical on call schedule (ID)", "Mnemonic" : "22"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID2 GMENU CONTACT CDSS STAFF", "DisplayText" : "", "Text" : "Comments or suggestions", "Mnemonic" : "24"},
{"Row" : 27, "Column" : 1, "Item" : "ORZID2 GMENU ABX EXCLUSIONS", "DisplayText" : "Exclusions", "Text" : "[Click Here]", "Mnemonic" : "26"},
{"Row" : 2, "Column" : 1, "Text" : "CDSS HELP AND ADDITIONAL INFORMATION", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "Allergies", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Penicillin desensitization"}, 
{"Row" : 9, "Column" : 1, "Text" : "Alternative antimicrobials", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "When to use and how to find"}, 
{"Row" : 13, "Column" : 1, "Text" : "Antimicrobial information", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Contact Information", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Excluded diseases and syndromes", "Header" : 1}, 
{"Row" : 6, "Column" : 2, "Item" : "ORZID2 GMENU ABX HOME IV AT MPLS", "DisplayText" : "Home IV at the Minneapolis VAMC", "Text" : "[Click Here]", "Mnemonic" : "28"},
{"Row" : 11, "Column" : 2, "Item" : "ORZID2 GMENU ABX HOW TO USE CDSS", "DisplayText" : "How to use the CDSS", "Text" : "[Click Here]", "Mnemonic" : "30"},
{"Row" : 15, "Column" : 2, "Item" : "ORZID2 GMENU ABX INFECTION CTRL", "DisplayText" : "Infection Control", "Text" : "[Click Here]", "Mnemonic" : "32"},
{"Row" : 18, "Column" : 2, "Item" : "ORZID2 GMENU ABX ABX RESTRICTION POLICY", "DisplayText" : "Antimicrobial restriction policy", "Text" : "[Click Here]", "Mnemonic" : "34"},
{"Row" : 21, "Column" : 2, "Item" : "ORZID2 GMENU ABX ABOUT THE CDSS", "DisplayText" : "About the CDSS", "Text" : "About the CDSS", "Mnemonic" : "36"},
{"Row" : 22, "Column" : 2, "Item" : "ORZID2 GMENU ABX ACKNOWLEDGEMENTS", "DisplayText" : "Acknowledgements", "Text" : "Acknowledgements", "Mnemonic" : "38"},
{"Row" : 23, "Column" : 2, "Item" : "ORZID2 GMENU ABX NEW UPDATES", "DisplayText" : "New Updates Information", "Text" : "New updates information", "Mnemonic" : "40"},
{"Row" : 25, "Column" : 2, "Item" : "ORZ GTX URL LEXICOMP ONLINE", "DisplayText" : "Lexicomp Online", "Text" : "Lexicomp online", "Mnemonic" : "42"},
{"Row" : 26, "Column" : 2, "Item" : "ORZ GTX URL MANDELL", "DisplayText" : "Mandell Online", "Text" : "Mandell's online", "Mnemonic" : "44"},
{"Row" : 27, "Column" : 2, "Item" : "ORZ GTX URL UP TO DATE WEBSITE", "DisplayText" : "Up To Date Web Site", "Text" : "Up-to-date online", "Mnemonic" : "46"},
{"Row" : 28, "Column" : 2, "Item" : "ORZ GTX URL SANFORD", "DisplayText" : "Sanford Guide Web Site", "Text" : "Sanford Guide online", "Mnemonic" : "48"},
{"Row" : 5, "Column" : 2, "Text" : "Home IV Treatment Information", "Header" : 1}, 
{"Row" : 8, "Column" : 2, "Text" : "How to use the CDSS", "Header" : 1}, 
{"Row" : 9, "Column" : 2, "Text" : "Navigation, adjusting regimens, menu"}, 
{"Row" : 10, "Column" : 2, "Text" : "elements"}, 
{"Row" : 13, "Column" : 2, "Text" : "Infection Control", "Header" : 1}, 
{"Row" : 14, "Column" : 2, "Text" : "Contact info, links, precautions"}, 
{"Row" : 17, "Column" : 2, "Text" : "Restriction policy information", "Header" : 1}, 
{"Row" : 20, "Column" : 2, "Text" : "Other/additional resources", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Item" : "ORZID2 GMENU ABX BETA-LACTAM ALLERGY ASSESMENT", "DisplayText" : "Beta-lactam Allergy Assessment", "Text" : "Beta-lactam reaction assessment", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "ORZID2 GMENU ABX DRUG ALLERGIES", "DisplayText" : "Drug allergies", "Text" : "History, types, implications,", "Mnemonic" : "4"}
]},
{"Name" : "ORZID2 GMENU ABX HEPATITIS A", "Term1" : "Hepatitis A", "DisplayText" : "Hepatitis A  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "HEPATITIS A", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Disease Management", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Most acute disease is self-limited, and the virus does not cause chronic"}, 
{"Row" : 7, "Column" : 1, "Text" : "disease. No specific antiviral therapy is available."}, 
{"Row" : 9, "Column" : 1, "Text" : "Patients who appear to be developing fulminant hepatitis, including those with"}, 
{"Row" : 10, "Column" : 1, "Text" : "mental status changes should receive supportive treatment. Fulminant hepatitis"}, 
{"Row" : 11, "Column" : 1, "Text" : "is suggested by increased prothrombin time, cholestasis, ascites, decreased"}, 
{"Row" : 12, "Column" : 1, "Text" : "liver size, or decreasing serum albumin. Supportive treatment includes"}, 
{"Row" : 13, "Column" : 1, "Text" : "maintenance of fluid and electrolyte balance, monitoring and possible correction"}, 
{"Row" : 14, "Column" : 1, "Text" : "of coagulation defects, treatment of hepatic encephalopathy, and good nutrition"}, 
{"Row" : 15, "Column" : 1, "Text" : "with a low-protein diet."}, 
{"Row" : 17, "Column" : 1, "Text" : "Prevention for persons with continuing high risk of disease", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Vaccine should be offered to persons at high risk of hepatitis A infection: men"}, 
{"Row" : 19, "Column" : 1, "Text" : "who have sex with men, travelers to endemic areas likely to be exposed, illegal"}, 
{"Row" : 20, "Column" : 1, "Text" : "drug users, persons at occupational risk of disease, persons with chronic liver"}, 
{"Row" : 21, "Column" : 1, "Text" : "disease or clotting factor disorders."}, 
{"Row" : 23, "Column" : 1, "Text" : "Give Hepatitis A vaccine 1 ml IM x 2, separated by 6 to 12 months"}, 
{"Row" : 25, "Column" : 1, "Text" : "Prevention for persons with a specific, defined exposure", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Post-exposure prophylaxis should be offered to persons with substantial exposure"}, 
{"Row" : 27, "Column" : 1, "Text" : "to hepatitis A. Specifically, persons exposed to acute hepatitis through"}, 
{"Row" : 28, "Column" : 1, "Text" : "household or sexual contact, persons who attend or work in a day care center"}, 
{"Row" : 29, "Column" : 1, "Text" : "with a recent case, or employee or patron of a restaurant with a food handler"}, 
{"Row" : 30, "Column" : 1, "Text" : "with hepatitis. Post exposure prophylaxis must be given within 2 weeks of"}, 
{"Row" : 31, "Column" : 1, "Text" : "exposure. Vaccine can be given at the same time as immune-globulin."}, 
{"Row" : 33, "Column" : 1, "Text" : "Immune globulin 0.02 ml/kg IM x 1 <AND>"}, 
{"Row" : 34, "Column" : 1, "Text" : "Give Hepatitis A vaccine 1 ml IM x 2, separated by 6 to 12 months"}, 
{"Row" : 37, "Column" : 1, "Text" : "References:"}, 
{"Row" : 39, "Column" : 1, "Text" : "Mandell chapter: Acute viral hepatitis"}, 
{"Row" : 40, "Column" : 1, "Text" : "Sanford keyword: Hepatitis A, Acute, Treatment"}, 
{"Row" : 41, "Column" : 1, "Text" : "Up-to-date article: Hepatitis A virus infections: Treatment and prevention"}
]},
{"Name" : "ORZID2 GMENU ABX HEPATITIS B", "Term1" : "Hepatitis B", "DisplayText" : "Hepatitis B  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 24, "Column" : 1, "Item" : "ORZID3 GMENU ABX HEPB VACCINE INFORMATION PAGE", "DisplayText" : "Hepatitis B Vaccine Information Page", "Text" : "Hepatitis B Vaccine Information Page", "Mnemonic" : "4"},
{"Row" : 28, "Column" : 1, "Item" : "ORZID3 GMENU HEPATITIS B EVALUATION ANTI-CD20 ANTIBODY", "DisplayText" : "Hepatitis B Evaluation Anti-CD20 Antibody", "Text" : "Hepatitis B Evaluation", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "HEPATITIS B", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Acute disease management", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Most acute hepatitis B disease is mild and self-limited. Patients who appear to"}, 
{"Row" : 7, "Column" : 1, "Text" : "be developing fulminant hepatitis, including those with mental status changes"}, 
{"Row" : 8, "Column" : 1, "Text" : "should receive supportive treatment. Fulminant hepatitis is suggested by"}, 
{"Row" : 9, "Column" : 1, "Text" : "increased prothrombin time, cholestasis, ascites, decreased liver size, or"}, 
{"Row" : 10, "Column" : 1, "Text" : "decreasing serum albumin. Supportive treatment includes maintenance of fluid"}, 
{"Row" : 11, "Column" : 1, "Text" : "and electrolyte balance, monitoring and possible correction of coagulation"}, 
{"Row" : 12, "Column" : 1, "Text" : "defects, treatment of hepatic encephalopathy, and good nutrition with a low-"}, 
{"Row" : 13, "Column" : 1, "Text" : "protein diet. Antiviral therapy is not indicated. Gastroenterology consult"}, 
{"Row" : 14, "Column" : 1, "Text" : "encouraged."}, 
{"Row" : 16, "Column" : 1, "Text" : "Chronic disease management", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Antiviral therapy for chronic hepatitis B is a complicated, highly specialized"}, 
{"Row" : 18, "Column" : 1, "Text" : "task. Consult with gastroenterology and infectious diseases."}, 
{"Row" : 20, "Column" : 1, "Text" : "Prevention", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Vaccinate persons at high risk of disease including men who have sex with men,"}, 
{"Row" : 22, "Column" : 1, "Text" : "illegal drug users, and health care workers with substantial exposure to blood"}, 
{"Row" : 23, "Column" : 1, "Text" : "or body fluids."}, 
{"Row" : 26, "Column" : 1, "Text" : "Select below for Hepatitis B evaluation for patients receiving Anti-CD20", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Antibody Treatment", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "References:"}, 
{"Row" : 32, "Column" : 1, "Text" : "Mandell chapter: Acute viral hepatitis"}, 
{"Row" : 33, "Column" : 1, "Text" : "Mandell chapter: Chronic viral hepatitis"}, 
{"Row" : 34, "Column" : 1, "Text" : "Up-to-date article: Hepatitis B virus: Overview of management"}
]},
{"Name" : "ORZID2 GMENU ABX HEPATITIS C", "Term1" : "Hepatitis C", "DisplayText" : "Hepatitis C  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 3, "Column" : 1, "Text" : "HEPATITIS C", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Treatment of acute disease", "Header" : 1}, 
{"Row" : 6, "Column" : 1, "Text" : "Most acute disease is asymptomatic or mild. Patients with acute hepatitis C"}, 
{"Row" : 7, "Column" : 1, "Text" : "should be referred to the Hepatitis C clinic. Treatment may be indicated for"}, 
{"Row" : 8, "Column" : 1, "Text" : "disease that persists beyond 2 months"}, 
{"Row" : 10, "Column" : 1, "Text" : "Chronic disease treatment", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Antiviral therapy for chronic hepatitis C is a complicated, highly specialized"}, 
{"Row" : 12, "Column" : 1, "Text" : "task"}, 
{"Row" : 15, "Column" : 1, "Text" : "References:"}, 
{"Row" : 17, "Column" : 1, "Text" : "Mandell chapter: Acute viral hepatitis"}, 
{"Row" : 18, "Column" : 1, "Text" : "Mandell chapter: Chronic viral hepatitis"}, 
{"Row" : 19, "Column" : 1, "Text" : "Up-to-date article: Overview of the management of chronic hepatitis C virus"}, 
{"Row" : 20, "Column" : 1, "Text" : "infection"}
]},
{"Name" : "ORZID2 GMENU ABX HERPES KERATITIS", "Term1" : "Herpes keratitis", "DisplayText" : "Herpes Keratitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 25, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h for 7-10 days ($) [R]", "Mnemonic" : "4"},
{"Row" : 27, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 500MG PO BID", "DisplayText" : "Valacyclovir 500MG PO BID", "Text" : "Valacyclovir 500 mg PO q12h for 7-10 days ($) [R]", "Mnemonic" : "6"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 800MG PO 5X/D", "DisplayText" : "Acyclovir 800MG PO 5x/d", "Text" : "Acyclovir 800 mg PO 5x/day for 14-21 days ($) [R]", "Mnemonic" : "8"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q8H", "DisplayText" : "Valacyclovir 1gm po q8h", "Text" : "Valacyclovir 1 gm PO q8h for 14-21 days ($) [R]", "Mnemonic" : "10"},
{"Row" : 36, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO BID", "DisplayText" : "Acyclovir 400MG PO BID", "Text" : "Acyclovir 400 mg PO Q12h for 12 months ($) [R]", "Mnemonic" : "12"},
{"Row" : 38, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 500MG PO Q24H", "DisplayText" : "Valacyclovir 500MG PO Q24H", "Text" : "Valacyclovir 500 mg PO Q24h for 12 months ($) [R]", "Mnemonic" : "14"},
{"Row" : 3, "Column" : 1, "Text" : "HERPES KERATITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Ocular herpes infection can be caused by either HSV-1 or HSV-2. The majority of"}, 
{"Row" : 6, "Column" : 1, "Text" : "cases are caused by HSV-1. The recurrence rate of ocular herpes is 40% over a 5"}, 
{"Row" : 7, "Column" : 1, "Text" : "year period, less than that of oral or genital herpes. Ocular herpes is a"}, 
{"Row" : 8, "Column" : 1, "Text" : "major cause of blindness and typically presents as infection of the epithelium"}, 
{"Row" : 9, "Column" : 1, "Text" : "of the cornea but can also rarely involve the stroma and endothelium."}, 
{"Row" : 10, "Column" : 1, "Text" : "Ophthalmology consultation is recommended."}, 
{"Row" : 12, "Column" : 1, "Text" : "Involvement of the stroma or endothelium requires treatment with topical"}, 
{"Row" : 13, "Column" : 1, "Text" : "steroid and close monitoring. For these cases, start oral antiviral and consult"}, 
{"Row" : 14, "Column" : 1, "Text" : "ophthalmology for management."}, 
{"Row" : 16, "Column" : 1, "Text" : "Antiviral prophylaxis is recommended for patients with multiple recurrences,"}, 
{"Row" : 17, "Column" : 1, "Text" : "recurrent episodes with ulceration, recurrent inflammation with"}, 
{"Row" : 18, "Column" : 1, "Text" : "scar/vascularization approaching visual axis, patients who have had keratoplasty"}, 
{"Row" : 19, "Column" : 1, "Text" : "for HSV-related scarring/astigmatism, and patients who have had HSV keratitis"}, 
{"Row" : 20, "Column" : 1, "Text" : "while on immunosuppressive therapy. Post-surgical prophylaxis is not discussed"}, 
{"Row" : 21, "Column" : 1, "Text" : "here. Please consult ophthalmology for more information."}, 
{"Row" : 23, "Column" : 1, "Text" : "Treatment of acute infection", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Without epithelial ulceration"}, 
{"Row" : 26, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 29, "Column" : 1, "Text" : "Ulceration of epithelium (Geographic ulcer)"}, 
{"Row" : 31, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 34, "Column" : 1, "Text" : "Infection prophylaxis for prevention of recurrence", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Reassess need for prophylaxis every 12 months"}, 
{"Row" : 37, "Column" : 1, "Text" : "<OR>"}, 
{"Row" : 41, "Column" : 1, "Text" : "References:"}, 
{"Row" : 43, "Column" : 1, "Text" : "Baratz, Arch Ophthalmology, (2012) 130.1: 108-110"}, 
{"Row" : 44, "Column" : 1, "Text" : "Guess et al, The Ocular Surface, (2007) 5.3:240-250"}, 
{"Row" : 45, "Column" : 1, "Text" : "Wilhelmus, Cochrane Database of Systematic Reviews, (2015), 1:CD002898"}, 
{"Row" : 46, "Column" : 1, "Text" : "Miserocchi et al, Efficacy of Valacyclovir vs Acyclovir for the Prevention of"}, 
{"Row" : 47, "Column" : 1, "Text" : "Recurrent Herpes Simplex"}, 
{"Row" : 48, "Column" : 1, "Text" : "Virus Eye Disease: A Pilot Study, American Journal of Ophthalmology, 2007"}, 
{"Row" : 49, "Column" : 1, "Text" : "144:547-551"}, 
{"Row" : 50, "Column" : 1, "Text" : "White et al, Ocular Microbiology and Immunology Group and American Academy of"}, 
{"Row" : 51, "Column" : 1, "Text" : "Ophthalmology, (2014)"}
]},
{"Name" : "ORZID2 GMENU ABX HERPES SIMPLEX ESOPHAGITIS", "Term1" : "Herpes esophagitis", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 22, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO 5X/DAYS", "DisplayText" : "Acyclovir 400MG PO 5x/days", "Text" : "Acyclovir 400 mg PO 5x/day (Cost $) [R] < OR >", "Mnemonic" : "4"},
{"Row" : 24, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h (Cost $) [R]", "Mnemonic" : "6"},
{"Row" : 30, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO 5X/DAYS", "DisplayText" : "Acyclovir 400MG PO 5x/days", "Text" : "Acyclovir 400 mg PO 5x/day (Cost $) [R] < OR >", "Mnemonic" : "8"},
{"Row" : 32, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h (Cost $) [R]", "Mnemonic" : "10"},
{"Row" : 36, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 5 MG/KG IV Q8H", "DisplayText" : "Acyclovir 5 mg/kg IV Q8H", "Text" : "Acyclovir 5 mg/kg IV q8h (Cost $) [R]", "Mnemonic" : "12"},
{"Row" : 39, "Column" : 1, "Item" : "ORZID2 GMENU ABX REFERENCES", "DisplayText" : "References", "Text" : "References", "Mnemonic" : "14"},
{"Row" : 3, "Column" : 1, "Text" : "HERPES SIMPLEX ESOPHAGITIS"}, 
{"Row" : 5, "Column" : 1, "Text" : "HSV infection of the esophagus usually occurs in patients who are"}, 
{"Row" : 6, "Column" : 1, "Text" : "immunocompromised, typically solid organ and bone marrow transplant"}, 
{"Row" : 7, "Column" : 1, "Text" : "recipients.  In healthy patients HSV esophagitis occurs occasionally,"}, 
{"Row" : 8, "Column" : 1, "Text" : "usually in men under the age of 40."}, 
{"Row" : 10, "Column" : 1, "Text" : "Patients usually present with odynophagia and dysphagia.  Fever"}, 
{"Row" : 11, "Column" : 1, "Text" : "epigastric pain, nausea, vomiting, and heartburn are less frequent."}, 
{"Row" : 12, "Column" : 1, "Text" : "Some patients may have coexistent herpes labialis or oropharyngeal"}, 
{"Row" : 13, "Column" : 1, "Text" : "ulcers.  Diagnosis is usually established with an upper endoscopy."}, 
{"Row" : 14, "Column" : 1, "Text" : "Suggestive findings may also be seen during a barium swallow."}, 
{"Row" : 16, "Column" : 1, "Text" : "Immunocompetent patients", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Spontaneous resolution usually occurs in immunocompetent patients after"}, 
{"Row" : 18, "Column" : 1, "Text" : "one to two weeks. Patients may respond more quickly if treated with a"}, 
{"Row" : 19, "Column" : 1, "Text" : "short course of oral acyclovir."}, 
{"Row" : 20, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Treat for 7-10 days"}, 
{"Row" : 25, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Immunocompromised patients", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Treatment for mild to moderate disease", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Treat for 14-21 days"}, 
{"Row" : 34, "Column" : 1, "Text" : "Treatment for severe disease", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Treat for 7-14 days"}, 
{"Row" : 41, "Column" : 1, "Text" : "John Hopkin's Guides keyword: Herpes simplex virus"}, 
{"Row" : 42, "Column" : 1, "Text" : "Mandell chapter: Herpes simplex virus"}, 
{"Row" : 43, "Column" : 1, "Text" : "Sanford keyword: Herpes simplex"}, 
{"Row" : 44, "Column" : 1, "Text" : "Up-to-Date article: Herpes simplex virus infection of the esophagitis"}
]},
{"Name" : "ORZID2 GMENU ABX HERPES WHITLOW", "Term1" : "Cellulitis, herpes whitlow ", "Term2" : "Herpes whitlow (digit or hand cellulitis)", "DisplayText" : "Herpes Whitlow  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Select here for help, legend, consults, alternative antimicrobials and more (Ip)", "Mnemonic" : "2"},
{"Row" : 6, "Column" : 1, "Item" : "PSJZID ACYCLOVIR 400MG PO Q8H", "DisplayText" : "Acyclovir 400MG PO q8h", "Text" : "Acyclovir 400 mg PO q8h for 10 days ($) [R]", "Mnemonic" : "4"},
{"Row" : 9, "Column" : 1, "Item" : "PSJZID VALACYCLOVIR 1GM PO Q12H", "DisplayText" : "Valacyclovir 1GM PO q12h", "Text" : "Valacyclovir 1 gm PO q12h for 10 days ($) [R]", "Mnemonic" : "6"},
{"Row" : 3, "Column" : 1, "Text" : "HERPES WHITLOW (DIGIT OR HAND CELLULITIS)", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Treatment", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Alternative for easier compliance schedule", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "References:"}, 
{"Row" : 14, "Column" : 1, "Text" : "Mandell chapter: Herpes simplex virus"}, 
{"Row" : 15, "Column" : 1, "Text" : "Sanford keyword: Whitlow, herpetic"}
]},
{"Name" : "ORZID2 GMENU ABX HIV-AIDS", "Term1" : "HIV infection, general", "DisplayText" : "HIV-AIDS  ", "Version" : "StCloud", "Contents" : [
{"Row" : 13, "Column" : 1, "Item" : "GMRCTZ IFC MPLS INFECTIOUS DISEASE", "DisplayText" : "Mpls Infectious Disease", "Text" : "ID consult", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "HIV", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "HIV infection and AIDS are associated with several host defense defects. Cell-"}, 
{"Row" : 6, "Column" : 1, "Text" : "mediated immune defects render a patient more susceptible to opportunistic"}, 
{"Row" : 7, "Column" : 1, "Text" : "infections with pathogens like Pneumocystis jirovecii (formerly Pneumocystis"}, 
{"Row" : 8, "Column" : 1, "Text" : "carinii), Toxoplasma gondii, cytomegalovirus, mycobacterium-avium intracellulare"}, 
{"Row" : 9, "Column" : 1, "Text" : "complex, and Candida spp."}, 
{"Row" : 11, "Column" : 1, "Text" : "Contact ID or HIV (MRTC) service for assistance."}, 
{"Row" : 17, "Column" : 1, "Text" : "References:"}, 
{"Row" : 19, "Column" : 1, "Text" : "Rich RR, et al, eds. Clinical Immunology"}, 
{"Row" : 20, "Column" : 1, "Text" : "Roitt l, et al, eds. Immunology"}, 
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"}
]},
{"Name" : "ORZID2 GMENU ABX HOME IV AT MPLS", "Term1" : "Home IV therapy at MVAMC ", "Term2" : "Intravenous therapy at home, MVAMC", "DisplayText" : "Home IV at the Minneapolis VAMC", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "HOME IV AT THE MINNEAPOLIS VA"}, 
{"Row" : 5, "Column" : 1, "Text" : "Minneapolis VA provides home IV therapy contracts with commercial providers.  To"}, 
{"Row" : 6, "Column" : 1, "Text" : "order home IV antimicrobials:"}, 
{"Row" : 8, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 10, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "Step 1", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "An Infectious Disease staff physician must approve Outpatient IV antimicrobials"}, 
{"Row" : 17, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "___________________________________", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Step 2", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Item" : "PSOQ CBOC BOWEL PREP KIT", "DisplayText" : "Flex Sig Prep Kit", "Text" : "Home IV consult (or page 7253)", "Mnemonic" : "08"},
{"Row" : 13, "Column" : 1, "Text" : "in each case.  Call x4185, or call the operator on off-tours to contact the the"}, 
{"Row" : 14, "Column" : 1, "Text" : "ID staff member on-call.  If the ID service has been consulted, you must request"}, 
{"Row" : 15, "Column" : 1, "Text" : "Home IV approval and recommendations from the ID staff on-call."}, 
{"Row" : 21, "Column" : 1, "Text" : "Order a Home IV consult (menu option #41 under \"ECC and Rehab\" consults, or page"}, 
{"Row" : 22, "Column" : 1, "Text" : "7253).  Note:  Allow 24 hours for home IV service assessment, teaching, etc to"}, 
{"Row" : 23, "Column" : 1, "Text" : "occur."}
]},
{"Name" : "ORZID2 GMENU ABX HOW TO FIND ALT ABX", "DisplayText" : "How to find an alternative antimicrobial", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "HOW TO FIND AN ALTERNATIVE ANTIMICROBIAL WITHIN THE CDSS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "The CDSS has been developed locally with input from a broad, representative"}, 
{"Row" : 6, "Column" : 1, "Text" : "group of clinicians. All antimicrobial recommendations within the Antimicrobial"}, 
{"Row" : 7, "Column" : 1, "Text" : "CDSS are reviewed by a clinical pharmacist and an Infectious Diseases Medical"}, 
{"Row" : 8, "Column" : 1, "Text" : "Specialist. Recommendations provided are based on local susceptibility patterns,"}, 
{"Row" : 9, "Column" : 1, "Text" : "clinical evidence, local preferences, and national guidelines. In rare cases,"}, 
{"Row" : 10, "Column" : 1, "Text" : "the recommended antimicrobials and listed alternatives may not be preferred for"}, 
{"Row" : 11, "Column" : 1, "Text" : "the patient you are treating (e.g. isolate resistance, allergies, etc.). In"}, 
{"Row" : 12, "Column" : 1, "Text" : "these cases, a broader set of alternative antimicrobials may be ordered through"}, 
{"Row" : 13, "Column" : 1, "Text" : "the Antimicrobial CDSS. Like other antimicrobial orders in the CDSS,"}, 
{"Row" : 14, "Column" : 1, "Text" : "antimicrobials ordered through the Alternative Antimicrobials menu do on require"}, 
{"Row" : 15, "Column" : 1, "Text" : "a prior authorization or ID approval."}, 
{"Row" : 17, "Column" : 1, "Text" : "To access the Alternative Antimicrobials menu, navigate to the menu containing"}, 
{"Row" : 18, "Column" : 1, "Text" : "antimicrobial recommendations for the infectious disease you are treating. At"}, 
{"Row" : 19, "Column" : 1, "Text" : "the top of the menu, select the option Need an alternative antimicrobial"}, 
{"Row" : 20, "Column" : 1, "Text" : "(typically item #6). Select the reason an alternative antimicrobial is required,"}, 
{"Row" : 21, "Column" : 1, "Text" : "then the Alternative Antimicrobials menu will pop up."}, 
{"Row" : 23, "Column" : 1, "Text" : "The Alternative Antimicrobial menu contains antimicrobial regimens that have"}, 
{"Row" : 24, "Column" : 1, "Text" : "been deemed appropriate for use as alternatives to recommended antimicrobials by"}, 
{"Row" : 25, "Column" : 1, "Text" : "the Antimicrobial P&T Subcommittee. If the list does not contain the preferred"}, 
{"Row" : 26, "Column" : 1, "Text" : "antimicrobial, contact or consult Infectious Diseases."}, 
{"Row" : 28, "Column" : 1, "Text" : "The regimens provided in the Alternative Antimicrobial menu are not tailored for"}, 
{"Row" : 29, "Column" : 1, "Text" : "a specific infectious disease. The dose, frequency, and duration must be changed"}, 
{"Row" : 30, "Column" : 1, "Text" : "based on the infectious disease you are treating as well as for patient specific"}, 
{"Row" : 31, "Column" : 1, "Text" : "factors. The usage of alternative antimicrobials are monitored by the"}, 
{"Row" : 32, "Column" : 1, "Text" : "Antimicrobial CDSS team for appropriateness and to identify infectious diseases"}, 
{"Row" : 33, "Column" : 1, "Text" : "for addition to the system."}
]},
{"Name" : "ORZID2 GMENU ABX HOW TO USE CDSS", "DisplayText" : "How to use the CDSS", "Version" : "StCloud", "Contents" : [
{"Row" : 47, "Column" : 1, "Item" : "ORZID2 GMENU ABX DURATION OF ABX THERAPY", "DisplayText" : "Duration of antimicrobial therapy", "Text" : "More information on duration of antimicrobial therapy", "Mnemonic" : "2"},
{"Row" : 61, "Column" : 1, "Item" : "ORZID2 GMENU ABX ELEMENTS OF CDSS ADVICE PAGE", "DisplayText" : "Elements of a CDSS Advice Page", "Text" : "[Click Here]", "Mnemonic" : "4"},
{"Row" : 64, "Column" : 1, "Item" : "ORZID2 GMENU ABX ADJ EXIST ABX THERAPY", "DisplayText" : "Adjust existing antimicrobial therapy", "Text" : "Adjusting existing antimicrobial therapy", "Mnemonic" : "6"},
{"Row" : 67, "Column" : 1, "Item" : "ORZID2 GMENU ABX HOW TO FIND ALT ABX", "DisplayText" : "How to find an alternative antimicrobial", "Text" : "How to find an alternative antimicrobial within the CDSS", "Mnemonic" : "8"},
{"Row" : 3, "Column" : 1, "Text" : "HOW TO USE THE CDSS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "The CDSS has been designed to offer antimicrobial prescribing advice quickly and"}, 
{"Row" : 6, "Column" : 1, "Text" : "efficiently. Since inpatient and outpatient drugs are ordered differently, the"}, 
{"Row" : 7, "Column" : 1, "Text" : "CDSS has both and inpatient and outpatient versions for prescribing."}, 
{"Row" : 9, "Column" : 1, "Text" : "The Antimicrobial CDSS is located within CPRS. When CPRS is open, click on the"}, 
{"Row" : 10, "Column" : 1, "Text" : "Orders tab at the bottom left hand side of the CPRS window."}, 
{"Row" : 12, "Column" : 1, "Text" : "For inpatients", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "On the left-hand side of the Orders tab, click on the Medicine Inpt Orders."}, 
{"Row" : 16, "Column" : 1, "Text" : "now be open."}, 
{"Row" : 18, "Column" : 1, "Text" : "For outpatients", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "On the left-hand side of the Orders tab, click on the Medicine Outpt Orders."}, 
{"Row" : 22, "Column" : 1, "Text" : "now be open."}, 
{"Row" : 24, "Column" : 1, "Text" : "Navigating Within the CDSS", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "*Using the decision tree"}, 
{"Row" : 26, "Column" : 1, "Text" : "The main menu of the Antimicrobial CDSS contains links to categories of"}, 
{"Row" : 27, "Column" : 1, "Text" : "infectious diseases based on syndrome/organ system (e.g. cardiovascular,"}, 
{"Row" : 28, "Column" : 1, "Text" : "genitourinary, etc.), organisms (e.g. gram-positive bacteria, gram-negative"}, 
{"Row" : 29, "Column" : 1, "Text" : "bacteria, viruses, etc.) and other special cases. To navigate to specific"}, 
{"Row" : 30, "Column" : 1, "Text" : "infectious disease, select the category the infectious disease is associated"}, 
{"Row" : 31, "Column" : 1, "Text" : "with. Within the category menu, select the specific infectious disease sub-menu"}, 
{"Row" : 32, "Column" : 1, "Text" : "for recommendations, quick orders and pertinent resources (e.g., section-"}, 
{"Row" : 33, "Column" : 1, "Text" : "specific consults, important drug properties, CDSS system help resources, etc.)."}, 
{"Row" : 36, "Column" : 1, "Text" : "*Using the Index"}, 
{"Row" : 37, "Column" : 1, "Text" : "The Index is in the main menu at the top of the left-hand column under the"}, 
{"Row" : 38, "Column" : 1, "Text" : "header Index of Antimicrobial CDSS content. The Index contains an alphabetized"}, 
{"Row" : 39, "Column" : 1, "Text" : "list of Antimicrobial CDSS content. Find the infectious disease, organism or"}, 
{"Row" : 40, "Column" : 1, "Text" : "other topic you are looking for by scrolling down the list. When you locate the"}, 
{"Row" : 41, "Column" : 1, "Text" : "term you are looking for, click on it to be linked to the menu containing"}, 
{"Row" : 42, "Column" : 1, "Text" : "specific recommendations, quick orders and pertinent resources."}, 
{"Row" : 44, "Column" : 1, "Text" : "Quick Orders", "Header" : 1}, 
{"Row" : 45, "Column" : 1, "Text" : "Quick orders are preprogrammed with the usually recommended antimicrobial dose,"}, 
{"Row" : 46, "Column" : 1, "Text" : "frequency and solution for the specific infectious disease."}, 
{"Row" : 49, "Column" : 1, "Text" : "Quick orders are not tailored to specific patient factors such as renal"}, 
{"Row" : 50, "Column" : 1, "Text" : "insufficiency, comorbidities, contraindications, weight, allergies, etc. The"}, 
{"Row" : 51, "Column" : 1, "Text" : "provider must assess every patient closely for these factors and modify"}, 
{"Row" : 52, "Column" : 1, "Text" : "recommended antimicrobials if needed. To assist the provider, additional drug"}, 
{"Row" : 53, "Column" : 1, "Text" : "information is provided within specific infectious diseases recommendation menus"}, 
{"Row" : 54, "Column" : 1, "Text" : "and a link to more in depth information is provided at the top of these menus."}, 
{"Row" : 55, "Column" : 1, "Text" : "Alternatives to preferred antimicrobials quick orders are often provided in"}, 
{"Row" : 56, "Column" : 1, "Text" : "recommendations, a broader selection of alternative antimicrobials is provided"}, 
{"Row" : 57, "Column" : 1, "Text" : "in the Alternative Antimicrobial menu (see What if a Preferred Antimicrobial is"}, 
{"Row" : 58, "Column" : 1, "Text" : "not Provided in the Recommendations?)."}, 
{"Row" : 60, "Column" : 1, "Text" : "Elements of a CDSS Advice Page", "Header" : 1}, 
{"Row" : 63, "Column" : 1, "Text" : "If you need to modify existing therapy", "Header" : 1}, 
{"Row" : 66, "Column" : 1, "Text" : "If you need an alternative antimicrobial", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX HSV ENCEPHALITIS", "Term1" : "Encephalitis", "DisplayText" : "HSV Encephalitis", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Item" : "ORZID2 GMENU ABX GENERAL INFORMATION INPATIENT", "DisplayText" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Text" : "Help, legend, allergy info, consults, alternative antimicrobials and more (Inpt)", "Mnemonic" : "2"},
{"Row" : 18, "Column" : 1, "Item" : "PSJIZID ACYCLOVIR 10 MG/KG IV Q8H", "DisplayText" : "Acyclovir 10 mg/kg iv q8h", "Text" : "Acyclovir 10 mg/kg IV q8h ($$) [R,DI] for 14 to 20 days", "Mnemonic" : "4"},
{"Row" : 3, "Column" : 1, "Text" : "HERPES SIMPLEX ENCEPHALITIS", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "Herpes simplex virus (HSV) type 1 is the leading cause of sporadic fatal"}, 
{"Row" : 6, "Column" : 1, "Text" : "encephalitis worldwide and should be suspected in patients who have symptoms"}, 
{"Row" : 7, "Column" : 1, "Text" : "unexplained by other causes. Typical symptoms include acute alteration of"}, 
{"Row" : 8, "Column" : 1, "Text" : "consciousness for more than 24 hours, fever, new onset seizures and/or focal"}, 
{"Row" : 9, "Column" : 1, "Text" : "neurologic deficits. Patients taking natalizumab are at increased risk of HSV"}, 
{"Row" : 10, "Column" : 1, "Text" : "encephalitis. Early diagnosis and treatment are essential to achieve resolution"}, 
{"Row" : 11, "Column" : 1, "Text" : "of infection and symptoms. If diagnosis is not certain and there is little"}, 
{"Row" : 12, "Column" : 1, "Text" : "likelihood of herniation, obtain cerebrospinal fluid (CSF) sample for HSV"}, 
{"Row" : 13, "Column" : 1, "Text" : "polymerase chain reaction (PCR). MRI without contrast nearly always show"}, 
{"Row" : 14, "Column" : 1, "Text" : "abnormal signs in patients with HSV encephalitis. Neurology and Infectious"}, 
{"Row" : 15, "Column" : 1, "Text" : "disease consultations are strongly encouraged."}, 
{"Row" : 17, "Column" : 1, "Text" : "Treatment, Initiate Immediately When HSV Encephalitis is Suspected", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "_______________________________________________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "References:"}, 
{"Row" : 23, "Column" : 1, "Text" : "Rabinstein, Neurol Clin, 2017, 695-705"}, 
{"Row" : 24, "Column" : 1, "Text" : "Sanford keyword: Encephalitis"}, 
{"Row" : 25, "Column" : 1, "Text" : "Up-to-Date Article: Herpes simplex virus type 1 encephalitis"}
]},
{"Name" : "ORZID2 GMENU ABX IDP ACYCL IV", "DisplayText" : "Acyclovir IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Acyclovir IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "10 mg/kg IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Confusion, anxiety, somnolence, renal impairment (especially in patients who are"}, 
{"Row" : 27, "Column" : 1, "Text" : "inadequately hydrated), thrombotic thrombocytopenic purpura/hemolytic uremic"}, 
{"Row" : 28, "Column" : 1, "Text" : "syndrome (especially in immunocompromised patients)."}, 
{"Row" : 17, "Column" : 1, "Text" : "25-50Give usual dose q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-24Give usual dose q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10  Give 50% of usual dose q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis Give 50% of usual dose q24h"}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP ACYCLOVIR PO", "DisplayText" : "Acyclovir PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Acyclovir PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-800 mg PO TID to 5x/day"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Nausea, vomiting, and diarrhea."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-25  Give 50% of the usual dose"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 Give 33% of the usual dose"}, 
{"Row" : 19, "Column" : 1, "Text" : "HemodialysisGive 33% of the usual dose"}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP ALBENDAZOLE PO", "DisplayText" : "Albendazole PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Albendazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea, vomiting, headache, rare blood dyscrasias, rare hepatotoxicity, rare"}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMANTADINE PO", "DisplayText" : "Amantadine PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amantadine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients who are 65 years of age or older give 100 mg PO once daily."}, 
{"Row" : 17, "Column" : 1, "Text" : "Regardless of age:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "< 15200 mg every 7 days"}, 
{"Row" : 24, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Dizziness, hallucinations, nervousness, CNS stimulation, nausea, increased"}, 
{"Row" : 29, "Column" : 1, "Text" : "seizure risk in patients with a history of seizures."}, 
{"Row" : 22, "Column" : 1, "Text" : "Hemodialysis  200 mg every 7 days"}, 
{"Row" : 20, "Column" : 1, "Text" : "15-29 200 mg on first day then 100 every other day"}, 
{"Row" : 19, "Column" : 1, "Text" : "30-50 200 mg on day one, then 100 mg daily."}, 
{"Row" : 31, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMBISOME IV", "DisplayText" : "Ambisome IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ambisome IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "3 to 5 mg/kg q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "The dosing for ambisome and other lipid-associated amphotericin products are"}, 
{"Row" : 16, "Column" : 1, "Text" : "DIFFERENT than the dosing for conventional amphotericin B."}, 
{"Row" : 18, "Column" : 1, "Text" : "Dose in consultation with an infectious disease physician, according to response"}, 
{"Row" : 19, "Column" : 1, "Text" : "of infection and patient tolerance."}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Corticosteroids can potentiate hypokalemia caused by amphotericin products."}, 
{"Row" : 23, "Column" : 1, "Text" : "Potassium concentrations should be monitored during amphotericin therapy."}, 
{"Row" : 24, "Column" : 1, "Text" : "amphotericin and digoxin are used concurrently.  Potassium and digoxin"}, 
{"Row" : 25, "Column" : 1, "Text" : "concentrations should be monitored during amphotericin."}, 
{"Row" : 27, "Column" : 1, "Text" : "Azole antifungal agents and amphotericin have displayed antagonistic effects in"}, 
{"Row" : 28, "Column" : 1, "Text" : "vitro.  They should generally not be used concurrently except under the care of"}, 
{"Row" : 29, "Column" : 1, "Text" : "an infectious disease specialist."}, 
{"Row" : 31, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Infusion reactions, hypotension, renal failure, electrolyte abnormalities occur,"}, 
{"Row" : 33, "Column" : 1, "Text" : "but at a lower rate than with conventional amphotericin B.  Slowing the infusion"}, 
{"Row" : 34, "Column" : 1, "Text" : "rate may prevent some infusion reactions."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMIK DOSING TABLE", "DisplayText" : "Amikacin Dosing Table ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "ORZ GTX URL MICROMEDEX WEB SITE", "DisplayText" : "Micromedex Online", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "ORZ GTX URL UP TO DATE WEBSITE", "DisplayText" : "Up To Date Web Site", "Text" : "Up To Date Website", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amikacin Dosing Table", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 16, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 18, "Column" : 1, "Text" : "infection -  q24hrecommended recommended  established< 5"}, 
{"Row" : 19, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 20, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 21, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 11, "Column" : 1, "Text" : "IndicationDose for  Dose for Dose for  Desired Desired", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "creatininecreatinine  creatininepeak  trough", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "clearance clearance  clearance(mcg/ml) (mcg/ml)", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "negative15 mg/kg Not  Not Not"}, 
{"Row" : 14, "Column" : 1, "Text" : ">50 ml/min10-50 ml/min<10 ml/min", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 23, "Column" : 1, "Text" : "negative 7.5 mg/kg  2.3-5.3 1.5-2.3"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection -  q12h mg/kg mg/kg  20-30  < 2"}, 
{"Row" : 25, "Column" : 1, "Text" : "multiple q12-18hq24-48h"}, 
{"Row" : 26, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 27, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 28, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 29, "Column" : 1, "Text" : "tract 15 mg/kgNot  NotNot"}, 
{"Row" : 30, "Column" : 1, "Text" : "infection - q24h recommended recommended  established< 5"}, 
{"Row" : 31, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 32, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 33, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 34, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 35, "Column" : 1, "Text" : "tract7.5 mg/kg2.3-5.3 1.5-2.3"}, 
{"Row" : 36, "Column" : 1, "Text" : "infection -  q12hmg/kg mg/kg  15-20< 4"}, 
{"Row" : 37, "Column" : 1, "Text" : "multiple  q12-18h  q24-48h"}, 
{"Row" : 38, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 39, "Column" : 1, "Text" : "______________________________________________________________________________"}, 
{"Row" : 41, "Column" : 1, "Text" : "Pharmacy at MVAMC will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 42, "Column" : 1, "Text" : "Call a pharmacist at x3128 for more information."}, 
{"Row" : 44, "Column" : 1, "Text" : "Once daily dosing may be an option for many indications in patients with"}, 
{"Row" : 45, "Column" : 1, "Text" : "creatinine clearance of greater than 50 ml/min.  The dose is 15 mg/kg IV q24h."}, 
{"Row" : 46, "Column" : 1, "Text" : "Target trough concentrations are less than 6 mcg/ml.  Ideal peak concentrations"}, 
{"Row" : 47, "Column" : 1, "Text" : "are not established.  Order a trough concentration to be drawn prior to the 2nd"}, 
{"Row" : 48, "Column" : 1, "Text" : "dose."}, 
{"Row" : 50, "Column" : 1, "Text" : "Using multiple daily dose regimens, for a moderate to severe infection, doses"}, 
{"Row" : 51, "Column" : 1, "Text" : "should be calculated to achieve a peak concentration of 20-30 mcg/ml and a"}, 
{"Row" : 52, "Column" : 1, "Text" : "trough of 1-4 mcg/ml."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMIKACIN IV", "DisplayText" : "Amikacin IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amikacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "15-20 mg/kg QD or divided into 2 to 3 daily doses."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP AMIK DOSING TABLE", "DisplayText" : "Amikacin Dosing Table", "Text" : "Link to amikacin dosing table", "Mnemonic" : "08"},
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Potentiates the effects of neuromuscular blockers."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nephrotoxicity, ototoxicity, neuromuscular blockade."}, 
{"Row" : 24, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMOX/CLAV PO", "DisplayText" : "Amoxicillin-clavulanate PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amoxicillin-clavulanate PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "875-125 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Diarrhea, nausea/vomiting, rash, rare anaphylaxis."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-30  250-500 mg q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 250-500 mg q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis  250-500 mg q24h"}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMOXICILLIN PO", "DisplayText" : "Amoxicillin PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amoxicillin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500-1000 mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Rash, diarrhea, nausea/vomiting, rare anaphylaxis."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-30250-500 mg q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  250-500 mg q24h"}, 
{"Row" : 26, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMPHOTERICIN B IV", "DisplayText" : "Amphotericin B IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Amphotericin B IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "0.6 to 1 mg/kg q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose in consultation with an infectious disease physician, according to response"}, 
{"Row" : 16, "Column" : 1, "Text" : "of infection and patient tolerance."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Corticosteroids can potentiate hypokalemia caused by amphotericin products."}, 
{"Row" : 20, "Column" : 1, "Text" : "Potassium concentrations should be monitored during amphotericin therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Low potassium concentrations can contribute to digoxin toxicity when"}, 
{"Row" : 23, "Column" : 1, "Text" : "amphotericin and digoxin are used concurrently.  Potassium and digoxin"}, 
{"Row" : 24, "Column" : 1, "Text" : "concentrations should be monitored during amphotericin."}, 
{"Row" : 26, "Column" : 1, "Text" : "Azole antifungal agents and amphotericin have displayed antagonistic effects in"}, 
{"Row" : 27, "Column" : 1, "Text" : "vitro.  They should generally not be used concurrently except under the care of"}, 
{"Row" : 28, "Column" : 1, "Text" : "an infectious disease specialist."}, 
{"Row" : 30, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Infusion reactions, hypotension, renal failure, electrolyte abnormalities.  Pre-"}, 
{"Row" : 32, "Column" : 1, "Text" : "medication with acetaminophen 650 mg, hydrocortisone 25 mg, and diphenhydramine"}, 
{"Row" : 33, "Column" : 1, "Text" : "50 mg  and slowing the infusion rate may prevent some infusion reactions."}, 
{"Row" : 34, "Column" : 1, "Text" : "Sodium loading with 250 ml 0.9% NaCl reduces risk of nephrotoxicity."}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMPIC/SULBACT IV", "DisplayText" : "Ampicillin-sulbactam IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ampicillin-sulbactam IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1.5-3 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "15-291.5-3 gm q12h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Diarrhea, rash, rare anaphylaxis, pain at injection site."}, 
{"Row" : 18, "Column" : 1, "Text" : "5-14  1.5-3 gm q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis 1.5-3 gm q24h"}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AMPICILLIN IV", "DisplayText" : "Ampicillin IV", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ampicillin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q4-6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Rash, allergy, nausea, diarrhea, rare anaphylaxis, rare leukopenia, rare"}, 
{"Row" : 26, "Column" : 1, "Text" : "seizures."}, 
{"Row" : 17, "Column" : 1, "Text" : "10-50  1-2 gm q6h-q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 1-2 gm q12-24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis1-2 gm IV after each hemodialysis"}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP ATOVAQUONE PO", "DisplayText" : "Atovaquone PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Atovaquone PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "750 mg PO BID-QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Rifampin may decrease atovaquone levels.  Do not use these together."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Anxiety, asthenia, rash, liver transaminase elevations."}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AZITH IV", "DisplayText" : "Azithromycin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Azithromycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg IV once, then 250 mg IV QD for 4 days."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Fewer drug interactions than erythromycin and clarithromycin.  Monitor"}, 
{"Row" : 19, "Column" : 1, "Text" : "international normalized ratio (INR) frequently in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nausea, diarrhea, rare QT interval prolongation."}, 
{"Row" : 24, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AZITHROMYCIN PO", "DisplayText" : "Azithromycin PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Azithromycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg PO once, then 250 mg PO QD for 4 days"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Fewer drug interactions than erythromycin and clarithromycin.  Monitor"}, 
{"Row" : 19, "Column" : 1, "Text" : "international normalized ratio (INR) frequently in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nausea, diarrhea, rare QT interval prolongation."}, 
{"Row" : 24, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP AZTREONAM IV", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Aztreonam IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Give usual dose for the initial dose, then maintenance doses should be adjusted"}, 
{"Row" : 16, "Column" : 1, "Text" : "as follows:"}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "10-30  50% of usual dose q8h"}, 
{"Row" : 20, "Column" : 1, "Text" : "< 10 25% of usual dosage q8h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hemodialysis25% of usual dose q8h"}, 
{"Row" : 23, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Toxic epidermal necrosis, injection site reaction, rare anaphylaxis, rare"}, 
{"Row" : 28, "Column" : 1, "Text" : "neutropenia, rare hepatotoxicity."}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP BENZATHINE PENICILLIN IM", "DisplayText" : "Benzathine Penicillin IM ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "_____________________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Benzathine Penicillin (dose in million units) IM", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1.2 million units IM once"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Rash, rare anaphylaxis."}
]},
{"Name" : "ORZID2 GMENU ABX IDP CASPOFUNGIN IV", "DisplayText" : "Caspofungin IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Caspofungin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "70 mg IV on day 1, then 50 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with mild hepatic insufficiency (Child-Pugh score 5-6), no dosing"}, 
{"Row" : 16, "Column" : 1, "Text" : "adjustment is needed. For patients with moderate hepatic insufficiency (Child-"}, 
{"Row" : 17, "Column" : 1, "Text" : "Pugh score 7-9), decrease the maintenance dose to 35 mg QD. For patients with"}, 
{"Row" : 18, "Column" : 1, "Text" : "severe hepatic insufficiency (Child-Pugh score over 9), no dosing information is"}, 
{"Row" : 19, "Column" : 1, "Text" : "available.  Consult infectious diseases for advice."}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Caspofungin levels are decreased when caspofungin is used along with  enzyme"}, 
{"Row" : 23, "Column" : 1, "Text" : "inducers (such as rifampin, carbamazepine, efavirenz, nevirapine, dexamethasone,"}, 
{"Row" : 24, "Column" : 1, "Text" : "phenytoin).  In these cases, increase the maintenance dose of caspofungin to 70"}, 
{"Row" : 25, "Column" : 1, "Text" : "mg QD."}, 
{"Row" : 27, "Column" : 1, "Text" : "Caspofungin may decrease tacrolimus levels.  Monitor tacrolimus levels when the"}, 
{"Row" : 28, "Column" : 1, "Text" : "drugs are used concurrently, as tacrolimus dose adjustments may be necessary"}, 
{"Row" : 29, "Column" : 1, "Text" : "while the patient is taking caspofungin."}, 
{"Row" : 31, "Column" : 1, "Text" : "The risk of cyclosporine toxicity is increased in patients who are also on"}, 
{"Row" : 32, "Column" : 1, "Text" : "caspofungin.  Avoid this combination."}, 
{"Row" : 34, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Infusion reactions, rash, nausea/vomiting, hepatotoxicity."}, 
{"Row" : 37, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFAZOLIN IV", "DisplayText" : "Cefazolin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefazolin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:"}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-301-2 gm q12h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Slightly increased risk of bleeding with heparin, warfarin, or other"}, 
{"Row" : 23, "Column" : 1, "Text" : "anticoagulant."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Rash, rare anaphylaxis, rare blood dyscrasias."}, 
{"Row" : 18, "Column" : 1, "Text" : "<101-2 gm q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis 1-2 gm q24h"}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFEPIME IV", "DisplayText" : "Cefepime IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefepime IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-601-2 gm q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "11-291-2 gm q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Phlebitis, rash, rare anaphylaxis and at high doses, encephalopathy and"}, 
{"Row" : 25, "Column" : 1, "Text" : "seizures."}, 
{"Row" : 19, "Column" : 1, "Text" : "< 11  1 gm q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis, give 1 gm IV once, then 500 mg QD"}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFOTETAN IV", "DisplayText" : "Cefotetan IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefotetan IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-301-2 gm QD"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  1-2 gm every other day"}, 
{"Row" : 19, "Column" : 1, "Text" : "Hemodialysis  0.5 gm QD on days between dialysis AND"}, 
{"Row" : 20, "Column" : 1, "Text" : "1-2 gm pt on the day of dialysis"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Increased risk of bleeding with heparin, warfarin, or other anticoagulant."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Nausea/vomiting, elevated liver transaminase levels, rare anaphylaxis, rare"}, 
{"Row" : 27, "Column" : 1, "Text" : "bleeding, rare hemolytic anemia."}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFOXITIN IV", "DisplayText" : "Cefoxitin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefoxitin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-501-2 gm q8-12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-291-2 gm q12-24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "5-9 0.5-1 gm q12-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "< 5 0.5-1 gm q24-48h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hemodialysis 0.5-1 gm q24-48 h AND"}, 
{"Row" : 22, "Column" : 1, "Text" : "1-2 gm after hemodialysis"}, 
{"Row" : 24, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Injection site pain, diarrhea, rare anaphylaxis."}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTAZIDIME IV", "DisplayText" : "Ceftazidime IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftazidime IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-501-2 gm q12h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Phlebitis, rash, rare anaphylaxis, and at high doses, encephalopathy or"}, 
{"Row" : 27, "Column" : 1, "Text" : "seizures."}, 
{"Row" : 18, "Column" : 1, "Text" : "10-30 mL/min  1-2 gm q24h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10  1-2 gm q48-72h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis 1-2 gm q48-72h"}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTIZOXIME IV", "DisplayText" : "Ceftizoxime IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftizoxime IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "50-79500 mg-1.5 gm q8h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis 250-500 mg q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Fever, injection site pain, rare transient liver transaminase elevation,"}, 
{"Row" : 27, "Column" : 1, "Text" : "rare anaphylaxis."}, 
{"Row" : 18, "Column" : 1, "Text" : "5-49  250 mg-1 gm q12h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 5 250-500 mg q24h"}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTRIAX INTRAVENOUS", "DisplayText" : "Ceftriaxone IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftriaxone IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 gm IV q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Moderate increase in cyclosporine concentrations.  Monitor cyclosporine blood"}, 
{"Row" : 19, "Column" : 1, "Text" : "concentrations and the patient for signs of cyclosporine-related nephrotoxicity"}, 
{"Row" : 20, "Column" : 1, "Text" : "or neurotoxicity."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Rash, diarrhea, reversible gall bladder disease, transient increases in liver"}, 
{"Row" : 24, "Column" : 1, "Text" : "transaminases levels, rare anaphylaxis."}, 
{"Row" : 26, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFTRIAXONE IM", "DisplayText" : "Ceftriaxone IM  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ceftriaxone IM", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "125 mg IM once"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Moderate increase in cyclosporine concentrations.  Monitor cyclosporine blood"}, 
{"Row" : 19, "Column" : 1, "Text" : "concentrations and monitor the patient for signs of cyclosporine-related"}, 
{"Row" : 20, "Column" : 1, "Text" : "nephrotoxicity or neurotoxicity."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Rash, diarrhea, reversible gall bladder disease, transient increases in liver"}, 
{"Row" : 24, "Column" : 1, "Text" : "transaminase levels, rare anaphylaxis."}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEFUROXIME PO", "DisplayText" : "Cefuroxime PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cefuroxime PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with creatinine clearance less than 10 mL/min, including patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "on hemodialysis, give 250-500 mg q24h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Diarrhea, nausea/vomiting, rare anaphylaxis, rare transient liver transaminase"}, 
{"Row" : 23, "Column" : 1, "Text" : "elevation."}, 
{"Row" : 25, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CEPHALEXIN PO", "DisplayText" : "Cephalexin PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Cephalexin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-40250-500 mg q8-12h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare anaphylaxis, rare transient liver transaminase"}, 
{"Row" : 25, "Column" : 1, "Text" : "elevation."}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  250-500 mg q12h"}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CHLORAMPHENICOL IV", "DisplayText" : "Chloramphenicol IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Chloramphenicol IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "0.5-1 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Avoid use in patients with severe hepatic failure."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Phenobarbital and rifampin may decrease chloramphenicol concentrations."}, 
{"Row" : 20, "Column" : 1, "Text" : "May increase concentrations of warfarin and phenytoin, monitor international"}, 
{"Row" : 21, "Column" : 1, "Text" : "normalized ratio (INR) and phenytoin concentrations during chloramphenicol"}, 
{"Row" : 22, "Column" : 1, "Text" : "therapy."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Aplastic anemia, bone marrow suppression, Gray's syndrome, delerium."}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CIPROFLOXACIN PO", "DisplayText" : "Ciprofloxacin PO", "Version" : "StCloud", "Contents" : [
{"Row" : 3, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 4, "Column" : 1, "Text" : "Ciprofloxacin PO", "Header" : 1}, 
{"Row" : 5, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 7, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "250-500 mg q12h"}, 
{"Row" : 10, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Creatinine clearance (ml/min) Dose adjustment", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "< 30250 mg q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Hemodialysis  250-500 mg q24h"}, 
{"Row" : 16, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Hypoglycemia that can lead to coma especially in diabetics taking"}, 
{"Row" : 18, "Column" : 1, "Text" : "oral hypoglycemic medicine or insulin."}, 
{"Row" : 20, "Column" : 1, "Text" : "Calcium, dairy products, iron, zinc, magnesium, aluminum  inhibit the absorption"}, 
{"Row" : 21, "Column" : 1, "Text" : "of oral ciprofloxacin.  Give ciprofloxacin 2 hours before or 6 hours after these"}, 
{"Row" : 22, "Column" : 1, "Text" : "drugs."}, 
{"Row" : 24, "Column" : 1, "Text" : "Increases effects of caffeine and theophylline by inhibiting  metabolism."}, 
{"Row" : 25, "Column" : 1, "Text" : "Monitor the patient for signs of agitation or anxiety."}, 
{"Row" : 27, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 28, "Column" : 1, "Text" : "ratio (INR) frequently in patients taking warfarin."}, 
{"Row" : 30, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "FDA Drug Safety Communication", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "The U.S. Food and Drug Administration advised that the serious"}, 
{"Row" : 33, "Column" : 1, "Text" : "side effects associated with fluoroquinolone antibacterial drugs"}, 
{"Row" : 34, "Column" : 1, "Text" : "generally outweigh the benefits for patients with acute sinusitis, acute"}, 
{"Row" : 35, "Column" : 1, "Text" : "bronchitis, and uncomplicated urinary tract infections who have other"}, 
{"Row" : 36, "Column" : 1, "Text" : "treatment options. For patients with these conditions, fluoroquinolones should"}, 
{"Row" : 37, "Column" : 1, "Text" : "be reserved for those who do not have alternative treatment options."}, 
{"Row" : 39, "Column" : 1, "Text" : "An FDA safety review has shown that fluoroquinolones when used systemically"}, 
{"Row" : 40, "Column" : 1, "Text" : "are associated with disabling and potentially permanent serious side effects"}, 
{"Row" : 41, "Column" : 1, "Text" : "that can occur together. These side effects can involve the tendons,"}, 
{"Row" : 42, "Column" : 1, "Text" : "muscles, joints, nerves, and central nervous system."}, 
{"Row" : 44, "Column" : 1, "Text" : "FDA identified cases of hypoglycemic coma, resulting in death in some"}, 
{"Row" : 45, "Column" : 1, "Text" : "instances. Most pateints had risk factors for hypoglycemia such as older age,"}, 
{"Row" : 46, "Column" : 1, "Text" : "diabetes, renal insufficiency, and concomitant use of hypoglycemic drugs,"}, 
{"Row" : 47, "Column" : 1, "Text" : "especally sulfonylureas.  FDA also identified reports of additional mental"}, 
{"Row" : 48, "Column" : 1, "Text" : "health side effects, and requires that all fluoroquinolones include six"}, 
{"Row" : 49, "Column" : 1, "Text" : "psychiatric adverse reactions (disturbance in attention, memory impairment,"}, 
{"Row" : 50, "Column" : 1, "Text" : "delirium, nervousness, agitation and disorientation)."}, 
{"Row" : 52, "Column" : 1, "Text" : "Other adverse reactions:", "Header" : 1}, 
{"Row" : 53, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, dizziness, confusion, CNS"}, 
{"Row" : 54, "Column" : 1, "Text" : "stimulation, rare seizures, rare QT interval prolongation, and"}, 
{"Row" : 55, "Column" : 1, "Text" : "tendinitis/tendon rupture. Six psychiatric adverse reactions"}, 
{"Row" : 56, "Column" : 1, "Text" : "including disturbance in attention, memory impairment, delirium,"}, 
{"Row" : 57, "Column" : 1, "Text" : "nervousness, agitation and disorientation."}, 
{"Row" : 58, "Column" : 1, "Text" : "Hypoglycemia that can lead to coma, occuring more frequently in"}, 
{"Row" : 59, "Column" : 1, "Text" : "the elderly and those with diabetes."}, 
{"Row" : 61, "Column" : 1, "Text" : "Pregnancy Risk Factor Category: C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CLARITHROMYCIN PO", "DisplayText" : "Clarithromycin PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clarithromycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500mg PO q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with CrCl less than 30 ml/min, cut dose in half or increase dosing"}, 
{"Row" : 16, "Column" : 1, "Text" : "interval to q24h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Increases the levels of many drugs.  Some that are especially clinically"}, 
{"Row" : 20, "Column" : 1, "Text" : "significant include warfarin, statins, sildenafil, calcium channel blockers."}, 
{"Row" : 21, "Column" : 1, "Text" : "Consult Micromedex, Up-to-date, and/or a pharmacist for more information."}, 
{"Row" : 23, "Column" : 1, "Text" : "May prolong the QT interval, especially when combined with CYP 3A4 substrates or"}, 
{"Row" : 24, "Column" : 1, "Text" : "inhibitors, or other pro-arrhythmic agents.  Avoid concurrent use, if possible."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare hepatotoxicity, and rare QT interval"}, 
{"Row" : 28, "Column" : 1, "Text" : "prolongation."}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CLINDAMYCIN PO", "DisplayText" : "Clindamycin PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clindamycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "300 mg PO q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with hepatic failure, give 300 mg q8h."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, pseudomembranous colitis, rare jaundice."}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP CLOTRIMAZOLE TOPICAL", "DisplayText" : "Clotrimazole Topical  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clotrimazole topical", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Apply to affected area topically QID."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP DAPTOMYCIN IV", "DisplayText" : "Daptomycin IV", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Daptomycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "4 mg/kg IV q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with creatinine clearance less than 30 mL/min, including patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "on hemodialysis, give 4 mg/kg IV q48h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Temporarily discontinue HMG-CoA reductase inhibitors (\"statins\") during"}, 
{"Row" : 20, "Column" : 1, "Text" : "daptomycin therapy, due to risk of rhabdomyolysis."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Myalgias, rhabdomyolysis, injection site reaction, renal failure, elevated liver"}, 
{"Row" : 24, "Column" : 1, "Text" : "transaminase levels."}, 
{"Row" : 26, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP DICLOXACILLIN PO", "DisplayText" : "Dicloxacillin PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Dicloxacillin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Induces warfarin metabolism, decreasing the effect of warfarin.  When these"}, 
{"Row" : 19, "Column" : 1, "Text" : "drugs are used together, monitor international normalized ratio (INR) frequently"}, 
{"Row" : 20, "Column" : 1, "Text" : "and for several weeks after dicloxacillin therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Diarrhea, nausea/vomiting, rash, rare anaphylaxis."}, 
{"Row" : 25, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP DOSING TABLE GENTAMICIN", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gentamicin Dosing Table", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "IndicationDose for  Dose for Dose for  Desired Desired", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "creatinine creatinine  creatinine  peaktrough", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "clearance  clearance clearance  (mcg/ml)  (mcg/ml)", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : ">50 ml/min10-50 ml/min<10 ml/min", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 17, "Column" : 1, "Text" : "negative 5 mg/kg  NotNot Not"}, 
{"Row" : 18, "Column" : 1, "Text" : "infection - q24hrecommended recommended established<1.5"}, 
{"Row" : 19, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 20, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 21, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 23, "Column" : 1, "Text" : "negative 2 mg/kg load,0.3-0.5"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection - then 1.7 0.5-1.2mg/kg6-8  <2"}, 
{"Row" : 25, "Column" : 1, "Text" : "multiple mg/kg q8h mg/kg q12h  q24-48h"}, 
{"Row" : 26, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 27, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 29, "Column" : 1, "Text" : "tract  5 mg/kg  NotNot Not"}, 
{"Row" : 30, "Column" : 1, "Text" : "infection - q24hrecommended recommended established<1.5"}, 
{"Row" : 31, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 32, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 33, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 35, "Column" : 1, "Text" : "tract1.5 mg/kg0.5-1  0.3-0.5"}, 
{"Row" : 36, "Column" : 1, "Text" : "infection -q8hmg/kg q12h  mg/kg4-6  <2"}, 
{"Row" : 37, "Column" : 1, "Text" : "multiple  q24-48h"}, 
{"Row" : 38, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 39, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Synergy *  1 mg/kg  0.5 mg/kg0.5 mg/kg 3-4<2"}, 
{"Row" : 41, "Column" : 1, "Text" : "q8hq12-24h  q24-72h"}, 
{"Row" : 42, "Column" : 1, "Text" : "______________________________________________________________________________", "Header" : 1}, 
{"Row" : 44, "Column" : 1, "Text" : "* Gentamicin is used for synergy in severe staphylococcus aureus infections, and"}, 
{"Row" : 45, "Column" : 1, "Text" : "streptococcal and enterococcal endocarditis.  Use multiple daily dosing for"}, 
{"Row" : 46, "Column" : 1, "Text" : "enterococcal and staphylococcal endocarditis."}, 
{"Row" : 48, "Column" : 1, "Text" : "Pharmacy (x3128) will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 50, "Column" : 1, "Text" : "Once daily dosing may be an option for many indications in patients with a"}, 
{"Row" : 51, "Column" : 1, "Text" : "creatinine clearance greater than 50 ml/min.  The dose is 5 mg/kg q24h.  Target"}, 
{"Row" : 52, "Column" : 1, "Text" : "trough concentrations are less than 1.5 mcg/ml.  Ideal peak concentrations are"}, 
{"Row" : 53, "Column" : 1, "Text" : "not established.  Order a trough concentration to be drawn prior to the second"}, 
{"Row" : 54, "Column" : 1, "Text" : "dose."}
]},
{"Name" : "ORZID2 GMENU ABX IDP DOXYCYCLINE PO", "DisplayText" : "Doxycycline PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Doxycycline PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Enzyme inducers such as phenytoin, phenobarbital, and carbamazepine decrease"}, 
{"Row" : 19, "Column" : 1, "Text" : "levels of doxycycline.  Consider doubling the doxycycline dose or choosing an"}, 
{"Row" : 20, "Column" : 1, "Text" : "alternative agent."}, 
{"Row" : 22, "Column" : 1, "Text" : "Iron salts, calcium, and other antacids reduce PO absorption of doxycycline.  If"}, 
{"Row" : 23, "Column" : 1, "Text" : "iron must be used at the same time as doxycycline, give doxycycline 2 hours"}, 
{"Row" : 24, "Column" : 1, "Text" : "before or 4 hours after the iron dose."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash, nausea/vomiting."}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP DS TOBRAMYCIN", "DisplayText" : "Tobramycin Dosing Table  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Tobramycin Dosing table", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "IndicationDose for  Dose for Dose for  Desired Desired", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "creatinine creatinine creatinine  peak  trough", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "clearance clearanceclearance (mcg/ml)(mcg/ml)", "Header" : 1}, 
{"Row" : 14, "Column" : 1, "Text" : ">50 ml/min10-50 ml/min<10 ml/min", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 17, "Column" : 1, "Text" : "negative  5 mg/kgNotNotNot"}, 
{"Row" : 18, "Column" : 1, "Text" : "infection -  q24hrecommended recommended  established  <1.5"}, 
{"Row" : 19, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 20, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 21, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Gram"}, 
{"Row" : 23, "Column" : 1, "Text" : "negative  2 mg/kg load, 0.3-0.5"}, 
{"Row" : 24, "Column" : 1, "Text" : "infection -  then 1.7 0.5-1.2  mg/kg6-8<2"}, 
{"Row" : 25, "Column" : 1, "Text" : "multiple  mg/kg q8hmg/kg q12hq24-48h"}, 
{"Row" : 26, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 27, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 29, "Column" : 1, "Text" : "tract  5 mg/kgNot Not  Not"}, 
{"Row" : 30, "Column" : 1, "Text" : "infection -  q24hrecommended recommendedestablished <1.5"}, 
{"Row" : 31, "Column" : 1, "Text" : "once daily"}, 
{"Row" : 32, "Column" : 1, "Text" : "dosing"}, 
{"Row" : 33, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Urinary"}, 
{"Row" : 35, "Column" : 1, "Text" : "tract  1.5 mg/kg 0.5-1 0.3-0.5"}, 
{"Row" : 36, "Column" : 1, "Text" : "infection -  q8h mg/kg q12hmg/kg  4-6 <2"}, 
{"Row" : 37, "Column" : 1, "Text" : "multiple  q24-48h"}, 
{"Row" : 38, "Column" : 1, "Text" : "daily dosing"}, 
{"Row" : 39, "Column" : 1, "Text" : "_________________________________________________________________", "Header" : 1}, 
{"Row" : 40, "Column" : 1, "Text" : "Pharmacy (x3128) will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 42, "Column" : 1, "Text" : "Once daily dosing may be an option for many indications in patients with a"}, 
{"Row" : 43, "Column" : 1, "Text" : "creatinine clearance greater than 50 ml/min.  The dose is 5 mg/kg q24h.  Target"}, 
{"Row" : 44, "Column" : 1, "Text" : "trough concentrations are less than 1.5 mcg/ml.  Ideal peak concentrations are"}, 
{"Row" : 45, "Column" : 1, "Text" : "not established.  Order a trough concentration to be drawn prior to the second"}, 
{"Row" : 46, "Column" : 1, "Text" : "dose."}
]},
{"Name" : "ORZID2 GMENU ABX IDP ERTAPENEM IV", "DisplayText" : "Ertapenem IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ertapenem IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 gm IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with a creatinine clearance less than 30 mL/min, including patients"}, 
{"Row" : 16, "Column" : 1, "Text" : "on hemodialysis, give 500 mg/day."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Ertapenem may decrease valproic acid (Depakote) levels.Monitor valproic acid"}, 
{"Row" : 20, "Column" : 1, "Text" : "levels during ertapenem therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Infusion site reactions, confusion, and nausea/vomiting.  Seizures are less"}, 
{"Row" : 24, "Column" : 1, "Text" : "common with ertapenem than with other carbapenems.  Ertapenem can be used with"}, 
{"Row" : 25, "Column" : 1, "Text" : "caution in patients with histories of seizure disorder."}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP ERYTHROMYCIN PO", "DisplayText" : "Erythromycin PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Erythromycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Erythromycin increases the levels of many drugs.  Some that are especially"}, 
{"Row" : 19, "Column" : 1, "Text" : "clinically significant include warfarin, statins, sildenafil, calcium channel"}, 
{"Row" : 20, "Column" : 1, "Text" : "blockers.  Consult Micromedex, Up-to-date, and/or a pharmacist for more"}, 
{"Row" : 21, "Column" : 1, "Text" : "information."}, 
{"Row" : 23, "Column" : 1, "Text" : "Erythromycin may prolong the QT interval, especially when combined with"}, 
{"Row" : 24, "Column" : 1, "Text" : "cytochrome p450 3A4 enzyme substrates or inhibitors, or other pro-arrhythmic"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents.  Avoid concurrent use, if possible."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare hepatotoxicity, rare interval prolongation."}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP ETHAMBUTOL PO", "DisplayText" : "Ethambutol PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ethambutol PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "15 mg/kg q24h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Creatinine clearance(ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Do not give within 4 hours of any aluminum containing products"}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Nausea/vomiting, hyperuricemia, mania, optic neuritis - requires vision"}, 
{"Row" : 24, "Column" : 1, "Text" : "monitoring, peripheral neuropathy, rare blood dyscrasias."}, 
{"Row" : 16, "Column" : 1, "Text" : "10-5015 mg/kg PO q36h"}, 
{"Row" : 17, "Column" : 1, "Text" : "<1015 mg/kg PO q48h"}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP FLUCONAZOLE PO", "DisplayText" : "Fluconazole PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Fluconazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with renal impairment, administer the usual loading dose, then"}, 
{"Row" : 16, "Column" : 1, "Text" : "adjust the maintenance dose according to renal function."}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "< 50 Give half the usual dose q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Fluconazole increases levels of several drugs, especially in higher doses."}, 
{"Row" : 24, "Column" : 1, "Text" : "Drugs whose effects are significantly increased by fluconazole include warfarin,"}, 
{"Row" : 25, "Column" : 1, "Text" : "HMG-CoA reductase inhibitors (\"statins\"), benzodiazepines, calcium channel"}, 
{"Row" : 26, "Column" : 1, "Text" : "blockers, cyclosporine, tacrolimus,sirolimus.  Consult Micromedex, Up-to-date,"}, 
{"Row" : 27, "Column" : 1, "Text" : "or a pharmacist for more information."}, 
{"Row" : 29, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Headache, nausea, rash, hepatotoxicity, rare QT interval prolongation."}, 
{"Row" : 20, "Column" : 1, "Text" : "HemodialysisGive usual dose after each dialysis"}, 
{"Row" : 32, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP FOSCARNET IV", "DisplayText" : "Foscarnet IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "_______________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Foscarnet IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "90 mg/kg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Adjust for renal function - must divide Cockroft-Gault derived creatinine"}, 
{"Row" : 17, "Column" : 1, "Text" : "clearance by patients weight.  Doses listed are for induction therapy only."}, 
{"Row" : 18, "Column" : 1, "Text" : "Consult infectious diseases for more information."}, 
{"Row" : 20, "Column" : 1, "Text" : "Cockroft-Gault CrCl per kgDose", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "(mL/min/kg)", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "______________________________________", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 33, "Column" : 1, "Text" : "Use with ciprofloxacin increases seizure risk."}, 
{"Row" : 35, "Column" : 1, "Text" : "Increased nephrotoxicity when used with other nephrotoxic agents,such as"}, 
{"Row" : 36, "Column" : 1, "Text" : "aminoglycosides, amphotericin, cyclosporine, or ganciclovir."}, 
{"Row" : 38, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 39, "Column" : 1, "Text" : "Nephrotoxicity, anemia, fever, diarrhea, electrolyte disturbances."}, 
{"Row" : 24, "Column" : 1, "Text" : "> 1.490 q12h"}, 
{"Row" : 25, "Column" : 1, "Text" : "1.0-1.470 q12h"}, 
{"Row" : 26, "Column" : 1, "Text" : "0.8-1.050 q12h"}, 
{"Row" : 27, "Column" : 1, "Text" : "0.6-0.880 q24h"}, 
{"Row" : 28, "Column" : 1, "Text" : "0.5-0.660 q24h"}, 
{"Row" : 29, "Column" : 1, "Text" : "0.4-0.550 q24h"}, 
{"Row" : 30, "Column" : 1, "Text" : "< 0.4not recommended"}, 
{"Row" : 41, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP GANCICLOVIR IV", "DisplayText" : "Ganciclovir IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ganciclovir IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "5 mg/kg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Increased risk of nephrotoxicity with other nephrotoxic drugs such as"}, 
{"Row" : 27, "Column" : 1, "Text" : "aminoglycosides, amphotericin, cyclosporine, or foscarnet."}, 
{"Row" : 29, "Column" : 1, "Text" : "Didanosine and zidovudine can decrease ganciclovir levels, potentially"}, 
{"Row" : 30, "Column" : 1, "Text" : "decreasing ganciclovir's efficacy.  An alternative to ganciclovir should be used"}, 
{"Row" : 31, "Column" : 1, "Text" : "for patients on didanosine or zidovudine."}, 
{"Row" : 33, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Nephrotoxicity, neutropenia, thrombocytopenia, anemia, nausea/vomiting."}, 
{"Row" : 18, "Column" : 1, "Text" : "(ml/min)THERAPY  Therapy", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "clearancefor INDUCTION for MAINTENANCE", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "CreatinineDose adjustment  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "50-692.5 mg/kg q12h2.5 mg/kg q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "25-492.5 mg/kg q24h1.25 mg/kg q24h"}, 
{"Row" : 21, "Column" : 1, "Text" : "10-241.25 mg/kg q24h 0.625 mg/kg q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "< 10  1.25 mg/kg 3 times/week0.625 mg/kg 3 times/week"}, 
{"Row" : 23, "Column" : 1, "Text" : "Hemodialysis 1.25 mg//kg 3 times/week 0.625 mg//kg 3 times/week"}, 
{"Row" : 36, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP GATIFLOXACIN PO", "DisplayText" : "Gatifloxacin PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gatifloxacin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "< 40 400 mg once, then 200 mg QD"}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Zinc, iron, magnesium, and aluminum decrease the oral absorption of"}, 
{"Row" : 21, "Column" : 1, "Text" : "gatifloxacin.  Give gatifloxacin 2 hours before or 6 hours after these metal"}, 
{"Row" : 22, "Column" : 1, "Text" : "ions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 25, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, rare QT interval"}, 
{"Row" : 29, "Column" : 1, "Text" : "prolongation."}, 
{"Row" : 31, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP GENTAMICIN IV", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gentamicin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "5 mg/kg IV QD for treatment of gram negative infections, 1 mg/kg q8h along with"}, 
{"Row" : 13, "Column" : 1, "Text" : "a beta-lactam antibiotic for synergy against gram positive bacteria."}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DOSING TABLE GENTAMICIN", "DisplayText" : "", "Text" : "Link to gentamicin dosing table", "Mnemonic" : "08"},
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Potentiates effects of neuromuscular blockers."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Nephrotoxicity, ototoxicity, neuromuscular blockade."}, 
{"Row" : 25, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IODOQUINOL PO", "DisplayText" : "Iodoquinol PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Iodoquinol PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "650mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, urticaria, peripheral neuropathy, optic neuritis"}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP ITRACONAZOLE IV", "DisplayText" : "Itraconazole IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Itraconazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "The intravenous route is contraindicated in patients with creatinine clearance"}, 
{"Row" : 16, "Column" : 1, "Text" : "less than 30 ml/min, due to renal accumulation of the formulation's cyclodextrin"}, 
{"Row" : 17, "Column" : 1, "Text" : "vehicle."}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Itraconazole increase the levels of many drugs, including warfarin, HMG-CoA"}, 
{"Row" : 21, "Column" : 1, "Text" : "reductase inhibitors (\"statins\"), benzodiazepines, calcium channel blockers,"}, 
{"Row" : 22, "Column" : 1, "Text" : "cyclosporine, tacrolimus, and sirolimus.  Consult Micromedex, Up-to-date, or a"}, 
{"Row" : 23, "Column" : 1, "Text" : "pharmacist for more information."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Hepatotoxicity, nausea, rash, edema."}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV CIPROFLOXACIN", "DisplayText" : "Ciprofloxacin IV", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ciprofloxacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "5-29  200-400 mg q18-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Increases effects of caffeine and theophylline by inhibiting metabolism. Monitor"}, 
{"Row" : 22, "Column" : 1, "Text" : "the patient for signs of agitation or anxiety."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, confusion, CNS"}, 
{"Row" : 26, "Column" : 1, "Text" : "stimulation, rare seizures, rare QT interval prolongation."}, 
{"Row" : 18, "Column" : 1, "Text" : "Hemodialysis 400 mg q24h"}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV CLINDAMYCIN", "DisplayText" : "Clindamycin IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Clindamycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "600 mg IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with hepatic failure, give 600 mg q12h."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, pseudomembranous colitis, rare jaundice."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV DOXYCYCLINE", "DisplayText" : "Doxycycline IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Doxycycline IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Enzyme inducers such as phenytoin, phenobarbital, and carbamazepine decrease"}, 
{"Row" : 19, "Column" : 1, "Text" : "levels of doxycycline.  Consider doubling the doxycycline dose or choosing an"}, 
{"Row" : 20, "Column" : 1, "Text" : "alternative agent."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash."}, 
{"Row" : 25, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV ERYTHROMYCIN", "DisplayText" : "Erythromycin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Erythromycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Erythromycin increases the levels of many drugs.  Some that are especially"}, 
{"Row" : 19, "Column" : 1, "Text" : "clinically significant include warfarin, statins, sildenafil, calcium channel"}, 
{"Row" : 20, "Column" : 1, "Text" : "blockers.  Consult Micromedex, Up-to-date, and/or a pharmacist for more"}, 
{"Row" : 21, "Column" : 1, "Text" : "information."}, 
{"Row" : 23, "Column" : 1, "Text" : "Erythromycin may prolong the QT interval, especially when combined with"}, 
{"Row" : 24, "Column" : 1, "Text" : "cytochrome p450 3A4 enzyme substrates or inhibitors, or other pro-arrhythmic"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents.  Avoid concurrent use, if possible."}, 
{"Row" : 27, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, rare hepatotoxicity, rare interval prolongation."}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV FLUCONAZOLE", "DisplayText" : "Fluconazole IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Fluconazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "200-400 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with renal impairment, administer the usual loading dose, then"}, 
{"Row" : 16, "Column" : 1, "Text" : "adjust the maintenance dose according to renal function."}, 
{"Row" : 18, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "< 50  Give half the usual dose q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "HemodialysisGive usual dose after each dialysis"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Fluconazole increases levels of several drugs, especially in higher doses."}, 
{"Row" : 24, "Column" : 1, "Text" : "Drugs whose effects are significantly increased by fluconazole include warfarin,"}, 
{"Row" : 25, "Column" : 1, "Text" : "HMG-CoA reductase inhibitors (\"statins\"), benzodiazepines, calcium channel"}, 
{"Row" : 26, "Column" : 1, "Text" : "blockers, cyclosporine, tacrolimus,sirolimus.  Consult Micromedex, Up-to-date,"}, 
{"Row" : 27, "Column" : 1, "Text" : "or a pharmacist for more information."}, 
{"Row" : 29, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Headache, nausea, rash, hepatotoxicity, rare QT interval prolongation."}, 
{"Row" : 32, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV GATIFLOXACIN", "DisplayText" : "Gatifloxacin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Gatifloxacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg IV QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance  Dose adjustment", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 21, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse effects include nausea/vomiting, diarrhea, hypo- or hyperglycemia,"}, 
{"Row" : 25, "Column" : 1, "Text" : "dizziness, rare QT interval prolongation."}, 
{"Row" : 17, "Column" : 1, "Text" : "< 40400 mg once, then 200 mg QD"}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV LINEZOLID", "DisplayText" : "Linezolid IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Linezolid IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "600 mg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Increased risk of serotonin syndrome when is given with  serotonergic agents,"}, 
{"Row" : 19, "Column" : 1, "Text" : "including selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine,"}, 
{"Row" : 20, "Column" : 1, "Text" : "paroxetine, sertraline, and citalopram, tricyclic antidepressants (TCAs) such as"}, 
{"Row" : 21, "Column" : 1, "Text" : "amitriptyline, nortriptyline, imipramine, and doxepin, and other drugs such as"}, 
{"Row" : 22, "Column" : 1, "Text" : "mirtazapine, clomipramine, venlafaxine, trazodone, sibutramine, meperidine,"}, 
{"Row" : 23, "Column" : 1, "Text" : "dextromethorphan. Wait 14 days after any of these drugs are discontinued before"}, 
{"Row" : 24, "Column" : 1, "Text" : "starting linezolid.  If linezolid must be given concurrently with any of these"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents, monitor the patient closely for signs and symptoms of serotonin syndrome"}, 
{"Row" : 26, "Column" : 1, "Text" : "such as sweating, nausea/vomiting, fever, muscle weakness and dysreflexia."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Diarrhea, myelosuppression, headache, nausea, optic and peripheral neuropathy."}, 
{"Row" : 31, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV METRONIDAZOLE", "DisplayText" : "Metronidazole IV", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Metronidazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1000 mg IV q12h OR 500 mg IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with creatinine clearance less than 10 mL/minute, including"}, 
{"Row" : 16, "Column" : 1, "Text" : "patients on hemodialysis, give 500 mg q12h."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Metronidazole increases the effects of warfarin.  Monitor the international"}, 
{"Row" : 20, "Column" : 1, "Text" : "normalized ration (INR) frequently during metronidazole therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Metronidazole increases lithium concentrations.  Monitor lithium concentrations"}, 
{"Row" : 23, "Column" : 1, "Text" : "during metronidazole therapy."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Metallic taste, nausea, disulfuram reaction."}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV PENICILLIN", "DisplayText" : "Penicillin IV", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Penicillin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "2-4 million units IV q4-6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "30-502-4 million units q6h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-292-4 million units q8h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10 2-4 million units q12h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Rash, diarrhea, rare anaphylaxis, rare hemolytic anemia, and at higher doses,"}, 
{"Row" : 26, "Column" : 1, "Text" : "interstitial nephritis and seizures."}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP IV TRIMETHOPRIM-SULFA", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "10-20 mg/kg/day divided into 2-4 doses.  Mg/kg doses are basedon the"}, 
{"Row" : 13, "Column" : 1, "Text" : "trimethoprim component."}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "For patients with creatinine clearance less than 30ml/min, give half of the"}, 
{"Row" : 17, "Column" : 1, "Text" : "usual dose."}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Increases international normalized ratio (INR) in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Monitor INR daily."}, 
{"Row" : 23, "Column" : 1, "Text" : "Contraindicated with dofetilide, it doubles dofetilide serum concentrations."}, 
{"Row" : 25, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole may increase digoxin  or unbound  phenytoin"}, 
{"Row" : 26, "Column" : 1, "Text" : "concentrations.  If these either of these drugs must be used concurrently with"}, 
{"Row" : 27, "Column" : 1, "Text" : "trimethoprim-sulfamethoxazole, monitor serum concentrations of digoxin or"}, 
{"Row" : 28, "Column" : 1, "Text" : "unbound pheytoin."}, 
{"Row" : 30, "Column" : 1, "Text" : "Avoid using trimethoprim-sulfamethoxazole with methotrexate due to an increased"}, 
{"Row" : 31, "Column" : 1, "Text" : "risk of bone marrow toxicity."}, 
{"Row" : 33, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Rash, nausea/vomiting, rare severe allergic reaction including Stevens-Johnson"}, 
{"Row" : 35, "Column" : 1, "Text" : "syndrome, rare blood dyscrasias."}, 
{"Row" : 37, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP LINEZOLID PO", "DisplayText" : "Linezolid PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Linezolid PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "600 mg PO q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Increased risk of serotonin syndrome when is given with  serotonergic agents,"}, 
{"Row" : 19, "Column" : 1, "Text" : "including selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine,"}, 
{"Row" : 20, "Column" : 1, "Text" : "paroxetine, sertraline, and citalopram, tricyclic antidepressants (TCAs) such as"}, 
{"Row" : 21, "Column" : 1, "Text" : "amitriptyline, nortriptyline, imipramine, and doxepin, and other drugs such as"}, 
{"Row" : 22, "Column" : 1, "Text" : "mirtazapine, clomipramine, venlafaxine, trazodone, sibutramine, meperidine,"}, 
{"Row" : 23, "Column" : 1, "Text" : "dextromethorphan.  Wait 14 days after any of these drugs are discontinued before"}, 
{"Row" : 24, "Column" : 1, "Text" : "starting linezolid.  If linezolid must be given concurrently with any of these"}, 
{"Row" : 25, "Column" : 1, "Text" : "agents, monitor the patient closely for signs and symptoms of serotonin syndrome"}, 
{"Row" : 26, "Column" : 1, "Text" : "such as sweating, nausea/vomiting, fever, muscle weakness and dysreflexia."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Diarrhea, myelosuppression, headache, nausea, optic peripheral neuropathy."}, 
{"Row" : 31, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP METRONIDAZOLE PO", "DisplayText" : "Metronidazole PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Metronidazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500 mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "CrCl <10 mL/minute, but not on dialysis: Give 500 mg po q12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "Hemodialysis: Dosage reduction NOT recommended. Administer full dose"}, 
{"Row" : 27, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 28, "Column" : 1, "Text" : "Metronidazole increases the effects of warfarin.  Monitor the international"}, 
{"Row" : 29, "Column" : 1, "Text" : "normalized ration (INR) frequently during metronidazole therapy."}, 
{"Row" : 31, "Column" : 1, "Text" : "Metronidazole increases lithium concentrations.  Monitor lithium concentrations"}, 
{"Row" : 32, "Column" : 1, "Text" : "during metronidazole therapy."}, 
{"Row" : 34, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 35, "Column" : 1, "Text" : "Metallic taste, nausea, disulfuram reaction."}, 
{"Row" : 15, "Column" : 1, "Text" : "Renal Impairment:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "Extensively removed by hemodialysis and peritoneal dialysis (50 t0 100%)"}, 
{"Row" : 19, "Column" : 1, "Text" : "posthemodialysis"}, 
{"Row" : 20, "Column" : 1, "Text" : "Peritoneal dialysis: Dose the same as for CrCl <10mL/minute."}, 
{"Row" : 21, "Column" : 1, "Text" : "Continuous arteriovenous or venovenous hemofiltration: Dose as normal"}, 
{"Row" : 22, "Column" : 1, "Text" : "renal function."}, 
{"Row" : 23, "Column" : 1, "Text" : "Hepatic Impairment:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Unchanged in mild liver disease, reduce dosage in severe liver disease."}, 
{"Row" : 37, "Column" : 1, "Text" : "Pregnancy Risk Factor Category: B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP MICAFUNGIN IV", "Term" : "011613 njt for CDSS", "DisplayText" : "Micafungin IV", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Micafungin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Invasive candidiasis: 100-150mg IV once daily"}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "*Sirlimus AUC increased by 21 percent with co-administration"}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Rash, facial swelling, pruritus & vasodilation, local phlebitis, fever,"}, 
{"Row" : 16, "Column" : 1, "Text" : "No adjustment required."}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category: C", "Header" : 1}, 
{"Row" : 13, "Column" : 1, "Text" : "Invasive aspergillosis: 150mg IV once daily"}, 
{"Row" : 21, "Column" : 1, "Text" : "*Nifedipine AUC increased by 18 percent with co-administration"}, 
{"Row" : 25, "Column" : 1, "Text" : "chills, nausea, vomiting, headache, transient LFT elevation, BUN and"}, 
{"Row" : 26, "Column" : 1, "Text" : "creatinine. Hepatitis and renal insufficiency are rare adverse reactions."}
]},
{"Name" : "ORZID2 GMENU ABX IDP MINOCYCLINE PO", "DisplayText" : "Minocycline PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Minocycline PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Iron salts reduce PO absorption of minocycline.  If iron must be continued while"}, 
{"Row" : 19, "Column" : 1, "Text" : "on minocycline, give minocycline 2 hours before or 4 hours after iron dose."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash, and dizziness."}, 
{"Row" : 24, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP MOXIFL IV", "DisplayText" : "Moxifloxacin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Moxifloxacin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg iv qd"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dosage adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 19, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse drug reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, Clostridium"}, 
{"Row" : 23, "Column" : 1, "Text" : "difficile disease, and rare QT interval prolongation."}, 
{"Row" : 25, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP MOXIFLOX PO", "DisplayText" : "Moxifloxacin PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "______________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Moxifloxacin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg  po qd"}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Zinc, iron, magnesium, and aluminum decrease the oral absorption of"}, 
{"Row" : 19, "Column" : 1, "Text" : "gatifloxacin.  Give moxifloxacin 2 hours before or 6 hours after these metal"}, 
{"Row" : 20, "Column" : 1, "Text" : "ions."}, 
{"Row" : 22, "Column" : 1, "Text" : "Increases the effect of warfarin.  Monitor international normalized ratio (INR)"}, 
{"Row" : 23, "Column" : 1, "Text" : "frequently in patients taking warfarin."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse drug reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, hypo- or hyperglycemia, dizziness, Clostridium"}, 
{"Row" : 27, "Column" : 1, "Text" : "difficile disease, and rare QT interval prolongation."}, 
{"Row" : 14, "Column" : 1, "Text" : "Dosage adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP MOXIFLOXACIN OPHTHALMIC", "DisplayText" : "Moxifloxacin Ophthalmic  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Moxifloxacin ophthalmic", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 drop in affected eye TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}
]},
{"Name" : "ORZID2 GMENU ABX IDP NAFCILLIN IV", "DisplayText" : "Nafcillin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Nafcillin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 gm IV q4-6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Nafcillin induces the metabolism of warfarin and decreases the international"}, 
{"Row" : 19, "Column" : 1, "Text" : "normalized ratio (INR).  Monitor INR during and for several weeks after"}, 
{"Row" : 20, "Column" : 1, "Text" : "nafcillin therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Nafcillin may decrease levels of cyclosporine.  If these drugs must be used"}, 
{"Row" : 23, "Column" : 1, "Text" : "concurrently, monitor cyclosporine levels."}, 
{"Row" : 25, "Column" : 1, "Text" : "Probenecid may increase levels of nafcillin.  If these drugs must be used"}, 
{"Row" : 26, "Column" : 1, "Text" : "together, monitor for signs of nafcillin toxicity."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Phlebitis, diarrhea, rash, rare anaphylaxis, rare hepatotoxicity, rare"}, 
{"Row" : 30, "Column" : 1, "Text" : "myelosuppression, rare interstitial nephritis."}, 
{"Row" : 32, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP NEOMYCIN PO", "DisplayText" : "Neomycin PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Neomycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 gm PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-50 1 gm q12-18h"}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10  1 gm q18-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 23, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "Nausea/vomiting, diarrhea, nephrotoxicity, ototoxicity, and neuromuscular"}, 
{"Row" : 25, "Column" : 1, "Text" : "blockade."}, 
{"Row" : 27, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP NITAZOXANIDE PO", "DisplayText" : "Nitazoxanide PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Nitazoxanide PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Not studied in hepatic and renal failure"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea, vomiting, headache"}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP NITROFURANTOIN PO", "DisplayText" : "Nitrofurantoin PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Nitrofurantoin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "Contraindicated in patients with creatinine clearance less than 60 ml/min."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Contraindicated with fluconazole due to  additive risk of hepatotoxicity."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea/vomiting, rare peripheral neuropathy, rare interstitial pneumonitis, rare"}, 
{"Row" : 22, "Column" : 1, "Text" : "hepatotoxicity."}, 
{"Row" : 24, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP OPHTHALMIC ERYTHROMYCIN", "DisplayText" : "Erythromycin Ophthalmic  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Erythromycin ophthalmic", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Apply 1/2\" ribbon to affected eye QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Temporary blurred vision after application."}
]},
{"Name" : "ORZID2 GMENU ABX IDP OSELTAMIVIR PO", "DisplayText" : "Oseltamivir PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Oseltamivir PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "75 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : ">>  Influenza treatment:"}, 
{"Row" : 16, "Column" : 1, "Text" : "In patients with creatinine clearance less than 30 mL/min, give 75 mg once a day"}, 
{"Row" : 17, "Column" : 1, "Text" : "for 5 days."}, 
{"Row" : 19, "Column" : 1, "Text" : ">>  Influenza prophylaxis:"}, 
{"Row" : 20, "Column" : 1, "Text" : "In patients with creatinine clearance less than 30 mL/min, give 75 mg every"}, 
{"Row" : 21, "Column" : 1, "Text" : "other day."}, 
{"Row" : 23, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Insomnia, vertigo, nausea/vomiting."}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP PAROMOMYCIN PO", "DisplayText" : "Paromomycin PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Paromomycin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "500-750mg PO TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "May reduce digoxin levels"}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Nausea, vomiting, abdominal cramps"}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP PENICILLIN PO", "DisplayText" : "Penicillin PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Penicillin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients with creatinine clearance less than 10 ml/min, decrease the dose by"}, 
{"Row" : 16, "Column" : 1, "Text" : "25%."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Rash, diarrhea, rare hemolytic anemia."}, 
{"Row" : 24, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP PIPERACILLIN-TAZOBACTAM IV", "DisplayText" : "Piperacillin-tazobactam IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Piperacillin-tazobactam IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "3.375-4.5 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine  Dose adjustmentDose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "clearancefor NOSOCOMIAL for all indications", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "(ml/min) PNEUMONIAEXCEPT nosocomial pneumonia", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "20-40  3.375 gm q6h2.25 gm q6h"}, 
{"Row" : 20, "Column" : 1, "Text" : "< 202.25 gm q6h 2.25 gm q8h"}, 
{"Row" : 21, "Column" : 1, "Text" : "Hemodialysis 2.25 gm q8h 2.25 gm q12h"}, 
{"Row" : 23, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 24, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 27, "Column" : 1, "Text" : "Rash, injection site reaction, diarrhea, rare anaphylaxis, rare blood"}, 
{"Row" : 28, "Column" : 1, "Text" : "dyscrasias."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP PYRIMETHAMINE", "DisplayText" : "Pyrimethamine PO", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Pyrimethamine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "75 mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Additive risk of bone marrow suppression with sulfa drugs, methotrexate, or"}, 
{"Row" : 19, "Column" : 1, "Text" : "zidovudine.  If the drugs must be used together, monitor complete blood count"}, 
{"Row" : 20, "Column" : 1, "Text" : "(CBC) frequently."}, 
{"Row" : 22, "Column" : 1, "Text" : "Pyrimethamine inhibits the metabolism of warfarin, phenytoin, phenthiazine"}, 
{"Row" : 23, "Column" : 1, "Text" : "antipsychotics, tricyclic antidepressants (TCAs), selective serotonin reuptake"}, 
{"Row" : 24, "Column" : 1, "Text" : "inhibitors (SSRIs), venlafaxine, and beta-blockers."}, 
{"Row" : 26, "Column" : 1, "Text" : "Pyrimethamine can decrease the effectiveness of drugs that are activated by"}, 
{"Row" : 27, "Column" : 1, "Text" : "cytochrome p450 2D6 enzyme, including codeine, hydrocodone, oxycodone, and"}, 
{"Row" : 28, "Column" : 1, "Text" : "tramadol."}, 
{"Row" : 30, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 31, "Column" : 1, "Text" : "Rash, nausea/vomiting, leukopenia, rare Stevens-Johnson syndrome, and at high"}, 
{"Row" : 32, "Column" : 1, "Text" : "doses, arrhythmias."}, 
{"Row" : 34, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP QUINUPRISTIN-DALFOPRISIN", "DisplayText" : "Quinupristin-dalfoprisin ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Quinupristin-dalfoprisin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "7.5 mg/kg IV q8h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "HMG-CoA reductase inhibitors (\"statins\") should be temporarily discontinued"}, 
{"Row" : 19, "Column" : 1, "Text" : "during quinupristin-dalfopristin therapy due to an increased risk of myalgias"}, 
{"Row" : 20, "Column" : 1, "Text" : "and rhabdomyolysis."}, 
{"Row" : 22, "Column" : 1, "Text" : "Quinupristin-dalfopristin is a moderately potent enzyme inhibitor that increases"}, 
{"Row" : 23, "Column" : 1, "Text" : "he effects of many drugs.  Consult Micromedex, Up-to-date, or a pharmacist for"}, 
{"Row" : 24, "Column" : 1, "Text" : "more information."}, 
{"Row" : 26, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 27, "Column" : 1, "Text" : "Arthralgias/myalgias, infusion site reactions and pain, rash,"}, 
{"Row" : 28, "Column" : 1, "Text" : "hyperbilirubinemia."}, 
{"Row" : 30, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIFABUTIN PO", "DisplayText" : "Ribabutin PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rifabutin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "300mg PO QD"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "For patients with CrCL less than 30 ml/min, decrease dose by 50%"}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Rifampin is a potent enzyme inducer, and reduces therapeutic levels of many"}, 
{"Row" : 19, "Column" : 1, "Text" : "drugs. Some of the most clincally important drugs affected include warfarin,"}, 
{"Row" : 20, "Column" : 1, "Text" : "oral contraceptives, corticosteroids, cyclosporine, \"azole\" antifungal agents,"}, 
{"Row" : 21, "Column" : 1, "Text" : "HIV protease inhibitors, and some anti-arrhythmic medications.  Many other drugs"}, 
{"Row" : 22, "Column" : 1, "Text" : "also interact with rifampin.  Consult Micromedex, Up-to-date, or a pharmacist"}, 
{"Row" : 23, "Column" : 1, "Text" : "for more information."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Hepatotoxicity, thrombocytopenia, and nausea/vomiting.  Rifampin may turn urine"}, 
{"Row" : 27, "Column" : 1, "Text" : "and other bodily fluids reddish-orange."}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIFAMPIN IV", "DisplayText" : "Rifampin IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rifampin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "300 mg IV BID-TID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Rifampin is a potent enzyme inducer, and reduces therapeutic levels of many"}, 
{"Row" : 19, "Column" : 1, "Text" : "drugs, including warfarin, oral contraceptives, corticosteroids, cyclosporine,"}, 
{"Row" : 20, "Column" : 1, "Text" : "\"azole\" antifungal agents, HIV protease inhibitors, and some anti-arrhythmic"}, 
{"Row" : 21, "Column" : 1, "Text" : "medications.  Many other drugs also interact with rifampin.  Consult Micromedex,"}, 
{"Row" : 22, "Column" : 1, "Text" : "Up-to-date, or a pharmacist for more information."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Hepatotoxicity, thrombocytopenia, and nausea/vomiting.  Rifampin may turn urine"}, 
{"Row" : 26, "Column" : 1, "Text" : "and other bodily fluids reddish-orange."}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIFAXIMIN PO", "DisplayText" : "Rifaximin PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rifaximin PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "400 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Constipation, headache, and nausea."}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP RIMANTADINE PO", "DisplayText" : "Rimantadine PO  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Rimantadine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "100 mg PO BID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "In patients who are over 65 years, or have significant hepatic impairment or a"}, 
{"Row" : 16, "Column" : 1, "Text" : "creatinine clearance less than 10 ml/min, give 100 mg QD."}, 
{"Row" : 18, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 21, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 22, "Column" : 1, "Text" : "Dizziness, nervousness, nausea, decrease in the seizure threshhold.  Central"}, 
{"Row" : 23, "Column" : 1, "Text" : "nervous system-related side effects are less likely with rimantadine than with"}, 
{"Row" : 24, "Column" : 1, "Text" : "amantadine."}, 
{"Row" : 26, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP STREPTOMYCIN IV", "DisplayText" : "Streptomycin IV ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Streptomycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "7.5 mg/kg IV q12h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Dose for  Dose for  Dose for Desired Desired", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "creatininecreatininecreatinine  peak trough", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "clearance clearance clearance(mcg/ml)(mcg/ml)", "Header" : 1}, 
{"Row" : 19, "Column" : 1, "Text" : ">50 ml/min  10-50 ml/min  <10 ml/min", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "7.5 mg/kg  7.5 mg/kg 7.5 mg/kg  20-30  <5"}, 
{"Row" : 22, "Column" : 1, "Text" : "q12hq24-72hq72-96h"}, 
{"Row" : 23, "Column" : 1, "Text" : "__________________________________________________________________", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Pharmacy at MVAMC will review dose estimates for all aminoglycoside orders."}, 
{"Row" : 26, "Column" : 1, "Text" : "Call a pharmacist at x3128 for more information."}, 
{"Row" : 28, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Potentiates the effects of neuromuscular blockers."}, 
{"Row" : 31, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 32, "Column" : 1, "Text" : "Fever, eosinophilia, facial paresthesia, nephrotoxicity, ototoxicity,"}, 
{"Row" : 33, "Column" : 1, "Text" : "neuromuscular blockade."}, 
{"Row" : 35, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP SULFACETAMIDE OPHTHALMIC", "DisplayText" : "Sulfacetamide Ophthalmic ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Sulfacetamide ophthalmic", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1-2 drops to affected eye q3h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No common, major drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP SULFADIAZINE PO", "DisplayText" : "Sulfadiazine PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Sulfadiazine PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "Decreases cyclosporine concentrations, and increases phenytoin concentrations."}, 
{"Row" : 19, "Column" : 1, "Text" : "Monitor cyclosporine or phenytoin concentrations frequently during sulfadiazine"}, 
{"Row" : 20, "Column" : 1, "Text" : "therapy."}, 
{"Row" : 22, "Column" : 1, "Text" : "Sulfadiazine may increase risk of hypoglycemia when given with sulfonylureas."}, 
{"Row" : 24, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 25, "Column" : 1, "Text" : "Rash, rare Stevens-Johnson syndrome, diarrhea, nausea, blood dyscrasias, renal"}, 
{"Row" : 26, "Column" : 1, "Text" : "failure."}, 
{"Row" : 28, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP TERCONAZOLE 0.4% VAGINAL", "DisplayText" : "Terconazole 0.4% Vaginal ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Terconazole 0.4% vaginal", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "1 applicatorful vaginally qhs"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 15, "Column" : 1, "Text" : "None needed."}, 
{"Row" : 17, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 18, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 20, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 21, "Column" : 1, "Text" : "Uncommon."}, 
{"Row" : 23, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP TETRACYCLINE PO", "DisplayText" : "Tetracycline PO ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Tetracycline PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "250-500 mg PO QID"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "50-80 250-500 mg  q8-12h"}, 
{"Row" : 18, "Column" : 1, "Text" : "10-50 250-500 mg q12-24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis  250-500 mg q24h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Iron salts, calcium, magnesium, aluminum, zinc and antacids reduce oral"}, 
{"Row" : 24, "Column" : 1, "Text" : "absorption of tetracycline.  If these metal ions or antacids must be continued"}, 
{"Row" : 25, "Column" : 1, "Text" : "while on tetracycline, give tetracycline 2 hours before or 6 hours after the"}, 
{"Row" : 26, "Column" : 1, "Text" : "dose."}, 
{"Row" : 28, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 29, "Column" : 1, "Text" : "Photosensitivity, nausea/vomiting, rash."}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10250-500 mg q24h"}, 
{"Row" : 31, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP TICARCILLIN-CLAVULANATE IV", "DisplayText" : "Ticarcillin-clavulanate IV  ", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Ticarcillin-clavulanate IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "3.1 gm IV q6h"}, 
{"Row" : 14, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "Creatinine clearance (ml/min)  Dose adjustment", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Text" : "10-302 gm q8h"}, 
{"Row" : 22, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "No major, common drug interactions."}, 
{"Row" : 25, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 26, "Column" : 1, "Text" : "Rash, allergic reaction, rare neutropenia, rare hypokalemia, seizures at high"}, 
{"Row" : 27, "Column" : 1, "Text" : "doses."}, 
{"Row" : 18, "Column" : 1, "Text" : "< 10 without hepatic dysfunction2 gm q12h"}, 
{"Row" : 19, "Column" : 1, "Text" : "< 10 with hepatic dysfunction  2 gm q24h"}, 
{"Row" : 20, "Column" : 1, "Text" : "Hemodialysis2 gm q12 plus 3.1 gm after dialysis"}, 
{"Row" : 29, "Column" : 1, "Text" : "Pregnancy Risk Factor Category B", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP TOBRAMYCIN IV", "DisplayText" : "Tobramycin IV", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Tobramycin IV", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "5 mg/kg IV QD for treatment of gram negative infections, 1mg/kg q8h along with a"}, 
{"Row" : 13, "Column" : 1, "Text" : "beta-lactam antibiotic for synergy against gram positive bacteria."}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 17, "Column" : 1, "Item" : "ORZID2 GMENU ABX IDP DS TOBRAMYCIN", "DisplayText" : "Tobramycin Dosing Table", "Text" : "Link to tobramycin dosing table", "Mnemonic" : "08"},
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Potentiates the effects of neuromuscular blockers."}, 
{"Row" : 22, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 23, "Column" : 1, "Text" : "Nephrotoxicity, ototoxicity, neuromuscular blockade."}, 
{"Row" : 25, "Column" : 1, "Text" : "Pregnancy Risk Factor Category D", "Header" : 1}
]},
{"Name" : "ORZID2 GMENU ABX IDP TRIMETHOPRIM-SULFAMETHOXAZOLE PO", "DisplayText" : "", "Version" : "StCloud", "Contents" : [
{"Row" : 1, "Column" : 1, "Text" : "HELP, additional information:", "Header" : 1}, 
{"Row" : 2, "Column" : 1, "Item" : "9628", "DisplayText" : "", "Text" : "Micromedex Online", "Mnemonic" : "02"},
{"Row" : 3, "Column" : 1, "Item" : "9223", "DisplayText" : "", "Text" : "Up To Date Online", "Mnemonic" : "04"},
{"Row" : 4, "Column" : 1, "Item" : "ORZID2 GMENU ABX PHARMACISTS PHONE/PAGERS NUMBERS", "DisplayText" : "List of Clinical Pharmacists phone/pagers numbers", "Text" : "List of Clinical Pharmacists phone/pagers numbers", "Mnemonic" : "06"},
{"Row" : 7, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 9, "Column" : 1, "Text" : "________________________________________", "Header" : 1}, 
{"Row" : 8, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole PO", "Header" : 1}, 
{"Row" : 11, "Column" : 1, "Text" : "Usual dose:", "Header" : 1}, 
{"Row" : 12, "Column" : 1, "Text" : "Treatment: 1 DS tablet (160-800 mg) BID"}, 
{"Row" : 13, "Column" : 1, "Text" : "Prophylaxis: 1 SS tablet (80-400 mg) QD"}, 
{"Row" : 15, "Column" : 1, "Text" : "Dose adjustments for renal or hepatic insufficiency:", "Header" : 1}, 
{"Row" : 16, "Column" : 1, "Text" : "For patients with creatinine clearance less than 30 ml/min, give half of the"}, 
{"Row" : 17, "Column" : 1, "Text" : "usual dose."}, 
{"Row" : 19, "Column" : 1, "Text" : "Drug Interactions:", "Header" : 1}, 
{"Row" : 20, "Column" : 1, "Text" : "Increases international normalized ratio (INR) in patients taking warfarin."}, 
{"Row" : 21, "Column" : 1, "Text" : "Monitor INR daily."}, 
{"Row" : 23, "Column" : 1, "Text" : "Contraindicated with dofetilide, it doubles dofetilide serum concentrations."}, 
{"Row" : 25, "Column" : 1, "Text" : "Trimethoprim-sulfamethoxazole may increase digoxin or unbound  phenytoin"}, 
{"Row" : 26, "Column" : 1, "Text" : "concentrations.  If these either of these drugs must be used concurrently with"}, 
{"Row" : 27, "Column" : 1, "Text" : "trimethoprim-sulfamethoxazole, monitor serum concentrations of digoxin or"}, 
{"Row" : 28, "Column" : 1, "Text" : "unbound pheytoin."}, 
{"Row" : 30, "Column" : 1, "Text" : "Avoid using trimethoprim-sulfamethoxazole with methotrexate due to an increased"}, 
{"Row" : 31, "Column" : 1, "Text" : "risk of bone marrow toxicity."}, 
{"Row" : 33, "Column" : 1, "Text" : "Adverse Drug Reactions:", "Header" : 1}, 
{"Row" : 34, "Column" : 1, "Text" : "Rash, nausea/vomiting, rare severe allergic reaction including Stevens-Johnson"}, 
{"Row" : 35, "Column" : 1, "Text" : "syndrome, rare blood dyscrasias."}, 
{"Row" : 37, "Column" : 1, "Text" : "Pregnancy Risk Factor Category C", "Header" : 1}
]}
]
